CHEBI ONTOLOGY - ANNOTATIONS |
|
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
| Term: | selenium molecular entity |
|
| Accession: | CHEBI:26628
|
browse the term
|
| Synonyms: | related_synonym: | selenium molecular entities |
|
|
|
|
| G
|
Aak1
|
AP2 associated kinase 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:120,845,012...121,009,170
Ensembl chr 4:120,858,557...121,004,236
|
|
| G
|
Acbd3
|
acyl-CoA binding domain containing 3
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of ACHE mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ankar
|
ankyrin and armadillo repeat containing
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in increased expression of ANKAR mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:55,633,681...55,709,721
Ensembl chr 9:55,633,566...55,707,369
|
|
| G
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS2 mRNA] which results in increased expression of ARAP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:165,160,701...165,226,219
Ensembl chr 1:165,160,678...165,226,218
|
|
| G
|
Arhgap30
|
Rho GTPase activating protein 30
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ARHGAP30 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr13:86,354,448...86,376,552
Ensembl chr13:86,354,547...86,376,888
|
|
| G
|
Arln
|
allregulin
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of ARLN mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:213,740,519...213,742,279
Ensembl chr 2:213,740,525...213,742,952
|
|
| G
|
Bex1
|
brain expressed X-linked 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of BEX2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr X:104,010,639...104,012,143
Ensembl chr X:104,010,371...104,011,236
|
|
| G
|
C5ar1
|
complement C5a receptor 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of C5AR1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:86,077,309...86,088,001
|
|
| G
|
Catip
|
ciliogenesis associated TTC17 interacting protein
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:83,395,095...83,402,743
Ensembl chr 9:83,394,896...83,402,740
|
|
| G
|
Ccdc183
|
coiled-coil domain containing 183
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:28,826,918...28,837,072
Ensembl chr 3:28,826,921...28,835,326
|
|
| G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of CDH2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Celf3
|
CUGBP, Elav-like family member 3
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:184,805,078...184,819,189
Ensembl chr 2:184,805,081...184,819,187
|
|
| G
|
Cimap1c
|
ciliary microtubule associated protein 1C
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:66,144,726...66,176,985
Ensembl chr 8:66,144,726...66,181,546
|
|
| G
|
Col4a2
|
collagen type IV alpha 2 chain
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
|
|
| G
|
Col7a1
|
collagen type VII alpha 1 chain
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
|
|
| G
|
Coro1a
|
coronin 1A
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Ddx59
|
DEAD-box helicase 59
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr13:50,427,940...50,452,893
Ensembl chr13:50,427,936...50,453,208
|
|
| G
|
Dlgap1
|
DLG associated protein 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:117,304,144...118,173,463
Ensembl chr 9:117,614,061...118,173,463
|
|
| G
|
Dnmt3l
|
DNA methyltransferase 3 like
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:10,614,591...10,628,989
Ensembl chr20:10,614,591...10,629,168
|
|
| G
|
Dock3
|
dedicator of cyto-kinesis 3
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195
|
|
| G
|
Dynlt2b
|
dynein light chain Tctex-type 2B
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in increased expression of DYNLT2B mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr11:81,864,195...81,872,555
Ensembl chr11:81,864,195...81,872,555
|
|
| G
|
E2f8
|
E2F transcription factor 8
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:165,389,295...165,512,821
Ensembl chr 3:165,389,293...165,510,498
|
|
| G
|
Fam83f
|
family with sequence similarity 83, member F
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 7:114,091,356...114,120,640
Ensembl chr 7:114,091,335...114,120,638
|
|
| G
|
Fbxw7
|
F-box and WD repeat domain containing 7
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:172,447,738...172,609,591
Ensembl chr 2:172,447,738...172,609,591
|
|
| G
|
Fhad1
|
forkhead associated phosphopeptide binding domain 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 5:159,474,111...159,593,455
Ensembl chr 5:159,474,158...159,593,367
|
|
| G
|
Flnb
|
filamin B
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209
|
|
| G
|
Flnc
|
filamin C
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240
|
|
| G
|
Foxc2
|
forkhead box C2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977
|
|
| G
|
Foxl2
|
forkhead box L2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mRNA] which results in increased expression of FOXL2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:108,382,872...108,396,835
|
|
| G
|
Gcc2
|
GRIP and coiled-coil domain containing 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:26,788,472...26,836,728
Ensembl chr20:26,790,516...26,836,726
|
|
| G
|
Gk
|
glycerol kinase
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr X:54,106,708...54,189,940
Ensembl chr X:54,112,214...54,196,701
|
|
| G
|
Gsn
|
gelsolin
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HIF1A-AS1 mRNA] which results in decreased expression of HIF1A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hk2
|
hexokinase 2
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HK2-DT mRNA] which results in decreased expression of HK2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
|
|
| G
|
Hmgn3
|
high mobility group nucleosomal binding domain 3
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMGN3-AS1 mRNA] which results in decreased expression of HMGN3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:92,902,555...92,939,980
|
|
| G
|
Hmmr
|
hyaluronan-mediated motility receptor
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMMR-AS1 mRNA] which results in decreased expression of HMMR mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390
|
|
| G
|
Hoxa10
|
homeobox A10
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:82,662,204...82,671,490
Ensembl chr 4:82,662,204...82,665,922
|
|
| G
|
Hoxb4
|
homeo box B4
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of HOXB4 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:81,781,090...81,783,672
Ensembl chr10:81,781,090...81,783,666
|
|
| G
|
Hoxb9
|
homeo box B9
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:81,733,857...81,737,363
Ensembl chr10:81,733,658...81,738,872
|
|
| G
|
Hoxc13
|
homeobox C13
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 7:135,937,126...135,943,962
Ensembl chr 7:135,937,126...135,943,283
|
|
| G
|
Icoslg
|
inducible T-cell co-stimulator ligand
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of INHBA mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Insig1
|
insulin induced gene 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
| G
|
Iqsec3
|
IQ motif and Sec7 domain ArfGEF 3
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IQSEC3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:156,283,040...156,379,396
Ensembl chr 4:156,283,043...156,379,396
|
|
| G
|
Irgq
|
immunity-related GTPase Q
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IRGQ mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:89,251,846...89,259,799
Ensembl chr 1:89,239,205...89,259,799
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Kcna7
|
potassium voltage-gated channel subfamily A member 7
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of KCNA7 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of KCNA7 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:105,022,549...105,028,041
Ensembl chr 1:105,022,549...105,028,041
|
|
| G
|
Kcnc4
|
potassium voltage-gated channel subfamily C member 4
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of KCNC4 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:197,747,095...197,788,467
Ensembl chr 2:197,759,010...197,788,433
|
|
| G
|
Kiaa1614
|
KIAA1614 homolog
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr13:69,939,228...69,977,703
Ensembl chr13:69,939,228...69,971,557
|
|
| G
|
Krt7
|
keratin 7
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786
|
|
| G
|
Lbx2
|
ladybird homeobox 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:117,149,690...117,151,575
Ensembl chr 4:117,149,690...117,151,575
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Lmnb1
|
lamin B1
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LMNB1-DT mRNA] which results in decreased expression of LMNB1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283
|
|
| G
|
Mafa
|
MAF bZIP transcription factor A
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MAFA-AS1 mRNA] which results in increased expression of MAFA mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 7:109,313,021...109,315,813
Ensembl chr 7:109,313,121...109,315,760
|
|
| G
|
Marveld1
|
MARVEL domain containing 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of MARVELD1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Metrn
|
meteorin, glial cell differentiation regulator
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:15,321,200...15,323,218
Ensembl chr10:15,321,200...15,323,642
|
|
| G
|
Mex3b
|
mex-3 RNA binding family member B
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:146,264,319...146,268,554
Ensembl chr 1:146,264,318...146,268,543
|
|
| G
|
Mid1ip1
|
MID1 interacting protein 1
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr X:14,733,539...14,735,859
Ensembl chr X:14,732,830...14,739,079
|
|
| G
|
Mmel1
|
membrane metallo-endopeptidase-like 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of MMEL1-AS1 mRNA] which results in decreased expression of MMEL1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 5:170,713,602...170,744,058
Ensembl chr 5:170,713,627...170,744,058
|
|
| G
|
Mmrn2
|
multimerin 2
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ADIRF-AS1 mRNA] which results in increased expression of MMRN2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr16:9,712,181...9,733,653
Ensembl chr16:9,711,953...9,733,653
|
|
| G
|
Mypn
|
myopalladin
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:25,435,554...25,521,149
Ensembl chr20:25,435,554...25,521,149
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Npr3
|
natriuretic peptide receptor 3
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of NPR3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of NPR3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066
|
|
| G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
| G
|
Nucb1
|
nucleobindin 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of NUCB1-AS1 mRNA] which results in decreased expression of NUCB1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:105,104,793...105,135,730
Ensembl chr 1:105,104,793...105,135,837
|
|
| G
|
Nyap1
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of NYAP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr12:24,591,574...24,604,417
Ensembl chr12:24,593,064...24,604,336
|
|
| G
|
Osgepl1
|
O-sialoglycoprotein endopeptidase-like 1
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:55,707,389...55,725,325
Ensembl chr 9:55,707,392...55,721,346
|
|
| G
|
Otog
|
otogelin
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:105,882,747...105,951,825
Ensembl chr 1:105,882,747...105,951,824
|
|
| G
|
Pgpep1
|
pyroglutamyl-peptidase I
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr16:18,804,408...18,817,466
Ensembl chr16:18,805,009...18,817,462
|
|
| G
|
Pilral1
|
paired immunoglobin-like type 2 receptor alpha like 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ZNF37A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr12:23,409,774...23,421,574
|
|
| G
|
Piwil2
|
piwi-like RNA-mediated gene silencing 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of PIWIL2-DT mRNA] which results in increased expression of PIWIL2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:51,841,104...51,907,729
Ensembl chr15:51,841,405...51,907,819
|
|
| G
|
Pla2g4e
|
phospholipase A2, group IVE
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:127,586,318...127,652,369
Ensembl chr 3:127,587,027...127,651,868
|
|
| G
|
Plcl2
|
phospholipase C-like 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:3,529,117...3,713,712
Ensembl chr 9:3,529,841...3,713,712
|
|
| G
|
Polh
|
DNA polymerase eta
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577
|
|
| G
|
Popdc2
|
popeye domain cAMP effector 2
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of POPDC2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr11:75,850,068...75,897,094
Ensembl chr11:75,880,274...75,896,269
|
|
| G
|
Prickle2
|
prickle planar cell polarity protein 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:126,426,767...126,771,986
Ensembl chr 4:126,426,771...126,772,008
|
|
| G
|
Psmb11
|
proteasome subunit beta 11
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:32,054,747...32,055,666
Ensembl chr15:32,049,118...32,056,299
|
|
| G
|
Riiad1
|
regulatory subunit of type II PKA R-subunit domain containing 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of RIIAD1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:184,788,948...184,807,344
Ensembl chr 2:184,790,822...184,799,172
|
|
| G
|
S100a2
|
S100 calcium binding protein A2
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of S100A2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:178,374,659...178,375,903
|
|
| G
|
Samd14
|
sterile alpha motif domain containing 14
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SAMD14 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:80,453,952...80,469,182
Ensembl chr10:80,454,641...80,469,179
|
|
| G
|
Sema3g
|
semaphorin 3G
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of SEMA3G mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr16:6,420,025...6,431,655
Ensembl chr16:6,420,012...6,432,553
|
|
| G
|
Sh3rf3
|
SH3 domain containing ring finger 3
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr20:27,306,937...27,642,315
Ensembl chr20:27,308,188...27,640,544
|
|
| G
|
Shf
|
Src homology 2 domain containing F
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SHF mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:129,749,903...129,769,912
Ensembl chr 3:129,749,584...129,769,929
|
|
| G
|
Skap1
|
src kinase associated phosphoprotein 1
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SKAP1-AS1 mRNA] which results in increased expression of SKAP1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:81,921,961...82,229,106
Ensembl chr10:81,921,980...82,229,105
|
|
| G
|
Slc25a34
|
solute carrier family 25, member 34
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 5:159,215,120...159,219,892
Ensembl chr 5:159,215,120...159,219,892
|
|
| G
|
Smad5
|
SMAD family member 5
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,871,984...7,890,992
|
|
| G
|
Smtnl2
|
smoothelin-like 2
|
multiple interactions
|
ISO
|
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:57,506,873...57,528,050
Ensembl chr10:57,506,873...57,528,050
|
|
| G
|
Srcin1
|
SRC kinase signaling inhibitor 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SRCIN1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,991,033...83,067,419
|
|
| G
|
Sstr5
|
somatostatin receptor 5
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of SSTR5 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:15,010,209...15,017,469
Ensembl chr10:15,011,391...15,017,469
|
|
| G
|
Stab1
|
stabilin 1
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,336,871...6,364,579
|
|
| G
|
Syp
|
synaptophysin
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:17,521,348...17,536,984
|
|
| G
|
Tab3
|
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr X:53,923,473...53,995,777
Ensembl chr X:53,923,492...53,995,610
|
|
| G
|
Thy1
|
Thy-1 cell surface antigen
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
| G
|
Tlx2
|
T-cell leukemia homeobox 2
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 4:117,131,516...117,133,359
Ensembl chr 4:117,131,516...117,133,359
|
|
| G
|
Tm4sf19
|
transmembrane 4 L six family member 19
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr11:81,876,714...81,899,603
Ensembl chr11:81,877,435...81,888,484
|
|
| G
|
Tnfrsf10b
|
TNF receptor superfamily member 10b
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
|
|
| G
|
Tp53i11
|
tumor protein p53 inducible protein 11
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of TP53I11 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432
|
|
| G
|
Trim8
|
tripartite motif-containing 8
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:255,311,039...255,325,937
Ensembl chr 1:255,310,457...255,325,937
|
|
| G
|
Ttc23l
|
tetratricopeptide repeat domain 23-like
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TTC23L-AS1 mRNA] which results in increased expression of TTC23L mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 2:61,203,825...61,265,453
Ensembl chr 2:61,206,329...61,265,587
|
|
| G
|
Upk1a
|
uroplakin 1A
|
multiple interactions
|
ISO
|
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:94,987,108...94,997,787
|
|
| G
|
Wnt9a
|
Wnt family member 9A
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:44,593,691...44,620,682
Ensembl chr10:44,593,691...44,620,682
|
|
| G
|
Zbtb5
|
zinc finger and BTB domain containing 5
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of ZBTB5 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr 5:64,039,805...64,062,451
Ensembl chr 5:64,035,080...64,074,912
|
|
| G
|
Zfp385d
|
zinc finger protein 385D
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of ZNF385D mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:7,473,431...7,854,364
Ensembl chr15:7,473,435...8,504,582
|
|
| G
|
Zfp503
|
zinc finger protein 503
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr15:2,362,450...2,366,238
Ensembl chr15:2,362,427...2,366,238
|
|
| G
|
Zfp672
|
zinc finger protein 672
|
multiple interactions
|
ISO
|
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA
|
CTD |
PMID:33656867 |
|
NCBI chr10:42,996,996...43,012,564
Ensembl chr10:42,984,851...43,013,195
|
|
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ABCA1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abca8
|
ATP binding cassette subfamily A member 8
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ABCA8 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:95,416,984...95,490,647
Ensembl chr10:95,416,205...95,490,452
|
|
| G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
decreases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of ABCB11 mRNA Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of ABCB11 mRNA]
|
CTD |
PMID:18175754 PMID:38945390 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [arsenite results in increased expression of ABCC2 protein] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]
|
CTD |
PMID:34678219 PMID:36464106 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ABCC3 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [arsenite results in increased expression of ABCC4 protein]
|
CTD |
PMID:34678219 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcd1
|
ATP binding cassette subfamily D member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ABCD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:156,579,669...156,601,448
Ensembl chr X:156,579,785...156,601,446
|
|
| G
|
Abcf1
|
ATP binding cassette subfamily F member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ABCF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
| G
|
Ablim3
|
actin binding LIM protein family, member 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ABLIM3 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr18:57,527,917...57,646,936
Ensembl chr18:57,527,917...57,646,710
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ACAA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acan
|
aggrecan
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ACAN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779
|
|
| G
|
Ache
|
acetylcholinesterase
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of ACHE mRNA [zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased activity of ACHE protein]
|
CTD |
PMID:16542727 PMID:36646412 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acot11
|
acyl-CoA thioesterase 11
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ACOT11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:126,756,255...126,804,526
Ensembl chr 5:126,756,255...126,804,507
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
ISO
|
dimethyl mercaptosuccinate inhibits the reaction [Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
|
CTD |
PMID:16757516 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actb
|
actin, beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ACTB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Adam11
|
ADAM metallopeptidase domain 11
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ADAM11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:88,224,185...88,242,865
Ensembl chr10:88,224,347...88,242,864
|
|
| G
|
Adam12
|
ADAM metallopeptidase domain 12
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ADAM12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:198,116,968...198,443,680
Ensembl chr 1:198,116,975...198,447,552
|
|
| G
|
Adamts5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of ADAMTS5 protein]
|
CTD |
PMID:28285737 |
|
NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516
|
|
| G
|
Adat3
|
adenosine deaminase, tRNA-specific 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ADAT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:9,759,758...9,761,127
Ensembl chr 7:9,758,671...9,764,582
|
|
| G
|
Add1
|
adducin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ADD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732
|
|
| G
|
Adgrl4
|
adhesion G protein-coupled receptor L4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ADGRL4 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222
|
|
| G
|
Adgrv1
|
adhesion G protein-coupled receptor V1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of ADGRV1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ADIPOQ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adsl
|
adenylosuccinate lyase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ADSL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872
|
|
| G
|
Aebp1
|
AE binding protein 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of AEBP1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:84,951,577...84,962,840
Ensembl chr14:84,952,822...84,962,843
|
|
| G
|
Afg1l
|
AFG1 like ATPase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AFG1L mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:47,380,582...47,550,307
Ensembl chr20:47,380,583...47,550,126
|
|
| G
|
Aga
|
aspartylglucosaminidase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AGA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551
|
|
| G
|
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AGAP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:64,782,618...64,799,624
Ensembl chr 7:64,782,612...64,799,640
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of AGER protein]
|
CTD |
PMID:22476978 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agmo
|
alkylglycerol monooxygenase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of AGMO mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:59,713,495...60,044,851
Ensembl chr 6:59,713,467...60,044,854
|
|
| G
|
Agr2
|
anterior gradient 2, protein disulphide isomerase family member
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of AGR2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677
|
|
| G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of AHRR mRNA [ptaquiloside co-treated with Sodium Selenite] results in increased expression of AHRR mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
|
|
| G
|
Aida
|
axin interactor, dorsalization associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AIDA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:97,471,931...97,499,531
Ensembl chr13:97,471,604...97,499,535
|
|
| G
|
Aif1l
|
allograft inflammatory factor 1-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of AIF1L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AIFM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AIMP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
|
|
| G
|
Aip
|
aryl-hydrocarbon receptor-interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AIP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634
|
|
| G
|
Akirin1
|
akirin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AKIRIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:141,274,175...141,289,575
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases expression multiple interactions increases phosphorylation
|
ISO EXP
|
Sodium Selenite results in decreased expression of AKT1 mRNA Sodium Selenite inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein] Sodium Selenite results in increased phosphorylation of AKT1 protein mitoquinone inhibits the reaction [Sodium Selenite inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; Sodium Selenite inhibits the reaction [2-cresol results in increased expression of AKT1 mRNA]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein]; Sodium Selenite inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:12896980 PMID:15845651 PMID:16705456 PMID:21705299 PMID:24140496 PMID:31419397 More...
|
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alad
|
aminolevulinate dehydratase
|
decreases activity multiple interactions
|
ISO
|
Sodium Selenite results in decreased activity of ALAD protein Mercuric Chloride promotes the reaction [Sodium Selenite results in decreased activity of ALAD protein]; Sodium Selenite inhibits the reaction [Mercury results in decreased activity of ALAD protein]; Sodium Selenite promotes the reaction [Mercuric Chloride results in decreased activity of ALAD protein]
|
CTD |
PMID:12499120 PMID:12595158 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
| G
|
Alb
|
albumin
|
multiple interactions
|
EXP
|
[Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of ALB protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of ALB protein]
|
CTD |
PMID:24954678 PMID:26085057 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alkbh6
|
alkB homolog 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ALKBH6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:94,690,979...94,696,429
Ensembl chr 1:94,691,822...94,696,427
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]
|
CTD |
PMID:34970773 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Anapc11
|
anaphase promoting complex subunit 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANAPC11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,373,610...106,384,633
Ensembl chr10:106,373,634...106,384,633
|
|
| G
|
Ang
|
angiogenin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Angel1
|
angel homolog 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ANGEL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:112,080,074...112,117,178
Ensembl chr 6:112,080,075...112,113,453
|
|
| G
|
Angptl2
|
angiopoietin-like 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ANGPTL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876
|
|
| G
|
Ankra2
|
ankyrin repeat family A member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANKRA2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:31,347,158...31,358,002
Ensembl chr 2:31,347,090...31,364,394
|
|
| G
|
Ankrd26
|
ankyrin repeat domain containing 26
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ANKRD26 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256
|
|
| G
|
Ankrd46
|
ankyrin repeat domain 46
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANKRD46 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:69,532,303...69,553,311
Ensembl chr 7:69,532,304...69,545,421
|
|
| G
|
Anln
|
anillin, actin binding protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ANLN mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
|
|
| G
|
Anxa1
|
annexin A1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANXA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa11
|
annexin A11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANXA11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839
|
|
| G
|
Anxa7
|
annexin A7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ANXA7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891
|
|
| G
|
Apc
|
APC regulator of WNT signaling pathway
|
decreases methylation increases expression
|
ISO
|
Sodium Selenite results in decreased methylation of APC promoter Sodium Selenite results in increased expression of APC mRNA
|
CTD |
PMID:18676679 |
|
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022
|
|
| G
|
Apcdd1
|
APC down-regulated 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of APCDD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of APEX1 mRNA [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of and affects the localization of APEX1 protein; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of APEX1 mRNA
|
CTD |
PMID:18175754 PMID:28757135 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Apmap
|
adipocyte plasma membrane associated protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of APMAP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:159,869,451...159,897,727
Ensembl chr 3:159,869,451...159,897,726
|
|
| G
|
Apoa1
|
apolipoprotein A1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of APOA1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of APP mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Aprt
|
adenine phosphoribosyl transferase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of APRT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:67,534,737...67,537,027
|
|
| G
|
Aqp7
|
aquaporin 7
|
increases expression multiple interactions
|
EXP ISO
|
Sodium Selenite results in increased expression of AQP7 mRNA Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of AQP7 mRNA]
|
CTD |
PMID:31419397 |
|
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions decreases expression
|
ISO
|
[Sodium Selenite results in decreased activity of SP1 protein] which results in decreased expression of AR protein; [Sodium Selenite results in increased expression of JUN protein] which results in decreased activity of AR protein; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR mRNA]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR protein]; Sodium Selenite inhibits the reaction [IL6 protein results in increased activity of AR protein] Sodium Selenite results in decreased expression of AR mRNA; Sodium Selenite results in decreased expression of AR protein
|
CTD |
PMID:16928829 PMID:17346688 PMID:18760546 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Arf5
|
ARF GTPase 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARF5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835
|
|
| G
|
Arfgap3
|
ARF GTPase activating protein 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARFGAP3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:116,312,996...116,359,300
Ensembl chr 7:116,313,001...116,359,592
|
|
| G
|
Arg1
|
arginase 1
|
increases activity increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased activity of ARG1 protein Sodium Selenite results in increased expression of ARG1 mRNA 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Sodium Selenite results in increased activity of ARG1 protein]
|
CTD |
PMID:21669866 PMID:25187657 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arhgap6
|
Rho GTPase activating protein 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ARHGAP6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:28,525,917...29,061,244
|
|
| G
|
Arhgef1
|
Rho guanine nucleotide exchange factor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ARHGEF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:89,626,884...89,648,823
Ensembl chr 1:89,628,266...89,649,067
|
|
| G
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARHGEF6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:140,182,734...140,302,812
Ensembl chr X:140,182,734...140,344,458
|
|
| G
|
Arid5a
|
AT-rich interaction domain 5A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARID5A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363
|
|
| G
|
Arih2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARIH2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284
|
|
| G
|
Ark2n
|
arkadia (RNF111) N-terminal like PKA signaling regulator 2N
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ARK2N mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:73,431,104...73,520,759
Ensembl chr18:73,431,104...73,518,144
|
|
| G
|
Arl2bp
|
ARF like GTPase 2 binding protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARL2BP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514
|
|
| G
|
Arl4c
|
ARF like GTPase 4C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARL4C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772
|
|
| G
|
Arl6ip4
|
ARF like GTPase 6 interacting protein 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARL6IP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724
|
|
| G
|
Armcx5
|
armadillo repeat containing, X-linked 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARMCX5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:103,501,552...103,505,978
Ensembl chr X:103,501,146...103,539,449
|
|
| G
|
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ARNT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997
|
|
| G
|
Arpc2
|
actin related protein 2/3 complex, subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ARPC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409
|
|
| G
|
Art4
|
ADP-ribosyltransferase 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ART4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:171,468,415...171,482,435
Ensembl chr 4:171,471,534...171,481,868
|
|
| G
|
Asah2
|
N-acylsphingosine amidohydrolase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ASAH2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:239,278,994...239,386,598
Ensembl chr 1:239,278,994...239,382,024
|
|
| G
|
Ascc3
|
activating signal cointegrator 1 complex subunit 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ASCC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374
|
|
| G
|
Ascl1
|
achaete-scute family bHLH transcription factor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ASCL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231
|
|
| G
|
Asic2
|
acid sensing ion channel subunit 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ASIC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:66,368,308...67,438,237
Ensembl chr10:66,368,310...66,636,245
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ASNS mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Aspm
|
assembly factor for spindle microtubules
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ASPM mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489
|
|
| G
|
Atad2b
|
ATPase family, AAA domain containing 2B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ATAD2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:33,646,075...33,789,532
Ensembl chr 6:33,646,075...33,789,532
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATF4 protein
|
CTD |
PMID:34520753 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf5
|
activating transcription factor 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATF5 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
|
|
| G
|
Atf6
|
activating transcription factor 6
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of ATF6 protein 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]
|
CTD |
PMID:34520753 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atg4a
|
autophagy related 4A, cysteine peptidase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATG4A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:109,453,712...109,553,758
Ensembl chr X:109,453,689...109,553,760
|
|
| G
|
Atg4c
|
autophagy related 4C, cysteine peptidase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATG4C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:118,977,594...119,050,894
Ensembl chr 5:118,982,918...119,052,695
|
|
| G
|
Atg5
|
autophagy related 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATG5 protein
|
CTD |
PMID:25204997 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
increases phosphorylation
|
ISO
|
Sodium Selenite results in increased phosphorylation of ATM protein
|
CTD |
PMID:36113632 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atp1a4
|
ATPase Na+/K+ transporting subunit alpha 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP1A4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:87,216,139...87,252,155
Ensembl chr13:87,216,139...87,251,724
|
|
| G
|
Atp2b3
|
ATPase plasma membrane Ca2+ transporting 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ATP2B3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153
|
|
| G
|
Atp5f1e
|
ATP synthase F1 subunit epsilon
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP5F1E mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214
|
|
| G
|
Atp5mc2
|
ATP synthase membrane subunit c locus 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP5MC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:135,669,848...135,678,231
|
|
| G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP5PB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387
|
|
| G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP5PD mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
| G
|
Atp6v0a1
|
ATPase H+ transporting V0 subunit a1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ATP6V0A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181
|
|
| G
|
Atp6v0e2
|
ATPase, H+ transporting V0 subunit e2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP6V0E2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680
|
|
| G
|
Atp6v1g2
|
ATPase H+ transporting V1 subunit G2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ATP6V1G2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:3,592,374...3,595,986
Ensembl chr20:3,592,364...3,595,475
|
|
| G
|
Atp8b1
|
ATPase phospholipid transporting 8B1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ATP8B1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027
|
|
| G
|
Aup1
|
AUP1, lipid droplet regulating VLDL assembly factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AUP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:117,117,999...117,121,061
|
|
| G
|
Axin1
|
axin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of AXIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092
|
|
| G
|
B3galt6
|
Beta-1,3-galactosyltransferase 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of B3GALT6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,866,428...171,868,564
Ensembl chr 5:171,864,094...171,874,789
|
|
| G
|
B3gnt6
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of B3GNT6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:161,897,504...161,915,046
Ensembl chr 1:161,898,323...161,903,354
|
|
| G
|
B4gat1
|
beta-1,4-glucuronyltransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of B4GAT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:211,772,644...211,774,866
Ensembl chr 1:211,772,606...211,775,442
|
|
| G
|
Bag5
|
BAG cochaperone 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BAG5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BAK1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Banp
|
Btg3 associated nuclear protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BANP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317
|
|
| G
|
Batf3
|
basic leucine zipper ATF-like transcription factor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BATF3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Sodium Selenite results in increased expression of BAX mRNA; Sodium Selenite results in increased expression of BAX protein Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of BAX protein] [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of BAX protein Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BAX mRNA]; Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of BAX protein] Sodium Selenite results in decreased expression of BAX protein
|
CTD |
PMID:16542727 PMID:16705456 PMID:18209489 PMID:21705299 PMID:28757135 PMID:31419397 PMID:34520753 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz1a
|
bromodomain adjacent to zinc finger domain, 1A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BAZ1A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648
|
|
| G
|
Baz2a
|
bromodomain adjacent to zinc finger domain, 2A
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A protein]
|
CTD |
PMID:39354181 |
|
NCBI chr 7:1,107,377...1,145,507
Ensembl chr 7:1,107,796...1,145,507
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BBC3 mRNA
|
CTD |
PMID:28161410 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bbs4
|
Bardet-Biedl syndrome 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BBS4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:68,627,656...68,661,358
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein]; Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] Sodium Selenite results in decreased expression of BCL2 protein [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of BCL2 protein Sodium Selenite results in decreased expression of BCL2 mRNA Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA]; Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of BCL2 mRNA]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] Sodium Selenite results in increased expression of BCL2 protein
|
CTD |
PMID:16039982 PMID:16542727 PMID:17989939 PMID:18209489 PMID:19363675 PMID:21705299 PMID:28757135 PMID:31419397 PMID:34520753 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl9
|
BCL9, transcription coactivator
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BCL9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:187,449,425...187,475,241
Ensembl chr 2:187,449,425...187,475,241
|
|
| G
|
Becn1
|
beclin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BECN1 protein
|
CTD |
PMID:25204997 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bicra
|
BRD4 interacting chromatin remodeling complex associated protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BICRA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:85,790,093...85,867,656
Ensembl chr 1:85,790,093...85,864,306
|
|
| G
|
Bik
|
BCL2-interacting killer
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BIK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
decreases expression decreases abundance increases expression
|
ISO
|
Sodium Selenite results in decreased expression of BIRC2 protein Selenite decreases abundance of BIRC2 protein in colorectal cancer cells Sodium Selenite results in increased expression of BIRC2 mRNA
|
CTD RGD |
PMID:14737004 PMID:16705456 PMID:24577083 |
RGD:152998972 |
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
decreases expression decreases abundance
|
ISO
|
Sodium Selenite results in decreased expression of BIRC3 mRNA Selenite decreases abundance of BIRC3 protein in colorectal cancer cells
|
CTD RGD |
PMID:16705456 PMID:24577083 |
RGD:152998972 |
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
| G
|
Blzf1
|
basic leucine zipper nuclear factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BLZF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:79,174,898...79,190,116
Ensembl chr13:79,174,902...79,190,116
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of BMP4 mRNA Sodium Selenite results in decreased expression of BMP4 mRNA
|
CTD |
PMID:23274088 PMID:24383545 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bnipl
|
BCL2 interacting protein like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BNIPL mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:185,507,591...185,519,415
Ensembl chr 2:185,507,593...185,517,582
|
|
| G
|
Borcs7
|
BLOC-1 related complex subunit 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BORCS7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:255,505,745...255,519,579
Ensembl chr 1:255,505,745...255,518,815
|
|
| G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BRAF mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
|
|
| G
|
Brat1
|
BRCA1-associated ATM activator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BRAT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:19,043,004...19,065,686
Ensembl chr12:19,042,591...19,055,369
|
|
| G
|
Brca1
|
BRCA1, DNA repair associated
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BRCA1 mRNA
|
CTD |
PMID:10344722 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
|
|
| G
|
Brca2
|
BRCA2, DNA repair associated
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BRCA2 mRNA
|
CTD |
PMID:10344722 |
|
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194
|
|
| G
|
Brf1
|
BRF1 general transcription factor IIIB subunit
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BRF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386
|
|
| G
|
Btbd7
|
BTB domain containing 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BTBD7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:127,685,185...127,774,947
Ensembl chr 6:127,688,421...127,737,222
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of BTG2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
Btla
|
B and T lymphocyte associated
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of BTLA mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr11:69,069,734...69,099,331
Ensembl chr11:69,052,644...69,093,224
|
|
| G
|
C18h18orf21
|
similar to human chromosome 18 open reading frame 21
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RMP24 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:16,054,038...16,062,645
Ensembl chr18:16,053,880...16,064,239
|
|
| G
|
C18h5orf46
|
similar to human chromosome 5 open reading frame 46
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of C5ORF46 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:36,199,309...36,220,409
Ensembl chr18:36,199,309...36,220,409
|
|
| G
|
C1h9orf40
|
similar to human chromosome 9 open reading frame 40
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of C9ORF40 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:225,555,300...225,559,509
Ensembl chr 1:225,555,280...225,559,693
|
|
| G
|
C1qc
|
complement C1q C chain
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of C1QC mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468
|
|
| G
|
C2h1orf162
|
similar to human chromosome 1 open reading frame 162
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of C1ORF162 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:196,101,669...196,107,404
Ensembl chr 2:196,100,702...196,106,832
|
|
| G
|
C8a
|
complement C8 alpha chain
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of C8A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:124,812,131...124,866,710
|
|
| G
|
C9
|
complement C9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of C9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:57,300,427...57,348,752
|
|
| G
|
C9h2orf88
|
similar to human chromosome 2 open reading frame 88
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of AKAP19 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:56,037,234...56,076,793
Ensembl chr 9:56,031,114...56,131,839
|
|
| G
|
Cacna1c
|
calcium voltage-gated channel subunit alpha1 C
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CACNA1C mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
|
|
| G
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CACNA2D3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,105,048...4,919,098
|
|
| G
|
Cacna2d4
|
calcium voltage-gated channel auxiliary subunit alpha2delta 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CACNA2D4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:154,080,877...154,197,369
Ensembl chr 4:154,080,877...154,193,778
|
|
| G
|
Cacnb1
|
calcium voltage-gated channel auxiliary subunit beta 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CACNB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146
|
|
| G
|
Cacnb4
|
calcium voltage-gated channel auxiliary subunit beta 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CACNB4 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:57,315,900...57,578,220
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
decreases response to substance
|
ISO
|
CALCA protein results in decreased susceptibility to Sodium Selenite
|
CTD |
PMID:16222118 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Calm1
|
calmodulin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CALM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Camlg
|
calcium modulating ligand
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CAMLG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:8,997,868...9,009,140
Ensembl chr17:8,997,272...9,009,012
|
|
| G
|
Camp
|
cathelicidin antimicrobial peptide
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CAMP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998
|
|
| G
|
Capns2
|
calpain, small subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CAPNS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:30,277,324...30,278,266
|
|
| G
|
Caprin1
|
cell cycle associated protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CAPRIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562
|
|
| G
|
Carf
|
calcium responsive transcription factor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CARF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479
|
|
| G
|
Cask
|
calcium/calmodulin dependent serine protein kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CASK mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr X:11,572,328...11,915,831
Ensembl chr X:11,572,636...11,911,948
|
|
| G
|
Casp12
|
caspase 12
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CASP12 protein
|
CTD |
PMID:34520753 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
decreases expression multiple interactions increases cleavage increases activity increases expression decreases activity
|
ISO EXP
|
Sodium Selenite results in decreased expression of CASP3 mRNA [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased cleavage of CASP3 protein Sodium Selenite results in increased cleavage of CASP3 protein Sodium Selenite results in increased activity of CASP3 protein Sodium Selenite results in increased expression of CASP3 mRNA Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of CASP3 mRNA] Sodium Selenite results in decreased activity of CASP3 protein Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in increased expression of CASP3 mRNA]
|
CTD |
PMID:16705456 PMID:17989939 PMID:18209489 PMID:19363675 PMID:20067779 PMID:21215776 PMID:28161410 PMID:28757135 PMID:34520753 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
increases cleavage
|
ISO
|
Sodium Selenite results in increased cleavage of CASP4 protein
|
CTD |
PMID:28161410 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp7
|
caspase 7
|
affects expression increases cleavage multiple interactions
|
ISO
|
Sodium Selenite affects the expression of CASP7 mRNA Sodium Selenite results in increased cleavage of CASP7 protein Sodium Selenite inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]
|
CTD |
PMID:16705456 PMID:28161410 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
increases expression increases cleavage decreases activity
|
ISO EXP
|
Sodium Selenite results in increased expression of CASP8 mRNA Sodium Selenite results in increased cleavage of CASP8 protein Sodium Selenite results in decreased activity of CASP8 protein
|
CTD |
PMID:18209489 PMID:19363675 PMID:34520753 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
increases expression increases cleavage decreases activity
|
ISO EXP
|
Sodium Selenite results in increased expression of CASP9 mRNA Sodium Selenite results in increased cleavage of CASP9 protein Sodium Selenite results in decreased activity of CASP9 protein
|
CTD |
PMID:16705456 PMID:18209489 PMID:28161410 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
decreases expression decreases activity increases activity multiple interactions
|
EXP
|
Sodium Selenite results in decreased expression of CAT mRNA Sodium Selenite results in decreased activity of CAT protein Sodium Selenite results in increased activity of CAT protein [[Sodium Selenite results in increased abundance of Selenium] which co-treated with Ascorbic Acid] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased activity of CAT protein]; Acetylcarnitine inhibits the reaction [Sodium Selenite results in decreased expression of CAT mRNA]; Curcumin inhibits the reaction [Sodium Selenite results in decreased activity of CAT protein]; isorhamnetin 3-O-glucoside inhibits the reaction [Sodium Selenite results in decreased activity of CAT protein]; lupeol inhibits the reaction [Sodium Selenite results in decreased activity of CAT protein]; pimagedine inhibits the reaction [Sodium Selenite results in decreased activity of CAT protein]; Sodium Selenite inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased activity of CAT protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of CAT protein]; Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of CAT mRNA]; Sodium Selenite inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
|
CTD |
PMID:19481068 PMID:20067779 PMID:20566334 PMID:20643113 PMID:22476978 PMID:23369933 PMID:23603382 PMID:24954678 PMID:26697995 PMID:27941167 PMID:30057697 PMID:30526071 PMID:31022331 PMID:36646412 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cav2
|
caveolin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CAV2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CBS mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Ccbe1
|
collagen and calcium binding EGF domains 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCBE1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:61,849,821...62,093,876
Ensembl chr18:61,853,149...62,094,075
|
|
| G
|
Ccdc142
|
coiled-coil domain containing 142
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCDC142 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:117,164,055...117,172,286
Ensembl chr 4:117,166,135...117,173,935
|
|
| G
|
Ccdc167
|
coiled-coil domain containing 167
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCDC167 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:7,768,425...7,783,181
Ensembl chr20:7,753,072...7,783,181
|
|
| G
|
Ccdc6
|
coiled-coil domain containing 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCDC6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
|
|
| G
|
Ccdc69
|
coiled-coil domain containing 69
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCDC69 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:39,673,984...39,701,080
Ensembl chr10:39,673,985...39,700,579
|
|
| G
|
Ccdc86
|
coiled-coil domain containing 86
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCDC86 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:217,014,848...217,021,468
|
|
| G
|
Ccl21
|
C-C motif chemokine ligand 21
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCL21 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540
|
|
| G
|
Ccl24
|
C-C motif chemokine ligand 24
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CCL24 mRNA Sodium Selenite results in decreased expression of CCL24 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924
|
|
| G
|
Ccna2
|
cyclin A2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCNA2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of CCNB1 mRNA [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of CCNB1 mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of CCNB1 protein
|
CTD |
PMID:24383545 PMID:28757135 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnc
|
cyclin C
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCNC mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression decreases expression
|
ISO EXP
|
Sodium Selenite results in increased expression of CCND1 mRNA Sodium Selenite results in decreased expression of CCND1 mRNA; Sodium Selenite results in decreased expression of CCND1 protein
|
CTD |
PMID:16705456 PMID:19276161 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCND2 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccne1
|
cyclin E1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCNE1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccng1
|
cyclin G1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCNG1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Ccsap
|
centriole, cilia and spindle-associated protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CCSAP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:68,722,417...68,740,908
|
|
| G
|
Cct3
|
chaperonin containing TCP1 subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925
|
|
| G
|
Cct6a
|
chaperonin containing TCP1 subunit 6A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CCT6A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:32,508,842...32,519,072
Ensembl chr12:32,508,675...32,519,119
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression decreases expression
|
ISO
|
Sodium Selenite results in increased expression of CD14 mRNA Sodium Selenite results in decreased expression of CD14 mRNA
|
CTD |
PMID:18175754 PMID:23274088 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd180
|
CD180 molecule
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CD180 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:35,589,451...35,603,982
|
|
| G
|
Cd2
|
Cd2 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665
|
|
| G
|
Cd226
|
CD226 molecule
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CD226 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr18:84,723,330...84,819,836
Ensembl chr18:84,725,242...84,819,835
|
|
| G
|
Cd300lb
|
CD300 molecule-like family member b
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TREM5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:100,463,815...100,473,804
Ensembl chr10:100,463,815...100,473,804
|
|
| G
|
Cd47
|
Cd47 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD47 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
|
|
| G
|
Cd5
|
Cd5 molecule
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CD5 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209
|
|
| G
|
Cd52
|
CD52 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD52 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086
|
|
| G
|
Cd53
|
Cd53 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD53 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593
|
|
| G
|
Cd70
|
Cd70 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD70 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 9:2,093,540...2,096,692
Ensembl chr 9:2,086,848...2,096,692
|
|
| G
|
Cd79b
|
CD79b molecule
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CD79B mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405
|
|
| G
|
Cd83
|
CD83 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD83 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
|
|
| G
|
Cd84
|
CD84 molecule
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CD84 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318
|
|
| G
|
Cd8b
|
CD8 subunit beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD8B1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868
|
|
| G
|
Cd96
|
CD96 molecule
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CD96 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937
|
|
| G
|
Cdc14b
|
cell division cycle 14B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDC14B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164
|
|
| G
|
Cdc37
|
cell division cycle 37, HSP90 cochaperone
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDC37 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931
|
|
| G
|
Cdc42
|
cell division cycle 42
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDC42 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627
|
|
| G
|
Cdc6
|
cell division cycle 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDC6 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdh2
|
cadherin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDH2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdk17
|
cyclin-dependent kinase 17
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDK17 mRNA Sodium Selenite results in increased expression of CDK17 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 7:29,570,982...29,677,613
Ensembl chr 7:29,570,816...29,652,008
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDK4 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDK5 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDK5R1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
| G
|
Cdk7
|
cyclin-dependent kinase 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDK7 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
|
|
| G
|
Cdk9
|
cyclin-dependent kinase 9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDK9 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 3:36,394,168...36,399,016
Ensembl chr 3:36,394,169...36,399,528
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO
|
[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of CDKN1A mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of CDKN1A protein; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein] Sodium Selenite results in increased expression of CDKN1A mRNA; Sodium Selenite results in increased expression of CDKN1A protein
|
CTD |
PMID:21515331 PMID:24383545 PMID:25204997 PMID:28757135 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
increases expression
|
EXP
|
Sodium Selenite results in increased expression of CDKN1B protein
|
CTD |
PMID:19276161 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDKN1C mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDKN2A protein
|
CTD |
PMID:25204997 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CDKN2B mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CDKN3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
|
|
| G
|
Cebpe
|
CCAAT/enhancer binding protein epsilon
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CEBPE mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:32,139,716...32,141,476
Ensembl chr15:32,139,716...32,141,476
|
|
| G
|
Cebpg
|
CCAAT/enhancer binding protein gamma
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CEBPG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283
|
|
| G
|
Cela1
|
chymotrypsin like elastase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CELA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061
|
|
| G
|
Celf6
|
CUGBP, Elav-like family member 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CELF6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:68,870,902...68,901,863
Ensembl chr 8:68,871,093...68,901,863
|
|
| G
|
Cenpe
|
centromere protein E
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CENPE mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
| G
|
Cenpf
|
centromere protein F
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CENPF mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenpk
|
centromere protein K
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CENPK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488
|
|
| G
|
Cep76
|
centrosomal protein 76
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CEP76 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:63,444,389...63,478,358
Ensembl chr18:63,443,746...63,478,358
|
|
| G
|
Cep85
|
centrosomal protein 85
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CEP85 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:151,640,316...151,687,891
Ensembl chr 5:151,639,282...151,687,860
|
|
| G
|
Cetn2
|
centrin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CETN2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:155,812,212...155,817,186
Ensembl chr X:155,812,003...155,817,744
|
|
| G
|
Cfl1
|
cofilin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CFL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Chac1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHAC1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
|
|
| G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CHAF1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
|
|
| G
|
Champ1
|
chromosome alignment maintaining phosphoprotein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHAMP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:82,436,172...82,447,144
Ensembl chr16:82,434,823...82,458,984
|
|
| G
|
Chchd2
|
coiled-coil-helix-coiled-coil-helix domain containing 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHCHD2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:32,464,847...32,470,871
Ensembl chr12:32,464,824...32,470,871
|
|
| G
|
Chga
|
chromogranin A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHGA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237
|
|
| G
|
Chml
|
CHM like Rab escort protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CHML mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:90,141,880...90,152,097
Ensembl chr13:90,131,514...90,151,265
|
|
| G
|
Chmp2a
|
charged multivesicular body protein 2A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHMP2A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:82,732,231...82,738,613
|
|
| G
|
Chmp6
|
charged multivesicular body protein 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CHMP6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:105,690,400...105,696,070
Ensembl chr10:105,690,398...105,696,333
|
|
| G
|
Chrac1
|
chromatin accessibility complex subunit 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHRAC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:106,901,841...106,905,441
|
|
| G
|
Chsy1
|
chondroitin sulfate synthase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHSY1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:129,100,088...129,161,167
Ensembl chr 1:129,100,041...129,161,081
|
|
| G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
affects localization
|
ISO
|
Sodium Selenite affects the localization of CHUK protein
|
CTD |
PMID:36113632 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
|
|
| G
|
Churc1
|
churchill domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHURC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:101,203,778...101,218,364
Ensembl chr 6:101,203,841...101,237,748
|
|
| G
|
Cib3
|
calcium and integrin binding family member 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CIB3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:17,656,453...17,665,848
Ensembl chr16:17,656,453...17,665,848
|
|
| G
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CITED4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361
|
|
| G
|
Ckb
|
creatine kinase B
|
multiple interactions
|
ISO EXP
|
Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
|
CTD |
PMID:31419397 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
multiple interactions
|
ISO EXP
|
Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
|
CTD |
PMID:31419397 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Cks1b
|
CDC28 protein kinase regulatory subunit 1B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CKS1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CKS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clcc1
|
chloride channel CLIC-like 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLCC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014
|
|
| G
|
Clcn1
|
chloride voltage-gated channel 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLCN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:72,138,739...72,168,113
Ensembl chr 4:72,139,162...72,168,128
|
|
| G
|
Clcn6
|
chloride voltage-gated channel 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLCN6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:163,717,439...163,748,198
|
|
| G
|
Cldn18
|
claudin 18
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLDN18 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:109,125,819...109,145,110
Ensembl chr 8:109,126,949...109,152,701
|
|
| G
|
Clec1b
|
C-type lectin domain family 1, member B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLEC1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:164,534,055...164,542,867
|
|
| G
|
Clgn
|
calmegin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CLGN mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325
|
|
| G
|
Clic5
|
chloride intracellular channel 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CLIC5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:24,208,455...24,310,964
Ensembl chr 9:24,208,456...24,358,780
|
|
| G
|
Clk3
|
CDC-like kinase 3
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of CLK3 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 8:67,048,121...67,063,192
Ensembl chr 8:67,048,123...67,062,881
|
|
| G
|
Clns1a
|
chloride nucleotide-sensitive channel 1A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CLNS1A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:161,429,437...161,450,904
Ensembl chr 1:161,421,808...161,450,902
|
|
| G
|
Clpp
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CLPP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705
|
|
| G
|
Clptm1
|
CLPTM1 regulator of GABA type A receptor forward trafficking
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CLPTM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:88,417,447...88,449,446
|
|
| G
|
Clta
|
clathrin, light chain A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CLTA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:63,022,046...63,059,223
Ensembl chr 5:63,041,184...63,059,215
|
|
| G
|
Cndp1
|
carnosine dipeptidase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CNDP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:80,254,499...80,305,845
Ensembl chr18:80,255,784...80,282,643
|
|
| G
|
Cnep1r1
|
CTD nuclear envelope phosphatase 1 regulatory subunit 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CNEP1R1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:35,106,802...35,121,101
Ensembl chr19:35,106,802...35,121,101
|
|
| G
|
Coa4
|
cytochrome c oxidase assembly factor 4 homolog
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COA4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:164,294,312...164,297,571
Ensembl chr 1:164,294,319...164,297,578
|
|
| G
|
Coa8
|
cytochrome c oxidase assembly factor 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COA8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:136,593,399...136,618,237
Ensembl chr 6:136,592,787...136,619,602
|
|
| G
|
Coasy
|
Coenzyme A synthase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COASY mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,514,850...86,519,130
Ensembl chr10:86,514,874...86,519,130
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
decreases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of COL1A1 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL1A1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col27a1
|
collagen type XXVII alpha 1 chain
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of COL27A1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502
|
|
| G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL2A1 mRNA Sodium Selenite results in decreased expression of COL2A1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of COL3A1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Col6a2
|
collagen type VI alpha 2 chain
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of COL6A2 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA
|
CTD |
PMID:18175754 PMID:23274088 |
|
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
|
|
| G
|
Commd8
|
COMM domain containing 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COMMD8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:36,403,000...36,413,577
Ensembl chr14:36,403,022...36,413,574
|
|
| G
|
Cops2
|
COP9 signalosome subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COPS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369
|
|
| G
|
Cops3
|
COP9 signalosome subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COPS3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:45,117,664...45,151,868
Ensembl chr10:45,117,657...45,152,074
|
|
| G
|
Cops5
|
COP9 signalosome subunit 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COPS5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387
|
|
| G
|
Copz1
|
COPI coat complex subunit zeta 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COPZ1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:136,288,032...136,314,135
|
|
| G
|
Coq8b
|
coenzyme Q8B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COQ8B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:91,653,241...91,676,822
Ensembl chr 1:91,654,225...91,676,819
|
|
| G
|
Coq9
|
coenzyme Q9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COQ9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:10,172,943...10,185,960
Ensembl chr19:10,172,949...10,185,937
|
|
| G
|
Cox14
|
cytochrome c oxidase assembly factor COX14
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX14 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159
|
|
| G
|
Cox16
|
cytochrome c oxidase assembly factor COX16
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX4I1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX5A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
| G
|
Cox6c
|
cytochrome c oxidase subunit 6C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX6C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166
|
|
| G
|
Cox8a
|
cytochrome c oxidase subunit 8A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COX8A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623
|
|
| G
|
Cplx3
|
complexin 3
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CPLX3 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 8:66,899,438...66,906,200
Ensembl chr 8:66,899,438...66,906,200
|
|
| G
|
Crbn
|
cereblon
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CRBN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038
|
|
| G
|
Creb3l4
|
cAMP responsive element binding protein 3-like 4
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CREB3L4 mRNA Sodium Selenite results in decreased expression of CREB3L4 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485
|
|
| G
|
Crebl2
|
cAMP responsive element binding protein-like 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CREBL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611
|
|
| G
|
Crhr1
|
corticotropin releasing hormone receptor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CRHR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
|
|
| G
|
Crmp1
|
collapsin response mediator protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CRMP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916
|
|
| G
|
Crp
|
C-reactive protein
|
affects expression multiple interactions
|
ISO EXP
|
Sodium Selenite affects the expression of CRP protein Sodium Selenite inhibits the reaction [bisphenol A results in increased secretion of CRP protein]
|
CTD |
PMID:12867288 PMID:33847390 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Csn1s1
|
casein alpha s1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CSN1S1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:20,622,858...20,638,849
|
|
| G
|
Csnk1e
|
casein kinase 1, epsilon
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CSNK1E mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101
|
|
| G
|
Csrnp2
|
cysteine and serine rich nuclear protein 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CSRNP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:133,473,027...133,488,868
Ensembl chr 7:133,473,027...133,488,868
|
|
| G
|
Csrp3
|
cysteine and glycine rich protein 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CSRP3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916
|
|
| G
|
Csta
|
cystatin A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CSTA mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822
|
|
| G
|
Ctc1
|
CST telomere replication complex component 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CTC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:54,212,537...54,234,146
Ensembl chr10:54,207,083...54,234,147
|
|
| G
|
Ctdnep1
|
CTD nuclear envelope phosphatase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CTDNEP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CX3CR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of CXCL12 mRNA]
|
CTD |
PMID:17997286 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CXCL2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxxc5
|
CXXC finger protein 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CXXC5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635
|
|
| G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of CYP11A1 mRNA]
|
CTD |
PMID:39354181 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
| G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[Sodium Selenite co-treated with Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP27A1 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]
|
CTD |
PMID:36464106 PMID:38945390 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of CYP2S1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP3A13 mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA]
|
CTD |
PMID:36464106 PMID:38945390 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Cyp8b1
|
cytochrome P450 family 8 subfamily B member 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
|
|
| G
|
Cytip
|
cytohesin 1 interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CYTIP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:63,106,895...63,183,769
Ensembl chr 3:63,107,607...63,134,832
|
|
| G
|
Daglb
|
diacylglycerol lipase, beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DAGLB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:16,173,345...16,215,777
Ensembl chr12:16,173,345...16,215,758
|
|
| G
|
Dalrd3
|
DALR anticodon binding domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DALRD3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,142,009...118,147,082
Ensembl chr 8:118,144,197...118,147,822
|
|
| G
|
Dap3
|
death associated protein 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DAP3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:176,617,151...176,645,293
Ensembl chr 2:176,617,155...176,644,270
|
|
| G
|
Dapk1
|
death associated protein kinase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DAPK1 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581
|
|
| G
|
Dars1
|
aspartyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DARS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Daxx
|
death-domain associated protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DAXX mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Dbf4b
|
DBF4B-CDC7 kinase regulatory subunit
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DBF4B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:88,209,913...88,219,336
|
|
| G
|
Dbi
|
diazepam binding inhibitor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DBI mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
|
|
| G
|
Dctpp1
|
dCTP pyrophosphatase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DCTPP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405
|
|
| G
|
Ddi2
|
DNA damage inducible 1 homolog 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DDI2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:159,272,625...159,318,365
Ensembl chr 5:159,272,625...159,318,310
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of DDIT3 mRNA Sodium Selenite results in increased expression of DDIT3 mRNA; Sodium Selenite results in increased expression of DDIT3 protein
|
CTD |
PMID:16705456 PMID:24383545 PMID:28161410 PMID:34520753 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DDIT4L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225
|
|
| G
|
Ddrgk1
|
DDRGK domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDRGK1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:138,315,006...138,336,691
Ensembl chr 3:138,315,282...138,335,766
|
|
| G
|
Ddx18
|
DEAD-box helicase 18
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDX18 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:35,282,391...35,296,038
Ensembl chr13:35,282,467...35,295,972
|
|
| G
|
Ddx3x
|
DEAD-box helicase 3, X-linked
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDX3X mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:12,152,346...12,165,983
Ensembl chr X:12,152,346...12,165,983
|
|
| G
|
Ddx3y
|
DEAD box helicase 3, Y-linked
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDX3Y mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr Y:1,190,042...1,210,699
Ensembl chr Y:1,191,242...1,210,650
|
|
| G
|
Ddx41
|
DEAD-box helicase 41
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDX41 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,108,074...9,113,561
|
|
| G
|
Ddx47
|
DEAD-box helicase 47
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DDX47 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:169,577,013...169,589,473
Ensembl chr 4:169,577,003...169,590,474
|
|
| G
|
Depdc5
|
DEP domain containing 5, GATOR1 subcomplex subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DEPDC5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:81,956,777...82,087,392
Ensembl chr14:81,956,777...82,087,246
|
|
| G
|
Dffb
|
DNA fragmentation factor subunit beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DFFB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225
|
|
| G
|
Dgka
|
diacylglycerol kinase, alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DGKA mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569
|
|
| G
|
Dgkq
|
diacylglycerol kinase, theta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DGKQ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:1,203,380...1,217,536
Ensembl chr14:1,203,565...1,218,024
|
|
| G
|
Dgkz
|
diacylglycerol kinase zeta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DGKZ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951
|
|
| G
|
Dhrs9
|
dehydrogenase/reductase 9
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of DHRS9 mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376
|
|
| G
|
Dhx30
|
DExH-box helicase 30
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DHX30 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,943,186...118,975,319
Ensembl chr 8:118,943,187...118,975,592
|
|
| G
|
Dhx36
|
DEAH-box helicase 36
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DHX36 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:149,006,089...149,044,192
Ensembl chr 2:149,006,089...149,044,191
|
|
| G
|
Dimt1
|
DIM1 rRNA methyltransferase and ribosome maturation factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DIMT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:40,076,622...40,101,792
Ensembl chr 2:40,076,570...40,101,787
|
|
| G
|
Dio2
|
iodothyronine deiodinase 2
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Colforsin results in increased activity of DIO2 protein]]
|
CTD |
PMID:18420745 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
| G
|
Dio3
|
iodothyronine deiodinase 3
|
multiple interactions
|
EXP
|
Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Sodium Selenite] promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased activity of DIO3 protein]
|
CTD |
PMID:18420745 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
|
|
| G
|
Dkc1
|
dyskerin pseudouridine synthase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DKC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:157,751,651...157,757,796
Ensembl chr Y:380,743...385,405 Ensembl chr X:380,743...385,405
|
|
| G
|
Dlg4
|
discs large MAGUK scaffold protein 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DLG4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
|
|
| G
|
Dlgap2
|
DLG associated protein 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DLGAP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:81,489,059...82,198,693
Ensembl chr16:81,494,649...82,198,684
|
|
| G
|
Dlk2
|
delta like non-canonical Notch ligand 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DLK2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149
|
|
| G
|
Dmwd
|
DM1 locus, WD repeat containing
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DMWD mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:87,850,475...87,857,263
Ensembl chr 1:87,850,604...87,857,624
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DNMT1 mRNA; Sodium Selenite results in decreased expression of DNMT1 protein
|
CTD |
PMID:18676679 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DNMT3A mRNA
|
CTD |
PMID:18676679 PMID:37142062 |
|
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
| G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DNMT3B mRNA
|
CTD |
PMID:37142062 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313
|
|
| G
|
Dnpep
|
aspartyl aminopeptidase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DNPEP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:84,248,581...84,257,484
Ensembl chr 9:84,233,486...84,256,977
|
|
| G
|
Dnph1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DNPH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631
|
|
| G
|
Dnttip2
|
deoxynucleotidyltransferase, terminal, interacting protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DNTTIP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:213,058,975...213,071,020
Ensembl chr 2:213,058,962...213,071,016
|
|
| G
|
Dock4
|
dedicator of cytokinesis 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DOCK4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772
|
|
| G
|
Dph3
|
diphthamide biosynthesis 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DPH3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:7,294,580...7,299,996
Ensembl chr16:7,294,580...7,299,996
|
|
| G
|
Dpp3
|
dipeptidylpeptidase 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DPP3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:211,634,067...211,657,898
Ensembl chr 1:211,634,068...211,658,310
|
|
| G
|
Dram1
|
DNA-damage regulated autophagy modulator 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DRAM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354
|
|
| G
|
Dsc2
|
desmocollin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DSC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
|
|
| G
|
Dync1li2
|
dynein, cytoplasmic 1 light intermediate chain 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of DYNC1LI2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:538,207...561,110
Ensembl chr19:538,211...561,107
|
|
| G
|
Dync2li1
|
dynein cytoplasmic 2 light intermediate chain 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DYNC2LI1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:15,745,350...15,778,166
Ensembl chr 6:15,745,350...15,778,166
|
|
| G
|
Dynlt3
|
dynein light chain Tctex-type 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of DYNLT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:16,000,425...16,009,632
Ensembl chr X:16,000,395...16,009,627
|
|
| G
|
E2f3
|
E2F transcription factor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of E2F3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725
|
|
| G
|
Ebf1
|
EBF transcription factor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EBF1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702
|
|
| G
|
Ebpl
|
EBP like
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EBPL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537
|
|
| G
|
Ech1
|
enoyl-CoA hydratase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ECH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
|
|
| G
|
Ecsit
|
ECSIT signaling integrator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ECSIT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:28,881,594...28,894,397
|
|
| G
|
Eda2r
|
ectodysplasin A2 receptor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EDA2R mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr X:66,225,557...66,280,674
Ensembl chr X:66,236,111...66,280,663
|
|
| G
|
Ednra
|
endothelin receptor type A
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of EDNRA mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Edrf1
|
erythroid differentiation regulatory factor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EDRF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:197,869,873...197,908,693
Ensembl chr 1:197,870,962...197,908,731
|
|
| G
|
Eef1akmt3
|
EEF1A lysine methyltransferase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EEF1AKMT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:64,738,726...64,749,904
Ensembl chr 7:64,740,232...64,750,055
|
|
| G
|
Eef1e1
|
eukaryotic translation elongation factor 1 epsilon 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EEF1E1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EEF2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Efcab14
|
EF-hand calcium binding domain 14
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EFCAB14 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:134,454,908...134,493,714
Ensembl chr 5:134,454,924...134,495,384
|
|
| G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of EGF mRNA]
|
CTD |
PMID:17997286 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EGFR mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of EGR1 mRNA Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of EGR1 mRNA]
|
CTD |
PMID:18175754 PMID:20067779 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr4
|
early growth response 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EGR4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368
|
|
| G
|
Ei24
|
EI24, autophagy associated transmembrane protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EI24 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214
|
|
| G
|
Eid2
|
EP300 interacting inhibitor of differentiation 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EID2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,665,837...92,667,162
Ensembl chr 1:92,665,481...92,675,307
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EIF2AK3 protein
|
CTD |
PMID:34520753 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases phosphorylation multiple interactions
|
ISO
|
Sodium Selenite results in increased phosphorylation of EIF2S1 protein 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:34520753 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF3A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3h
|
eukaryotic translation initiation factor 3, subunit H
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF3H mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:84,980,891...85,071,546
|
|
| G
|
Eif4a3
|
eukaryotic translation initiation factor 4A3
|
increases expression
|
EXP
|
Sodium Selenite deficiency results in increased expression of EIF4A3 protein
|
CTD |
PMID:19716792 |
|
NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207
|
|
| G
|
Eif4b
|
eukaryotic translation initiation factor 4B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF4B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
|
|
| G
|
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF4EBP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:29,922,260...29,942,922
Ensembl chr20:29,922,260...29,942,922
|
|
| G
|
Eif4g1
|
eukaryotic translation initiation factor 4 gamma 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF4G1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
|
|
| G
|
Eif4g2
|
eukaryotic translation initiation factor 4, gamma 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF4G2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252
|
|
| G
|
Eif4h
|
eukaryotic translation initiation factor 4H
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF4H mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346
|
|
| G
|
Eif5b
|
eukaryotic translation initiation factor 5B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EIF5B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583
|
|
| G
|
Elfn2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ELFN2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,101,998...112,153,280
Ensembl chr 7:112,074,331...112,153,451
|
|
| G
|
Elp3
|
elongator acetyltransferase complex subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ELP3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:43,930,234...43,992,065
Ensembl chr15:43,930,234...43,992,214
|
|
| G
|
Emb
|
embigin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EMB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920
|
|
| G
|
Emc10
|
ER membrane protein complex subunit 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EMC10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:104,119,040...104,125,409
Ensembl chr 1:104,119,040...104,125,368
|
|
| G
|
Emc3
|
ER membrane protein complex subunit 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EMC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:148,218,686...148,234,595
Ensembl chr 4:148,217,395...148,234,595
|
|
| G
|
Emc8
|
ER membrane protein complex subunit 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EMC8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:65,620,365...65,630,328
Ensembl chr19:65,620,375...65,630,235
|
|
| G
|
Emilin3
|
elastin microfibril interfacer 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EMILIN3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:169,978,488...169,984,718
Ensembl chr 3:169,978,672...169,984,488
|
|
| G
|
En2
|
engrailed homeobox 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EN2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:7,954,953...7,960,793
Ensembl chr 4:7,954,953...7,960,793
|
|
| G
|
Enpep
|
glutamyl aminopeptidase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ENPEP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218
|
|
| G
|
Entpd7
|
ectonucleoside triphosphate diphosphohydrolase 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ENTPD7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:252,508,594...252,550,269
Ensembl chr 1:252,508,594...252,550,269
|
|
| G
|
Entr1
|
endosome associated trafficking regulator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ENTR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:29,599,059...29,605,780
Ensembl chr 3:29,599,059...29,605,898
|
|
| G
|
Ep300
|
E1A binding protein p300
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EP300 mRNA; Sodium Selenite results in decreased expression of EP300 protein
|
CTD |
PMID:10344722 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EPAS1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Eps8
|
EGFR pathway substrate 8, signaling adaptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EPS8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160
|
|
| G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ERCC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
|
|
| G
|
Ercc3
|
ERCC excision repair 3, TFIIH core complex helicase subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ERCC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898
|
|
| G
|
Ereg
|
epiregulin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EREG mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
|
|
| G
|
Erlin1
|
ER lipid raft associated 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ERLIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:252,870,356...252,905,681
Ensembl chr 1:252,870,356...252,905,947
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
EXP
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of ESR1 mRNA]
|
CTD |
PMID:30526071 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of ESR2 mRNA
|
CTD |
PMID:16928829 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Esyt2
|
extended synaptotagmin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ESYT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:143,359,870...143,455,600
Ensembl chr 6:143,362,694...143,455,593
|
|
| G
|
Etfb
|
electron transfer flavoprotein subunit beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ETFB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659
|
|
| G
|
Etfdh
|
electron transfer flavoprotein dehydrogenase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ETFDH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770
|
|
| G
|
Exog
|
exo/endonuclease G
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of EXOG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:128,062,688...128,082,529
Ensembl chr 8:128,059,126...128,083,460
|
|
| G
|
Exosc6
|
exosome component 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EXOSC6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:55,931,523...55,932,937
Ensembl chr19:55,931,523...55,932,937
|
|
| G
|
Ext2
|
exostosin glycosyltransferase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EXT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596
|
|
| G
|
Ezh1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of EZH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,626,308...86,652,620
|
|
| G
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of F2RL2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473
|
|
| G
|
F8a1
|
coagulation factor VIII-associated 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of F8A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:155,977,859...155,979,373
Ensembl chr X:155,976,941...156,108,974
|
|
| G
|
Faap100
|
FA core complex associated protein 100
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAAP100 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,140,820...106,152,500
Ensembl chr10:106,142,040...106,151,607
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
increases expression multiple interactions
|
EXP ISO
|
Sodium Selenite results in increased expression of FABP4 mRNA Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA]
|
CTD |
PMID:31419397 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Faf1
|
Fas associated factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:129,654,677...130,018,604
Ensembl chr 5:129,654,445...130,020,516
|
|
| G
|
Fam117a
|
family with sequence similarity 117, member A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAM117A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:80,778,229...80,822,119
Ensembl chr10:80,755,883...80,822,119
|
|
| G
|
Fam135b
|
family with sequence similarity 135, member B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAM135B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:105,269,831...105,538,716
Ensembl chr 7:105,269,831...105,538,165
|
|
| G
|
Fam162a
|
family with sequence similarity 162, member A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAM162A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560
|
|
| G
|
Fam98c
|
family with sequence similarity 98, member C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FAM98C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:93,580,286...93,583,894
Ensembl chr 1:93,580,287...93,583,831
|
|
| G
|
Farp1
|
FERM, ARH/RhoGEF and pleckstrin domain protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FARP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:104,531,196...104,770,148
Ensembl chr15:104,531,813...104,770,147
|
|
| G
|
Farsb
|
phenylalanyl-tRNA synthetase subunit beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FARSB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:87,336,321...87,395,546
Ensembl chr 9:87,336,326...87,395,505
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fat2
|
FAT atypical cadherin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FAT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902
|
|
| G
|
Fbl
|
fibrillarin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FBL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506
|
|
| G
|
Fbxl12
|
F-box and leucine-rich repeat protein 12
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FBXL12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:27,453,042...27,459,136
Ensembl chr 8:27,445,823...27,457,772
|
|
| G
|
Fbxl5
|
F-box and leucine-rich repeat protein 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FBXL5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:71,517,452...71,559,850
Ensembl chr14:71,480,270...71,560,652
|
|
| G
|
Fbxo32
|
F-box protein 32
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FBXO32 mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491
|
|
| G
|
Fbxo5
|
F-box protein 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FBXO5 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
|
|
| G
|
Fcer1a
|
Fc epsilon receptor Ia
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FCER1A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:88,218,427...88,224,723
Ensembl chr13:88,218,420...88,224,681
|
|
| G
|
Fdxr
|
ferredoxin reductase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FDXR mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542
|
|
| G
|
Fermt2
|
FERM domain containing kindlin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FERMT2 mRNA
|
CTD |
PMID:18175754 PMID:23274088 |
|
NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115
|
|
| G
|
Fez1
|
fasciculation and elongation protein zeta 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FEZ1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of FGFR2 mRNA]
|
CTD |
PMID:17997286 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FHL2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FLT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Fmn2
|
formin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FMN2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:88,986,863...89,303,789
Ensembl chr13:88,986,842...89,303,789
|
|
| G
|
Fmo3
|
flavin containing dimethylaniline monoxygenase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FMO3 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256
|
|
| G
|
Fnbp1
|
formin binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FNBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117
|
|
| G
|
Fnbp1l
|
formin binding protein 1-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FNBP1L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051
|
|
| G
|
Fnta
|
farnesyltransferase, CAAX box, subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FNTA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:72,767,864...72,786,193
Ensembl chr16:72,767,627...72,788,229
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of FOS mRNA [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of FOS mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of FOS protein Sodium Selenite results in increased expression of FOS protein Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] Buthionine Sulfoximine inhibits the reaction [Sodium Selenite results in increased expression of FOS mRNA]; Glutathione affects the reaction [Sodium Selenite results in increased expression of FOS mRNA]
|
CTD |
PMID:11769627 PMID:16542727 PMID:16944776 PMID:18175754 PMID:18449455 PMID:28757135 More...
|
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxn3
|
forkhead box N3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of CHES1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040
|
|
| G
|
Foxo1
|
forkhead box O1
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased phosphorylation of FOXO1 protein]
|
CTD |
PMID:26522834 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxp1
|
forkhead box P1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FOXP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272
|
|
| G
|
Foxred2
|
FAD-dependent oxidoreductase domain containing 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FOXRED2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:111,402,322...111,417,988
|
|
| G
|
Frs2
|
fibroblast growth factor receptor substrate 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FRS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:54,597,182...54,678,656
Ensembl chr 7:54,597,182...54,678,774
|
|
| G
|
Fsaf1
|
40S small subunit processome assembly factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FSAF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:69,705,313...69,719,894
Ensembl chr19:69,705,321...69,720,093
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of FSHB protein]
|
CTD |
PMID:12883085 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Fstl1
|
follistatin-like 1
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of FSTL1 protein]
|
CTD |
PMID:28285737 |
|
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
|
|
| G
|
Fus
|
Fus RNA binding protein
|
affects localization multiple interactions
|
ISO
|
Sodium Selenite affects the localization of FUS protein Sodium Selenite promotes the reaction [TUBA4A protein binds to FUS protein]
|
CTD |
PMID:31585128 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fut4-ps1
|
fucosyltransferase 4, pseudogene 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FUT6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:1,656,732...1,659,085
|
|
| G
|
Fut7
|
fucosyltransferase 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of FUT7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:28,635,913...28,640,407
Ensembl chr 3:28,637,107...28,641,388
|
|
| G
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of FXYD5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364
|
|
| G
|
Fzd1
|
frizzled class receptor 1
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of FZD1 mRNA Sodium Selenite results in decreased expression of FZD1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
multiple interactions
|
EXP ISO
|
Sodium Selenite inhibits the reaction [Alloxan results in increased activity of G6PC1 protein] Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of G6PC1 mRNA]
|
CTD |
PMID:25779343 PMID:26522834 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Gab1
|
GRB2-associated binding protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GAB1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GAD1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GADD45A mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gak
|
cyclin G associated kinase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GAK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:1,234,272...1,308,492
Ensembl chr14:1,234,266...1,323,974
|
|
| G
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GALNT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
|
|
| G
|
Galnt11
|
polypeptide N-acetylgalactosaminyltransferase 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GALNT11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:10,571,464...10,604,974
Ensembl chr 4:10,571,464...10,604,974
|
|
| G
|
Galr3
|
galanin receptor 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GALR3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,483,183...112,496,359
Ensembl chr 7:112,485,672...112,488,136
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of GAPDH mRNA]
|
CTD |
PMID:38945390 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gars1
|
glycyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GARS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
|
|
| G
|
Gas6
|
growth arrest specific 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GAS6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
|
|
| G
|
Gata3
|
GATA binding protein 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GATA3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GATM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gba3
|
glucosylceramidase beta 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GBA3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:64,787,601...64,934,043
Ensembl chr14:64,787,601...64,934,043
|
|
| G
|
Gbx2
|
gastrulation brain homeobox 2
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of GBX2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 9:97,957,304...97,959,883
Ensembl chr 9:97,957,304...97,959,883
|
|
| G
|
Gcc1
|
GRIP and coiled-coil domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GCC1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,996,267...58,002,185
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GCLC mRNA
|
CTD |
PMID:18449455 PMID:24383545 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gcnt3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GCNT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GDF15 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDNF mRNA]
|
CTD |
PMID:17997286 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
multiple interactions decreases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] Sodium Selenite results in decreased expression of GFAP mRNA
|
CTD |
PMID:17997286 PMID:18209489 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Ggps1
|
geranylgeranyl diphosphate synthase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GGPS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:55,958,750...55,982,762
Ensembl chr17:55,958,755...55,971,709
|
|
| G
|
Ghr
|
growth hormone receptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GHR mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Gimap1
|
GTPase, IMAP family member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GIMAP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:79,018,473...79,022,360
Ensembl chr 4:79,018,202...79,022,525
|
|
| G
|
Gjb4
|
gap junction protein, beta 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GJB4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:144,948,231...144,964,014
Ensembl chr 5:144,951,184...144,964,097
|
|
| G
|
Glg1
|
golgi glycoprotein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GLG1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528
|
|
| G
|
Gli2
|
GLI family zinc finger 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GLI2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418
|
|
| G
|
Glod4
|
glyoxalase domain containing 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GLOD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:61,575,770...61,594,111
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GLUD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Gmfg
|
glia maturation factor, gamma
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GMFG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,856,154...92,866,722
Ensembl chr 1:92,854,995...92,866,723
|
|
| G
|
Gmnn
|
geminin, DNA replication inhibitor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GMNN mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068
|
|
| G
|
Gmps
|
guanine monophosphate synthase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GMPS mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:150,587,824...150,641,564
Ensembl chr 2:150,587,854...150,648,986
|
|
| G
|
Golga5
|
golgin A5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GOLGA5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:127,377,244...127,405,404
Ensembl chr 6:127,377,236...127,405,403
|
|
| G
|
Golga7
|
golgin A7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GOLGA7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:75,469,794...75,485,055
Ensembl chr16:75,469,838...75,485,069
|
|
| G
|
Gon4l
|
gon-4 like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GON4L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:176,531,274...176,604,446
Ensembl chr 2:176,531,274...176,604,444
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of GOT1 mRNA Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of GOT1 protein]
|
CTD |
PMID:24383545 PMID:33847390 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpatch11
|
G patch domain containing 11
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GPATCH11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:21,982,074...21,995,562
Ensembl chr 6:21,985,202...21,995,381
|
|
| G
|
Gpbp1
|
GC-rich promoter binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:44,756,861...44,824,315
|
|
| G
|
Gpc1
|
glypican 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933
|
|
| G
|
Gper1
|
G protein-coupled estrogen receptor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPER1 protein
|
CTD |
PMID:37142062 |
|
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144
|
|
| G
|
Gphb5
|
glycoprotein hormone subunit beta 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPHB5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:99,865,691...99,870,308
Ensembl chr 6:99,865,691...99,870,308
|
|
| G
|
Gpr132
|
G protein-coupled receptor 132
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPR132 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:137,745,142...137,763,037
Ensembl chr 6:137,745,241...137,763,157
|
|
| G
|
Gpr161
|
G protein-coupled receptor 161
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GPR161 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:80,111,271...80,156,517
Ensembl chr13:80,117,114...80,152,861
|
|
| G
|
Gpr19
|
G protein-coupled receptor 19
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GPR19 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:169,442,278...169,468,805
Ensembl chr 4:169,436,658...169,471,249
|
|
| G
|
Gpr39
|
G protein-coupled receptor 39
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GPR39 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:39,667,908...39,879,944
Ensembl chr13:39,667,909...39,880,902
|
|
| G
|
Gpr65
|
G-protein coupled receptor 65
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPR65 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:123,245,534...123,262,758
Ensembl chr 6:123,219,633...123,266,285
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of GPT mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of GPT protein]; Sodium Selenite inhibits the reaction [Matrines results in increased expression of GPT protein] [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of GPT protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of GPT protein]
|
CTD |
PMID:18175754 PMID:30031400 PMID:33847390 PMID:36464106 PMID:37716422 PMID:38945390 More...
|
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions increases expression decreases expression increases activity affects expression affects activity
|
ISO EXP
|
GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased activity of GPX1 protein]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased expression of GPX1 protein] Sodium selenite increases expression of GPX1 protein in epithelial cells Sodium Selenite deficiency results in decreased expression of GPX1 protein Sodium Selenite results in increased expression of GPX1 mRNA; Sodium Selenite results in increased expression of GPX1 protein [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of GPX1 mRNA]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of GPX1 mRNA]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in decreased activity of GPX1 protein] Sodium Selenite affects the expression of GPX1 mRNA Sodium Selenite affects the activity of GPX1 protein SEPHS1 protein affects the reaction [Sodium Selenite results in increased expression of GPX1 protein]; Sodium Selenite affects the reaction [GPX1 gene mutant form affects the susceptibility to Paraquat]; Sodium Selenite inhibits the reaction [Diethylhexyl Phthalate results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [Streptozocin results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [Streptozocin results in decreased expression of GPX1 mRNA]; Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of GPX1 mRNA]
|
CTD RGD |
PMID:12449240 PMID:12654481 PMID:12667700 PMID:12896980 PMID:15203190 PMID:16039982 PMID:16443359 PMID:16632112 PMID:16757516 PMID:18400727 PMID:18481333 PMID:18514395 PMID:18789669 PMID:19033020 PMID:19716792 PMID:20659492 PMID:21669866 PMID:23603382 PMID:24140496 PMID:24535002 PMID:28544404 PMID:31585128 PMID:33847390 PMID:36736877 PMID:37967787 PMID:38945390 PMID:20530237 More...
|
RGD:151708728 |
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GPX2 protein
|
CTD |
PMID:25187657 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
multiple interactions increases activity increases expression
|
ISO
|
GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased activity of GPX3 protein]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased expression of GPX3 protein] Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of GPX3 mRNA]
|
CTD |
PMID:16952904 PMID:17536041 PMID:18400727 PMID:38945390 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions increases expression affects expression affects activity affects response to substance
|
ISO EXP
|
alpha-Tocopherol inhibits the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]; Arachidonic Acid promotes the reaction [Sodium Selenite results in increased expression of and results in increased activity of GPX4 protein]; Docosahexaenoic Acids inhibits the reaction [Sodium Selenite results in increased expression of and results in increased activity of GPX4 protein]; Docosahexaenoic Acids promotes the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased activity of GPX1 protein]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased activity of GPX3 protein]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased expression of GPX1 protein]; GPX4 gene SNP inhibits the reaction [Sodium Selenite results in increased expression of GPX3 protein]; IL1B protein promotes the reaction [Sodium Selenite results in increased expression of and results in increased activity of GPX4 protein]; IL1B protein promotes the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]; Linoleic Acids, Conjugated promotes the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]; Sodium Selenite inhibits the reaction [Matrines results in decreased expression of GPX4 protein]; Sodium Selenite results in increased expression of and results in increased activity of GPX4 protein; TNF protein affects the reaction [Sodium Selenite results in increased activity of GPX4 protein]; TNF protein affects the reaction [Sodium Selenite results in increased expression of GPX4 mRNA] [Sodium Selenite co-treated with Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of GPX4 mRNA; Sodium Selenite inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein]; Sodium Selenite inhibits the reaction [sodium aescinate results in decreased expression of GPX4 protein] Sodium Selenite results in increased expression of GPX4 mRNA; Sodium Selenite results in increased expression of GPX4 protein Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of GPX4 mRNA]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of GPX4 mRNA]; Sodium Selenite inhibits the reaction [Matrines results in decreased expression of GPX4 protein]; Sodium Selenite inhibits the reaction [sodium aescinate results in decreased expression of GPX4 protein] Sodium Selenite affects the expression of GPX4 protein polymorphism Sodium Selenite affects the activity of GPX4 protein polymorphism GPX4 gene SNP affects the susceptibility to Sodium Selenite
|
CTD |
PMID:14642406 PMID:18400727 PMID:18514395 PMID:20643113 PMID:34970773 PMID:37716422 PMID:38364601 PMID:38723914 PMID:38945390 PMID:39549767 More...
|
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gramd1b
|
GRAM domain containing 1B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRAMD1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:49,551,642...49,790,965
Ensembl chr 8:49,556,332...49,791,052
|
|
| G
|
Gramd2b
|
GRAM domain containing 2B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRAMD2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:52,082,128...52,180,056
Ensembl chr18:52,082,029...52,180,054
|
|
| G
|
Gramd4
|
GRAM domain containing 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRAMD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:119,030,225...119,103,875
Ensembl chr 7:119,030,225...119,103,875
|
|
| G
|
Grb10
|
growth factor receptor bound protein 10
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRB10 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
|
|
| G
|
Grb2
|
growth factor receptor bound protein 2
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRB2 mRNA Sodium Selenite results in increased expression of GRB2 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138
|
|
| G
|
Grhl1
|
grainyhead-like transcription factor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GRHL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264
|
|
| G
|
Grik1
|
glutamate ionotropic receptor kainate type subunit 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GRIK1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517
|
|
| G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GRIK3 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
| G
|
Grk6
|
G protein-coupled receptor kinase 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GRK6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GSK3B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gskip
|
GSK3B interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GSKIP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:130,357,241...130,373,221
Ensembl chr 6:130,370,042...130,373,873
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
increases expression decreases activity increases activity multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of GSR protein Sodium Selenite results in decreased activity of GSR protein Sodium Selenite results in increased activity of GSR protein Methylmercury Compounds inhibits the reaction [Sodium Selenite results in increased activity of GSR protein] lupeol inhibits the reaction [Sodium Selenite results in decreased activity of GSR protein]; Sodium Selenite inhibits the reaction [Streptozocin results in decreased activity of GSR protein]
|
CTD |
PMID:20620206 PMID:21215776 PMID:22476978 PMID:26697995 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstk1
|
glutathione S-transferase kappa 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GSTK1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
|
|
| G
|
Gstm5
|
glutathione S-transferase, mu 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GSTM3 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GSTO1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions increases expression decreases methylation
|
ISO
|
Sodium Selenite affects the reaction [H3-4 protein modified form binds to GSTP1 promoter]; Sodium Selenite inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene] Sodium Selenite results in increased expression of GSTP1 mRNA; Sodium Selenite results in increased expression of GSTP1 protein Sodium Selenite results in decreased methylation of GSTP1 promoter
|
CTD |
PMID:18676679 PMID:22401947 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GSTT1 mRNA
|
CTD |
PMID:16705456 PMID:24383545 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gtf2f2
|
general transcription factor IIF subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GTF2F2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:57,615,361...57,736,477
Ensembl chr15:57,614,841...57,736,516
|
|
| G
|
Gtpbp4
|
GTP binding protein 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GTPBP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:65,997,472...66,019,530
Ensembl chr17:66,276,566...66,289,637
|
|
| G
|
Gtpbp6
|
GTP binding protein 6 (putative)
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GTPBP6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:52,234,646...52,238,578
Ensembl chr12:52,234,572...52,238,578
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GUCY1A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
Gulp1
|
GULP PTB domain containing engulfment adaptor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of GULP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452
|
|
| G
|
Gzmk
|
granzyme K
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of GZMK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:46,573,997...46,582,015
Ensembl chr 2:46,573,997...46,582,015
|
|
| G
|
H1f0
|
H1.0 linker histone
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of H1-0 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of H2AX mRNA Sodium Selenite results in increased expression of H2AX protein
|
CTD |
PMID:18175754 PMID:37142062 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2az2
|
H2A.Z variant histone 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of H2AZ2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:85,507,228...85,526,166
Ensembl chr14:85,507,228...85,526,207 Ensembl chr16:85,507,228...85,526,207
|
|
| G
|
H2bc6
|
H2B clustered histone 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of H2BC6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:41,948,813...41,949,276
Ensembl chr17:47,392,229...47,449,312
|
|
| G
|
H3f4
|
H3.4 histone, cluster member
|
multiple interactions decreases methylation increases acetylation
|
ISO
|
Sodium Selenite affects the reaction [H3-4 protein modified form binds to GSTP1 promoter] Sodium Selenite results in decreased methylation of H3-4 Sodium Selenite results in increased acetylation of H3-4
|
CTD |
PMID:18676679 |
|
NCBI chr10:44,240,282...44,240,842
|
|
| G
|
H4c14
|
H4 clustered histone 14
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of H4C2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:186,520,468...186,520,863
Ensembl chr 4:171,403,627...171,403,938 Ensembl chr17:171,403,627...171,403,938 Ensembl chr17:171,403,627...171,403,938 Ensembl chr17:171,403,627...171,403,938
|
|
| G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HADHA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
| G
|
Haus3
|
HAUS augmin-like complex, subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HAUS3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:80,805,036...80,977,012
Ensembl chr14:80,806,040...80,977,015
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [sodium aescinate results in increased expression of HAVCR1]
|
CTD |
PMID:38364601 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hax1
|
HCLS1 associated protein X-1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HAX1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:177,731,918...177,735,670
Ensembl chr 2:177,731,921...177,735,390
|
|
| G
|
Hbe1
|
hemoglobin subunit epsilon 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HBE1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:167,694,820...167,872,091
Ensembl chr 1:167,694,825...167,696,280
|
|
| G
|
Hbg1
|
hemoglobin subunit gamma 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HBG1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:167,683,760...167,685,315
Ensembl chr 1:167,683,760...167,706,139
|
|
| G
|
Hbq1b
|
hemoglobin subunit theta 1B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HBQ1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:15,838,752...15,840,074
Ensembl chr10:15,825,223...15,825,858
|
|
| G
|
Hbs1l
|
HBS1-like translational GTPase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HBS1L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:17,912,139...17,989,651
Ensembl chr 1:17,912,070...17,989,646
|
|
| G
|
Hcrt
|
hypocretin neuropeptide precursor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HCRT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524
|
|
| G
|
Hdac3
|
histone deacetylase 3
|
decreases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in decreased expression of HDAC3 protein Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of HDAC3 mRNA]
|
CTD |
PMID:18676679 PMID:39354181 |
|
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025
|
|
| G
|
Hdac6
|
histone deacetylase 6
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of HDAC6 mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of HDAC6 protein]
|
CTD |
PMID:39354181 |
|
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
|
|
| G
|
Hdac7
|
histone deacetylase 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HDAC7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017
|
|
| G
|
Heatr1
|
HEAT repeat containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HEATR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186
|
|
| G
|
Hebp2
|
heme binding protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HEBP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:15,014,729...15,021,523
Ensembl chr 1:15,014,729...15,021,523
|
|
| G
|
Heca
|
hdc homolog, cell cycle regulator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HECA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:14,345,306...14,395,226
Ensembl chr 1:14,345,306...14,395,191
|
|
| G
|
Herc6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HERC6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993
|
|
| G
|
Hes2
|
hes family bHLH transcription factor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HES2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:167,947,948...167,964,660
Ensembl chr 5:167,949,918...167,955,601
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
multiple interactions decreases expression
|
ISO
|
Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of HGF protein] [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of HGF mRNA Sodium Selenite results in decreased expression of HGF mRNA
|
CTD |
PMID:16757516 PMID:18175754 PMID:23274088 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hic1
|
HIC ZBTB transcriptional repressor 1
|
multiple interactions increases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in increased expression of HIC1 mRNA Sodium Selenite results in increased expression of HIC1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448
|
|
| G
|
Hint1
|
histidine triad nucleotide binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HINT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642 Ensembl chr10:93,430,926...93,431,642
|
|
| G
|
Hipk2
|
homeodomain interacting protein kinase 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HIPK2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
|
|
| G
|
Hmbox1
|
homeobox containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HMBOX1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr15:43,243,503...43,376,011
Ensembl chr15:43,222,470...43,376,011
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP ISO
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of HMGCR mRNA]
|
CTD |
PMID:30031400 PMID:36464106 PMID:38945390 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmgn5
|
high mobility group nucleosome binding domain 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HMGN5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:78,161,439...78,170,613
Ensembl chr X:78,161,442...78,169,924
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
EXP ISO
|
[zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased expression of HMOX1 protein]; Sodium Selenite inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased expression of HMOX1 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of HMOX1 protein]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 mRNA]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 protein] [Sodium Selenite co-treated with Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of HMOX1 mRNA
|
CTD |
PMID:23603382 PMID:36646412 PMID:36736877 PMID:38945390 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hmox2
|
heme oxygenase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HMOX2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:11,303,512...11,337,640
Ensembl chr10:11,303,512...11,318,800
|
|
| G
|
Hnrnpd
|
heterogeneous nuclear ribonucleoprotein D
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HNRNPD mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066
|
|
| G
|
Hnrnpk
|
heterogeneous nuclear ribonucleoprotein K
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HNRNPK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565
|
|
| G
|
Hoxb1
|
homeo box B1
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of HOXB1 mRNA Sodium Selenite results in decreased expression of HOXB1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:81,827,915...81,830,404
Ensembl chr10:81,827,915...81,830,404
|
|
| G
|
Hoxb6
|
homeo box B6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HOXB6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:81,755,263...81,763,999
|
|
| G
|
Hoxd3
|
homeo box D3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HOXD3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:80,041,598...80,057,700
Ensembl chr 3:80,046,126...80,057,700
|
|
| G
|
Hpgd
|
15-hydroxyprostaglandin dehydrogenase
|
multiple interactions increases expression
|
ISO
|
N-TUTCA2 gene mutant form inhibits the reaction [Sodium Selenite results in increased expression of HPGD mRNA]; N-TUTCA2 gene mutant form inhibits the reaction [Sodium Selenite results in increased expression of HPGD protein] Sodium Selenite results in increased expression of HPGD mRNA; Sodium Selenite results in increased expression of HPGD protein
|
CTD |
PMID:25187657 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831
|
|
| G
|
Hpgds
|
hematopoietic prostaglandin D synthase
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of HPGDS mRNA; Sodium Selenite results in increased expression of HPGDS protein SEPHS2 protein affects the reaction [Sodium Selenite results in increased expression of HPGDS protein]
|
CTD |
PMID:21669866 |
|
NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501
|
|
| G
|
Hpn
|
hepsin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HPN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199
|
|
| G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
multiple interactions
|
EXP ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of HSD11B2 protein
|
CTD |
PMID:35384129 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
| G
|
Hsd17b1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of HSD17B1 mRNA]
|
CTD |
PMID:39354181 |
|
NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSP90AB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of HSPA2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSPA5 protein
|
CTD |
PMID:28161410 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSPA8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSPA9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspb9
|
heat shock protein family B (small) member 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSPB9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,141,603...86,142,248
Ensembl chr10:86,141,269...86,147,839
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HSPD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
|
CTD |
PMID:11888521 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Icos
|
inducible T-cell co-stimulator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ICOS mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:69,862,042...69,900,864
Ensembl chr 9:69,877,785...69,900,960
|
|
| G
|
Idua
|
alpha-L-iduronidase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of IDUA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:1,175,994...1,203,913
Ensembl chr14:1,176,577...1,204,066
|
|
| G
|
Ier3
|
immediate early response 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IER3 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Ifnar2
|
interferon alpha and beta receptor subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IFNAR2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:44,099,574...44,131,941
Ensembl chr11:44,099,753...44,131,937
|
|
| G
|
Ifnb1
|
interferon beta 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA]
|
CTD |
PMID:18279804 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
| G
|
Ifne
|
interferon, epsilon
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of IFNE mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:108,687,443...108,688,103
Ensembl chr 5:108,687,443...108,688,103
|
|
| G
|
Ifng
|
interferon gamma
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Sodium Selenite results in increased expression of IFNG protein Sodium Selenite results in decreased expression of IFNG mRNA N-TUTCA2 gene mutant form inhibits the reaction [Sodium Selenite results in decreased expression of IFNG mRNA]; Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of SP1 protein]; Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA]; Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA]; Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of IFNG mRNA] Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of IFNG protein]
|
CTD |
PMID:15650415 PMID:18789669 PMID:24954678 PMID:25187657 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifrd1
|
interferon-related developmental regulator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IFRD1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
|
|
| G
|
Ifrd2
|
interferon-related developmental regulator 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IFRD2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
| G
|
Ift27
|
intraflagellar transport 27
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IFT27 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:111,619,077...111,634,936
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of IGF1 mRNA Sodium Selenite results in decreased expression of IGF1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of IGF2BP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:92,378,908...92,478,893
Ensembl chr11:92,378,908...92,478,867
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
multiple interactions
|
EXP
|
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA
|
CTD |
PMID:23859036 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Igfbp7
|
insulin-like growth factor binding protein 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IGFBP7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions decreases expression
|
EXP
|
Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of IL10 protein] Sodium Selenite results in decreased expression of IL10 protein
|
CTD |
PMID:24954678 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il10rb
|
interleukin 10 receptor subunit beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of IL10RB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:44,132,471...44,154,062
Ensembl chr11:44,132,189...44,154,053
|
|
| G
|
Il17ra
|
interleukin 17 receptor A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IL17R mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
|
|
| G
|
Il18
|
interleukin 18
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL18 mRNA]
|
CTD |
PMID:28285737 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
IL1B protein promotes the reaction [Sodium Selenite results in increased expression of and results in increased activity of GPX4 protein]; IL1B protein promotes the reaction [Sodium Selenite results in increased expression of GPX4 mRNA] [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased expression of IL1B protein] Sodium Selenite results in decreased expression of IL1B mRNA N-TUTCA2 gene mutant form promotes the reaction [Sodium Selenite deficiency results in increased expression of IL1B mRNA]; Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] Sodium Selenite results in increased expression of IL1B protein
|
CTD |
PMID:10871427 PMID:14642406 PMID:18789669 PMID:25187657 PMID:37967787 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il22ra2
|
interleukin 22 receptor subunit alpha 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of IL22RA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:16,172,238...16,228,009
Ensembl chr 1:16,184,113...16,197,950
|
|
| G
|
Il23a
|
interleukin 23 subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IL23A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
|
|
| G
|
Il27
|
interleukin 27
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IL27 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258
|
|
| G
|
Il3ra
|
interleukin 3 receptor subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IL3RA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:21,431,848...21,437,336
Ensembl chr12:21,431,848...21,437,250
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [IL6 protein results in increased activity of AR protein]; Sodium Selenite inhibits the reaction [IL6 protein results in increased expression of KLK3 protein]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein] [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in increased expression of IL6 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased secretion of IL6 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of IL6 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of IL6 protein]; Sodium Selenite promotes the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of IL6 protein]; zinc chloride inhibits the reaction [Sodium Selenite promotes the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of IL6 protein]] Sodium Selenite results in increased expression of IL6 mRNA
|
CTD |
PMID:16757516 PMID:17346688 PMID:18175754 PMID:24954678 PMID:26085057 PMID:33847390 PMID:36646412 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Impa2
|
inositol monophosphatase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IMPA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543
|
|
| G
|
Inha
|
inhibin subunit alpha
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of INHA mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009
|
|
| G
|
Inhbe
|
inhibin subunit beta E
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of INHBE mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions
|
EXP ISO
|
mitoquinone inhibits the reaction [Sodium Selenite inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; Sodium Selenite inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of INS1 protein]
|
CTD |
PMID:23795780 PMID:24140496 PMID:26522834 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ins2
|
insulin 2
|
multiple interactions decreases expression
|
ISO
|
INS protein inhibits the reaction [Sodium Selenite results in increased secretion of SELENOP protein] [Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein; [Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD2 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD3 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SOX9 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SP7 protein; TGFB1 protein affects the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein]; TGFB1 protein inhibits the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein] Sodium Selenite results in decreased expression of INS2 mRNA
|
CTD |
PMID:18972406 PMID:23274088 PMID:32324263 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Iqgap2
|
IQ motif containing GTPase activating protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IQGAP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649
|
|
| G
|
Irak4
|
interleukin-1 receptor-associated kinase 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IRAK4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:127,561,717...127,597,109
|
|
| G
|
Irf3
|
interferon regulatory factor 3
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased activity of IRF3 protein]; Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]; Sodium Selenite inhibits the reaction [Poly I-C results in increased activity of IRF3 protein]; Sodium Selenite inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; Sodium Selenite inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein]
|
CTD |
PMID:18279804 |
|
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] affects the phosphorylation of IRS1 protein]
|
CTD |
PMID:26522834 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Isca2
|
iron-sulfur cluster assembly 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ISCA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:110,149,593...110,151,103
Ensembl chr14:71,931,399...71,934,660 Ensembl chr 6:71,931,399...71,934,660
|
|
| G
|
Iscu
|
iron-sulfur cluster assembly enzyme
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ISCU mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:48,512,852...48,518,696
Ensembl chr12:48,512,852...48,518,696
|
|
| G
|
Itch
|
itchy E3 ubiquitin protein ligase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ITCH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:164,102,490...164,193,932
Ensembl chr 3:164,105,812...164,193,932
|
|
| G
|
Itga1
|
integrin subunit alpha 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ITGA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284
|
|
| G
|
Itga5
|
integrin subunit alpha 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ITGA5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
|
|
| G
|
Itk
|
IL2-inducible T-cell kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ITK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:31,254,667...31,316,004
Ensembl chr10:31,254,667...31,316,004
|
|
| G
|
Itpa
|
inosine triphosphatase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ITPA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:138,338,549...138,350,329
Ensembl chr 3:138,338,349...138,350,329
|
|
| G
|
Jtb
|
jumping translocation breakpoint
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of JTB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:177,983,033...177,987,250
Ensembl chr 2:177,982,635...177,987,905
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases phosphorylation increases expression decreases activity
|
ISO EXP
|
[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of JUN mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of JUN protein; [Sodium Selenite results in increased expression of JUN protein] which results in decreased activity of AR protein; MAPK8 protein affects the reaction [Sodium Selenite results in decreased activity of JUN protein] Sodium Selenite results in increased phosphorylation of JUN protein Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA] Sodium Selenite results in increased expression of JUN mRNA Buthionine Sulfoximine inhibits the reaction [Sodium Selenite results in increased expression of JUN mRNA]; Glutathione affects the reaction [Sodium Selenite results in increased expression of JUN mRNA]
|
CTD |
PMID:10644709 PMID:11769627 PMID:16944776 PMID:17346688 PMID:18449455 PMID:19276161 PMID:28757135 More...
|
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kat2a
|
lysine acetyltransferase 2A
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of KAT2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of KAT2A protein]
|
CTD |
PMID:39354181 |
|
NCBI chr10:86,132,535...86,140,877
Ensembl chr10:86,132,535...86,140,485
|
|
| G
|
Kat2b
|
lysine acetyltransferase 2B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KAT2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616
|
|
| G
|
Kbtbd11
|
kelch repeat and BTB domain containing 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KBTBD11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390
|
|
| G
|
Kcna2
|
potassium voltage-gated channel subfamily A member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:197,392,746...197,406,606
Ensembl chr 2:197,392,698...197,407,519
|
|
| G
|
Kcna5
|
potassium voltage-gated channel subfamily A member 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNA5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:160,996,950...161,044,408
|
|
| G
|
Kcnab1
|
potassium voltage-gated channel subfamily A regulatory beta subunit 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNAB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:151,446,975...151,913,636
Ensembl chr 2:151,446,947...151,913,636
|
|
| G
|
Kcnh4
|
potassium voltage-gated channel subfamily H member 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNH4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,168,644...86,188,476
Ensembl chr10:86,168,644...86,188,476
|
|
| G
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KCNJ10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678
|
|
| G
|
Kcnj13
|
potassium inwardly-rectifying channel, subfamily J, member 13
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNJ13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:95,509,228...95,528,400
Ensembl chr 9:95,510,877...95,520,817
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KCNN4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Kcns2
|
potassium voltage-gated channel, modifier subfamily S, member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KCNS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:67,907,492...67,913,562
Ensembl chr 7:67,906,467...67,931,276
|
|
| G
|
Kctd1
|
potassium channel tetramerization domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KCTD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:6,396,947...6,591,026
Ensembl chr18:6,396,947...6,515,191
|
|
| G
|
Kdm1b
|
lysine demethylase 1B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KDM1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:17,809,232...17,850,141
Ensembl chr17:17,809,232...17,850,068
|
|
| G
|
Kdm5a
|
lysine demethylase 5A
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of KDM5A mRNA Sodium Selenite results in increased expression of KDM5A mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 4:155,238,124...155,316,121
Ensembl chr 4:155,238,044...155,316,121
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [Sodium Fluoride results in decreased expression of KEAP1 mRNA]
|
CTD |
PMID:36736877 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Kgd4
|
alpha-ketoglutarate dehydrogenase subunit 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KGD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:33,604,611...33,614,988
Ensembl chr 2:33,604,613...33,615,095
|
|
| G
|
Khdrbs1
|
KH RNA binding domain containing, signal transduction associated 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KHDRBS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
|
|
| G
|
Khsrp
|
KH-type splicing regulatory protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KHSRP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,949,557...1,959,497
|
|
| G
|
Kif14
|
kinesin family member 14
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KIF14 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248
|
|
| G
|
Kif4a
|
kinesin family member 4A
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KIF4A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335
|
|
| G
|
Klf7
|
KLF transcription factor 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KLF7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056
|
|
| G
|
Klhl7
|
kelch-like family member 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KLHL7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:11,898,766...11,947,796
Ensembl chr 4:11,898,769...11,947,796
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
multiple interactions decreases expression decreases secretion
|
ISO
|
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Sodium Selenite results in decreased expression of KLK3 protein]; Sodium Selenite inhibits the reaction [IL6 protein results in increased expression of KLK3 protein]; Sodium Selenite inhibits the reaction [Metribolone results in increased expression of KLK3 protein] Sodium Selenite results in decreased expression of KLK3 mRNA Sodium Selenite results in decreased secretion of KLK3 protein
|
CTD |
PMID:16928829 PMID:17346688 PMID:18760546 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Knl1
|
kinetochore scaffold 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of KNL1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774
|
|
| G
|
Krt35
|
keratin 35
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KRT35 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:85,526,571...85,529,968
Ensembl chr10:85,526,571...85,529,968
|
|
| G
|
Krt72
|
keratin 72
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KRT72 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:134,789,082...134,799,547
Ensembl chr 7:134,789,082...134,799,547
|
|
| G
|
Ktn1
|
kinectin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of KTN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263
|
|
| G
|
Lama2
|
laminin subunit alpha 2
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LAMA2 mRNA Sodium Selenite results in decreased expression of LAMA2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056
|
|
| G
|
Lama4
|
laminin subunit alpha 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LAMA4 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr20:43,946,898...44,087,972
Ensembl chr20:43,946,898...44,087,972
|
|
| G
|
Lamc1
|
laminin subunit gamma 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LAMC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986
|
|
| G
|
Lcat
|
lecithin cholesterol acyltransferase
|
multiple interactions
|
EXP
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA]
|
CTD |
PMID:30031400 |
|
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
| G
|
Lce1f
|
late cornified envelope 1F
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LCE1F mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:181,001,399...181,002,985
Ensembl chr 2:181,001,399...181,002,985
|
|
| G
|
Lcmt1
|
leucine carboxyl methyltransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LCMT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:187,327,706...187,391,516
|
|
| G
|
Lcmt2
|
leucine carboxyl methyltransferase 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LCMT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:128,553,707...128,555,831
Ensembl chr 3:128,553,052...128,590,969
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LDHA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldhb
|
lactate dehydrogenase B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LDHB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Ldlrad3
|
low density lipoprotein receptor class A domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LDLRAD3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368
|
|
| G
|
Ldoc1
|
LDOC1, regulator of NFKB signaling
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LDOC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:144,837,879...145,110,607
Ensembl chr X:144,837,865...145,111,017
|
|
| G
|
Leng1
|
leukocyte receptor cluster member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LENG1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:74,467,343...74,472,275
Ensembl chr 1:74,467,326...74,472,280
|
|
| G
|
Lep
|
leptin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LEP mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lgals4
|
galectin 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LGALS4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:93,248,463...93,260,002
Ensembl chr 1:93,252,283...93,259,998
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of LHB protein]
|
CTD |
PMID:12883085 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Lhx1
|
LIM homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LHX1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:69,894,288...69,901,076
Ensembl chr10:69,894,288...69,901,076
|
|
| G
|
Lhx5
|
LIM homeobox 5
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LHX5 mRNA Sodium Selenite results in decreased expression of LHX5 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr12:41,786,746...41,795,183
Ensembl chr12:41,786,746...41,795,183
|
|
| G
|
Lilra5
|
leukocyte immunoglobulin like receptor A5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LILRA5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:79,011,865...79,073,860
Ensembl chr 1:79,045,546...79,050,111
|
|
| G
|
Limd2
|
LIM domain containing 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LIMD2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,590,082...91,592,439
|
|
| G
|
Lipe
|
lipase E, hormone sensitive type
|
increases phosphorylation
|
EXP
|
Sodium Selenite results in increased phosphorylation of LIPE protein
|
CTD |
PMID:24140496 |
|
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117
|
|
| G
|
Llph
|
LLP homolog, long-term synaptic facilitation factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LLPH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:57,620,925...57,625,924
Ensembl chr 7:57,620,993...57,625,925
|
|
| G
|
Lmtk3
|
lemur tyrosine kinase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LMTK3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:105,397,504...105,417,146
Ensembl chr 1:105,397,460...105,422,196
|
|
| G
|
Loxl2
|
lysyl oxidase-like 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LOXL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:51,091,547...51,182,843
Ensembl chr15:51,069,997...51,182,842
|
|
| G
|
Lpin1
|
lipin 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
|
|
| G
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LPP mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr11:89,292,060...89,933,973
Ensembl chr11:89,305,187...89,805,264
|
|
| G
|
Lpxn
|
leupaxin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LPXN mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
|
|
| G
|
Lrfn3
|
leucine rich repeat and fibronectin type III domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LRFN3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:94,744,315...94,751,001
Ensembl chr 1:94,744,321...94,751,178
|
|
| G
|
Lrp10
|
LDL receptor related protein 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LRP10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:31,891,358...31,897,530
Ensembl chr15:31,891,362...31,897,528
|
|
| G
|
Lrp12
|
LDL receptor related protein 12
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LRP12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:72,825,979...72,897,308
Ensembl chr 7:72,825,979...72,897,171
|
|
| G
|
Lrrc45
|
leucine rich repeat containing 45
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LRRC45 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,492,846...106,500,751
Ensembl chr10:106,492,592...106,500,751
|
|
| G
|
Lrrc47
|
leucine rich repeat containing 47
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LRRC47 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:169,852,926...169,862,598
Ensembl chr 5:169,852,897...169,862,598
|
|
| G
|
Lrsam1
|
leucine rich repeat and sterile alpha motif containing 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LRSAM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:36,621,042...36,661,932
Ensembl chr 3:36,621,042...36,661,825
|
|
| G
|
Lsm10
|
LSM10, U7 small nuclear RNA associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LSM10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:143,649,817...143,660,391
Ensembl chr 5:143,615,360...143,663,986
|
|
| G
|
Lsm6
|
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LSM6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:46,002,592...46,017,152
|
|
| G
|
Lsm8
|
LSM8 homolog, U6 small nuclear RNA associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LSM8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:48,272,128...48,277,994
Ensembl chr 4:48,272,164...48,280,162
|
|
| G
|
Ltb
|
lymphotoxin beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LTB mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054
|
|
| G
|
Ltbp1
|
latent transforming growth factor beta binding protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of LTBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:25,781,625...26,177,346
Ensembl chr 6:25,781,638...26,454,036
|
|
| G
|
Ltf
|
lactotransferrin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LTF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189
|
|
| G
|
Ltv1
|
LTV1 ribosome biogenesis factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LTV1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:9,385,834...9,398,557
Ensembl chr 1:9,385,830...9,398,677
|
|
| G
|
Ly6g6c
|
lymphocyte antigen 6 family member G6C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LY6G6C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:3,758,290...3,760,987
Ensembl chr20:3,758,290...3,762,927
|
|
| G
|
Ly86
|
lymphocyte antigen 86
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LY86 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:27,621,313...27,705,336
Ensembl chr17:27,621,313...27,692,743
|
|
| G
|
Macroh2a1
|
macroH2A.1 histone
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MACROH2A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,484,246...8,547,257
|
|
| G
|
Mafg
|
MAF bZIP transcription factor G
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAFG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,401,633...106,410,159
|
|
| G
|
Maged1
|
MAGE family member D1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MAGED1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:63,416,464...63,423,167
Ensembl chr X:63,416,466...63,423,112
|
|
| G
|
Maml3
|
mastermind-like transcriptional coactivator 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAML3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:137,871,267...138,288,615
Ensembl chr 2:137,871,267...138,287,960
|
|
| G
|
Man1c1
|
mannosidase, alpha, class 1C, member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MAN1C1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
ISO EXP
|
[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of MAP1LC3B protein modified form Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]
|
CTD |
PMID:28757135 PMID:31419397 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAP2K1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map2k2
|
mitogen activated protein kinase kinase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MAP2K2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
|
|
| G
|
Map2k4
|
mitogen activated protein kinase kinase 4
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP2K4 protein]
|
CTD |
PMID:26522834 |
|
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185
|
|
| G
|
Map2k6
|
mitogen-activated protein kinase kinase 6
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAP2K6 mRNA Sodium Selenite results in increased expression of MAP2K6 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
|
|
| G
|
Map3k14
|
mitogen-activated protein kinase kinase kinase 14
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAP3K14 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,665,417...88,715,592
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein]
|
CTD |
PMID:26522834 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MAP3K7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Map4k5
|
mitogen-activated protein kinase kinase kinase kinase 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAP4K5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:94,020,079...94,112,943
|
|
| G
|
Map7d3
|
MAP7 domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MAP7D3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:139,656,587...139,723,239
Ensembl chr X:139,656,587...139,723,251
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions decreases phosphorylation
|
ISO EXP
|
Sodium Selenite results in increased phosphorylation of MAPK1 protein [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] Sodium Selenite results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:15845651 PMID:21215776 PMID:34520753 PMID:37967787 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
multiple interactions increases expression decreases expression
|
ISO
|
Sodium Selenite inhibits the reaction [Buthionine Sulfoximine results in decreased expression of MAPK11 mRNA] Sodium Selenite results in increased expression of MAPK11 mRNA; Sodium Selenite results in increased expression of MAPK11 protein Sodium Selenite results in decreased expression of MAPK11 mRNA
|
CTD |
PMID:17989939 PMID:19363675 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk12
|
mitogen-activated protein kinase 12
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MAPK12 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 7:122,085,647...122,096,307
Ensembl chr 7:122,085,913...122,096,307
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
[Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein]
|
CTD |
PMID:37967787 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation decreases phosphorylation multiple interactions
|
ISO
|
Sodium Selenite results in increased phosphorylation of MAPK3 protein Sodium Selenite results in decreased phosphorylation of MAPK3 protein Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:15845651 PMID:18481333 PMID:21215776 PMID:34520753 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases phosphorylation decreases expression decreases activity
|
ISO EXP
|
Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of MAPK8 protein]; Dithiothreitol inhibits the reaction [Sodium Selenite results in decreased activity of MAPK8 protein]; MAPK8 protein affects the reaction [Sodium Selenite results in decreased activity of JUN protein]; Mercaptoethanol inhibits the reaction [Sodium Selenite results in decreased activity of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK8 protein [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK8 protein] Sodium Selenite results in decreased expression of MAPK8 mRNA
|
CTD |
PMID:10644709 PMID:18175754 PMID:18481333 PMID:18728404 PMID:26522834 PMID:34520753 PMID:37967787 More...
|
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions affects expression increases expression
|
ISO EXP
|
pyrazolanthrone inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein] Sodium Selenite affects the expression of MAPK9 Sodium Selenite results in increased expression of MAPK9 protein
|
CTD |
PMID:18209489 PMID:18728404 PMID:26522834 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Marchf2
|
membrane associated ring-CH-type finger 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MARCHF2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:15,183,925...15,202,002
|
|
| G
|
Mark4
|
microtubule affinity regulating kinase 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MARK4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:88,203,352...88,239,858
Ensembl chr 1:88,203,393...88,236,553
|
|
| G
|
Marveld1
|
MARVEL domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MARVELD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393
|
|
| G
|
Marveld2
|
MARVEL domain containing 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MARVELD2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:33,474,750...33,498,225
Ensembl chr 2:33,462,950...33,498,077
|
|
| G
|
Matk
|
megakaryocyte-associated tyrosine kinase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MATK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:9,107,711...9,116,864
Ensembl chr 7:9,107,722...9,112,746
|
|
| G
|
Mbd4
|
methyl-CpG binding domain 4 DNA glycosylase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MBD4 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:150,565,655...150,577,578
|
|
| G
|
Mbd6
|
methyl-CpG binding domain protein 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MBD6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:64,992,877...65,001,274
Ensembl chr 7:64,992,877...64,998,589
|
|
| G
|
Mcam
|
melanoma cell adhesion molecule
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MCAM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
|
|
| G
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MCF2L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956
|
|
| G
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MCM10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:78,172,049...78,197,644
Ensembl chr17:78,175,398...78,197,636
|
|
| G
|
Mcts1
|
MCTS1, re-initiation and release factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MCTS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:122,215,602...122,228,101
Ensembl chr X:122,216,439...122,229,631
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MDH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdk
|
midkine
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MDK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MDM2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mea1
|
male-enhanced antigen 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MEA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:21,797,884...21,801,693
Ensembl chr 9:21,797,887...21,802,216
|
|
| G
|
Meaf6
|
MYST/Esa1-associated factor 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MEAF6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:142,628,281...142,653,076
Ensembl chr 5:142,628,968...142,656,293
|
|
| G
|
Med10
|
mediator complex subunit 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MED10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:35,298,494...35,310,163
Ensembl chr 1:35,298,495...35,304,154
|
|
| G
|
Med4
|
mediator complex subunit 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MED4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:55,106,079...55,116,354
Ensembl chr15:55,105,998...55,116,429
|
|
| G
|
Meis1
|
Meis homeobox 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MEIS1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:97,356,949...97,499,646
Ensembl chr14:97,322,748...97,495,083
|
|
| G
|
Meis2
|
Meis homeobox 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MEIS2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:123,197,066...123,399,002
Ensembl chr 3:123,197,066...123,397,751
|
|
| G
|
Mertk
|
MER proto-oncogene, tyrosine kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MERTK mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192
|
|
| G
|
Mettl16
|
methyltransferase 16, RNA N6-adenosine
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of METTL16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:60,139,317...60,185,438
Ensembl chr10:60,139,330...60,187,571
|
|
| G
|
Mettl17
|
methyltransferase like 17
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of METTL17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:27,055,851...27,062,530
Ensembl chr15:27,055,897...27,062,522
|
|
| G
|
Mettl5
|
methyltransferase 5, N6-adenosine
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of METTL5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:75,033,605...75,046,359
Ensembl chr 3:75,026,861...75,045,831
|
|
| G
|
Mfng
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MFNG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:112,161,071...112,209,129
|
|
| G
|
Mgarp
|
mitochondria-localized glutamic acid-rich protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MGARP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of MGST1 mRNA Sodium Selenite results in increased expression of MGST1 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mical2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MICAL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:175,780,441...175,965,157
Ensembl chr 1:175,825,596...175,905,155
|
|
| G
|
Mir328
|
microRNA 328
|
decreases expression
|
EXP
|
Sodium Selenite results in decreased expression of MIR328 mRNA
|
CTD |
PMID:28544404 |
|
NCBI chr19:50,094,691...50,094,774
|
|
| G
|
Mitf
|
melanocyte inducing transcription factor
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MITF mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790
|
|
| G
|
Mixl1
|
Mix paired-like homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MIXL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:94,953,907...94,957,938
Ensembl chr13:94,953,907...94,957,938
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in decreased expression of MKI67 mRNA [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA
|
CTD |
PMID:23859036 PMID:24383545 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mknk2
|
MAPK interacting serine/threonine kinase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MKNK2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529
|
|
| G
|
Mkrn3
|
makorin, ring finger protein, 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MKRN3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:125,338,664...125,341,178
Ensembl chr 1:125,338,564...125,341,164
|
|
| G
|
Mlana
|
melan-A
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MLANA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:236,883,075...236,897,693
Ensembl chr 1:236,883,075...236,896,880
|
|
| G
|
Mlxipl
|
MLX interacting protein-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MLXIPL mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
| G
|
Mmadhc
|
metabolism of cobalamin associated D
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MMADHC mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:55,117,832...55,135,735
Ensembl chr 3:55,117,833...55,135,851
|
|
| G
|
Mmp17
|
matrix metallopeptidase 17
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MMP17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:32,710,504...32,735,418
Ensembl chr12:32,710,504...32,735,414
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of MMP2 mRNA] Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP2 protein]
|
CTD |
PMID:17997286 PMID:19933942 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
EXP ISO
|
Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA
|
CTD |
PMID:19933942 PMID:23274088 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mnat1
|
MNAT1 component of CDK activating kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MNAT1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 6:97,550,566...97,706,598
Ensembl chr 6:97,550,543...97,706,595
|
|
| G
|
Mob3b
|
MOB kinase activator 3B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MOB3B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678
|
|
| G
|
Mocos
|
molybdenum cofactor sulfurase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MOCOS mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:16,206,402...16,251,928
Ensembl chr18:16,206,402...16,251,928
|
|
| G
|
Mogat3
|
monoacylglycerol O-acyltransferase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MOGAT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:25,305,390...25,307,024
Ensembl chr12:25,305,404...25,307,497
|
|
| G
|
Mphosph10
|
M-phase phosphoprotein 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MPHOSPH10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:127,359,909...127,375,926
Ensembl chr 1:127,359,909...127,375,926
|
|
| G
|
Mplkip
|
M-phase specific PLK1 interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MPLKIP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:52,069,154...52,071,978
Ensembl chr17:52,069,154...52,071,720
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of MPO protein]
|
CTD |
PMID:31022331 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mprip
|
myosin phosphatase Rho interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MPRIP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:44,953,472...45,073,388
Ensembl chr10:44,953,500...45,073,388
|
|
| G
|
Mpv17l
|
MPV17 mitochondrial inner membrane protein like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MPV17L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:2,495,605...2,532,448
Ensembl chr10:2,495,607...2,532,448
|
|
| G
|
Mrc1
|
mannose receptor, C type 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MRC1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
|
|
| G
|
Mrpl12
|
mitochondrial ribosomal protein L12
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,256,746...106,261,249
Ensembl chr10:106,256,547...106,263,088
|
|
| G
|
Mrpl17
|
mitochondrial ribosomal protein L17
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:169,574,010...169,575,699
Ensembl chr 1:169,574,010...169,575,818
|
|
| G
|
Mrpl18
|
mitochondrial ribosomal protein L18
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL18 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:50,384,951...50,389,769
Ensembl chr 1:50,384,367...50,389,763
|
|
| G
|
Mrpl20
|
mitochondrial ribosomal protein L20
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL20 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,690,664...171,695,728
Ensembl chr 5:171,691,198...171,695,728
|
|
| G
|
Mrpl32
|
mitochondrial ribosomal protein L32
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL32 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:55,260,651...55,263,517
Ensembl chr17:55,260,270...55,263,517
|
|
| G
|
Mrpl42
|
mitochondrial ribosomal protein L42
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL42 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:32,004,863...32,028,640
Ensembl chr 7:32,004,777...32,035,104
|
|
| G
|
Mrpl45
|
mitochondrial ribosomal protein L45
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL45 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:82,805,039...82,816,862
Ensembl chr10:82,804,874...82,816,139
|
|
| G
|
Mrpl57
|
mitochondrial ribosomal protein L57
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPL57 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:36,086,457...36,087,319
Ensembl chr15:36,086,457...36,087,298
|
|
| G
|
Mrps15
|
mitochondrial ribosomal protein S15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:143,606,141...143,616,734
Ensembl chr 5:143,606,148...143,616,339
|
|
| G
|
Mrps17
|
mitochondrial ribosomal protein S17
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:32,584,635...32,587,934
Ensembl chr12:32,584,635...32,587,812
|
|
| G
|
Mrps2
|
mitochondrial ribosomal protein S2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:32,201,037...32,204,317
Ensembl chr 3:32,198,641...32,204,892
|
|
| G
|
Mrps24
|
mitochondrial ribosomal protein S24
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS24 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:84,798,649...84,802,777
|
|
| G
|
Mrps26
|
mitochondrial ribosomal protein S26
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS26 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:138,222,324...138,223,987
Ensembl chr 3:138,222,165...138,223,987
|
|
| G
|
Mrps34
|
mitochondrial ribosomal protein S34
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRPS34 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:14,420,543...14,421,674
Ensembl chr10:14,408,136...14,421,771
|
|
| G
|
Mrtfa
|
myocardin related transcription factor A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRTFA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:114,424,481...114,594,594
|
|
| G
|
Msc
|
musculin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MSC mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:9,330,522...9,336,391
Ensembl chr 5:9,330,544...9,336,857
|
|
| G
|
Msr1
|
macrophage scavenger receptor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MSR1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070
|
|
| G
|
Mt-co1
|
mitochondrially encoded cytochrome c oxidase I
|
multiple interactions decreases expression
|
EXP
|
Acetylcarnitine inhibits the reaction [Sodium Selenite results in decreased expression of COX1 mRNA]
|
CTD |
PMID:20067779 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
|
|
| G
|
Mt1a
|
metallothionein 1A
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of MT1A mRNA [Sodium Selenite co-treated with Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of MT1 mRNA; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of MT1 mRNA]; Sodium Selenite inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]
|
CTD |
PMID:11551972 PMID:18175754 PMID:38945390 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt2
|
metallothionein 2
|
multiple interactions
|
ISO
|
[Sodium Selenite co-treated with Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of MT2 mRNA
|
CTD |
PMID:38945390 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mtch1
|
mitochondrial carrier 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MTCH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:7,391,558...7,415,291
Ensembl chr20:7,391,565...7,415,042
|
|
| G
|
Mtdh
|
metadherin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LYRIC mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:67,192,592...67,250,819
Ensembl chr 7:67,192,393...67,249,584
|
|
| G
|
Mtfp1
|
mitochondrial fission process 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MTFP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:83,192,013...83,195,853
Ensembl chr14:83,192,021...83,195,927
|
|
| G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MTHFD2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
| G
|
Mtnr1a
|
melatonin receptor 1A
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MTNR1A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421
|
|
| G
|
Mto1
|
mitochondrial tRNA translation optimization 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MTO1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:88,188,918...88,215,516
Ensembl chr 8:88,190,259...88,215,509
|
|
| G
|
Mtrf1l
|
mitochondrial translation release factor 1 like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MTRF1L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:44,614,162...44,626,367
Ensembl chr 1:44,615,921...44,626,178
|
|
| G
|
Muc2
|
mucin 2, oligomeric mucus/gel-forming
|
decreases expression increases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of MUC2 mRNA Sodium Selenite results in increased expression of MUC2 mRNA N-TUTCA2 gene mutant form inhibits the reaction [Sodium Selenite results in increased expression of MUC2 mRNA]
|
CTD |
PMID:23274088 PMID:25187657 |
|
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280
|
|
| G
|
Mvb12a
|
multivesicular body subunit 12A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MVB12A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:18,286,231...18,291,096
Ensembl chr16:18,286,231...18,292,583
|
|
| G
|
Mvk
|
mevalonate kinase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MVK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503
|
|
| G
|
Mxra8
|
matrix remodeling associated 8
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MXRA8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,731,153...171,735,879
Ensembl chr 5:171,731,353...171,735,879
|
|
| G
|
Mybl1
|
MYB proto-oncogene like 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MYBL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588
|
|
| G
|
Mybpc2
|
myosin binding protein C2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MYBPC2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:104,130,642...104,154,101
Ensembl chr 1:104,131,323...104,154,101
|
|
| G
|
Mybpc3
|
myosin binding protein C3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MYBPC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:97,550,974...97,569,216
Ensembl chr 3:97,551,061...97,569,216
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Asbestos, Serpentine results in increased expression of MYC mRNA] Sodium Selenite results in increased expression of MYC protein Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of MYC mRNA]; Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of MYC mRNA]
|
CTD |
PMID:11198217 PMID:11769627 PMID:16039982 PMID:16944776 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Mycbp
|
Myc binding protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MYCBP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:141,420,727...141,427,938
Ensembl chr 5:141,420,707...141,430,681
|
|
| G
|
Mycbp2
|
MYC binding protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MYCBP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:86,352,061...86,590,126
Ensembl chr15:86,352,061...86,590,325
|
|
| G
|
Myl12b
|
myosin light chain 12B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MRLC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:118,320,479...118,334,810
Ensembl chr 9:118,320,489...118,324,418
|
|
| G
|
Myl3
|
myosin light chain 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MYL3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:119,617,077...119,623,215
Ensembl chr 8:119,616,868...119,623,216
|
|
| G
|
Myo9a
|
myosin IXA
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of MYO9A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:69,044,853...69,248,094
Ensembl chr 8:69,044,885...69,245,231
|
|
| G
|
Myom1
|
myomesin 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of MYOM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:118,362,547...118,485,954
Ensembl chr 9:118,362,621...118,485,952
|
|
| G
|
Naca
|
nascent polypeptide associated complex subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NACA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:1,053,474...1,066,606
Ensembl chr 7:1,054,338...1,066,605
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NAMPT mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nanog
|
Nanog homeobox
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NANOG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061
|
|
| G
|
Nap1l1
|
nucleosome assembly protein 1-like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NAP1L1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104
|
|
| G
|
Ncam1
|
neural cell adhesion molecule 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NCAM1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
|
|
| G
|
Ncapg
|
non-SMC condensin I complex, subunit G
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NCAPG mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
|
|
| G
|
Ncl
|
nucleolin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NCL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Ndc80
|
NDC80 kinetochore complex component
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NDC80 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
|
|
| G
|
Ndor1
|
NADPH dependent diflavin oxidoreductase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDOR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:28,460,787...28,469,018
Ensembl chr 3:28,460,797...28,469,018
|
|
| G
|
Ndrg4
|
NDRG family member 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NDRG4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972
|
|
| G
|
Ndufa2
|
NADH:ubiquinone oxidoreductase subunit A2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:28,629,795...28,631,884
Ensembl chr18:28,629,795...28,631,884
|
|
| G
|
Ndufa3
|
NADH:ubiquinone oxidoreductase subunit A3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFA3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:74,512,928...74,515,558
Ensembl chr 1:74,512,928...74,515,558
|
|
| G
|
Ndufa4
|
Ndufa4, mitochondrial complex associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of COXFA4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559
|
|
| G
|
Ndufab1
|
NADH:ubiquinone oxidoreductase subunit AB1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFAB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373
|
|
| G
|
Ndufb10
|
NADH:ubiquinone oxidoreductase subunit B10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFB10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:14,253,805...14,255,966
Ensembl chr10:14,253,805...14,255,966
|
|
| G
|
Ndufb4
|
NADH:ubiquinone oxidoreductase subunit B4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFB4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:76,569,178...76,575,879
Ensembl chr11:76,569,178...76,575,879
|
|
| G
|
Ndufs3
|
NADH:ubiquinone oxidoreductase core subunit S3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFS3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:97,332,477...97,339,654
Ensembl chr 3:97,332,477...97,345,323
|
|
| G
|
Ndufs5
|
NADH:ubiquinone oxidoreductase subunit S5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFS5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:141,258,828...141,264,552
Ensembl chr 2:184,849,197...185,028,909 Ensembl chr 5:184,849,197...185,028,909 Ensembl chr14:184,849,197...185,028,909
|
|
| G
|
Ndufv2
|
NADH:ubiquinone oxidoreductase core subunit V2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NDUFV2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:113,137,305...113,157,571
Ensembl chr 9:113,137,306...113,157,520
|
|
| G
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NEDD9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668
|
|
| G
|
Nelfa
|
negative elongation factor complex member A
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NELFA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:81,033,470...81,057,546
Ensembl chr14:81,033,514...81,058,719
|
|
| G
|
Nemf
|
nuclear export mediator factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NEMF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:93,527,690...93,571,863
Ensembl chr 6:93,527,704...93,571,863
|
|
| G
|
Neo1
|
neogenin 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NEO1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 8:68,169,711...68,322,158
Ensembl chr 8:68,169,716...68,322,152
|
|
| G
|
Nes
|
nestin
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of NES mRNA]
|
CTD |
PMID:17997286 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Net1
|
neuroepithelial cell transforming 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NET1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
|
|
| G
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NEURL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:256,008,012...256,094,219
Ensembl chr 1:256,008,160...256,094,224
|
|
| G
|
Neurog3
|
neurogenin 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NEUROG3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:30,622,533...30,624,015
Ensembl chr20:30,622,533...30,624,015
|
|
| G
|
Nf1
|
neurofibromin 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946
|
|
| G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NFE2L1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO EXP
|
Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein]; Sodium Selenite promotes the reaction [arsenite affects the localization of NFE2L2 protein] [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA]; [Sodium Selenite co-treated with zinc chloride] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of and results in increased localization of NFE2L2 protein]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of NFE2L2 mRNA]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of NFE2L2 protein] Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein]; Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein]
|
CTD |
PMID:19429247 PMID:24816296 PMID:26085057 PMID:36646412 PMID:36736877 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfe2l3
|
NFE2 like bZIP transcription factor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NFE2L3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:81,837,404...81,865,258
Ensembl chr 4:81,837,404...81,865,532
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions decreases expression
|
EXP
|
[Diethylnitrosamine co-treated with Sodium Selenite] results in increased expression of NFKB1 mRNA Sodium Selenite results in decreased expression of NFKB1 mRNA
|
CTD |
PMID:20492335 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NGF mRNA Sodium Selenite results in decreased expression of NGF mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngrn
|
neugrin, neurite outgrowth associated
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NGRN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:143,622,494...143,628,609
Ensembl chr 1:143,622,731...143,628,609
|
|
| G
|
Niban1
|
niban apoptosis regulator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NIBAN1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
|
|
| G
|
Ninj1
|
ninjurin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NINJ1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nkain1
|
Sodium/potassium transporting ATPase interacting 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NKAIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:148,031,685...148,076,834
Ensembl chr 5:148,031,338...148,076,834
|
|
| G
|
Nlrc5
|
NLR family, CARD domain containing 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NLRC5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,483,755...10,555,786
|
|
| G
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NME2 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497 Ensembl chr10:11,179,066...11,179,497
|
|
| G
|
Nme3
|
NME/NM23 nucleoside diphosphate kinase 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NME3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:14,421,922...14,422,878
Ensembl chr10:14,421,702...14,422,907
|
|
| G
|
Nmnat3
|
nicotinamide nucleotide adenylyltransferase 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NMNAT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:107,771,124...107,888,528
Ensembl chr 8:107,771,509...107,900,016
|
|
| G
|
Nop58
|
NOP58 ribonucleoprotein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NOP58 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NOS1 protein
|
CTD |
PMID:21215776 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of NOS2 protein]; Sodium Selenite inhibits the reaction [Streptozocin results in increased activity of NOS2 protein]; Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] Sodium Selenite results in increased expression of NOS2 mRNA; Sodium Selenite results in increased expression of NOS2 protein Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA]; Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein]; pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA]; pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein]
|
CTD |
PMID:18279804 PMID:18789669 PMID:19481068 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Npr1
|
natriuretic peptide receptor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NPR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:178,231,766...178,247,088
|
|
| G
|
Nprl2
|
NPR2-like, GATOR1 complex subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NPRL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:117,094,443...117,097,639
Ensembl chr 8:117,094,441...117,097,637
|
|
| G
|
Nptn
|
neuroplastin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NPTN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:67,892,678...67,959,231
Ensembl chr 8:67,892,702...67,959,236
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of NQO1 mRNA Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of NQO1 mRNA]; Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of NQO1 protein]
|
CTD |
PMID:16451816 PMID:24383545 PMID:36736877 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
multiple interactions
|
EXP
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] affects the reaction [Dietary Fats results in increased expression of NR1H3 mRNA]
|
CTD |
PMID:30031400 |
|
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of NR3C1 mRNA
|
CTD |
PMID:16928829 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Nr4a2
|
nuclear receptor subfamily 4, group A, member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NR4A2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
|
|
| G
|
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NR6A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:42,904,832...43,094,622
Ensembl chr 3:42,904,832...43,092,951
|
|
| G
|
Nrg1
|
neuregulin 1
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of NRG1 mRNA [ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Nrn1
|
neuritin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NRN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:28,335,426...28,344,354
Ensembl chr17:28,334,616...28,344,354
|
|
| G
|
Nrp1
|
neuropilin 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Ns5atp4
|
NS5A transactivated protein 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of LTAP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:177,792,070...177,804,943
Ensembl chr 2:177,791,958...177,804,942
|
|
| G
|
Nsl1
|
NSL1 component of MIS12 kinetochore complex
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NSL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117
|
|
| G
|
Nsmce3
|
NSE3 homolog, SMC5-SMC6 complex component
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NSMCE3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:127,812,572...127,813,899
|
|
| G
|
Nt5c3b
|
5'-nucleotidase, cytosolic IIIB
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NT5C3B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:85,859,509...85,876,731
Ensembl chr10:85,862,512...85,875,992
|
|
| G
|
Nt5dc1
|
5'-nucleotidase domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NT5C2L1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:39,660,707...39,763,647
Ensembl chr20:39,660,707...39,786,449
|
|
| G
|
Ntn4
|
netrin 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NTN4 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:30,073,637...30,187,407
Ensembl chr 7:30,073,333...30,188,309
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NTRK2 mRNA; Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of NTRK2 mRNA] Sodium Selenite results in decreased expression of NTRK2 mRNA
|
CTD |
PMID:17997286 PMID:23274088 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Nubp2
|
NUBP iron-sulfur cluster assembly factor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NUBP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:14,407,743...14,411,428
Ensembl chr10:14,407,745...14,411,600
|
|
| G
|
Nubpl
|
NUBP iron-sulfur cluster assembly factor, mitochondrial
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NUBPL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:75,294,609...75,516,603
Ensembl chr 6:75,294,632...75,516,601
|
|
| G
|
Nudt5
|
nudix hydrolase 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NUDT5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:77,345,041...77,368,308
Ensembl chr17:77,345,045...77,368,308
|
|
| G
|
Nuf2
|
NUF2 component of NDC80 kinetochore complex
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of NUF2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598
|
|
| G
|
Numb
|
NUMB, endocytic adaptor protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NUMB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:109,162,499...109,284,527
Ensembl chr 6:109,162,499...109,284,463
|
|
| G
|
Nup98
|
nucleoporin 98 and 96 precursor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NUP98 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:165,906,405...166,003,366
Ensembl chr 1:165,906,405...166,003,366
|
|
| G
|
Nxt1
|
nuclear transport factor 2-like export factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of NXT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:156,562,121...156,565,043
Ensembl chr 3:156,560,556...156,565,996
|
|
| G
|
Obi1
|
ORC ubiquitin ligase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OBI1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:87,684,022...87,723,342
Ensembl chr15:87,684,025...87,723,342
|
|
| G
|
Obscn
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OBSCN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297
|
|
| G
|
Odad3
|
outer dynein arm docking complex subunit 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ODAD3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:28,796,909...28,810,587
Ensembl chr 8:28,796,701...28,810,511
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [mezerein results in increased activity of ODC1 protein]; Sodium Selenite inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]
|
CTD |
PMID:3098411 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
Olig2
|
oligodendrocyte transcription factor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OLIG2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634
|
|
| G
|
Olr1433
|
olfactory receptor 1433
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR2W3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:43,542,833...43,546,698
|
|
| G
|
Opa3
|
outer mitochondrial membrane lipid metabolism regulator OPA3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OPA3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:88,007,707...88,037,639
Ensembl chr 1:88,025,696...88,028,657 Ensembl chr 1:88,025,696...88,028,657
|
|
| G
|
Opn1sw
|
opsin 1, short wave sensitive
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OPN1SW mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:58,942,685...58,945,825
Ensembl chr 4:58,942,681...58,945,825
|
|
| G
|
Optc
|
opticin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OPTC mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:47,906,145...47,920,334
Ensembl chr13:47,906,197...47,917,416
|
|
| G
|
Or10a4
|
olfactory receptor family 10 subfamily A member 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR10A4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:170,365,682...170,370,100
Ensembl chr 1:170,368,917...170,369,864
|
|
| G
|
Or13c3
|
olfactory receptor family 13 subfamily C member 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR13C4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:72,251,144...72,252,094
Ensembl chr 5:72,219,011...72,252,118
|
|
| G
|
Or13f5
|
olfactory receptor family 13 subfamily F member 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR13F1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:72,037,146...72,038,105
Ensembl chr 5:72,037,146...72,038,105
|
|
| G
|
Or14j1
|
olfactory receptor family 14 subfamily J member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR14J1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:694,951...695,913
Ensembl chr20:694,951...695,913
|
|
| G
|
Or14p1
|
olfactory receptor family 14 subfamily P member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR14A16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:53,529...54,476
Ensembl chr17:53,529...54,476
|
|
| G
|
Or1n2
|
olfactory receptor family 1 subfamily N member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR1N2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:40,847,349...40,848,302
Ensembl chr 3:40,847,349...40,848,302
|
|
| G
|
Or1q1
|
olfactory receptor family 1 subfamily Q member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR1Q1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:40,897,874...40,898,800
Ensembl chr 3:40,897,874...40,898,800
|
|
| G
|
Or4c15
|
olfactory receptor family 4 subfamily C member 15
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR4C15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:95,148,200...95,151,095
Ensembl chr 3:95,148,200...95,149,135
|
|
| G
|
Or4k2
|
olfactory receptor family 4 subfamily K member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR4K2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:25,878,316...25,879,269
Ensembl chr15:25,878,316...25,879,272
|
|
| G
|
Or52b4
|
olfactory receptor family 52 subfamily B member 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR52B4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:166,351,005...166,351,946
Ensembl chr 1:166,351,005...166,351,946
|
|
| G
|
Or52h1
|
olfactory receptor family 52 subfamily H member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR52H1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:168,056,638...168,057,588
Ensembl chr 1:168,056,638...168,057,588
|
|
| G
|
Or52k2
|
olfactory receptor family 52 subfamily K member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR52K2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:166,438,782...166,439,735
Ensembl chr 1:166,438,782...166,439,735
|
|
| G
|
Or52w1
|
olfactory receptor family 52 subfamily W member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR52W1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:169,127,607...169,128,596
Ensembl chr 1:169,127,607...169,128,596
|
|
| G
|
Or5w11
|
olfactory receptor family 5 subfamily W member 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR5W2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:93,504,527...93,505,456
Ensembl chr 3:93,504,527...93,505,456
|
|
| G
|
Or6y1
|
olfactory receptor family 6 subfamily Y member 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR6Y1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:88,925,706...88,926,683
Ensembl chr13:88,925,706...88,926,683
|
|
| G
|
Or7d9
|
olfactory receptor family 7 subfamily D member 9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of OR7D4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:26,912,238...26,913,236
Ensembl chr 8:26,908,664...26,913,173
|
|
| G
|
Or9g4
|
olfactory receptor family 9 subfamily G member 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OR9G4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:91,134,643...91,135,581
Ensembl chr 3:91,134,643...91,135,581
|
|
| G
|
Orc4
|
origin recognition complex, subunit 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ORC4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:53,700,046...53,743,293
Ensembl chr 3:53,703,615...53,742,264
|
|
| G
|
Ormdl1
|
ORMDL sphingolipid biosynthesis regulator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ORMDL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:55,735,081...55,745,287
Ensembl chr 9:55,735,097...55,745,340
|
|
| G
|
Ormdl2
|
ORMDL sphingolipid biosynthesis regulator 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ORMDL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:1,832,368...1,835,501
Ensembl chr 7:1,832,368...1,836,223
|
|
| G
|
Otof
|
otoferlin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OTOF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:31,647,869...31,744,476
Ensembl chr 6:31,647,914...31,744,476
|
|
| G
|
Otulinl
|
OTU deubiquitinase with linear linkage specificity like
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of OTULINL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:80,139,262...80,166,962
|
|
| G
|
P2rx1
|
purinergic receptor P2X 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of P2RX1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:58,117,107...58,132,167
Ensembl chr10:58,117,088...58,132,164
|
|
| G
|
P2rx4
|
purinergic receptor P2X 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of P2RX4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:39,505,438...39,523,349
Ensembl chr12:39,505,438...39,523,094
|
|
| G
|
P2ry10
|
P2Y receptor family member 10
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of P2RY10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:76,184,064...76,279,996
Ensembl chr X:76,184,001...76,280,953
|
|
| G
|
P2ry4
|
pyrimidinergic receptor P2Y4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of P2RY4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:69,722,604...69,757,726
Ensembl chr X:69,721,753...69,753,510
|
|
| G
|
P4ha1
|
prolyl 4-hydroxylase subunit alpha 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of P4HA1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404
|
|
| G
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PABPC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:69,663,068...69,675,050
|
|
| G
|
Papolg
|
poly(A) polymerase gamma
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PAPOLG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:102,028,842...102,062,155
Ensembl chr14:102,028,842...102,062,155
|
|
| G
|
Pappa
|
pappalysin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PAPPA mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Pappa2
|
pappalysin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PAPPA2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:73,407,385...73,683,699
Ensembl chr13:73,407,385...73,681,568
|
|
| G
|
Parg
|
poly (ADP-ribose) glycohydrolase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PARG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PARK7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage decreases activity increases expression
|
ISO EXP
|
Sodium Selenite results in increased cleavage of PARP1 protein Sodium Selenite results in decreased activity of PARP1 protein Sodium Selenite results in increased expression of PARP1 mRNA
|
CTD |
PMID:15845651 PMID:18175754 PMID:18209489 PMID:28161410 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Parp10
|
poly (ADP-ribose) polymerase family, member 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PARP10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:109,829,721...109,839,054
Ensembl chr 7:109,829,722...109,843,566
|
|
| G
|
Pate1
|
prostate and testis expressed 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PATE1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:42,306,092...42,308,549
Ensembl chr 8:42,306,092...42,308,549
|
|
| G
|
Paxbp1
|
PAX3 and PAX7 binding protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PAXBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:43,758,116...43,787,624
Ensembl chr11:43,758,116...43,787,542
|
|
| G
|
Pcbd1
|
pterin-4 alpha-carbinolamine dehydratase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PCBD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:29,573,362...29,587,181
Ensembl chr20:29,573,423...29,587,180
|
|
| G
|
Pcdh10
|
protocadherin 10
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PCDH10 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:130,553,432...130,619,591
Ensembl chr 2:130,553,425...130,613,407
|
|
| G
|
Pcdh19
|
protocadherin 19
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PCDH19 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr X:101,061,002...101,166,777
Ensembl chr X:101,065,263...101,165,269
|
|
| G
|
Pcdh9
|
protocadherin 9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PCDH9 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr15:75,748,472...76,646,644 NCBI chr15:76,078,024...76,127,778
Ensembl chr15:75,749,278...76,645,302
|
|
| G
|
Pcdhb5
|
protocadherin beta 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PCDHB4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:29,302,466...29,305,048
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PCK1 mRNA]
|
CTD |
PMID:26522834 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pck2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PCK2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of PCNA mRNA Sodium Selenite results in increased expression of PCNA mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pcnt
|
pericentrin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PCNT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:12,189,767...12,278,179
Ensembl chr20:12,192,353...12,278,178
|
|
| G
|
Pdcd2
|
programmed cell death 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PDCD2 mRNA
|
CTD |
PMID:16705456 PMID:18175754 |
|
NCBI chr 1:65,158,034...65,163,524
Ensembl chr 1:65,158,034...65,163,524
|
|
| G
|
Pde1b
|
phosphodiesterase 1B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PDE1B mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 7:136,505,834...136,533,034
Ensembl chr 7:136,505,689...136,533,033
|
|
| G
|
Pde7a
|
phosphodiesterase 7A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PDE7A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:103,631,655...103,723,057
Ensembl chr 2:103,634,594...103,722,890
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PDGFA mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
multiple interactions decreases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of PDGFRA mRNA] Sodium Selenite results in decreased expression of PDGFRA mRNA
|
CTD |
PMID:17997286 PMID:18209489 |
|
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
multiple interactions
|
EXP
|
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA; [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein
|
CTD |
PMID:23859036 |
|
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Pds5b
|
PDS5 cohesin associated factor B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of APRIN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:5,038,114...5,181,208
Ensembl chr12:5,038,160...5,181,208
|
|
| G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of IPF1 mRNA; Sodium Selenite results in increased expression of IPF1 protein
|
CTD |
PMID:18538137 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
| G
|
Pdzk1ip1
|
PDZK1 interacting protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PDZK1IP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:133,841,586...133,859,894
Ensembl chr 5:133,841,313...133,859,893
|
|
| G
|
Per2
|
period circadian regulator 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PER2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993
|
|
| G
|
Per3
|
period circadian regulator 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PER3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
|
|
| G
|
Pfdn5
|
prefoldin subunit 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PFDN5 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 7:135,330,364...135,335,102
Ensembl chr 7:135,330,172...135,335,099
|
|
| G
|
Pfkl
|
phosphofructokinase, liver type
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of PFKL mRNA]
|
CTD |
PMID:38945390 |
|
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,663,955...10,685,966
|
|
| G
|
Pgap2
|
post-GPI attachment to proteins 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PGAP2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:166,003,593...166,030,088
Ensembl chr 1:166,003,523...166,030,088
|
|
| G
|
Pgm1
|
phosphoglucomutase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PGM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159
|
|
| G
|
Pgm2
|
phosphoglucomutase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PGM2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:44,519,906...44,553,420
Ensembl chr14:44,519,906...44,553,770
|
|
| G
|
Pgm5
|
phosphoglucomutase 5
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PGM5 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:231,752,052...231,939,812
Ensembl chr 1:231,752,052...231,939,812
|
|
| G
|
Pgr
|
progesterone receptor
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of PGR mRNA
|
CTD |
PMID:16928829 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Phax
|
phosphorylated adaptor for RNA export
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PHAX mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:52,251,231...52,267,916
Ensembl chr18:52,248,709...52,267,915
|
|
| G
|
Phb2
|
prohibitin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of REA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:159,203,948...159,208,561
Ensembl chr 4:159,203,926...159,209,231
|
|
| G
|
Phc3
|
polyhomeotic homolog 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PHC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:114,337,180...114,412,132
Ensembl chr 2:114,337,227...114,405,816
|
|
| G
|
Phkg2
|
phosphorylase kinase catalytic subunit gamma 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PHKG2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:191,614,738...191,627,615
Ensembl chr 1:191,614,865...191,627,616
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PHLDA1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Pi4k2b
|
phosphatidylinositol 4-kinase type 2 beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PI4K2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:62,434,589...62,461,507
Ensembl chr14:62,424,511...62,461,446
|
|
| G
|
Pid1
|
phosphotyrosine interaction domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PID1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070
|
|
| G
|
Pigz
|
phosphatidylinositol glycan anchor biosynthesis, class Z
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PIGZ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:82,336,821...82,357,743
Ensembl chr11:82,336,823...82,340,684
|
|
| G
|
Pik3c2b
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PIK3C2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:47,046,866...47,107,733
Ensembl chr13:47,047,127...47,107,725
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
increases expression
|
EXP
|
Sodium Selenite results in increased expression of PIK3R1 mRNA
|
CTD |
PMID:14714311 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PKD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
|
|
| G
|
Pkhd1l1
|
PKHD1 like 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PKHD1L1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:77,505,063...77,679,994
Ensembl chr 7:77,505,152...77,679,994
|
|
| G
|
Pklr
|
pyruvate kinase L/R
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of PKLR mRNA]; Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PKLR mRNA]
|
CTD |
PMID:26522834 PMID:38945390 |
|
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
|
|
| G
|
Pla2g4b
|
phospholipase A2 group IVB
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLA2G4B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:127,458,022...127,467,637
Ensembl chr 3:127,459,273...127,467,637
|
|
| G
|
Plch2
|
phospholipase C, eta 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PLCH2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:170,826,543...170,885,012
Ensembl chr 5:170,826,543...170,885,152
|
|
| G
|
Pld4
|
phospholipase D family, member 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:137,639,948...137,647,462
Ensembl chr 6:137,639,945...137,649,024
|
|
| G
|
Plec
|
plectin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLEC mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:109,768,447...109,828,089
|
|
| G
|
Plekha4
|
pleckstrin homology domain containing A4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PLEKHA4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:105,142,296...105,165,297
Ensembl chr 1:105,142,348...105,165,297
|
|
| G
|
Plin1
|
perilipin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLIN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206
|
|
| G
|
Plk2
|
polo-like kinase 2
|
decreases expression increases expression
|
ISO
|
Sodium Selenite results in decreased expression of PLK2 mRNA Sodium Selenite results in increased expression of PLK2 mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
|
|
| G
|
Plk3
|
polo-like kinase 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLK3 mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900
|
|
| G
|
Plp2
|
proteolipid protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:17,506,153...17,509,552
Ensembl chr X:17,506,059...17,509,550
|
|
| G
|
Plscr3
|
phospholipid scramblase 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLSCR3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:55,064,349...55,070,120
Ensembl chr10:55,065,345...55,070,369
|
|
| G
|
Plxna1
|
plexin A1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PLXNA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:123,295,165...123,340,132
Ensembl chr 4:123,297,244...123,340,428
|
|
| G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
| G
|
Pmm2
|
phosphomannomutase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PMM2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:7,468,371...7,489,574
Ensembl chr10:7,468,372...7,489,554
|
|
| G
|
Pmpca
|
peptidase, mitochondrial processing subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PMPCA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:29,605,823...29,614,936
Ensembl chr 3:29,604,232...29,614,935
|
|
| G
|
Pnkd
|
PNKD metallo-beta-lactamase domain containing
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PNKD mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:83,317,757...83,386,263
Ensembl chr 9:83,317,738...83,386,262
|
|
| G
|
Pnp
|
purine nucleoside phosphorylase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PNP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:26,643,858...26,678,162
|
|
| G
|
Pnrc1
|
proline-rich nuclear receptor coactivator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PNRC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491
|
|
| G
|
Pole3
|
DNA polymerase epsilon 3, accessory subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POLE3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:80,989,508...80,992,742
Ensembl chr 5:80,989,511...80,992,742 Ensembl chr 7:80,989,511...80,992,742
|
|
| G
|
Polr1f
|
RNA polymerase I subunit F
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POLR1F mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:55,780,706...55,797,935
Ensembl chr 6:55,780,706...55,797,935
|
|
| G
|
Polr2a
|
RNA polymerase II subunit A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POLR2A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179
|
|
| G
|
Polr2f
|
RNA polymerase II, I and III subunit F
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POLR2F mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666
|
|
| G
|
Polr2l
|
RNA polymerase II, I and III subunit L
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POLR2L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:205,999,607...206,001,615
Ensembl chr19:8,341,868...8,342,071
|
|
| G
|
Pon1
|
paraoxonase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PON1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PON2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Pop4
|
POP4 homolog, ribonuclease P/MRP subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of POP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:100,096,722...100,105,056
Ensembl chr 1:100,096,723...100,105,104
|
|
| G
|
Porcn
|
porcupine O-acyltransferase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PORCN mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr X:16,957,811...16,970,440
Ensembl chr X:16,957,810...16,970,439
|
|
| G
|
Pou5f2
|
POU domain class 5, transcription factor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of POU5F2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:9,643,313...9,644,547
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PPARA mRNA Sodium Selenite results in decreased expression of PPARA mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions increases activity increases expression
|
EXP
|
Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] Sodium Selenite results in increased activity of PPARG protein Sodium Selenite results in increased expression of PPARG protein
|
CTD |
PMID:21705299 PMID:24140496 PMID:31419397 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PPARGC1A mRNA]
|
CTD |
PMID:26522834 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppargc1b
|
PPARG coactivator 1 beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPARGC1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:57,029,264...57,131,466
Ensembl chr18:57,029,275...57,131,466
|
|
| G
|
Pphln1
|
periphilin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPHLN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:126,418,042...126,509,430
Ensembl chr 7:126,417,555...126,509,430
|
|
| G
|
Ppm1d
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPM1D mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256
|
|
| G
|
Ppp1r10
|
protein phosphatase 1, regulatory subunit 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP1R10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,827,802...2,842,418
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP1R15A mRNA
|
CTD |
PMID:24383545 PMID:28161410 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp2r2d
|
protein phosphatase 2, regulatory subunit B, delta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP2R2D mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:203,095,536...203,129,895
Ensembl chr 1:203,095,531...203,129,893
|
|
| G
|
Ppp2r5e
|
protein phosphatase 2 regulatory subunit B', epsilon
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP2R5E mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573
|
|
| G
|
Ppp4c
|
protein phosphatase 4, catalytic subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP4C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168
|
|
| G
|
Ppp6c
|
protein phosphatase 6, catalytic subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPP6C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:43,339,521...43,371,807
Ensembl chr 3:43,341,108...43,371,807
|
|
| G
|
Pprc1
|
PPARG related coactivator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PPRC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570
|
|
| G
|
Pqbp1
|
polyglutamine binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PQBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:17,275,445...17,280,018
Ensembl chr X:17,275,759...17,280,016
|
|
| G
|
Prdm1
|
PR/SET domain 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRDM1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRDX1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prdx5
|
peroxiredoxin 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRDX5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020
|
|
| G
|
Prelid1
|
PRELI domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRELID1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:9,310,471...9,313,511
Ensembl chr17:9,310,472...9,313,531
|
|
| G
|
Prex1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PREX1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:175,724,939...175,875,764
Ensembl chr 3:175,726,012...175,875,764
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PRKCA mRNA]
|
CTD |
PMID:21705299 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
decreases localization
|
ISO
|
Sodium Selenite results in decreased localization of PRKCD protein
|
CTD |
PMID:14737004 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkcq
|
protein kinase C, theta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PRKCQ mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr17:72,156,215...72,288,508
Ensembl chr17:72,156,215...72,288,508
|
|
| G
|
Prkcz
|
protein kinase C, zeta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRKCZ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
|
|
| G
|
Prodh1
|
proline dehydrogenase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PRODH mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:96,414,224...96,433,418
|
|
| G
|
Prok2
|
prokineticin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PROK2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 4:133,903,210...133,918,126
Ensembl chr 4:133,903,210...133,917,933
|
|
| G
|
Prokr2
|
prokineticin receptor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PROKR2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:140,077,630...140,092,093
|
|
| G
|
Prox1
|
prospero homeobox 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PROX1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr13:104,196,615...104,251,007
Ensembl chr13:104,200,378...104,250,975
|
|
| G
|
Prpf6
|
pre-mRNA processing factor 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRPF6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:189,084,465...189,148,705
Ensembl chr 3:189,081,794...189,152,786
|
|
| G
|
Prpf8
|
pre-mRNA processing factor 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRPF8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:60,829,778...60,852,887
Ensembl chr10:60,829,778...60,852,887
|
|
| G
|
Prr13
|
proline rich 13
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PRR13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:135,471,040...135,474,344
Ensembl chr 7:135,470,933...135,474,579
|
|
| G
|
Prxl2c
|
peroxiredoxin like 2C
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PRXL2C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:817,932...849,965
Ensembl chr17:817,949...840,940
|
|
| G
|
Psat1
|
phosphoserine aminotransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSAT1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
|
|
| G
|
Psen1
|
presenilin 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PSEN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189
|
|
| G
|
Psma1
|
proteasome 20S subunit alpha 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949
|
|
| G
|
Psma2
|
proteasome 20S subunit alpha 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMA2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673
|
|
| G
|
Psma7
|
proteasome 20S subunit alpha 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMA7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:187,514,901...187,521,289
Ensembl chr 3:187,513,441...187,521,253
|
|
| G
|
Psmb1
|
proteasome 20S subunit beta 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640
|
|
| G
|
Psmb10
|
proteasome 20S subunit beta 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMB10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210
|
|
| G
|
Psmb7
|
proteasome 20S subunit beta 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMB7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:42,767,500...42,827,470
Ensembl chr 3:42,767,501...42,827,601
|
|
| G
|
Psmc4
|
proteasome 26S subunit, ATPase 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMC4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060
|
|
| G
|
Psmd4
|
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:185,286,868...185,297,201
|
|
| G
|
Psmd7
|
proteasome 26S subunit, non-ATPase 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSMD7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:52,404,032...52,411,316
Ensembl chr19:52,404,032...52,417,871
|
|
| G
|
Psrc1
|
proline and serine rich coiled-coil 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSRC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997
|
|
| G
|
Pstpip2
|
proline-serine-threonine phosphatase-interacting protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PSTPIP2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr18:73,585,729...73,671,868
Ensembl chr18:73,585,993...73,671,871
|
|
| G
|
Ptchd4
|
patched domain containing 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PTCHD4 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:25,951,395...26,163,296
Ensembl chr 9:25,959,954...26,163,284
|
|
| G
|
Ptger2
|
prostaglandin E receptor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PTGER2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950
|
|
| G
|
Ptger4
|
prostaglandin E receptor 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PTGER4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135
|
|
| G
|
Ptges
|
prostaglandin E synthase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PTGES mRNA; Sodium Selenite results in decreased expression of PTGES protein
|
CTD |
PMID:21669866 |
|
NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of PTGIS mRNA
|
CTD |
PMID:21669866 |
|
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions decreases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Sodium Selenite inhibits the reaction [Matrines results in increased expression of PTGS2 mRNA]; Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein]; Sodium Selenite inhibits the reaction [pyrazolanthrone promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] Sodium Selenite results in decreased expression of PTGS2 mRNA [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased expression of PTGS2 protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA]; Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:18279804 PMID:18481333 PMID:21705299 PMID:25187657 PMID:30526071 PMID:37716422 PMID:37967787 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
multiple interactions
|
ISO
|
Sodium Selenite results in increased phosphorylation of and results in increased activity of PTK2 protein
|
CTD |
PMID:12896980 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Ptp4a3
|
protein tyrosine phosphatase 4A3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PTP4A3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:107,518,220...107,549,949
Ensembl chr 7:107,541,047...107,549,949
|
|
| G
|
Ptpa
|
protein phosphatase 2 phosphatase activator
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PTPA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:34,087,575...34,162,772
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
increases expression decreases activity
|
ISO
|
Sodium Selenite results in increased expression of PTPN1 mRNA Selenite decreases activity of PTPN1 protein in vitro Sodium Selenite results in decreased activity of PTPN1 protein
|
CTD RGD |
PMID:16443359 PMID:22366233 PMID:22366233 |
RGD:401959220 |
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PTPN18 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:44,166,571...44,185,885
Ensembl chr 9:44,168,269...44,186,917
|
|
| G
|
Ptprm
|
protein tyrosine phosphatase, receptor type, M
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PTPRM mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 9:114,086,380...114,791,000
Ensembl chr 9:114,086,380...114,790,477
|
|
| G
|
Pttg1ip
|
PTTG1 interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PTTG1IP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:11,029,608...11,047,395
Ensembl chr20:11,029,608...11,046,909
|
|
| G
|
Pum1
|
pumilio RNA-binding family member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PUM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:148,120,712...148,238,468
Ensembl chr 5:148,121,254...148,238,466
|
|
| G
|
Purb
|
purine rich element binding protein B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PURB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:85,556,296...85,558,779
Ensembl chr14:85,550,417...85,572,205
|
|
| G
|
Pus1
|
pseudouridine synthase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PUS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:51,539,659...51,548,975
Ensembl chr12:51,540,212...51,548,973
|
|
| G
|
Pxmp2
|
peroxisomal membrane protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PXMP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:52,053,951...52,064,283
Ensembl chr12:52,053,788...52,064,283
|
|
| G
|
Pxn
|
paxillin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PXN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:46,721,546...46,768,706
Ensembl chr12:46,721,546...46,768,697
|
|
| G
|
Pygm
|
glycogen phosphorylase, muscle associated
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PYGM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:213,119,791...213,134,612
|
|
| G
|
Pym1
|
PYM homolog 1, exon junction complex associated factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of PYM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:1,761,556...1,785,318
Ensembl chr 7:1,759,110...1,783,948
|
|
| G
|
Pyy
|
peptide YY
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of PYY mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:87,561,347...87,562,470
Ensembl chr10:87,561,353...87,562,206
|
|
| G
|
Rab21
|
RAB21, member RAS oncogene family
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAB21 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:52,790,158...52,814,943
Ensembl chr 7:52,790,165...52,814,943
|
|
| G
|
Rab27b
|
RAB27B, member RAS oncogene family
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RAB27B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:65,870,230...66,069,597
Ensembl chr18:65,876,342...66,067,700
|
|
| G
|
Rab3b
|
RAB3B, member RAS oncogene family
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAB3B mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:128,859,034...128,926,087
Ensembl chr 5:128,841,716...128,926,086
|
|
| G
|
Rab4a
|
RAB4A, member RAS oncogene family
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAB4A mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr19:68,692,228...68,720,169
Ensembl chr19:68,692,890...68,720,166
|
|
| G
|
Rab5c
|
RAB5C, member RAS oncogene family
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAB5C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,142,872...86,166,449
Ensembl chr10:86,142,873...86,166,449
|
|
| G
|
Rabepk
|
Rab9 effector protein with kelch motifs
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RABEPK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:38,460,205...38,481,077
Ensembl chr 3:38,460,206...38,480,688
|
|
| G
|
Rac1
|
Rac family small GTPase 1
|
increases activity
|
ISO
|
Sodium Selenite results in increased activity of RAC1 protein
|
CTD |
PMID:12896980 |
|
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109
|
|
| G
|
Rac2
|
Rac family small GTPase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:111,996,742...112,009,267
|
|
| G
|
Rad50
|
RAD50 double strand break repair protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RAD50 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
|
|
| G
|
Rad51
|
RAD51 recombinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RAD51 mRNA; Sodium Selenite results in decreased expression of RAD51 protein
|
CTD |
PMID:10344722 PMID:18175754 |
|
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469
|
|
| G
|
Rag1
|
recombination activating 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of RAG1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:108,372,087...108,383,184
Ensembl chr 3:108,371,978...108,383,261
|
|
| G
|
Raph1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RAPH1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:69,401,517...69,484,019
|
|
| G
|
Rbbp4
|
RB binding protein 4, chromatin remodeling factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RBBP4 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501
|
|
| G
|
Rbbp6
|
RB binding protein 6, ubiquitin ligase
|
affects expression
|
ISO
|
Sodium Selenite affects the expression of RBBP6 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:186,934,938...186,966,852
|
|
| G
|
Rbbp9
|
RB binding protein 9, serine hydrolase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RBBP9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:152,378,426...152,392,370
Ensembl chr 3:152,378,699...152,385,489
|
|
| G
|
Rbck1
|
RANBP2-type and C3HC4-type zinc finger containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RBCK1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 3:161,249,389...161,266,321
Ensembl chr 3:161,249,390...161,266,032
|
|
| G
|
Rbm15b
|
RNA binding motif protein 15B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RBM15B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:116,422,309...116,425,374
Ensembl chr 8:116,421,540...116,425,940
|
|
| G
|
Rbm8a
|
RNA binding motif protein 8A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RBM8A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:186,854,018...186,856,802
Ensembl chr 2:186,854,036...186,856,802
|
|
| G
|
Rbpj
|
recombination signal binding protein for immunoglobulin kappa J region
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RBPJ mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:61,551,366...61,736,220
Ensembl chr14:61,551,366...61,736,307
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases phosphorylation increases expression
|
ISO EXP
|
Buthionine Sulfoximine promotes the reaction [Sodium Selenite results in increased expression of RELA mRNA]; Glutathione affects the reaction [Sodium Selenite results in increased expression of RELA mRNA]; Sodium Selenite results in decreased localization of and results in decreased activity of RELA protein [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased expression of RELA protein] Sodium Selenite results in increased phosphorylation of RELA protein Sodium Selenite inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein]
|
CTD |
PMID:12867288 PMID:14737004 PMID:18449455 PMID:21215776 PMID:37967787 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Relch
|
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RELCH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:22,321,495...22,417,371
Ensembl chr13:22,321,542...22,417,371
|
|
| G
|
Relt
|
RELT, TNF receptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RELT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:164,619,059...164,636,707
Ensembl chr 1:164,619,059...164,636,670
|
|
| G
|
Reps1
|
RALBP1 associated Eps domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of REPS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:14,517,589...14,595,404
Ensembl chr 1:14,517,589...14,595,404
|
|
| G
|
Rer1
|
retention in endoplasmic reticulum sorting receptor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RER1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:170,916,643...170,929,073
Ensembl chr 5:170,916,905...170,928,980
|
|
| G
|
Retsat
|
retinol saturase
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of RETSAT mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr 4:106,211,459...106,220,222
Ensembl chr 4:106,211,436...106,229,552
|
|
| G
|
Rfx5
|
regulatory factor X5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RFX5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:185,210,206...185,217,735
Ensembl chr 2:185,210,217...185,217,743
|
|
| G
|
Rgs2
|
regulator of G-protein signaling 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RGS2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
| G
|
Rgs20
|
regulator of G-protein signaling 20
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RGS20 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:19,282,249...19,412,122
Ensembl chr 5:19,282,153...19,413,286
|
|
| G
|
Rhbdl1
|
rhomboid like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RHBDL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:15,359,027...15,362,530
Ensembl chr10:15,359,027...15,361,839
|
|
| G
|
Rhoh
|
ras homolog family member H
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RHOH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:42,694,860...42,725,690
Ensembl chr14:42,693,413...42,749,967
|
|
| G
|
Ric8a
|
RIC8 guanine nucleotide exchange factor A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RIC8A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:205,364,796...205,371,102
Ensembl chr 1:205,363,882...205,371,102
|
|
| G
|
Ring1
|
ring finger protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RING1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:4,832,013...4,835,516
Ensembl chr20:4,831,993...4,835,513
|
|
| G
|
Ripor1
|
RHO family interacting cell polarization regulator 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RIPOR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:50,387,447...50,416,323
Ensembl chr19:50,387,523...50,416,319
|
|
| G
|
Rit2
|
Ras-like without CAAX 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RIT2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:22,839,914...23,196,137
Ensembl chr18:22,839,915...23,269,823
|
|
| G
|
Rmdn2
|
regulator of microtubule dynamics 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RMDN2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:21,101,383...21,195,221
Ensembl chr 6:21,119,396...21,193,684
|
|
| G
|
Rnase6
|
ribonuclease A family member 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RNASE6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:26,827,896...26,830,807
Ensembl chr15:26,827,009...26,830,825
|
|
| G
|
Rnf220
|
ring finger protein 220
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RNF220 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:135,975,739...136,198,017
Ensembl chr 5:135,975,739...136,197,858
|
|
| G
|
Rnf4
|
ring finger protein 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RNF4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:80,625,864...80,647,138
Ensembl chr14:80,625,866...80,647,148
|
|
| G
|
Rnf40
|
ring finger protein 40
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RNF40 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:191,632,988...191,649,231
Ensembl chr 1:191,633,034...191,648,421
|
|
| G
|
Rnpepl1
|
arginyl aminopeptidase like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RNPEPL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:100,921,053...100,933,748
Ensembl chr 9:100,923,856...100,933,485
|
|
| G
|
Rock1
|
Rho-associated coiled-coil containing protein kinase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ROCK1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147
|
|
| G
|
Rpf2
|
ribosome production factor 2 homolog
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPF2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:45,184,511...45,205,983
Ensembl chr20:45,184,512...45,206,001
|
|
| G
|
Rpia
|
ribose 5-phosphate isomerase A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPIA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:104,282,081...104,307,732
Ensembl chr 4:104,282,081...104,307,718
|
|
| G
|
Rpl10
|
ribosomal protein L10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:157,205,850...157,208,057
Ensembl chr X:157,205,836...157,208,049
|
|
| G
|
Rpl10a
|
ribosomal protein L10A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL10A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:6,390,533...6,393,091
Ensembl chr20:6,390,179...6,393,091
|
|
| G
|
Rpl10l
|
ribosomal protein L10 like
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL10L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:90,280,962...90,281,982
Ensembl chr 6:90,081,656...90,287,434
|
|
| G
|
Rpl12
|
ribosomal protein L12
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:36,661,940...36,664,314
Ensembl chr 3:36,661,939...36,664,306
|
|
| G
|
Rpl14
|
ribosomal protein L14
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL14 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:129,163,317...129,167,459
|
|
| G
|
Rpl15
|
ribosomal protein L15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308
|
|
| G
|
Rpl17
|
ribosomal protein L17
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:70,856,275...70,859,388
Ensembl chr 3:111,722,010...111,722,638 Ensembl chr18:111,722,010...111,722,638
|
|
| G
|
Rpl18a
|
ribosomal protein L18A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL18A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:18,576,467...18,578,653
Ensembl chr 1:70,166,729...70,167,654 Ensembl chr16:70,166,729...70,167,654
|
|
| G
|
Rpl22
|
ribosomal protein L22
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL22 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:168,114,432...168,126,114
Ensembl chr 5:168,111,074...168,126,114 Ensembl chr 4:168,111,074...168,126,114 Ensembl chr 7:168,111,074...168,126,114
|
|
| G
|
Rpl22l1
|
ribosomal protein L22 like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL22L1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:113,683,196...113,685,132
Ensembl chr 2:113,683,196...113,685,132
|
|
| G
|
Rpl24
|
ribosomal protein L24
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL24 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:58,122,997...58,128,405
Ensembl chr11:58,122,997...58,128,405
|
|
| G
|
Rpl28
|
ribosomal protein L28
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL28 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:78,080,945...78,083,771
|
|
| G
|
Rpl29
|
ribosomal protein L29
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL29 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:115,056,443...115,949,677
Ensembl chr 8:115,947,394...115,950,565
|
|
| G
|
Rpl30
|
ribosomal protein L30
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL30 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:67,533,420...67,536,555
Ensembl chr 7:67,465,332...67,536,555
|
|
| G
|
Rpl32
|
ribosomal protein L32
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL32 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:150,536,650...150,540,214
Ensembl chr 4:150,536,646...150,540,214
|
|
| G
|
Rpl35a
|
ribosomal protein L35A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL35A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:81,231,114...81,235,094
Ensembl chr 5:163,826,849...163,827,306 Ensembl chr11:163,826,849...163,827,306
|
|
| G
|
Rpl36al1
|
ribosomal protein L36A like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL36AL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:93,390,864...93,392,258
Ensembl chr 6:93,390,866...93,391,296 Ensembl chr20:93,390,866...93,391,296
|
|
| G
|
Rpl37a
|
ribosomal protein L37A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL37A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:81,748,091...81,750,174
Ensembl chr 9:81,748,103...81,751,975
|
|
| G
|
Rpl4
|
ribosomal protein L4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:73,566,477...73,571,600
Ensembl chr 8:73,566,466...73,571,788
|
|
| G
|
Rpl5
|
ribosomal protein L5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,988,793...1,995,225
|
|
| G
|
Rpl6
|
ribosomal protein L6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:41,008,142...41,012,756
Ensembl chr12:41,008,142...41,025,733
|
|
| G
|
Rpl7
|
ribosomal protein L7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:8,000,446...8,003,454
Ensembl chr 5:7,850,630...8,003,451
|
|
| G
|
Rpl7a
|
ribosomal protein L7A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL7A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:30,637,136...30,639,778
Ensembl chr 3:30,637,059...30,639,791 Ensembl chr18:30,637,059...30,639,791
|
|
| G
|
Rpl8
|
ribosomal protein L8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103 Ensembl chr 3:110,506,800...110,509,103
|
|
| G
|
Rpl9
|
ribosomal protein L9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPL9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:43,247,536...43,250,784
Ensembl chr14:43,247,588...43,250,782 Ensembl chr 1:43,247,588...43,250,782
|
|
| G
|
Rplp0
|
ribosomal protein lateral stalk subunit P0
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPLP0 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422
|
|
| G
|
Rplp2
|
ribosomal protein lateral stalk subunit P2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPLP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:205,975,598...205,978,192
Ensembl chr 1:205,975,894...205,978,191
|
|
| G
|
Rpp25l
|
ribonuclease P/MRP subunit p25 like
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPP25L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:61,674,299...61,675,844
Ensembl chr 5:61,672,199...61,675,168
|
|
| G
|
Rpp40
|
ribonuclease P/MRP subunit p40
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPP40 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:29,153,203...29,162,241
Ensembl chr17:29,153,180...29,162,241
|
|
| G
|
Rps13
|
ribosomal protein S13
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:180,007,230...180,009,660
Ensembl chr 1:180,002,471...180,009,660
|
|
| G
|
Rps15
|
ribosomal protein S15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:10,066,572...10,068,167
Ensembl chr 7:10,066,677...10,068,123
|
|
| G
|
Rps16
|
ribosomal protein S16
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,770,658...92,773,603
Ensembl chr19:56,922,246...56,923,020 Ensembl chr 1:56,922,246...56,923,020
|
|
| G
|
Rps3
|
ribosomal protein S3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:163,190,476...163,195,885
Ensembl chr 1:163,189,842...163,195,776
|
|
| G
|
Rps3a
|
ribosomal protein S3a
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS3A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:173,822,673...173,827,042
Ensembl chr 2:173,822,488...173,827,043
|
|
| G
|
Rps4x
|
ribosomal protein S4, X-linked
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS4X mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:71,338,478...71,342,921
Ensembl chr X:71,338,479...71,342,921 Ensembl chr 4:71,338,479...71,342,921
|
|
| G
|
Rps5
|
ribosomal protein S5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262
|
|
| G
|
Rps6kb2
|
ribosomal protein S6 kinase B2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS6KB2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:210,880,824...210,887,556
Ensembl chr 1:210,880,825...210,887,562
|
|
| G
|
Rps6kl1
|
ribosomal protein S6 kinase-like 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RPS6KL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:110,514,322...110,530,955
Ensembl chr 6:110,514,017...110,530,929
|
|
| G
|
Rps7
|
ribosomal protein S7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPS7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:50,994,581...50,999,447
|
|
| G
|
Rpsa
|
ribosomal protein SA
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPSA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737
|
|
| G
|
Rptor
|
regulatory associated protein of MTOR, complex 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPTOR mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:105,376,943...105,675,416
Ensembl chr10:105,376,943...105,675,413
|
|
| G
|
Rpusd1
|
RNA pseudouridine synthase domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RPUSD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:15,255,806...15,259,730
Ensembl chr10:15,255,868...15,259,730
|
|
| G
|
Rraga
|
Ras-related GTP binding A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRAGA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:106,159,335...106,160,930
Ensembl chr 5:106,158,853...106,160,504
|
|
| G
|
Rragc
|
Ras-related GTP binding C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRAGC mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
|
|
| G
|
Rrm2b
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRM2B mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670
|
|
| G
|
Rrp8
|
ribosomal RNA processing 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRP8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:169,489,829...169,500,551
Ensembl chr 1:169,465,397...169,501,164
|
|
| G
|
Rrp9
|
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRP9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:115,995,119...116,004,832
Ensembl chr 8:115,996,169...116,004,824
|
|
| G
|
Rrs1
|
ribosome biogenesis regulator 1 homolog
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RRS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:14,516,303...14,517,936
Ensembl chr 5:14,515,254...14,517,943
|
|
| G
|
Rsph14
|
radial spoke head 14 homolog
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of RSPH14 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:13,626,707...13,702,817
Ensembl chr20:13,595,523...13,706,782
|
|
| G
|
RT1-A2
|
RT1 class Ia, locus A2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HLA-E mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:4,872,720...4,876,425
|
|
| G
|
RT1-CE16
|
RT1 class I, locus CE16
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HLA-A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:3,261,656...3,265,548
|
|
| G
|
RT1-M3-1
|
RT1 class Ib, locus M3, gene 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of HLA-G mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366
|
|
| G
|
Rtn4
|
reticulon 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RTN4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:107,651,001...107,698,610
Ensembl chr14:107,650,732...107,698,611
|
|
| G
|
Rtraf
|
RNA transcription, translation and transport factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RTRAF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:4,482,699...4,507,115
Ensembl chr15:4,480,966...4,507,115
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
multiple interactions
|
ISO
|
[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 protein; TGFB1 protein inhibits the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein]
|
CTD |
PMID:32324263 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Runx3
|
RUNX family transcription factor 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RUNX3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:152,644,270...152,702,835
|
|
| G
|
Ruvbl1
|
RuvB-like AAA ATPase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of RUVBL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:122,489,754...122,524,666
Ensembl chr 4:122,489,680...122,524,665
|
|
| G
|
S100a16
|
S100 calcium binding protein A16
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of S100A16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:178,313,986...178,319,696
Ensembl chr 2:178,313,910...178,319,821
|
|
| G
|
S100a8
|
S100 calcium binding protein A8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of S100A8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
| G
|
S100z
|
S100 calcium binding protein Z
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of S100Z mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:28,472,527...28,476,750
Ensembl chr 2:28,472,527...28,476,750
|
|
| G
|
Sac3d1
|
SAC3 domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SAC3D1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:212,843,463...212,845,842
Ensembl chr 1:212,843,463...212,845,883
|
|
| G
|
Sap30l
|
SAP30-like
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SAP30L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:42,480,201...42,488,139
Ensembl chr10:42,480,201...42,488,139
|
|
| G
|
Sar1a
|
secretion associated, Ras related GTPase 1A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SAR1A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:30,166,310...30,178,718
Ensembl chr20:30,166,334...30,178,710
|
|
| G
|
Sart1
|
spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SART1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:212,119,824...212,128,517
Ensembl chr 1:212,104,557...212,128,486
|
|
| G
|
Sart3
|
spliceosome associated factor 3, U4/U6 recycling protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SART3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:48,519,579...48,547,584
Ensembl chr12:48,519,849...48,547,583
|
|
| G
|
Satb1
|
SATB homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SATB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,917,215...4,989,925
|
|
| G
|
Sbds
|
Sbds, ribosome maturation factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SBDS mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:32,056,649...32,065,816
Ensembl chr12:32,056,518...32,065,813
|
|
| G
|
Scamp2
|
secretory carrier membrane protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SCAMP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:66,861,504...66,888,151
Ensembl chr 8:66,861,537...66,888,150
|
|
| G
|
Scand1
|
SCAN domain-containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SCAND1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:165,278,723...165,279,587
Ensembl chr 3:165,278,723...165,279,587
|
|
| G
|
Scaper
|
S-phase cyclin A-associated protein in the ER
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SCAPER mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:64,828,789...65,228,240
Ensembl chr 8:64,828,789...65,228,453
|
|
| G
|
Scara3
|
scavenger receptor class A, member 3
|
decreases methylation increases expression
|
ISO
|
Sodium Selenite results in decreased methylation of SCARA3 promoter Sodium Selenite results in increased expression of SCARA3 mRNA
|
CTD |
PMID:18676679 |
|
NCBI chr15:44,315,422...44,348,416
Ensembl chr15:44,315,422...44,348,551
|
|
| G
|
Scarb1
|
scavenger receptor class B, member 1
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of SCARB1 mRNA [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased expression of SCARB1 protein]
|
CTD |
PMID:18514395 PMID:37967787 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SCD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Scn2b
|
sodium voltage-gated channel beta subunit 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SCN2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:54,322,383...54,334,519
Ensembl chr 8:54,322,383...54,334,519
|
|
| G
|
Scrib
|
scribble planar cell polarity protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SCRIB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:109,640,034...109,663,354
Ensembl chr 7:109,640,034...109,663,022
|
|
| G
|
Sdhaf2
|
succinate dehydrogenase complex assembly factor 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SDHAF2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:216,564,002...216,592,877
Ensembl chr 1:216,567,861...216,593,540
|
|
| G
|
Sdhb
|
succinate dehydrogenase complex iron sulfur subunit B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SDHB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:158,547,775...158,568,589
Ensembl chr 5:158,547,689...158,569,667
|
|
| G
|
Sec11a
|
SEC11 homolog A, signal peptidase complex subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEC11A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:144,290,680...144,318,658
Ensembl chr 1:144,284,497...144,324,009
|
|
| G
|
Sec24b
|
SEC24 homolog B, COPII coat complex component
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEC24B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:221,236,897...221,306,986
Ensembl chr 2:221,236,898...221,306,919
|
|
| G
|
Sec61g
|
Sec61 translocon subunit gamma
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEC61G mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:95,113,083...95,119,458
Ensembl chr 9:48,798,504...48,798,710 Ensembl chr14:48,798,504...48,798,710
|
|
| G
|
Sec63
|
SEC63 homolog, protein translocation regulator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEC63 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:47,827,291...47,896,248
Ensembl chr20:47,827,291...47,896,248
|
|
| G
|
Sele
|
selectin E
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of SELE protein]
|
CTD |
PMID:11888521 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Selenof
|
selenoprotein F
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SELENOF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:236,302,439...236,335,216
Ensembl chr 2:236,302,683...236,335,210
|
|
| G
|
Selenok
|
selenoprotein K
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SELENOK mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:5,158,601...5,167,183
Ensembl chr16:5,158,621...5,168,512
|
|
| G
|
Selenop
|
selenoprotein P
|
multiple interactions increases expression increases secretion
|
ISO EXP
|
[Sodium Selenite co-treated with sodium arsenite] results in decreased expression of SELENOP protein; INS protein inhibits the reaction [Sodium Selenite results in increased secretion of SELENOP protein] Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SELENOP mRNA] Sodium Selenite results in increased expression of SELENOP mRNA; Sodium Selenite results in increased expression of SELENOP protein [Sodium Selenite co-treated with Cadmium Chloride] results in increased expression of SELENOP mRNA
|
CTD |
PMID:12896980 PMID:14714311 PMID:17536041 PMID:18514395 PMID:18972406 PMID:20643113 PMID:24140496 PMID:24535192 PMID:26522834 More...
|
|
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019
|
|
| G
|
Selenow
|
selenoprotein W
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SELENOW mRNA
|
CTD |
PMID:18514395 PMID:19387567 PMID:24383545 |
|
NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703
|
|
| G
|
Selplg
|
selectin P ligand
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SELPLG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:48,456,932...48,473,154
|
|
| G
|
Sem1
|
SEM1 26S proteasome subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:35,638,306...35,658,462
Ensembl chr 4:35,638,306...35,658,462
|
|
| G
|
Sephs1
|
selenophosphate synthetase 1
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of SEPHS1 mRNA SEPHS1 protein affects the reaction [Sodium Selenite results in increased expression of GPX1 protein]
|
CTD |
PMID:18175754 PMID:21669866 |
|
NCBI chr17:78,263,725...78,296,132
Ensembl chr17:78,263,725...78,292,082
|
|
| G
|
Sephs2
|
selenophosphate synthetase 2
|
multiple interactions
|
ISO
|
[SEPHS2 protein co-treated with Sodium Selenite] affects the abundance of 15-deoxyprostaglandin J2; SEPHS2 protein affects the reaction [Sodium Selenite results in increased expression of HPGDS protein]
|
CTD |
PMID:21669866 |
|
NCBI chr 1:191,323,637...191,325,955
Ensembl chr 1:191,323,641...191,325,955
|
|
| G
|
Septin7
|
septin 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SEPTIN7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:31,995,597...32,059,069
Ensembl chr 8:31,995,005...32,059,072
|
|
| G
|
Serinc3
|
serine incorporator 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SERINC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:172,721,208...172,749,853
Ensembl chr 3:172,721,321...172,740,765
|
|
| G
|
Serpina11
|
serpin family A member 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SERPINA11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:128,668,030...128,677,476
Ensembl chr 6:128,668,034...128,677,454
|
|
| G
|
Serpinb2
|
serpin family B member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SERPINB2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:24,056,021...24,065,031
|
|
| G
|
Serping1
|
serpin family G member 1
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SERPING1 mRNA Sodium Selenite results in decreased expression of SERPING1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Sesn1
|
sestrin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SESN1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
|
|
| G
|
Sesn2
|
sestrin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SESN2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
|
|
| G
|
Setd5
|
SET domain containing 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SETD5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:147,772,955...147,850,669
Ensembl chr 4:147,773,028...147,850,667
|
|
| G
|
Sf3a1
|
splicing factor 3A subunit 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SF3A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:83,254,971...83,275,720
Ensembl chr14:83,254,971...83,275,720
|
|
| G
|
Sf3b5
|
splicing factor 3b, subunit 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SF3B5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:9,177,189...9,177,901
Ensembl chr 1:9,177,098...9,177,900
|
|
| G
|
Sfmbt1
|
Scm-like with four mbt domains 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SFMBT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:5,896,686...6,016,311
Ensembl chr16:5,897,187...6,011,934
|
|
| G
|
Sgsm3
|
small G protein signaling modulator 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SGSM3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:114,394,813...114,424,489
|
|
| G
|
Sgtb
|
small glutamine rich tetratricopeptide repeat co-chaperone beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SGTB mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:36,966,840...37,003,318
Ensembl chr 2:36,966,838...37,003,311
|
|
| G
|
Sh2d3a
|
SH2 domain containing 3A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SH2D3A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:2,235,359...2,239,578
|
|
| G
|
Sh3bp4
|
SH3-domain binding protein 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SH3BP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:97,107,877...97,186,878
Ensembl chr 9:97,107,877...97,186,878
|
|
| G
|
Sh3bp5
|
SH3-domain binding protein 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SH3BP5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
|
|
| G
|
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SH3KBP1 mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr X:38,686,530...39,031,658
Ensembl chr X:38,686,530...39,031,393
|
|
| G
|
Shc1
|
SHC adaptor protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SHC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914
|
|
| G
|
Shoc2
|
SHOC2 leucine-rich repeat scaffold protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SHOC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:262,964,345...263,052,898
Ensembl chr 1:262,965,011...263,052,634
|
|
| G
|
Shtn1
|
shootin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SHTN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:268,108,095...268,211,947
Ensembl chr 1:268,108,097...268,211,947
|
|
| G
|
Sipa1l1
|
signal-induced proliferation-associated 1 like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SIPA1L1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:107,570,569...107,849,613
Ensembl chr 6:107,737,392...107,848,160
|
|
| G
|
Sit1
|
signaling threshold regulating transmembrane adaptor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SIT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:62,536,003...62,538,230
Ensembl chr 5:62,536,009...62,537,911
|
|
| G
|
Skap1
|
src kinase associated phosphoprotein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SKAP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:81,921,961...82,229,106
Ensembl chr10:81,921,980...82,229,105
|
|
| G
|
Skp1
|
S-phase kinase-associated protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SKP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:36,898,670...36,917,828
Ensembl chr10:36,903,078...36,918,308
|
|
| G
|
Slamf1
|
signaling lymphocytic activation molecule family member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLAMF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890
|
|
| G
|
Slc14a1
|
solute carrier family 14 member 1 (Kidd blood group)
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC14A1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489
|
|
| G
|
Slc16a11
|
solute carrier family 16, member 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC16A11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:55,427,773...55,431,678
Ensembl chr10:55,427,903...55,431,678
|
|
| G
|
Slc1a5
|
solute carrier family 1 member 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC1A5 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:86,584,949...86,599,054
|
|
| G
|
Slc22a13
|
solute carrier family 22 member 13
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC22A13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:127,800,097...127,811,750
Ensembl chr 8:127,800,097...127,811,724
|
|
| G
|
Slc22a2
|
solute carrier family 22 member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC22A2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
|
|
| G
|
Slc25a30
|
solute carrier family 25, member 30
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC25A30 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr15:57,486,346...57,508,981
Ensembl chr15:57,486,350...57,502,690
|
|
| G
|
Slc25a40
|
solute carrier family 25, member 40
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC25A40 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:26,544,288...26,631,439
Ensembl chr 4:26,544,290...26,631,383
|
|
| G
|
Slc25a5
|
solute carrier family 25 member 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC25A5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:120,897,616...120,900,683
Ensembl chr X:120,897,563...120,900,688
|
|
| G
|
Slc25a51
|
solute carrier family 25, member 51
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC25A51 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:64,445,610...64,459,172
Ensembl chr 5:64,443,616...64,459,462
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
multiple interactions
|
ISO
|
[Sodium Selenite co-treated with Glucose] results in increased expression of SLC2A2 protein
|
CTD |
PMID:23795780 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Slc30a3
|
solute carrier family 30 member 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC30A3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:30,984,241...31,004,689
Ensembl chr 6:30,984,276...31,005,120
|
|
| G
|
Slc30a9
|
solute carrier family 30 member 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC30A9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:41,170,164...41,224,861
Ensembl chr14:41,170,166...41,224,788
|
|
| G
|
Slc35b1
|
solute carrier family 35, member B1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC35B1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:80,824,972...80,832,048
Ensembl chr10:80,824,696...80,832,045
|
|
| G
|
Slc35d1
|
solute carrier family 35 member D1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC35D1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:123,157,739...123,210,350
Ensembl chr 5:123,155,407...123,210,073
|
|
| G
|
Slc39a9
|
solute carrier family 39, member 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC39A9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:106,022,858...106,061,734
Ensembl chr 6:106,022,850...106,071,176
|
|
| G
|
Slc43a3
|
solute carrier family 43, member 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC43A3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:90,414,822...90,450,654
Ensembl chr 3:90,415,977...90,436,976
|
|
| G
|
Slc45a2
|
solute carrier family 45, member 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC45A2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:61,690,828...61,723,437
Ensembl chr 2:61,690,828...61,723,437
|
|
| G
|
Slc5a7
|
solute carrier family 5 member 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC5A7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,922,697...7,953,509
|
|
| G
|
Slc6a5
|
solute carrier family 6 member 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SLC6A5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:108,767,245...108,833,173
Ensembl chr 1:108,781,553...108,833,165
|
|
| G
|
Slc6a9
|
solute carrier family 6 member 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC6A9 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC7A11 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Slc7a5
|
solute carrier family 7 member 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC7A5 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLC9A1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Slfn5
|
schlafen family member 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SLFN5 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:68,378,440...68,392,515
Ensembl chr10:68,378,449...68,392,544
|
|
| G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
ISO
|
[Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD2 mRNA
|
CTD |
PMID:32324263 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Smad3
|
SMAD family member 3
|
increases expression multiple interactions
|
ISO
|
Sodium Selenite results in increased expression of SMAD3 mRNA [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD3 mRNA
|
CTD |
PMID:18175754 PMID:32324263 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smco2
|
single-pass membrane protein with coiled-coil domains 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SMCO2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:181,491,290...181,521,746
Ensembl chr 4:181,496,204...181,521,740
|
|
| G
|
Smim7
|
small integral membrane protein 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SMIM7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:17,308,466...17,312,384
Ensembl chr16:17,308,395...17,312,371
|
|
| G
|
Smo
|
smoothened, frizzled class receptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SMO mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281
|
|
| G
|
Smox
|
spermine oxidase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SMOX mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170 Ensembl chr X:139,184,798...139,220,170
|
|
| G
|
Snap23
|
synaptosome associated protein 23
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SNAP23 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067
|
|
| G
|
Snd1
|
staphylococcal nuclease and tudor domain containing 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SND1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:58,060,689...58,459,926
Ensembl chr 4:58,060,640...58,459,925
|
|
| G
|
Snora71d
|
small nucleolar RNA, H/ACA box 71D
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNORA71D mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:241,544,327...241,544,458
Ensembl chr 1:241,544,327...241,544,458
|
|
| G
|
Snrpf
|
small nuclear ribonucleoprotein polypeptide F
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNRPF mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:30,017,460...30,024,162
Ensembl chr 7:30,017,460...30,024,162
|
|
| G
|
Snta1
|
syntrophin, alpha 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNTA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:163,336,509...163,366,954
Ensembl chr 3:163,336,516...163,366,927
|
|
| G
|
Snu13
|
small nuclear ribonucleoprotein 13
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNU13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:115,445,415...115,451,008
Ensembl chr 1:269,702,002...269,703,004 Ensembl chr 7:269,702,002...269,703,004
|
|
| G
|
Snupn
|
snurportin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNUPN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:66,242,940...66,286,651
Ensembl chr 8:66,235,828...66,286,835
|
|
| G
|
Snx1
|
sorting nexin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNX1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:75,515,780...75,565,487
Ensembl chr 8:75,525,181...75,565,561
|
|
| G
|
Snx19
|
sorting nexin 19
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SNX19 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:37,088,142...37,125,317
Ensembl chr 8:37,088,191...37,125,264
|
|
| G
|
Socs2
|
suppressor of cytokine signaling 2
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of SOCS2 mRNA]
|
CTD |
PMID:31659573 |
|
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions decreases expression increases expression increases activity affects localization
|
ISO EXP
|
Sodium Selenite promotes the reaction [Reactive Oxygen Species results in increased activity of SOD1 protein]; Sodium Selenite promotes the reaction [Reactive Oxygen Species results in increased expression of SOD1 mRNA]; Sodium Selenite promotes the reaction [SOD1 protein binds to SOD1 protein] Sodium Selenite results in decreased expression of SOD1 protein Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Sodium Selenite promotes the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of SOD1 mRNA] Sodium Selenite results in increased expression of SOD1 mRNA; Sodium Selenite results in increased expression of SOD1 protein Sodium Selenite results in increased activity of SOD1 protein [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of SOD1 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of SOD1 mRNA] Sodium Selenite affects the localization of SOD1 protein
|
CTD |
PMID:16424399 PMID:18175754 PMID:21215776 PMID:23603382 PMID:23795780 PMID:24535002 PMID:31585128 PMID:37967787 PMID:38945390 More...
|
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
decreases response to substance multiple interactions increases expression decreases expression
|
ISO EXP
|
SOD2 protein results in decreased susceptibility to Sodium Selenite [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of SOD2 mRNA Sodium Selenite results in increased expression of SOD2 protein Sodium Selenite results in decreased expression of SOD2 mRNA; Sodium Selenite results in decreased expression of SOD2 protein Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA]
|
CTD |
PMID:15130278 PMID:15650415 PMID:21215776 PMID:23859036 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sorbs3
|
sorbin and SH3 domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SORBS3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:51,662,639...51,699,161
Ensembl chr15:51,663,095...51,694,522
|
|
| G
|
Sorcs1
|
sortilin-related VPS10 domain containing receptor 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SORCS1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:259,022,007...259,535,731
Ensembl chr 1:259,021,631...259,535,685
|
|
| G
|
Sort1
|
sortilin 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SORT1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481
|
|
| G
|
Sox8
|
SRY-box transcription factor 8
|
multiple interactions decreases expression
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SOX8 mRNA Sodium Selenite results in decreased expression of SOX8 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:15,089,357...15,094,345
Ensembl chr10:15,089,357...15,094,345
|
|
| G
|
Sox9
|
SRY-box transcription factor 9
|
multiple interactions
|
ISO
|
[Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SOX9 mRNA
|
CTD |
PMID:32324263 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
| G
|
Sp1
|
Sp1 transcription factor
|
multiple interactions
|
ISO EXP
|
[Sodium Selenite results in decreased activity of SP1 protein] which results in decreased expression of AR protein; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of SP1 protein]; Sodium Selenite results in decreased expression of and results in decreased activity of SP1 protein [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of SP1 protein Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of SP1 protein]
|
CTD |
PMID:15650415 PMID:16928829 PMID:35384129 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
| G
|
Sp7
|
Sp7 transcription factor
|
multiple interactions
|
ISO
|
[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SP7 protein; TGFB1 protein affects the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein]
|
CTD |
PMID:32324263 |
|
NCBI chr 7:135,363,193...135,373,376
Ensembl chr 7:135,363,199...135,373,559
|
|
| G
|
Spaca1
|
sperm acrosome associated 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SPACA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:53,321,741...53,337,018
Ensembl chr 5:53,321,741...53,337,173
|
|
| G
|
Spag9
|
sperm associated antigen 9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SPAG9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:79,440,311...79,574,709
Ensembl chr10:79,440,377...79,575,258
|
|
| G
|
Spdl1
|
spindle apparatus coiled-coil protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SPDL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:19,773,456...19,798,341
Ensembl chr10:19,773,457...19,798,297
|
|
| G
|
Sphk2
|
sphingosine kinase 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SPHK2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:105,317,332...105,324,985
Ensembl chr 1:105,317,333...105,321,637
|
|
| G
|
Spo11
|
SPO11 initiator of meiotic double strand breaks
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SPO11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:182,173,615...182,189,273
Ensembl chr 3:182,175,861...182,189,276
|
|
| G
|
Spon2
|
spondin 2
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SPON2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SPP1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Spp2
|
secreted phosphoprotein 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SPP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:96,454,636...96,474,453
Ensembl chr 9:96,454,957...96,474,452
|
|
| G
|
Sqstm1
|
sequestosome 1
|
increases expression multiple interactions
|
ISO EXP
|
Sodium Selenite results in increased expression of SQSTM1 mRNA Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein] [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of SQSTM1 protein
|
CTD |
PMID:24383545 PMID:28757135 PMID:31419397 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
decreases methylation multiple interactions increases expression
|
ISO EXP
|
Sodium Selenite results in decreased methylation of SREBF1 exon [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA] [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA] Sodium Selenite results in increased expression of SREBF1 mRNA
|
CTD |
PMID:28810182 PMID:30031400 PMID:36464106 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in increased expression of SREBF2 mRNA]
|
CTD |
PMID:38945390 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
| G
|
Srek1ip1
|
SREK1-interacting protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SREK1IP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:37,709,712...37,733,391
Ensembl chr 2:37,709,768...37,733,383 Ensembl chr 7:37,709,768...37,733,383
|
|
| G
|
Srp72
|
signal recognition particle 72
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SRP72 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:31,522,424...31,549,978
Ensembl chr14:31,522,963...31,550,151
|
|
| G
|
Srpra
|
SRP receptor subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SRPRA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:41,818,229...41,824,280
|
|
| G
|
Srsf1
|
serine and arginine rich splicing factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SRSF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548
|
|
| G
|
Srsf3
|
serine and arginine rich splicing factor 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SRSF3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,093,565...7,103,516
|
|
| G
|
Srsf7
|
serine and arginine rich splicing factor 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SRSF7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212
|
|
| G
|
Ss18
|
SS18 subunit of BAF chromatin remodeling complex
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SS18 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:6,047,619...6,169,151
Ensembl chr18:6,047,619...6,109,913
|
|
| G
|
Ss18l2
|
SS18 like 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SS18L2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:130,252,774...130,255,388
Ensembl chr 8:130,252,782...130,257,367
|
|
| G
|
Ssb
|
small RNA binding exonuclease protection factor La
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SSB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:75,024,385...75,034,016
Ensembl chr 3:75,024,474...75,034,031
|
|
| G
|
Ssbp1
|
single stranded DNA binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SSBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:70,232,794...70,243,700
|
|
| G
|
Sspn
|
sarcospan
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SSPN mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:180,620,762...180,666,893
Ensembl chr 4:180,627,848...180,662,284
|
|
| G
|
Ssr2
|
signal sequence receptor subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SSR2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:176,346,117...176,354,868
Ensembl chr 2:176,346,404...176,355,781
|
|
| G
|
Sstr3
|
somatostatin receptor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SSTR3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:111,972,811...111,997,368
|
|
| G
|
Ssu72
|
SSU72 homolog, RNA polymerase II CTD phosphatase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SSU72 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,595,919...171,625,675
Ensembl chr 5:171,595,851...171,625,268
|
|
| G
|
St13
|
ST13, Hsp70 interacting protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ST13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:114,769,758...114,805,877
Ensembl chr 7:114,769,759...114,805,941
|
|
| G
|
St3gal1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ST3GAL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:100,734,300...100,802,443
Ensembl chr 7:100,734,300...100,745,242
|
|
| G
|
St3gal6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ST3GAL6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:55,530,120...55,590,950
Ensembl chr11:55,530,248...55,598,720
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased activity of STAR protein] Sodium Selenite results in increased expression of STAR mRNA [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased expression of STAR protein]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of STAR mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of STAR mRNA]
|
CTD |
PMID:22828241 PMID:37967787 PMID:39354181 PMID:39549767 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stard13
|
StAR-related lipid transfer domain containing 13
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of STARD13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:5,401,878...5,797,937
Ensembl chr12:5,401,995...5,794,967
|
|
| G
|
Stard4
|
StAR-related lipid transfer domain containing 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STARD4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:25,088,831...25,104,172
Ensembl chr18:25,091,255...25,104,172
|
|
| G
|
Stard6
|
StAR-related lipid transfer domain containing 6
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of STARD6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:66,365,526...66,393,439
Ensembl chr18:66,365,007...66,382,468
|
|
| G
|
Stard7
|
StAR-related lipid transfer domain containing 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STARD7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:134,935,602...134,969,140
Ensembl chr 3:134,940,471...134,969,168
|
|
| G
|
Stat4
|
signal transducer and activator of transcription 4
|
multiple interactions increases expression
|
ISO
|
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA] Sodium Selenite results in increased expression of STAT4 mRNA
|
CTD |
PMID:18175754 PMID:31659573 |
|
NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:56,911,523...57,077,346
|
|
| G
|
Stau1
|
staufen double-stranded RNA binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STAU mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:176,099,053...176,144,947
Ensembl chr 3:176,099,053...176,144,947
|
|
| G
|
Stau2
|
staufen double-stranded RNA binding protein 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STAU2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:7,623,528...7,868,206
Ensembl chr 5:7,624,019...7,868,204
|
|
| G
|
Stc2
|
stanniocalcin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STC2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
|
|
| G
|
Steep1
|
STING1 ER exit protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of STEEP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:120,953,335...120,979,861
Ensembl chr X:120,926,647...120,979,861
|
|
| G
|
Stil
|
STIL, centriolar assembly protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of STIL mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:133,757,598...133,810,493
Ensembl chr 5:133,760,417...133,810,494
|
|
| G
|
Stk10
|
serine/threonine kinase 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STK10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:17,622,149...17,716,337
Ensembl chr10:17,622,162...17,716,332
|
|
| G
|
Stk3
|
serine/threonine kinase 3
|
multiple interactions
|
EXP
|
Sodium Selenite inhibits the reaction [Sodium Fluoride results in increased expression of STK3 protein]
|
CTD |
PMID:36736877 |
|
NCBI chr 7:67,938,341...68,208,472
Ensembl chr 7:67,938,378...68,208,508
|
|
| G
|
Stk4
|
serine/threonine kinase 4
|
multiple interactions
|
EXP
|
[Sodium Fluoride co-treated with Sodium Selenite] affects the expression of STK4 protein
|
CTD |
PMID:36736877 |
|
NCBI chr 3:173,165,238...173,247,135
Ensembl chr 3:173,165,083...173,247,134
|
|
| G
|
Stom
|
stomatin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STOM mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 3:39,042,503...39,064,818
Ensembl chr 3:39,042,503...39,064,818
|
|
| G
|
Stub1
|
STIP1 homology and U-box containing protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of STUB1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:15,355,278...15,357,559
Ensembl chr10:15,355,279...15,357,559
|
|
| G
|
Suclg1
|
succinate-CoA ligase GDP/ADP-forming subunit alpha
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SUCLG1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:106,866,329...106,895,686
Ensembl chr 4:106,866,114...106,895,689
|
|
| G
|
Sulf1
|
sulfatase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SULF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643
|
|
| G
|
Synj1
|
synaptojanin 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SYNJ1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:43,678,709...43,755,526
Ensembl chr11:43,678,709...43,755,526
|
|
| G
|
Sypl1
|
synaptophysin-like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SYPL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:55,292,555...55,311,519
Ensembl chr 6:55,292,567...55,314,714
|
|
| G
|
Syt1
|
synaptotagmin 1
|
decreases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of SYT1 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SYT1 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:45,702,228...46,244,213
|
|
| G
|
Syt7
|
synaptotagmin 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of SYT7 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:216,456,148...216,518,718
Ensembl chr 1:216,456,259...216,518,718
|
|
| G
|
Sytl3
|
synaptotagmin-like 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of SYTL3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:49,300,935...49,372,533
Ensembl chr 1:49,302,182...49,372,531
|
|
| G
|
Taf5
|
TATA-box binding protein associated factor 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TAF5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:255,899,774...255,915,259
Ensembl chr 1:255,899,770...255,915,268
|
|
| G
|
Taf7
|
TATA-box binding protein associated factor 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TAF7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:29,704,182...29,713,382
Ensembl chr18:29,705,920...29,712,712
|
|
| G
|
Tardbp
|
TAR DNA binding protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TARDBP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204
|
|
| G
|
Tas2r136
|
taste receptor, type 2, member 136
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TAS2R31 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:167,830,248...167,831,240
Ensembl chr 4:167,830,248...167,831,240
|
|
| G
|
Tbc1d9b
|
TBC1 domain family member 9B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TBC1D9B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:34,961,012...34,998,227
Ensembl chr10:34,960,996...34,998,213
|
|
| G
|
Tbca
|
tubulin folding cofactor A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TBCA mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:27,745,985...27,800,624
Ensembl chr 2:27,746,268...27,800,641
|
|
| G
|
Tbk1
|
TANK-binding kinase 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]
|
CTD |
PMID:18279804 |
|
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:58,963,325...58,996,357
|
|
| G
|
Tbl1xr1
|
TBL1X/Y related 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TBL1XR1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:106,718,811...106,857,989
Ensembl chr 2:106,730,665...106,857,989
|
|
| G
|
Tbl2
|
transducin (beta)-like 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TBL2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:27,154,150...27,168,446
Ensembl chr12:27,154,150...27,168,446
|
|
| G
|
Tbx3
|
T-box transcription factor 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TBX3 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr12:42,540,378...42,555,490
Ensembl chr12:42,540,378...42,554,171
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TBXAS1 mRNA; Sodium Selenite results in decreased expression of TBXAS1 protein
|
CTD |
PMID:21669866 |
|
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tcaf2
|
TRPM8 channel-associated factor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TCAF2 mRNA
|
CTD |
PMID:18175754 |
|
|
|
| G
|
Tcea1
|
transcription elongation factor A1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TCEA1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:19,414,351...19,466,629
Ensembl chr15:12,831,339...12,834,156 Ensembl chr 5:12,831,339...12,834,156
|
|
| G
|
Tceal8
|
transcription elongation factor A like 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TCEAL8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:103,962,930...103,965,000
Ensembl chr X:103,961,187...103,965,394
|
|
| G
|
Tcf7
|
transcription factor 7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TCF7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279
|
|
| G
|
Tcim
|
transcriptional and immune response regulator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TCIM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:74,298,344...74,299,637
Ensembl chr16:74,298,344...74,299,636
|
|
| G
|
Tcof1
|
treacle ribosome biogenesis factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TCOF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:56,537,437...56,570,727
Ensembl chr18:56,537,437...56,570,727
|
|
| G
|
Tdrd3
|
tudor domain containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TDRD3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:69,748,754...69,911,605
Ensembl chr15:69,749,217...69,884,656
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
increases activity increases expression
|
ISO
|
Sodium Selenite results in increased activity of TERT protein Sodium Selenite results in increased expression of TERT mRNA
|
CTD |
PMID:14673504 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tes
|
testin LIM domain protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TES mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:46,331,257...46,369,780
|
|
| G
|
Tf
|
transferrin
|
multiple interactions
|
ISO
|
[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein; [Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of RUNX2 protein; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD2 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SMAD3 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SOX9 mRNA; [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SP7 protein; TGFB1 protein affects the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein]; TGFB1 protein inhibits the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein]
|
CTD |
PMID:32324263 |
|
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
|
|
| G
|
Tfap2e
|
transcription factor AP-2 epsilon
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of TFAP2E mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 5:144,293,932...144,314,618
Ensembl chr 5:144,293,938...144,314,969
|
|
| G
|
Tfb1m
|
transcription factor B1, mitochondrial
|
multiple interactions
|
ISO
|
[ptaquiloside co-treated with Sodium Selenite] results in increased expression of TFB1M mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 1:46,520,510...46,567,004
Ensembl chr 1:46,524,435...46,566,948
|
|
| G
|
Tfdp1
|
transcription factor Dp-1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TFDP1 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:82,864,226...82,902,996
|
|
| G
|
Tff2
|
trefoil factor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TFF2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:9,217,110...9,220,979
Ensembl chr20:9,217,121...9,220,979
|
|
| G
|
Tg
|
thyroglobulin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:100,307,349...100,314,539 Ensembl chr 7:100,307,349...100,314,539
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
dimethyl mercaptosuccinate inhibits the reaction [Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of HGF protein]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein]; Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein] TGFB1 protein affects the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of SP7 protein]; TGFB1 protein inhibits the reaction [[Dexamethasone co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in decreased expression of RUNX2 protein]
|
CTD |
PMID:16757516 PMID:32324263 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgif1
|
TGFB-induced factor homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TGIF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:118,194,444...118,204,442
|
|
| G
|
Thap4
|
THAP domain containing 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of THAP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:101,689,935...101,729,656
Ensembl chr 9:101,689,936...101,729,441
|
|
| G
|
Thbs2
|
thrombospondin 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of THBS2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918
|
|
| G
|
Thyn1
|
thymocyte nuclear protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of THYN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:33,665,614...33,674,593
Ensembl chr 8:33,665,650...33,675,414
|
|
| G
|
Tia1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
multiple interactions
|
ISO
|
Sodium Selenite promotes the reaction [TUBA4A protein binds to TIA1 protein]
|
CTD |
PMID:31585128 |
|
NCBI chr 4:120,410,180...120,440,676
Ensembl chr 4:120,410,251...120,440,665
|
|
| G
|
Ticam1
|
TIR domain containing adaptor molecule 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein]
|
CTD |
PMID:18279804 |
|
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892
|
|
| G
|
Timm9
|
translocase of inner mitochondrial membrane 9
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TIMM9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:95,346,065...95,358,895
Ensembl chr 6:95,346,065...95,358,895
|
|
| G
|
Tincr
|
TINCR ubiquitin domain containing
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TINCR mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:1,476,770...1,477,039 NCBI chr 9:1,474,238...1,476,470
Ensembl chr 9:1,476,147...1,477,238
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TLR2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr7
|
toll-like receptor 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TLR7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:30,644,355...30,672,151
|
|
| G
|
Tm6sf1
|
transmembrane 6 superfamily member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TM6SF1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:145,209,052...145,237,725
Ensembl chr 1:145,209,585...145,237,715
|
|
| G
|
Tma16
|
translation machinery associated 16 homolog
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMA16 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:28,003,002...28,021,875
Ensembl chr16:27,980,900...28,021,875
|
|
| G
|
Tma7
|
translation machinery associated 7 homolog
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMA7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,604,680...118,609,368
Ensembl chr 8:118,604,680...118,609,368
|
|
| G
|
Tmc7
|
transmembrane channel-like 7
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMC7 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:182,287,742...182,340,000
Ensembl chr 1:182,287,742...182,339,947
|
|
| G
|
Tmed10
|
transmembrane p24 trafficking protein 10
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMED10 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:110,722,887...110,757,743
Ensembl chr 6:110,722,889...110,757,777
|
|
| G
|
Tmed4
|
transmembrane p24 trafficking protein 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMED4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:85,338,980...85,343,577
Ensembl chr14:85,338,980...85,343,577
|
|
| G
|
Tmed5
|
transmembrane p24 trafficking protein 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMED5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:1,752,857...1,763,990
Ensembl chr14:1,752,745...1,773,389
|
|
| G
|
Tmem115
|
transmembrane protein 115
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM115 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:117,086,106...117,090,970
Ensembl chr 8:117,086,106...117,090,970
|
|
| G
|
Tmem126a
|
transmembrane protein 126A
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM126A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:153,837,015...153,843,192
Ensembl chr 1:153,835,236...153,843,160
|
|
| G
|
Tmem140
|
transmembrane protein 140
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMEM140 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:64,503,621...64,514,620
Ensembl chr 4:64,500,439...64,521,990
|
|
| G
|
Tmem14c
|
transmembrane protein 14C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM14C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
|
|
| G
|
Tmem156
|
transmembrane protein 156
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM156 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:43,568,131...43,606,109
Ensembl chr14:43,577,023...43,606,109
|
|
| G
|
Tmem168
|
transmembrane protein 168
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMEM168 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:42,796,714...42,824,854
Ensembl chr 4:42,796,720...42,824,854
|
|
| G
|
Tmem184c
|
transmembrane protein 184C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM184C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:47,249,403...47,265,502
Ensembl chr19:47,249,500...47,265,949
|
|
| G
|
Tmem199
|
transmembrane protein 199
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VMA12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:63,900,543...63,905,115
Ensembl chr10:63,900,545...63,905,139
|
|
| G
|
Tmem203
|
transmembrane protein 203
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM203 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:28,469,062...28,469,890
Ensembl chr 3:28,465,345...28,472,140
|
|
| G
|
Tmem205
|
transmembrane protein 205
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM205 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:28,728,172...28,733,908
Ensembl chr 8:28,728,172...28,733,908
|
|
| G
|
Tmem208
|
transmembrane protein 208
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM208 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:50,113,494...50,116,210
Ensembl chr19:50,113,510...50,124,153
|
|
| G
|
Tmem223
|
transmembrane protein 223
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM223 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:215,097,835...215,099,196
Ensembl chr 1:215,097,827...215,099,188
|
|
| G
|
Tmem230
|
transmembrane protein 230
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TMEM230 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:139,925,878...139,950,517
|
|
| G
|
Tmem47
|
transmembrane protein 47
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMEM47 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:49,338,532...49,365,026
Ensembl chr X:49,338,326...49,521,541
|
|
| G
|
Tmem94
|
transmembrane protein 94
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMEM94 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:101,490,496...101,525,983
Ensembl chr10:101,490,481...101,525,975
|
|
| G
|
Tmpo
|
thymopoietin
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMPO mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937
|
|
| G
|
Tmsb15b2
|
thymosin beta 15B2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TMSB15A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:105,090,980...105,093,094
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
Sodium Selenite inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of SELE protein]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; TNF protein affects the reaction [Sodium Selenite results in increased activity of GPX4 protein]; TNF protein affects the reaction [Sodium Selenite results in increased expression of GPX4 mRNA] Sodium Selenite results in decreased expression of TNF mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of TNF mRNA; N-TUTCA2 gene mutant form inhibits the reaction [Sodium Selenite results in decreased expression of TNF mRNA]; Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] [Sodium Selenite co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; [Sodium Selenite co-treated with zinc chloride] affects the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein]; Sodium Selenite affects the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein] Sodium Selenite results in increased expression of TNF protein
|
CTD |
PMID:10871427 PMID:11888521 PMID:12867288 PMID:14642406 PMID:18481333 PMID:18789669 PMID:23274088 PMID:24954678 PMID:25187657 PMID:36646412 PMID:37967787 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNFRSF11B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfrsf25
|
TNF receptor superfamily member 25
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNFRSF25 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052
|
|
| G
|
Tnfrsf4
|
TNF receptor superfamily member 4
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TNFRSF4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:171,889,134...171,891,824
Ensembl chr 5:171,889,117...171,892,616
|
|
| G
|
Tnfrsf9
|
TNF receptor superfamily member 9
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNFRSF9 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNFSF10 mRNA
|
CTD |
PMID:16705456 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Tnfsf18
|
TNF superfamily member 18
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TNFSF18 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr13:76,366,790...76,440,673
Ensembl chr13:76,366,771...76,376,608
|
|
| G
|
Tnfsf4
|
TNF superfamily member 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNFSF4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:76,256,654...76,280,133
|
|
| G
|
Tnip1
|
TNFAIP3 interacting protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TNIP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:39,537,759...39,585,038
Ensembl chr10:39,537,437...39,585,158
|
|
| G
|
Tnnc1
|
troponin C1, slow skeletal and cardiac type
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNNC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:6,408,607...6,412,070
Ensembl chr16:6,408,607...6,412,070
|
|
| G
|
Tnni3k
|
TNNI3 interacting kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNNI3K mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:246,397,051...246,665,000
Ensembl chr 2:246,396,891...246,664,954
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
multiple interactions
|
ISO EXP
|
Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein]
|
CTD |
PMID:31419397 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tnp2
|
transition protein 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNP2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:5,386,735...5,387,463
Ensembl chr10:5,383,885...5,387,467
|
|
| G
|
Tns3
|
tensin 3
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNS3 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr14:87,387,441...87,619,457
Ensembl chr14:87,387,441...87,619,712
|
|
| G
|
Tnxb
|
tenascin XB
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TNXB mRNA
|
CTD |
PMID:23274088 |
|
Ensembl chr20:4,031,082...4,090,128
|
|
| G
|
Tom1l2
|
target of myb1 like 2 membrane trafficking protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TOM1L2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:45,535,548...45,657,528
Ensembl chr10:45,535,548...45,657,521
|
|
| G
|
Top1mt
|
DNA topoisomerase I mitochondrial
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TOP1MT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:109,223,269...109,248,855
Ensembl chr 7:109,139,527...109,246,799
|
|
| G
|
Top2a
|
DNA topoisomerase II alpha
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TOP2A mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
|
|
| G
|
Top3b
|
DNA topoisomerase III beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TOP3B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:97,601,223...97,629,678
Ensembl chr11:97,601,231...97,629,597
|
|
| G
|
Tox2
|
TOX high mobility group box family member 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TOX2 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 3:172,272,718...172,400,235
Ensembl chr 3:172,272,736...172,400,233
|
|
| G
|
Tp53
|
tumor protein p53
|
increases phosphorylation affects response to substance multiple interactions decreases expression increases expression
|
ISO
|
Sodium Selenite results in increased phosphorylation of TP53 protein TP53 protein affects the susceptibility to Sodium Selenite Diethylhexyl Phthalate inhibits the reaction [Sodium Selenite results in decreased expression of TRP53 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein] Sodium Selenite results in increased expression of TRP53 mRNA Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of TP53 protein]
|
CTD |
PMID:15845651 PMID:16542727 PMID:20390378 PMID:20659492 PMID:21515331 PMID:22200533 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53i11
|
tumor protein p53 inducible protein 11
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TP53I11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432
|
|
| G
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TP53INP1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484
|
|
| G
|
Tpra1
|
transmembrane protein adipocyte associated 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TPRA1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:122,921,304...122,932,519
Ensembl chr 4:122,921,323...122,932,517
|
|
| G
|
Tprkb
|
Tp53rk binding protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TPRKB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:119,900,374...119,915,374
Ensembl chr 4:119,900,484...119,915,382
|
|
| G
|
Tra2b
|
transformer 2 beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRA2B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:92,293,403...92,311,651
Ensembl chr11:92,293,410...92,311,781
|
|
| G
|
Tradd
|
TNFRSF1A-associated via death domain
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRADD mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
|
|
| G
|
Trerf1
|
transcriptional regulating factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRERF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:21,131,772...21,355,830
Ensembl chr 9:21,131,777...21,176,016
|
|
| G
|
Trh
|
thyrotropin releasing hormone
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TRH mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:126,299,236...126,301,762
Ensembl chr 4:126,299,236...126,301,762
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRIB3 mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Trim24
|
tripartite motif-containing 24
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRIM24 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:67,534,335...67,684,226
|
|
| G
|
Trim25
|
tripartite motif-containing 25
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRIM25 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:74,310,024...74,328,473
Ensembl chr10:74,310,022...74,331,716
|
|
| G
|
Trim35
|
tripartite motif-containing 35
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRIM35 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:44,669,222...44,685,766
Ensembl chr15:44,656,322...44,685,765
|
|
| G
|
Trmt10c
|
tRNA methyltransferase 10C, mitochondrial RNase P subunit
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRMT10C mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:58,053,455...58,058,533
Ensembl chr11:58,033,201...58,059,062
|
|
| G
|
Trmt112
|
tRNA methyltransferase activator subunit 11-2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRMT112 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:213,532,507...213,533,360
Ensembl chr 1:213,532,175...213,533,356
|
|
| G
|
Trmt1l
|
tRNA methyltransferase 1-like
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TRMT1L mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:66,060,186...66,093,247
Ensembl chr13:66,060,162...66,093,643
|
|
| G
|
Trnau1ap
|
tRNA selenocysteine 1 associated protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRNAU1AP mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:149,791,631...149,808,149
Ensembl chr 5:149,791,631...149,808,680
|
|
| G
|
Trpc4ap
|
transient receptor potential cation channel, subfamily C, member 4 associated protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TRPC4AP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:164,582,146...164,653,123
Ensembl chr 3:164,582,146...164,653,123
|
|
| G
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TRPM5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:207,684,811...207,707,380
Ensembl chr 1:207,685,157...207,707,088
|
|
| G
|
Tsen2
|
tRNA splicing endonuclease subunit 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TSEN2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:150,275,389...150,310,846
Ensembl chr 4:150,275,501...150,313,013
|
|
| G
|
Tsen34
|
tRNA splicing endonuclease subunit 34
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TSEN34 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:74,432,687...74,440,553
Ensembl chr 1:74,432,685...74,440,832
|
|
| G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TSHB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|
| G
|
Tshz1
|
teashirt zinc finger homeobox 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TSHZ1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:79,651,256...79,727,662
Ensembl chr18:79,651,256...79,727,662
|
|
| G
|
Tspan12
|
tetraspanin 12
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TSPAN12 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:51,279,562...51,355,030
Ensembl chr 4:51,279,563...51,355,030
|
|
| G
|
Ttc27
|
tetratricopeptide repeat domain 27
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TTC27 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:26,310,696...26,454,045
Ensembl chr 6:25,781,638...26,454,036
|
|
| G
|
Ttc3
|
tetratricopeptide repeat domain 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TTC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:47,158,792...47,258,418
|
|
| G
|
Ttc38
|
tetratricopeptide repeat domain 38
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TTC38 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:118,805,115...118,828,449
Ensembl chr 7:118,804,047...118,828,453
|
|
| G
|
Ttc39b
|
tetratricopeptide repeat domain 39B
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TTC39B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:102,649,259...102,754,092
Ensembl chr 5:102,655,322...102,782,162
|
|
| G
|
Tub
|
TUB bipartite transcription factor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TUB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:172,386,772...172,465,791
Ensembl chr 1:172,382,197...172,465,790
|
|
| G
|
Tuba4a
|
tubulin, alpha 4A
|
increases glutathionylation multiple interactions
|
ISO
|
Sodium Selenite results in increased glutathionylation of TUBA4A protein Sodium Selenite promotes the reaction [TUBA4A protein binds to FUS protein]; Sodium Selenite promotes the reaction [TUBA4A protein binds to TIA1 protein]
|
CTD |
PMID:31585128 |
|
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584
|
|
| G
|
Tubb4a
|
tubulin, beta 4A class IVa
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TUBB4A mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286
|
|
| G
|
Tube1
|
tubulin, epsilon 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TUBE1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:44,105,405...44,124,947
Ensembl chr20:44,107,022...44,125,271
|
|
| G
|
Tubgcp6
|
tubulin gamma complex component 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TUBGCP6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:122,057,328...122,078,639
Ensembl chr 7:122,057,328...122,078,490
|
|
| G
|
Tufm
|
Tu translation elongation factor, mitochondrial
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TUFM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:190,504,373...190,507,980
Ensembl chr 1:190,504,373...190,508,952
|
|
| G
|
Tusc2
|
tumor suppressor 2, mitochondrial calcium regulator
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TUSC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:117,115,479...117,118,697
Ensembl chr 8:117,115,479...117,118,697
|
|
| G
|
Tusc3
|
tumor suppressor candidate 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TUSC3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:59,899,642...60,048,813
Ensembl chr16:59,899,091...60,048,215
|
|
| G
|
Txn1
|
thioredoxin 1
|
multiple interactions
|
ISO
|
[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of and affects the localization of TXN protein; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN protein
|
CTD |
PMID:28757135 |
|
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Txndc15
|
thioredoxin domain containing 15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TXNDC15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:8,903,248...8,915,714
Ensembl chr17:8,903,252...8,916,079
|
|
| G
|
Txndc17
|
thioredoxin domain containing 17
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of TXNDC17 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:57,331,312...57,334,284
Ensembl chr10:57,331,312...57,334,284
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions increases activity increases expression affects expression increases oxidation decreases expression decreases activity
|
ISO EXP
|
[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 mRNA; [Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 protein; [sulforaphane co-treated with Sodium Selenite] results in increased activity of TXNRD1 protein; Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; Buthionine Sulfoximine promotes the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Mercuric Chloride promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; methylmercuric chloride inhibits the reaction [Sodium Selenite results in increased expression of TXNRD1 protein]; Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]; Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 mRNA]; Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 protein]; Sodium Selenite promotes the reaction [sulforaphane results in increased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; Sodium Selenite promotes the reaction [sulforaphane results in increased expression of TXNRD1 protein]; Sodium Selenite promotes the reaction [TXNRD1 protein results in increased susceptibility to (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane]; Sodium Selenite results in increased expression of and results in increased activity of TXNRD1 protein Sodium Selenite affects the expression of TXNRD1 [Sodium Selenite co-treated with NADP] inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Sodium Selenite inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides]; Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of TXNRD1 mRNA]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of TXNRD1 protein]; Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of TXNRD1 mRNA] Sodium Selenite promotes the reaction [arsenic acid results in increased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [arsenite results in increased activity of TXNRD1 protein] Sodium Selenite results in increased oxidation of TXNRD1 protein Sodium Selenite results in increased expression of TXNRD1 mRNA; Sodium Selenite results in increased expression of TXNRD1 mRNA alternative form; Sodium Selenite results in increased expression of TXNRD1 protein Sodium Selenite results in decreased expression of TXNRD1 protein Sodium Selenite results in decreased activity of TXNRD1 protein
|
CTD |
PMID:12449240 PMID:12663510 PMID:12949356 PMID:16039982 PMID:18209489 PMID:18215477 PMID:18405881 PMID:19429247 PMID:19486940 PMID:20457604 PMID:20810785 PMID:23603382 PMID:24383545 PMID:24816296 PMID:25179160 PMID:28544404 PMID:28757135 PMID:31585128 More...
|
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Txnrd2
|
thioredoxin reductase 2
|
multiple interactions increases expression increases activity decreases expression
|
ISO
|
Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]; Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA] Sodium Selenite results in increased expression of TXNRD2 protein
|
CTD |
PMID:19486940 PMID:31585128 |
|
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
|
|
| G
|
Tyro3
|
TYRO3 protein tyrosine kinase
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of TYRO3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:127,231,468...127,254,806
Ensembl chr 3:127,231,903...127,250,943
|
|
| G
|
U2af1
|
U2 small nuclear RNA auxiliary factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of U2AF1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr20:9,744,206...9,755,146
Ensembl chr20:9,744,207...9,755,094
|
|
| G
|
Uba52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UBA52 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:18,952,583...18,954,780
|
|
| G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of UBE2C mRNA
|
CTD |
PMID:18175754 PMID:24383545 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
|
|
| G
|
Ube2d2
|
ubiquitin-conjugating enzyme E2D 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UBE2D2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr18:27,638,399...27,680,386
Ensembl chr18:27,638,527...27,683,074
|
|
| G
|
Ube2d4l1
|
ubiquitin-conjugating enzyme E2D 4 like 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of UBE2DNL mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:81,470,592...81,471,523
Ensembl chr X:81,470,576...81,471,796
|
|
| G
|
Ube2v2
|
ubiquitin conjugating enzyme E2 V2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UBE2V2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:98,808,681...98,842,583
Ensembl chr11:98,807,538...98,843,211
|
|
| G
|
Ubxn1
|
UBX domain protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UBXN1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343
|
|
| G
|
Uchl5
|
ubiquitin C-terminal hydrolase L5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UCHL5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:58,042,029...58,107,441
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
multiple interactions decreases expression
|
ISO
|
[Sodium Selenite co-treated with Glucose] results in decreased expression of UCP2 protein; Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA] Sodium Selenite results in decreased expression of UCP2 mRNA; Sodium Selenite results in decreased expression of UCP2 protein
|
CTD |
PMID:15650415 PMID:23795780 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Ufd1
|
ubiquitin recognition factor in ER associated degradation 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UFD1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:95,665,971...95,689,423
Ensembl chr11:95,665,972...95,689,434
|
|
| G
|
Ugt1a6a
|
UDP glucuronosyltransferase family 1 member A6a
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UGT1A6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt2b7
|
UDP glucuronosyltransferase family 2 member B7
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UGT2B7 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451
|
|
| G
|
Uimc1
|
ubiquitin interaction motif containing 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of UIMC1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr17:9,528,923...9,597,967
Ensembl chr17:9,528,950...9,597,963
|
|
| G
|
Unc13a
|
unc-13 homolog A
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of UNC13A mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr16:18,367,891...18,415,808
Ensembl chr16:18,367,919...18,415,899
|
|
| G
|
Unc5b
|
unc-5 netrin receptor B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UNC5B mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270
|
|
| G
|
Ung
|
uracil-DNA glycosylase
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UNG mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
|
|
| G
|
Upp1
|
uridine phosphorylase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UPP1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
|
|
| G
|
Uqcr11
|
ubiquinol-cytochrome c reductase, complex III subunit XI
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UQCR11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:9,955,717...9,960,432
Ensembl chr 7:9,955,764...9,959,047
|
|
| G
|
Uqcrb
|
ubiquinol-cytochrome c reductase binding protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UQCRB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 7:65,700,016...65,705,382
Ensembl chr 7:65,700,029...65,705,558
|
|
| G
|
Uqcrc1
|
ubiquinol-cytochrome c reductase core protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UQCRC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
|
|
| G
|
Usp47
|
ubiquitin specific peptidase 47
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of USP47 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:175,586,758...175,669,904
Ensembl chr 1:175,586,723...175,669,904
|
|
| G
|
Uts2r
|
urotensin 2 receptor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UTS2R mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,932,325...106,938,056
|
|
| G
|
Uxt
|
ubiquitously-expressed, prefoldin-like chaperone
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of UXT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr X:3,679,630...3,691,944
Ensembl chr X:3,679,687...3,695,442
|
|
| G
|
Vamp4
|
vesicle-associated membrane protein 4
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of VAMP4 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:77,453,135...77,475,909
Ensembl chr13:77,453,121...77,476,024
|
|
| G
|
Vash2
|
vasohibin 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of VASH2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr13:105,060,857...105,092,325
Ensembl chr13:105,060,857...105,092,275
|
|
| G
|
Vat1
|
vesicle amine transport 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VAT1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
ISO
|
Sodium Selenite inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Sodium Selenite inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
|
CTD |
PMID:11888521 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
multiple interactions
|
EXP
|
Sodium Selenite promotes the reaction [VDAC1 protein binds to VDAC1 protein]
|
CTD |
PMID:20937774 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdac2
|
voltage-dependent anion channel 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VDAC2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,512,216...2,532,229
|
|
| G
|
Vdr
|
vitamin D receptor
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of VDR mRNA
|
CTD |
PMID:16928829 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions increases expression decreases expression
|
ISO
|
Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein] Sodium Selenite results in increased expression of VEGFA mRNA Sodium Selenite results in decreased expression of VEGFA mRNA Sodium Selenite promotes the reaction [Hydrogen Peroxide results in increased expression of VEGFA mRNA]
|
CTD |
PMID:16757516 PMID:17997286 PMID:18175754 PMID:24383545 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vegfc
|
vascular endothelial growth factor C
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VEGFC mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
|
|
| G
|
Vim
|
vimentin
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VIM mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of VKORC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:191,932,969...191,935,490
|
|
| G
|
Vldlr
|
very low density lipoprotein receptor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VLDLR mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154
|
|
| G
|
Vom1r30
|
vomeronasal 1 receptor 30
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of VN1R3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:73,880,464...73,881,722
Ensembl chr 1:73,880,464...73,881,722
|
|
| G
|
Vps29
|
VPS29 retromer complex component
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VPS29 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:39,869,688...39,878,732
Ensembl chr12:39,869,688...39,878,848
|
|
| G
|
Vps51
|
VPS51 subunit of GARP complex
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of VPS51 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:212,789,721...212,799,708
Ensembl chr 1:212,789,721...212,799,708
|
|
| G
|
Wars1
|
tryptophanyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of WARS1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
|
|
| G
|
Wdfy1
|
WD repeat and FYVE domain containing 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of WDFY1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:88,459,613...88,541,215
Ensembl chr 9:88,489,227...88,541,186
|
|
| G
|
Wdr6
|
WD repeat domain 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of WDR6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
|
|
| G
|
Wdr74
|
WD repeat domain 74
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of WDR74 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:215,060,901...215,065,687
Ensembl chr 1:215,060,961...215,066,336
|
|
| G
|
Wdr81
|
WD repeat domain 81
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of WDR81 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:60,780,268...60,793,671
Ensembl chr10:60,780,268...60,793,592
|
|
| G
|
Wdr83
|
WD repeat domain 83
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of WDR83 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:39,981,890...39,987,443
Ensembl chr19:39,981,262...39,987,442
|
|
| G
|
Wnt11
|
Wnt family member 11
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of WNT11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:162,545,660...162,565,456
Ensembl chr 1:162,545,680...162,564,660
|
|
| G
|
Wnt3
|
Wnt family member 3
|
decreases expression multiple interactions
|
ISO
|
Sodium Selenite results in decreased expression of WNT3 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of WNT3 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr10:89,180,224...89,224,195
Ensembl chr10:89,216,801...89,224,195
|
|
| G
|
Wtap
|
WT1 associated protein
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of WTAP mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:50,070,973...50,096,074
Ensembl chr 1:50,070,769...50,096,072
|
|
| G
|
Xaf1
|
XIAP associated factor 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of XAF1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr10:57,415,935...57,428,348
Ensembl chr10:57,415,658...57,428,349
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of XBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Xkr8
|
XK related 8
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of XKR8 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:150,222,058...150,229,184
Ensembl chr 5:150,222,061...150,228,564
|
|
| G
|
Xrcc5
|
X-ray repair cross complementing 5
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of XRCC5 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:81,404,507...81,493,293
Ensembl chr 9:81,375,863...81,493,293
|
|
| G
|
Yif1b
|
Yip1 interacting factor homolog B, membrane trafficking protein
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of YIF1B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:93,667,113...93,677,381
Ensembl chr 1:93,667,061...93,677,381
|
|
| G
|
Yipf1
|
Yip1 domain family, member 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of YIPF1 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 5:127,340,962...127,376,270
Ensembl chr 5:127,340,953...127,376,538
|
|
| G
|
Ypel1
|
yippee-like 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of YPEL1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:97,426,012...97,440,646
|
|
| G
|
Ythdc1
|
YTH N6-methyladenosine RNA binding protein C1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of YTHDC1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr14:21,540,276...21,570,724
Ensembl chr14:21,540,278...21,570,769
|
|
| G
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of YWHAB mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854
|
|
| G
|
Yy1
|
YY1 transcription factor
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of YY1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257
|
|
| G
|
Zap70
|
zeta chain of T cell receptor associated protein kinase 70
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZAP70 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062
|
|
| G
|
Zbp1
|
Z-DNA binding protein 1
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ZBP1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:182,411,665...182,427,604
Ensembl chr 3:182,411,665...182,422,839
|
|
| G
|
Zbtb11
|
zinc finger and BTB domain containing 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZBTB11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:58,061,355...58,121,768
Ensembl chr11:58,085,351...58,120,110
|
|
| G
|
Zbtb44
|
zinc finger and BTB domain containing 44
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZBTB44 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 8:37,724,237...37,782,220
Ensembl chr 8:37,724,250...37,776,691
|
|
| G
|
Zc3h15
|
zinc finger CCCH-type containing 15
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZC3H15 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:89,151,432...89,171,203
Ensembl chr 3:89,151,509...89,171,202
|
|
| G
|
Zdhhc13
|
zinc finger DHHC-type palmitoyltransferase 13
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ZDHHC13 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:107,623,599...107,662,178
Ensembl chr 1:107,623,599...107,662,178
|
|
| G
|
Zdhhc14
|
zinc finger DHHC-type palmitoyltransferase 14
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZDHHC14 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:48,473,860...48,746,201
Ensembl chr 1:48,474,274...48,744,413
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ZEB2 mRNA
|
CTD |
PMID:23274088 |
|
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
| G
|
Zfp148
|
zinc finger protein 148
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF148 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr11:80,780,865...80,890,877
Ensembl chr11:80,786,087...80,890,877
|
|
| G
|
Zfp260
|
zinc finger protein 260
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF260 mRNA
|
CTD |
PMID:24383545 |
|
NCBI chr 1:94,469,861...94,477,377
Ensembl chr 1:94,460,733...94,478,217
|
|
| G
|
Zfp280d
|
zinc finger protein 280D
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF280D mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 8:81,872,108...81,961,194
Ensembl chr 8:81,873,335...81,961,201
|
|
| G
|
Zfp319
|
zinc finger protein 319
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF319 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:9,708,881...9,712,860
Ensembl chr19:9,707,983...9,728,711
|
|
| G
|
Zfp329
|
zinc finger protein 329
|
decreases expression
|
ISO
|
Sodium Selenite results in decreased expression of ZNF329 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:82,469,019...82,570,542
Ensembl chr 1:82,430,646...82,570,552
|
|
| G
|
Zfp341
|
zinc finger protein 341
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF341 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:163,582,937...163,616,448
Ensembl chr 3:163,579,298...163,616,446
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZFP36 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
| G
|
Zfp36l2
|
zinc finger protein 36, C3H type-like 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZFP36L2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:16,242,610...16,246,653
|
|
| G
|
Zfp511
|
zinc finger protein 511
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF511 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 1:204,247,349...204,251,754
Ensembl chr 1:204,247,230...204,251,754
|
|
| G
|
Zfp68
|
zinc finger protein 68
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF84 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr12:21,139,838...21,154,775
Ensembl chr12:21,139,868...21,154,769
|
|
| G
|
Zfp709
|
zinc finger protein 709
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF443 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr16:17,942,986...17,953,720
Ensembl chr16:17,944,162...17,953,463
|
|
| G
|
Zfp777
|
zinc finger protein 777
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF777 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 4:78,347,315...78,377,720
Ensembl chr 4:78,347,315...78,373,357
|
|
| G
|
Zfpm1
|
zinc finger protein, multitype 1
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZFPM1 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr19:67,242,922...67,299,149
Ensembl chr19:67,179,751...67,299,149
|
|
| G
|
Zgpat
|
zinc finger CCCH-type and G-patch domain containing
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZGPAT mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 3:188,851,376...188,867,914
Ensembl chr 3:188,851,566...188,868,495
|
|
| G
|
Zmym6
|
zinc finger MYM-type containing 6
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZMYM6 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 5:144,680,819...144,728,805
Ensembl chr 5:144,681,197...144,728,803
|
|
| G
|
Zmynd11
|
zinc finger, MYND-type containing 11
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZMYND11 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr17:65,226,907...65,323,278
Ensembl chr17:65,234,045...65,323,276
|
|
| G
|
Znf354b
|
zinc finger protein 354B
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNF354B mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:35,734,794...35,752,882
Ensembl chr10:35,734,794...35,746,051
|
|
| G
|
Znhit3
|
zinc finger, HIT-type containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZNHIT3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr10:70,246,749...70,287,927
|
|
| G
|
Zranb2
|
zinc finger RANBP2-type containing 2
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZRANB2 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:249,232,010...249,245,786
Ensembl chr 2:249,232,010...249,245,780
|
|
| G
|
Zzz3
|
zinc finger, ZZ-type containing 3
|
increases expression
|
ISO
|
Sodium Selenite results in increased expression of ZZZ3 mRNA
|
CTD |
PMID:18175754 |
|
NCBI chr 2:243,990,305...244,057,251
Ensembl chr 2:243,990,289...244,056,118
|
|
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
|
CTD |
PMID:16757516 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Adam9
|
ADAM metallopeptidase domain 9
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein]
|
CTD |
PMID:17018608 |
|
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646
|
|
| G
|
Afp
|
alpha-fetoprotein
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Aflatoxin B1 results in increased expression of AFP mRNA]
|
CTD |
PMID:11133813 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
| G
|
Alad
|
aminolevulinate dehydratase
|
multiple interactions decreases activity
|
EXP ISO
|
Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein] ebselen inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]
|
CTD |
PMID:14630126 PMID:17624921 PMID:23933410 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
decreases activity
|
ISO
|
ebselen results in decreased activity of ALOX5 protein
|
CTD |
PMID:7590103 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [sodium arsenite results in increased expression of BAX protein]
|
CTD |
PMID:30558456 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]
|
CTD |
PMID:30558456 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
ISO EXP
|
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein] ebselen results in increased activity of CASP3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; ebselen inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]
|
CTD |
PMID:21300091 PMID:23649643 PMID:25068500 PMID:30558456 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO EXP
|
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]
|
CTD |
PMID:18629305 PMID:23649643 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
increases activity multiple interactions
|
EXP
|
ebselen results in increased activity of CAT protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]
|
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
increases expression
|
ISO
|
ebselen results in increased expression of COX4I1 protein
|
CTD |
PMID:27385396 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cs
|
citrate synthase
|
multiple interactions
|
ISO EXP
|
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] ebselen inhibits the reaction [Cisplatin results in decreased activity of CS protein]
|
CTD |
PMID:27385396 PMID:32860823 |
|
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA]
|
CTD |
PMID:11903743 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases phosphorylation
|
EXP
|
ebselen results in increased phosphorylation of EIF2S1 protein
|
CTD |
PMID:27282967 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
multiple interactions
|
ISO
|
ebselen binds to and results in decreased activity of EPHX2 protein
|
CTD |
PMID:23219563 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Fmr1
|
fragile X messenger ribonucleoprotein 1
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein]
|
CTD |
PMID:27385396 |
|
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein]
|
CTD |
PMID:14572605 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Cisplatin results in increased activity of G6PC1 protein]
|
CTD |
PMID:32860823 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Gck
|
glucokinase
|
multiple interactions
|
ISO
|
[ebselen co-treated with Glucose] results in increased activity of GCK protein
|
CTD |
PMID:23795780 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases phosphorylation
|
EXP
|
ebselen results in increased phosphorylation of GFAP protein
|
CTD |
PMID:27282967 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein]
|
CTD |
PMID:12958040 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] ebselen inhibits the reaction [Methylmercury Compounds results in decreased activity of GPX1 protein]
|
CTD |
PMID:23795780 PMID:28383113 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
increases activity multiple interactions
|
EXP
|
ebselen results in increased activity of GSR protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
|
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
multiple interactions
|
EXP
|
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein]
|
CTD |
PMID:8147899 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Gsta3
|
glutathione S-transferase alpha 3
|
multiple interactions
|
EXP
|
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein]; ebselen binds to and results in decreased activity of GSTA3 protein
|
CTD |
PMID:8147899 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
multiple interactions
|
EXP
|
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein]
|
CTD |
PMID:8147899 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm2
|
glutathione S-transferase mu 2
|
multiple interactions
|
EXP
|
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein]
|
CTD |
PMID:8147899 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions
|
EXP
|
ebselen binds to and results in decreased activity of GSTP1 protein
|
CTD |
PMID:8147899 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]
|
CTD |
PMID:19374849 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
EXP
|
[ebselen affects the abundance of Reactive Oxygen Species] which results in decreased expression of HMOX1 protein; [ebselen affects the abundance of Reactive Oxygen Species] which results in increased activity of HMOX1 protein
|
CTD |
PMID:16959961 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hpgds
|
hematopoietic prostaglandin D synthase
|
increases expression
|
ISO
|
ebselen results in increased expression of HPGDS mRNA
|
CTD |
PMID:21669866 |
|
NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases activity
|
ISO
|
ebselen results in increased activity of HSF1 protein
|
CTD |
PMID:34170685 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein]
|
CTD |
PMID:12794164 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [sodium arsenite results in increased expression of IL6 protein]
|
CTD |
PMID:30558456 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein]
|
CTD |
PMID:23795780 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases activity increases phosphorylation
|
ISO EXP
|
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen results in increased activity of MAPK1 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen analog results in increased phosphorylation of MAPK1 protein; ebselen results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases activity increases phosphorylation
|
ISO EXP
|
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen results in increased activity of MAPK3 protein ebselen analog results in increased phosphorylation of MAPK3 protein; ebselen results in increased phosphorylation of MAPK3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
increases phosphorylation
|
EXP
|
ebselen results in increased phosphorylation of MAPK9 protein
|
CTD |
PMID:27282967 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP13 mRNA]
|
CTD |
PMID:11903743 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:20495008 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions decreases activity
|
ISO EXP
|
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] ebselen results in decreased activity of NOS2 protein
|
CTD |
PMID:7590103 PMID:12794164 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
decreases activity
|
EXP
|
ebselen results in decreased activity of NQO1 protein
|
CTD |
PMID:7590103 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
multiple interactions
|
ISO
|
[ebselen co-treated with Glucose] results in increased expression of PDX1 protein
|
CTD |
PMID:23795780 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
| G
|
Phospho1
|
phosphoethanolamine/phosphocholine phosphatase 1
|
decreases activity
|
ISO
|
ebselen results in decreased activity of PHOSPHO1 protein
|
CTD |
PMID:17227223 |
|
NCBI chr10:81,258,810...81,266,345
Ensembl chr10:81,257,427...81,268,481
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein]
|
CTD |
PMID:14572605 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Slc11a2
|
solute carrier family 11 member 2
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron]
|
CTD |
PMID:16984886 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
multiple interactions
|
ISO EXP
|
[ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein ebselen inhibits the reaction [Cisplatin results in increased expression of SLC2A2 protein]
|
CTD |
PMID:23795780 PMID:32860823 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Smad3
|
SMAD family member 3
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:21131394 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
decreases response to substance multiple interactions
|
ISO
|
ebselen results in decreased susceptibility to SOD1 protein mutant form ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
|
CTD |
PMID:16702190 PMID:23795780 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:20495008 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Tat
|
tyrosine aminotransferase
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Cisplatin results in increased activity of TAT protein]
|
CTD |
PMID:32860823 |
|
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP ISO
|
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:11903743 PMID:16757516 PMID:21131394 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]
|
CTD |
PMID:11903743 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
ebselen inhibits the reaction [sodium arsenite results in increased expression of TNF protein]
|
CTD |
PMID:30558456 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions
|
ISO
|
ebselen results in increased expression of and results in increased activity of TXNRD1 protein
|
CTD |
PMID:28383113 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
multiple interactions
|
ISO
|
[ebselen co-treated with Glucose] results in decreased expression of UCP2 protein
|
CTD |
PMID:23795780 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
increases phosphorylation
|
EXP
|
ebselen results in increased phosphorylation of XBP1 protein
|
CTD |
PMID:27282967 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Xpa
|
XPA, DNA damage recognition and repair factor
|
multiple interactions
|
ISO
|
ebselen inhibits the reaction [Zinc binds to XPA protein]
|
CTD |
PMID:15265038 |
|
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425
|
|
|
|
| G
|
A2m
|
alpha-2-macroglobulin
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of A2M mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein]
|
CTD |
PMID:18997278 PMID:21144892 |
|
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868
|
|
| G
|
Aamp
|
angio-associated, migratory cell protein
|
increases expression
|
ISO
|
Selenium results in increased expression of AAMP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:83,312,519...83,318,325
Ensembl chr 9:83,312,519...83,318,325
|
|
| G
|
Aass
|
aminoadipate-semialdehyde synthase
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of AASS mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
|
|
| G
|
Aatf
|
apoptosis antagonizing transcription factor
|
increases expression
|
ISO
|
Selenium results in increased expression of AATF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:69,796,502...69,889,671
Ensembl chr10:69,794,007...69,889,634
|
|
| G
|
Abca7
|
ATP binding cassette subfamily A member 7
|
increases expression
|
ISO
|
Selenium results in increased expression of ABCA7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:10,342,092...10,362,094
Ensembl chr 7:10,342,092...10,361,989
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions
|
EXP ISO
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]
|
CTD |
PMID:11444866 PMID:36464106 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcf3
|
ATP binding cassette subfamily F member 3
|
increases expression
|
ISO
|
Selenium results in increased expression of ABCF3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
| G
|
Abhd17a
|
abhydrolase domain containing 17A, depalmitoylase
|
increases expression
|
ISO
|
Selenium results in increased expression of ABHD17A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,775,016...9,781,447
|
|
| G
|
Abhd2
|
abhydrolase domain containing 2, acylglycerol lipase
|
increases expression
|
ISO
|
Selenium results in increased expression of ABHD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
|
|
| G
|
Ablim2
|
actin binding LIM protein family, member 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of ABLIM2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr14:79,090,046...79,214,986
Ensembl chr14:79,090,923...79,214,972
|
|
| G
|
Abr
|
ABR activator of RhoGEF and GTPase
|
increases expression
|
ISO
|
Selenium results in increased expression of ABR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ACAA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acads
|
acyl-CoA dehydrogenase short chain
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Selenium results in increased expression of ACADS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
EXP
|
[Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium co-treated with Zinc] results in increased activity of ACHE protein; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in increased activity of ACHE protein; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in decreased activity of ACHE protein]
|
CTD |
PMID:20688495 PMID:37415728 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ACIN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Aco2
|
aconitase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ACO2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
|
|
| G
|
Acot2
|
acyl-CoA thioesterase 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Selenium results in increased expression of ACOT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
|
|
| G
|
Acoxl
|
acyl-CoA oxidase-like
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of ACOXL mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291
|
|
| G
|
Acp1
|
acid phosphatase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ACP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959
|
|
| G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
multiple interactions
|
EXP
|
[2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] inhibits the reaction [Aflatoxin B1 results in increased expression of ACSL4 protein]; [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in decreased expression of ACSL4 protein
|
CTD |
PMID:34116104 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
| G
|
Actb
|
actin, beta
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actg1
|
actin, gamma 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
| G
|
Actn1
|
actinin, alpha 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Actn4
|
actinin alpha 4
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTN4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320
|
|
| G
|
Actr1a
|
actin related protein 1A
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTR1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:255,179,241...255,199,009
Ensembl chr 1:255,179,242...255,199,459
|
|
| G
|
Actr1b
|
actin related protein 1B
|
increases expression
|
ISO
|
Selenium results in increased expression of ACTR1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341
|
|
| G
|
Acy1
|
aminoacylase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ACY1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
multiple interactions increases expression
|
ISO
|
[Selenium deficiency co-treated with bisphenol A] results in increased expression of ADAM17 protein; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of ADAM17 mRNA]
|
CTD |
PMID:37422542 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Adamts5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ADAMTS5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516
|
|
| G
|
Adap1
|
ArfGAP with dual PH domains 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ADAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:20,438,091...20,489,961
Ensembl chr12:20,438,063...20,495,020
|
|
| G
|
Adcy2
|
adenylate cyclase 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA Selenium results in decreased expression of ADCY2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
|
|
| G
|
Adcy6
|
adenylate cyclase 6
|
increases expression
|
ISO
|
Selenium results in increased expression of ADCY6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
|
|
| G
|
Add1
|
adducin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ADD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732
|
|
| G
|
Add3
|
adducin 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ADD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
|
|
| G
|
Adgrb1
|
adhesion G protein-coupled receptor B1
|
increases expression
|
ISO
|
Selenium results in increased expression of ADGRB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870
|
|
| G
|
Adissp
|
adipose secreted signaling protein
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:138,817,752...138,832,208
Ensembl chr 3:138,813,179...138,831,847
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of ADORA2A mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adra2c
|
adrenoceptor alpha 2C
|
increases expression
|
ISO
|
Selenium results in increased expression of ADRA2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656
|
|
| G
|
Adrm1
|
ADRM1 26S proteasome ubiquitin receptor
|
increases expression
|
ISO
|
Selenium results in increased expression of ADRM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
|
|
| G
|
Aebp2
|
AE binding protein 2
|
decreases methylation
|
ISO
|
Selenium results in decreased methylation of AEBP2 gene
|
CTD |
PMID:21606628 |
|
NCBI chr 4:175,258,286...175,297,149
Ensembl chr 4:175,258,887...175,326,422
|
|
| G
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA Selenium results in increased expression of AGPAT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581
|
|
| G
|
Agrn
|
agrin
|
increases expression
|
ISO
|
Selenium results in increased expression of AGRN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
|
|
| G
|
Aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Selenium results in decreased expression of AIMP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
|
|
| G
|
Aip
|
aryl-hydrocarbon receptor-interacting protein
|
increases expression
|
ISO
|
Selenium results in increased expression of AIP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634
|
|
| G
|
Ak1
|
adenylate kinase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of AK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak2
|
adenylate kinase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of AK2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610
|
|
| G
|
Ak3
|
adenylate kinase 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
|
|
| G
|
Akap13
|
A-kinase anchoring protein 13
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation increases expression decreases phosphorylation
|
ISO EXP
|
[Selenium results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] Selenium inhibits the reaction [arsenite results in decreased expression of and results in decreased phosphorylation of AKT1 protein]; Selenium inhibits the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein] Selenium results in increased phosphorylation of AKT1 protein Selenium inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein] Selenium results in increased expression of AKT1 mRNA
|
CTD |
PMID:17339365 PMID:17997286 PMID:19244175 PMID:29324385 PMID:38013145 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alad
|
aminolevulinate dehydratase
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [Arsenic results in decreased activity of ALAD protein]
|
CTD |
PMID:20587388 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
| G
|
Alas1
|
5'-aminolevulinate synthase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ALAS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642
|
|
| G
|
Alb
|
albumin
|
multiple interactions
|
EXP
|
[Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]
|
CTD |
PMID:24485406 PMID:37676925 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ALCAM mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of ALDH1B1 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
| G
|
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1
|
affects expression
|
EXP
|
Selenium affects the expression of ALDH1L1 protein
|
CTD |
PMID:19351701 |
|
NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704
|
|
| G
|
Aldh4a1
|
aldehyde dehydrogenase 4 family, member A1
|
increases expression
|
ISO
|
Selenium results in increased expression of ALDH4A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
increases expression
|
ISO
|
Selenium results in increased expression of ALDOA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Alg3
|
ALG3, alpha-1,3- mannosyltransferase
|
increases expression
|
ISO
|
Selenium results in increased expression of ALG3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060
|
|
| G
|
Alg9
|
ALG9, alpha-1,2-mannosyltransferase
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:60,013,429...60,085,159
Ensembl chr 8:60,009,618...60,085,054
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
increases expression multiple interactions
|
EXP ISO
|
Selenium deficiency results in increased expression of ALOX15 mRNA Selenomethionine inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]
|
CTD |
PMID:11444866 PMID:34970773 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
multiple interactions
|
EXP
|
[Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein
|
CTD |
PMID:22223226 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Als2cl
|
ALS2 C-terminal like
|
increases expression
|
ISO
|
Selenium results in increased expression of ALS2CL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843
|
|
| G
|
Ampd3
|
adenosine monophosphate deaminase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of AMPD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
|
|
| G
|
Anapc15
|
anaphase promoting complex subunit 15
|
increases expression
|
ISO
|
Selenium results in increased expression of ANAPC15 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:165,650,478...165,678,004
Ensembl chr 1:165,675,754...165,679,501
|
|
| G
|
Anapc2
|
anaphase promoting complex subunit 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ANAPC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:28,484,590...28,496,338
Ensembl chr 3:28,484,614...28,496,337
|
|
| G
|
Angpt1
|
angiopoietin 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ANGPT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Ank3
|
ankyrin 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879
|
|
| G
|
Ankra2
|
ankyrin repeat family A member 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ANKRA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:31,347,158...31,358,002
Ensembl chr 2:31,347,090...31,364,394
|
|
| G
|
Anp32b
|
acidic nuclear phosphoprotein 32 family member B
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437
|
|
| G
|
Anpep
|
alanyl aminopeptidase, membrane
|
increases expression
|
ISO
|
Selenium results in increased expression of ANPEP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101
|
|
| G
|
Aox1
|
aldehyde oxidase 1
|
multiple interactions decreases expression
|
EXP
|
Selenium deficiency results in decreased expression of and results in decreased activity of AOX1 protein Selenium deficiency results in decreased expression of AOX1 mRNA
|
CTD |
PMID:19182374 |
|
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980
|
|
| G
|
Ap1b1
|
adaptor related protein complex 1 subunit beta 1
|
increases expression
|
ISO
|
Selenium results in increased expression of AP1B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:84,093,529...84,144,835
Ensembl chr14:84,093,559...84,144,892
|
|
| G
|
Ap1m2
|
adaptor related protein complex 1 subunit mu 2
|
increases expression
|
ISO
|
Selenium results in increased expression of AP1M2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:28,114,748...28,132,642
|
|
| G
|
Ap2a2
|
adaptor related protein complex 2 subunit alpha 2
|
increases expression
|
ISO
|
Selenium results in increased expression of AP2A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:206,081,856...206,155,146
Ensembl chr 1:206,081,878...206,155,150
|
|
| G
|
Ap2m1
|
adaptor related protein complex 2 subunit mu 1
|
increases expression
|
ISO
|
Selenium results in increased expression of AP2M1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480
|
|
| G
|
Ap2s1
|
adaptor related protein complex 2 subunit sigma 1
|
increases expression
|
ISO
|
Selenium results in increased expression of AP2S1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:86,545,350...86,557,009
|
|
| G
|
Apba2
|
amyloid beta precursor protein binding family A member 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of APBA2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117
|
|
| G
|
Apc
|
APC regulator of WNT signaling pathway
|
decreases expression
|
ISO
|
Selenium results in decreased expression of APC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
increases expression
|
ISO
|
Selenium results in increased expression of APEH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Aplp2
|
amyloid beta precursor like protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of APLP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
| G
|
Apob
|
apolipoprotein B
|
multiple interactions decreases expression
|
EXP
|
Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] Selenium results in decreased expression of APOB protein
|
CTD |
PMID:16271152 PMID:16581047 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoe
|
apolipoprotein E
|
increases expression affects expression
|
ISO
|
Selenium results in increased expression of APOE mRNA Selenium affects the expression of APOE protein
|
CTD |
PMID:17996733 PMID:19244175 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of APP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Appbp2
|
amyloid beta precursor protein binding protein 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:70,555,212...70,597,267
Ensembl chr10:70,555,212...70,597,193
|
|
| G
|
Aqp3
|
aquaporin 3 (Gill blood group)
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions decreases localization decreases expression
|
ISO
|
Selenium results in decreased expression of and results in decreased activity of AR protein Selenium results in decreased localization of AR protein Selenium results in decreased expression of AR mRNA
|
CTD |
PMID:14729601 PMID:16648561 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Araf
|
A-Raf proto-oncogene, serine/threonine kinase
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ARAF mRNA [Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611
|
|
| G
|
Arf5
|
ARF GTPase 5
|
increases expression
|
ISO
|
Selenium results in increased expression of ARF5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835
|
|
| G
|
Arfgap2
|
ARF GTPase activating protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ARFGAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247
|
|
| G
|
Arfip2
|
ARF interacting protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ARFIP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:169,387,484...169,392,290
Ensembl chr 1:169,387,485...169,392,166
|
|
| G
|
Arfrp1
|
ARF related protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ARFRP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:188,844,013...188,851,473
Ensembl chr 3:188,845,511...188,851,431
|
|
| G
|
Arg1
|
arginase 1
|
multiple interactions
|
ISO
|
2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]
|
CTD |
PMID:21775527 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arg2
|
arginase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ARG2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375
|
|
| G
|
Arhgdia
|
Rho GDP dissociation inhibitor alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of ARHGDIA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
|
|
| G
|
Arih1
|
ariadne RBR E3 ubiquitin protein ligase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ARIH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:68,673,200...68,775,572
|
|
| G
|
Arl5a
|
ARF like GTPase 5A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ARL5A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:57,287,599...57,312,488
Ensembl chr 3:57,289,846...57,312,488
|
|
| G
|
Arl6ip4
|
ARF like GTPase 6 interacting protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of ARL6IP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724
|
|
| G
|
Arpc1a
|
actin related protein 2/3 complex, subunit 1A
|
increases expression
|
ISO
|
Selenium results in increased expression of ARPC1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052
|
|
| G
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B
|
increases expression
|
ISO
|
Selenium results in increased expression of ARPC1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504
|
|
| G
|
Arpc4
|
actin related protein 2/3 complex, subunit 4
|
increases expression
|
ISO
|
Selenium results in increased expression of ARPC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:148,077,799...148,088,427
Ensembl chr 4:148,077,240...148,088,428
|
|
| G
|
As3mt
|
arsenite methyltransferase
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [AS3MT protein results in increased methylation of Arsenic]
|
CTD |
PMID:19167370 |
|
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
|
|
| G
|
Asap3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
|
increases expression
|
ISO
|
Selenium results in increased expression of ASAP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:153,716,988...153,757,787
Ensembl chr 5:153,716,988...153,757,787
|
|
| G
|
Asb1
|
ankyrin repeat and SOCS box-containing 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Selenium results in increased expression of ASB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:99,567,867...99,583,907
|
|
| G
|
Ascc2
|
activating signal cointegrator 1 complex subunit 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ASCC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:83,726,975...83,771,312
Ensembl chr14:83,727,049...83,771,316
|
|
| G
|
Asl
|
argininosuccinate lyase
|
increases expression
|
ISO
|
Selenium results in increased expression of ASL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Asmtl
|
acetylserotonin O-methyltransferase-like
|
increases expression
|
ISO
|
Selenium results in increased expression of ASMTL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:21,429,119...21,431,847
Ensembl chr12:21,429,171...21,431,847
|
|
| G
|
Ass1
|
argininosuccinate synthase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ASS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
|
|
| G
|
Asxl1
|
ASXL transcriptional regulator 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ASXL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:162,273,828...162,341,742
|
|
| G
|
Asxl2
|
ASXL transcriptional regulator 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ASXL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:32,090,497...32,234,487
Ensembl chr 6:32,145,607...32,227,851
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
ISO
|
Selenium results in increased expression of ATF4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf5
|
activating transcription factor 5
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Selenium results in increased expression of ATF5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
|
|
| G
|
Atg12
|
autophagy related 12
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATG12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261
|
|
| G
|
Atg13
|
autophagy related 13
|
increases expression
|
ISO
|
Selenium results in increased expression of ATG13 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:98,101,552...98,136,743
|
|
| G
|
Atg14
|
autophagy related 14
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATG14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:23,275,457...23,306,817
Ensembl chr15:23,275,457...23,306,815
|
|
| G
|
Atg9a
|
autophagy related 9A
|
increases expression
|
ISO
|
Selenium results in increased expression of ATG9A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,126,071...84,136,723
Ensembl chr 9:84,126,071...84,136,666
|
|
| G
|
Atmin
|
ATM interactor
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Selenium results in decreased expression of ATMIN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:61,905,343...61,922,443
Ensembl chr19:61,905,144...61,922,443
|
|
| G
|
Atp10d
|
ATPase phospholipid transporting 10D (putative)
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP10D mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:36,265,696...36,366,460
Ensembl chr14:36,265,696...36,366,460
|
|
| G
|
Atp2b4
|
ATPase plasma membrane Ca2+ transporting 4
|
increases expression
|
ISO
|
Selenium results in increased expression of ATP2B4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876
|
|
| G
|
Atp2c1
|
ATPase secretory pathway Ca2+ transporting 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP2C1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826
|
|
| G
|
Atp5me
|
ATP synthase membrane subunit e
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP5ME mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988
|
|
| G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP5PD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
| G
|
Atp5pf
|
ATP synthase peripheral stalk subunit F6
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP5PF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466
|
|
| G
|
Atp6ap1
|
ATPase H+ transporting accessory protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ATP6AP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:157,231,243...157,238,323
Ensembl chr X:157,225,327...157,238,323
|
|
| G
|
Atp6v0d1
|
ATPase H+ transporting V0 subunit D1
|
increases expression
|
ISO
|
Selenium results in increased expression of ATP6V0D1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
|
|
| G
|
Atp6v0e1
|
ATPase H+ transporting V0 subunit e1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP6V0E mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
|
|
| G
|
Atp6v1c1
|
ATPase H+ transporting V1 subunit C1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATP6V1C1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184
|
|
| G
|
Atrx
|
ATRX, chromatin remodeler
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA Selenium results in decreased expression of ATRX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
|
|
| G
|
Atxn1
|
ataxin 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ATXN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:19,208,200...19,356,790
|
|
| G
|
Atxn7
|
ataxin 7
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Selenium results in decreased expression of ATXN7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:13,547,859...13,693,311
Ensembl chr15:13,547,862...13,693,526
|
|
| G
|
Avl9
|
AVL9 cell migration associated
|
decreases expression
|
ISO
|
Selenium results in decreased expression of AVL9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:87,291,062...87,338,537
Ensembl chr 4:87,291,798...87,331,916
|
|
| G
|
Axl
|
Axl receptor tyrosine kinase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of AXL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
|
|
| G
|
B3gat3
|
beta-1,3-glucuronyltransferase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of B3GAT3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
increases expression
|
ISO
|
Selenium results in increased expression of BAG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bag6
|
BAG cochaperone 6
|
increases expression
|
ISO
|
Selenium results in increased expression of BAG6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329
|
|
| G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of BAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,452,974...6,461,952
|
|
| G
|
Bard1
|
BRCA1 associated RING domain 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of BARD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873
|
|
| G
|
Batf
|
basic leucine zipper ATF-like transcription factor
|
increases expression
|
ISO
|
Selenium results in increased expression of BATF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
Selenium results in decreased expression of BAX protein Selenium inhibits the reaction [arsenite results in increased expression of BAX protein] [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium inhibits the reaction [T-2 Toxin results in increased expression of BAX mRNA]
|
CTD |
PMID:16307838 PMID:17997286 PMID:27920530 PMID:29324385 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz1b
|
bromodomain adjacent to zinc finger domain, 1B
|
increases expression
|
ISO
|
Selenium results in increased expression of BAZ1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511
|
|
| G
|
Bbx
|
BBX high mobility group box domain containing
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Selenium results in decreased expression of BBX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265
|
|
| G
|
Bcl11a
|
BCL11 transcription factor A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of BCL11A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
Selenium results in decreased expression of BCL2 protein Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]
|
CTD |
PMID:17523932 PMID:27920530 PMID:34612572 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
increases expression multiple interactions
|
ISO EXP
|
Selenium results in increased expression of BCL2L1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA
|
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
multiple interactions increases expression
|
ISO
|
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] Selenium results in increased expression of BCL2L11 protein
|
CTD |
PMID:17339365 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bcl3
|
BCL3, transcription coactivator
|
increases expression
|
ISO
|
Selenium results in increased expression of BCL3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
|
|
| G
|
Bcl7b
|
BAF chromatin remodeling complex subunit BCL7B
|
increases expression
|
ISO
|
Selenium results in increased expression of BCL7B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:27,133,412...27,146,631
Ensembl chr12:27,133,412...27,146,636
|
|
| G
|
Bclaf1
|
BCL2-associated transcription factor 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of BCLAF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801
|
|
| G
|
Bdh2
|
3-hydroxybutyrate dehydrogenase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of BDH2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
increases expression multiple interactions
|
EXP
|
Selenium results in increased expression of BDNF protein Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein]
|
CTD |
PMID:30695686 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
multiple interactions
|
EXP
|
Selenium deficiency inhibits the reaction [T-2 Toxin results in increased expression of BECN1 mRNA]; Selenium inhibits the reaction [Acrylamide results in increased expression of BECN1 protein]
|
CTD |
PMID:30629952 PMID:37987225 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bicd1
|
BICD cargo adaptor 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA Selenium results in decreased expression of BICD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:184,210,363...184,357,391
|
|
| G
|
Bicdl1
|
BICD family like cargo adaptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of BICDL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:46,537,525...46,626,876
Ensembl chr12:46,538,396...46,628,866
|
|
| G
|
Bicra
|
BRD4 interacting chromatin remodeling complex associated protein
|
increases expression
|
ISO
|
Selenium results in increased expression of BICRA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:85,790,093...85,867,656
Ensembl chr 1:85,790,093...85,864,306
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
increases cleavage
|
ISO
|
Selenium results in increased cleavage of BID protein
|
CTD |
PMID:12432279 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bin1
|
bridging integrator 1
|
increases expression
|
ISO
|
Selenium results in increased expression of BIN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
affects response to substance multiple interactions
|
ISO
|
BIRC5 protein affects the susceptibility to Selenium [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]
|
CTD |
PMID:17876054 PMID:27920530 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Bles03
|
basophilic leukemia expressed protein BLES03
|
increases expression
|
ISO
|
Selenium results in increased expression of C11ORF68 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,163,892...212,166,146
Ensembl chr 1:212,163,892...212,166,141
|
|
| G
|
Bltp2
|
bridge-like lipid transfer protein family member 2
|
increases expression
|
ISO
|
Selenium results in increased expression of BLTP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:63,654,072...63,683,282
Ensembl chr10:63,654,104...63,683,282
|
|
| G
|
Bltp3b
|
bridge-like lipid transfer protein family member 3B
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Selenium results in decreased expression of BLTP3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083
|
|
| G
|
Blvrb
|
biliverdin reductase B
|
increases expression
|
ISO
|
Selenium results in increased expression of BLVRB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225
|
|
| G
|
Bptf
|
bromodomain PHD finger transcription factor
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Selenium results in decreased expression of BPTF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413
|
|
| G
|
Brd2
|
bromodomain containing 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Selenium results in increased expression of BRD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Brf2
|
BRF2 general transcription factor 3B subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of BRF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:71,626,146...71,635,909
Ensembl chr16:71,623,238...71,635,903
|
|
| G
|
Brms1
|
BRMS1, transcriptional repressor and anoikis regulator
|
increases expression
|
ISO
|
Selenium results in increased expression of BRMS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:211,775,142...211,784,411
Ensembl chr 1:211,775,095...211,784,410
|
|
| G
|
Bscl2
|
BSCL2 lipid droplet biogenesis associated, seipin
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Selenium results in increased expression of BSCL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536
|
|
| G
|
Bst2
|
bone marrow stromal cell antigen 2
|
increases expression
|
ISO
|
Selenium results in increased expression of BST2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967
|
|
| G
|
Bysl
|
bystin-like
|
increases expression
|
ISO
|
Selenium results in increased expression of BYSL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:20,880,341...20,890,092
Ensembl chr 9:20,880,026...20,890,900
|
|
| G
|
C17h7orf25
|
similar to human chromosome 7 open reading frame 25
|
decreases expression
|
ISO
|
Selenium results in decreased expression of C7ORF25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:55,238,751...55,245,399
Ensembl chr17:55,236,313...55,246,284
|
|
| G
|
C1qb
|
complement C1q B chain
|
increases expression
|
ISO
|
Selenium results in increased expression of C1QB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
| G
|
C2cd5
|
C2 calcium-dependent domain containing 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of C2CD5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:177,700,515...177,790,576
Ensembl chr 4:177,700,516...177,786,717
|
|
| G
|
C2h1orf54
|
similar to human chromosome 1 open reading frame 54
|
decreases expression
|
ISO
|
Selenium results in decreased expression of C1ORF54 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:186,113,922...186,124,637
Ensembl chr 2:186,113,922...186,124,335
|
|
| G
|
C4h2orf42
|
similar to human chromosome 2 open reading frame 42
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Selenium results in decreased expression of C2ORF42 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:120,445,032...120,474,227
Ensembl chr 4:120,445,830...120,474,396
|
|
| G
|
C5h1orf50
|
similar to human chromosome 1 open reading frame 50
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA Selenium results in decreased expression of C1ORF50 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:138,122,595...138,126,973
Ensembl chr 5:138,122,236...138,127,240
|
|
| G
|
C6h14orf132
|
similar to human chromosome 14 open reading frame 132
|
decreases expression
|
ISO
|
Selenium results in decreased expression of C14ORF132 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:130,130,176...130,163,153
Ensembl chr 6:130,130,794...130,158,762
|
|
| G
|
Ca3
|
carbonic anhydrase 3
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
|
|
| G
|
Cabin1
|
calcineurin binding protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CABIN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:12,892,750...13,014,801
Ensembl chr20:12,892,771...13,014,800
|
|
| G
|
Calcoco1
|
calcium binding and coiled coil domain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CALCOCO1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,713,208...135,728,044
Ensembl chr 7:135,713,208...135,727,928
|
|
| G
|
Cald1
|
caldesmon 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CALD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
| G
|
Calhm2
|
calcium homeostasis modulator family member 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CALHM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:255,963,663...255,969,387
|
|
| G
|
Calm3
|
calmodulin 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CALM3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:86,717,321...86,725,960
|
|
| G
|
Calr
|
calreticulin
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Selenium results in decreased expression of CALR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Calu
|
calumenin
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Selenium results in increased expression of CALU mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
increases expression
|
ISO
|
Selenium results in increased expression of CAMK2B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camp
|
cathelicidin antimicrobial peptide
|
decreases expression multiple interactions
|
EXP
|
Selenium deficiency results in decreased expression of CAMP mRNA [Selenium deficiency co-treated with T-2 Toxin] results in decreased expression of CAMP mRNA
|
CTD |
PMID:38796086 |
|
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998
|
|
| G
|
Camta1
|
calmodulin binding transcription activator 1
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of CAMTA1 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 5:166,791,639...167,639,502
Ensembl chr 5:166,793,101...167,639,733
|
|
| G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563
|
|
| G
|
Capg
|
capping actin protein, gelsolin like
|
increases expression
|
ISO
|
Selenium results in increased expression of CAPG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
|
|
| G
|
Capn1
|
calpain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CAPN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445
|
|
| G
|
Capn7
|
calpain 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CAPN7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,552,049...6,588,316
|
|
| G
|
Capns1
|
calpain, small subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CAPNS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:94,572,083...94,583,368
|
|
| G
|
Capzb
|
capping actin protein of muscle Z-line subunit beta
|
increases expression
|
ISO
|
Selenium results in increased expression of CAPZB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619
|
|
| G
|
Casc3
|
CASC3 exon junction complex subunit
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:84,264,157...84,286,639
Ensembl chr10:84,265,033...84,286,637
|
|
| G
|
Casp12
|
caspase 12
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP12 protein]
|
CTD |
PMID:34612572 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
decreases activity multiple interactions increases activity
|
ISO EXP
|
Selenium results in decreased activity of CASP3 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CASP3 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form] [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Selenium deficiency promotes the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of CASP3 protein]; Selenium inhibits the reaction [arsenite results in increased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein] Selenium results in increased activity of CASP3 protein
|
CTD |
PMID:15318939 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:30629952 PMID:34612572 PMID:37676925 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
multiple interactions increases activity decreases expression
|
ISO
|
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]]; Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] Selenium results in increased activity of CASP8 protein Selenium deficiency results in decreased expression of CASP8 mRNA; Selenium deficiency results in decreased expression of CASP8 protein; Selenium results in decreased expression of CASP8 mRNA
|
CTD |
PMID:12432279 PMID:17970047 PMID:19244175 PMID:27920530 PMID:37422542 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions decreases activity
|
ISO EXP
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]]; [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] [Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased expression of CASP9 mRNA]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [arsenite results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] Selenium results in decreased activity of CASP9 protein
|
CTD |
PMID:17339365 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:33372294 PMID:34612572 More...
|
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions increases activity decreases expression increases expression
|
ISO EXP
|
Arsenic promotes the reaction [Selenium results in increased expression of CAT protein]; Fluorides promotes the reaction [Selenium results in increased activity of CAT protein]; Selenium inhibits the reaction [Fluorides results in decreased activity of CAT protein] Selenium deficiency results in decreased expression of CAT mRNA [[Sodium Selenite results in increased abundance of Selenium] which co-treated with Ascorbic Acid] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased activity of CAT protein; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of CAT protein]; Selenium affects the reaction [Clofibrate results in increased activity of CAT protein]; Selenium affects the reaction [Mercury results in decreased activity of CAT protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of CAT protein]; Selenium inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in increased activity of CAT protein]; Selenium inhibits the reaction [Chromium results in increased activity of CAT protein]; Selenium inhibits the reaction [cyfluthrin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Enrofloxacin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Selenium inhibits the reaction [nickel sulfate results in increased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in increased activity of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]]
|
CTD |
PMID:3456598 PMID:8250967 PMID:11260395 PMID:17512462 PMID:19652462 PMID:19913299 PMID:20143455 PMID:20478284 PMID:20494564 PMID:20580087 PMID:21628957 PMID:23595963 PMID:24485406 PMID:27083143 PMID:27941167 PMID:30526071 PMID:32233808 PMID:34612572 PMID:37415728 PMID:37676925 PMID:37987225 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cavin1
|
caveolae associated protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CAVIN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383
|
|
| G
|
Cblb
|
Cbl proto-oncogene B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CBLB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:62,058,829...62,225,904
Ensembl chr11:62,061,653...62,225,778
|
|
| G
|
Cbx5
|
chromobox 5
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Selenium results in decreased expression of CBX5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118
|
|
| G
|
Cbx7
|
chromobox 7
|
increases expression
|
ISO
|
Selenium results in increased expression of CBX7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346
|
|
| G
|
Ccdc85b
|
coiled-coil domain containing 85B
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Selenium results in increased expression of DIPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,192,979...212,193,994
Ensembl chr 1:212,189,468...212,196,911
|
|
| G
|
Cchcr1
|
coiled-coil alpha-helical rod protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CCHCR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,210,384...3,222,765
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA]
|
CTD |
PMID:16143069 PMID:21481475 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of CCNB1 mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnc
|
cyclin C
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of CCNC mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression multiple interactions
|
ISO EXP
|
Selenium results in increased expression of CCND1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA
|
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of CCND2 mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccpg1
|
cell cycle progression 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CPR8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246
|
|
| G
|
Ccr3
|
C-C motif chemokine receptor 3
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CCR3 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
|
|
| G
|
Ccser2
|
coiled-coil serine-rich protein 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CCSER2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:12,633,374...12,746,045
Ensembl chr16:12,637,083...12,746,003
|
|
| G
|
Cd14
|
CD14 molecule
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CD14 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd2bp2
|
Cd2 (cytoplasmic tail) binding protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CD2BP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,239,899...191,244,395
Ensembl chr 1:191,239,901...191,243,398
|
|
| G
|
Cd44
|
CD44 molecule
|
multiple interactions increases expression
|
ISO
|
Selenium inhibits the reaction [T-2 Toxin results in decreased expression of CD44 protein] Selenium results in increased expression of CD44 mRNA; Selenium results in increased expression of CD44 protein
|
CTD |
PMID:18196609 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd74
|
CD74 molecule
|
increases expression
|
ISO
|
Selenium results in increased expression of CD74 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
|
|
| G
|
Cd99
|
CD99 molecule (Xg blood group)
|
increases expression
|
ISO
|
Selenium results in increased expression of CD99 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:56,000,494...56,005,140
|
|
| G
|
Cdc14b
|
cell division cycle 14B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDC14B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164
|
|
| G
|
Cdc16
|
cell division cycle 16
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDC16 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:82,475,234...82,498,797
Ensembl chr16:82,474,523...82,498,765
|
|
| G
|
Cdc23
|
cell division cycle 23
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDC23 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646
|
|
| G
|
Cdc42bpa
|
CDC42 binding protein kinase alpha
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Selenium results in decreased expression of CDC42BPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681
|
|
| G
|
Cdc42ep4
|
CDC42 effector protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of CDC42EP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168
|
|
| G
|
Cdc73
|
cell division cycle 73
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDC73 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:57,883,983...57,999,978
|
|
| G
|
Cdh11
|
cadherin 11
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDH11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140
|
|
| G
|
Cdh3
|
cadherin 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CDH3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of CDK1 mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk10
|
cyclin-dependent kinase 10
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of CDK10 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:68,168,040...68,184,923
Ensembl chr19:68,169,874...68,177,599
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of CDK2 mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk2ap2
|
cyclin-dependent kinase 2 associated protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CDK2AP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases expression increases expression
|
ISO
|
Selenium deficiency results in decreased expression of CDK4 mRNA Selenium results in increased expression of CDK4 mRNA
|
CTD |
PMID:11925459 PMID:19244175 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDKN1C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
|
|
| G
|
Cds1
|
CDP-diacylglycerol synthase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CDS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of CEBPA mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cel
|
carboxyl ester lipase
|
increases expression
|
ISO
|
Selenium results in increased expression of CEL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:32,281,518...32,289,019
|
|
| G
|
Celf2
|
CUGBP, Elav-like family member 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CELF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362
|
|
| G
|
Cep170
|
centrosomal protein 170
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CEP170 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:91,201,808...91,285,990
Ensembl chr13:91,201,808...91,285,990
|
|
| G
|
Cep290
|
centrosomal protein 290
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CEP290 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955
|
|
| G
|
Cep350
|
centrosomal protein 350
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Selenium results in decreased expression of CEP350 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673
|
|
| G
|
Cep57
|
centrosomal protein 57
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Selenium results in decreased expression of CEP57 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890
|
|
| G
|
Cert1
|
ceramide transporter 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Selenium results in decreased expression of CERT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
increases expression
|
ISO
|
Selenium results in increased expression of CES1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Cfh
|
complement factor H
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CFH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
multiple interactions
|
ISO
|
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA]; Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Chd1
|
chromodomain helicase DNA binding protein 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of CHD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:65,334,905...65,402,270
Ensembl chr 1:65,335,218...65,401,280
|
|
| G
|
Chd3
|
chromodomain helicase DNA binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CHD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:54,562,437...54,588,842
Ensembl chr10:54,562,437...54,588,810
|
|
| G
|
Chd4
|
chromodomain helicase DNA binding protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of CHD4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:159,584,654...159,617,866
|
|
| G
|
Chd9
|
chromodomain helicase DNA binding protein 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CHD9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042
|
|
| G
|
Chka
|
choline kinase alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of CHKA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
|
|
| G
|
Chmp1a
|
charged multivesicular body protein 1A
|
increases expression
|
ISO
|
Selenium results in increased expression of CHMP1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:68,146,672...68,154,952
Ensembl chr19:68,146,672...68,154,952
|
|
| G
|
Chmp2a
|
charged multivesicular body protein 2A
|
increases expression
|
ISO
|
Selenium results in increased expression of CHMP2A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:82,732,231...82,738,613
|
|
| G
|
Chn2
|
chimerin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CHN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068
|
|
| G
|
Chordc1
|
cysteine and histidine rich domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CHORDC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
|
|
| G
|
Chpf
|
chondroitin polymerizing factor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA Selenium results in increased expression of CHPF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of CHRNA4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of CHRNE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chst3
|
carbohydrate sulfotransferase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CHST3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526
|
|
| G
|
Chst6
|
carbohydrate sulfotransferase 6
|
increases expression
|
ISO
|
Selenium results in increased expression of CHST6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306
|
|
| G
|
Ciz1
|
CDKN1A interacting zinc finger protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CIZ1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:36,055,753...36,071,510
Ensembl chr 3:36,056,370...36,075,192
|
|
| G
|
Ckap2
|
cytoskeleton associated protein 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CKAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352
|
|
| G
|
Ckb
|
creatine kinase B
|
increases expression
|
ISO
|
Selenium results in increased expression of CKB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CKS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clcc1
|
chloride channel CLIC-like 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CLCC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014
|
|
| G
|
Clcn3
|
chloride voltage-gated channel 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Selenium results in decreased expression of CLCN3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:34,138,004...34,210,984
Ensembl chr16:34,137,952...34,210,984
|
|
| G
|
Cldn4
|
claudin 4
|
increases expression
|
ISO
|
Selenium results in increased expression of CLDN4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cldn5
|
claudin 5
|
multiple interactions
|
ISO
|
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; Selenium results in increased expression of and results in increased localization of CLDN5 protein
|
CTD |
PMID:16514648 |
|
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
| G
|
Clec3b
|
C-type lectin domain family 3, member B
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Selenium results in increased expression of TNA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:131,687,575...131,693,292
|
|
| G
|
Cln3
|
CLN3 lysosomal/endosomal transmembrane protein, battenin
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Selenium results in increased expression of CLN3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:190,586,650...190,597,929
|
|
| G
|
Clptm1
|
CLPTM1 regulator of GABA type A receptor forward trafficking
|
increases expression
|
ISO
|
Selenium results in increased expression of CLPTM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:88,417,447...88,449,446
|
|
| G
|
Cltb
|
clathrin, light chain B
|
increases expression
|
ISO
|
Selenium results in increased expression of CLTB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
|
|
| G
|
Clu
|
clusterin
|
increases expression
|
ISO
|
Selenium results in increased expression of CLU mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cmc2
|
C-x(9)-C motif containing 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CMC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:61,852,126...61,880,768
Ensembl chr19:61,852,126...61,881,019
|
|
| G
|
Cnih1
|
cornichon family member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CNIH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:22,517,755...22,529,651
Ensembl chr15:22,497,340...22,529,578
|
|
| G
|
Cnih4
|
cornichon family member 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CNIH4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:95,442,054...95,458,163
Ensembl chr13:95,442,054...95,459,590
|
|
| G
|
Cnn2
|
calponin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CNN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312
|
|
| G
|
Cnn3
|
calponin 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CNN3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815
|
|
| G
|
Cnot8
|
CCR4-NOT transcription complex, subunit 8
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CNOT8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:42,782,042...42,795,207
Ensembl chr10:42,782,283...42,795,207
|
|
| G
|
Cnpy2
|
canopy FGF signaling regulator 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CNPY2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:1,332,293...1,338,081
Ensembl chr 7:1,334,335...1,340,333
|
|
| G
|
Cnpy3
|
canopy FGF signaling regulator 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CNPY3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:21,730,791...21,745,505
|
|
| G
|
Cog4
|
component of oligomeric golgi complex 4
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:55,729,854...55,763,902
Ensembl chr19:55,728,796...55,764,169
|
|
| G
|
Cog7
|
component of oligomeric golgi complex 7
|
increases expression
|
ISO
|
Selenium results in increased expression of COG7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:185,921,053...185,980,711
Ensembl chr 1:185,889,348...185,983,421
|
|
| G
|
Cog8
|
component of oligomeric golgi complex 8
|
increases expression
|
ISO
|
Selenium results in increased expression of COG8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:51,861,376...51,872,126
Ensembl chr19:51,861,376...51,872,129
|
|
| G
|
Col14a1
|
collagen type XIV alpha 1 chain
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COL14A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
|
|
| G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
increases expression
|
ISO
|
Selenium results in increased expression of COL18A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions
|
ISO
|
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL1A1 protein
|
CTD |
PMID:8435081 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions
|
ISO
|
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL2A1 protein
|
CTD |
PMID:8435081 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
| G
|
Col4a3
|
collagen type IV alpha 3 chain
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COL4A3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077
|
|
| G
|
Col6a2
|
collagen type VI alpha 2 chain
|
increases expression
|
ISO
|
Selenium results in increased expression of COL6A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
|
|
| G
|
Colec12
|
collectin sub-family member 12
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of COLEC12 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297
|
|
| G
|
Commd3
|
COMM domain containing 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COMMD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610
|
|
| G
|
Commd4
|
COMM domain containing 4
|
increases expression
|
ISO
|
Selenium results in increased expression of COMMD4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:66,462,188...66,465,700
Ensembl chr 8:66,462,188...66,465,756
|
|
| G
|
Cope
|
COPI coat complex subunit epsilon
|
increases expression
|
ISO
|
Selenium results in increased expression of COPE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212
|
|
| G
|
Copg1
|
COPI coat complex subunit gamma 1
|
increases expression
|
ISO
|
Selenium results in increased expression of COPG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:121,923,644...121,949,819
Ensembl chr 4:121,923,873...121,949,812
|
|
| G
|
Cops7a
|
COP9 signalosome subunit 7A
|
increases expression
|
ISO
|
Selenium results in increased expression of COPS7A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,452,878...159,478,878
Ensembl chr 4:159,452,897...159,460,315
|
|
| G
|
Cops8
|
COP9 signalosome subunit 8
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COPS8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:98,655,031...98,664,861
Ensembl chr 9:98,654,870...98,665,381
|
|
| G
|
Cox6a1
|
cytochrome c oxidase subunit 6A1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COX6A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768
|
|
| G
|
Cox7a1
|
cytochrome c oxidase subunit 7A1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COX7A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889
|
|
| G
|
Cox7a2
|
cytochrome c oxidase subunit 7A2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COX7A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512 Ensembl chr 8:55,514,261...55,514,512
|
|
| G
|
Cox7b
|
cytochrome c oxidase subunit 7B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COX7B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:75,149,036...75,155,285
Ensembl chr X:75,148,996...75,155,284
|
|
| G
|
Cox7c
|
cytochrome c oxidase subunit 7C
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COX7C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170
|
|
| G
|
Cpa3
|
carboxypeptidase A3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CPA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:104,641,619...104,673,253
Ensembl chr 2:104,641,621...104,673,237
|
|
| G
|
Cpd
|
carboxypeptidase D
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CPD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
|
|
| G
|
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of CPEB3 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
|
|
| G
|
Cpsf1
|
cleavage and polyadenylation specific factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CPSF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644
|
|
| G
|
Crabp2
|
cellular retinoic acid binding protein 2
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of CRABP2 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385
|
|
| G
|
Crat
|
carnitine O-acetyltransferase
|
increases expression
|
ISO
|
Selenium results in increased expression of CRAT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099
|
|
| G
|
Crbn
|
cereblon
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CRBN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions decreases expression
|
ISO EXP
|
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of CREB1 protein] Selenium results in decreased expression of CREB1 mRNA
|
CTD |
PMID:19244175 PMID:30695686 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Creb3
|
cAMP responsive element binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CREB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500
|
|
| G
|
Crebbp
|
CREB binding protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CREBBP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Creld1
|
cysteine-rich with EGF-like domains 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CRELD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:148,187,510...148,197,120
Ensembl chr 4:148,187,265...148,197,116
|
|
| G
|
Crtc1
|
CREB regulated transcription coactivator 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CRTC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,022,171...19,080,880
Ensembl chr16:19,022,005...19,080,880
|
|
| G
|
Crybg2
|
crystallin beta-gamma domain containing 2
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of CRYBG2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163
|
|
| G
|
Csf1
|
colony stimulating factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CSF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
|
|
| G
|
Csk
|
C-terminal Src kinase
|
increases expression
|
ISO
|
Selenium results in increased expression of CSK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:66,925,651...66,930,274
|
|
| G
|
Csnk1a1
|
casein kinase 1, alpha 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Selenium results in decreased expression of CSNK1A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538
|
|
| G
|
Csnk1e
|
casein kinase 1, epsilon
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA Selenium results in increased expression of CSNK1E mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CSNK2A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Csnk2b
|
casein kinase 2 beta
|
increases expression
|
ISO
|
Selenium results in increased expression of CSNK2B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525
|
|
| G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
|
|
| G
|
Cspp1
|
centrosome and spindle pole associated protein 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of CSPP1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:13,860,072...13,975,321
|
|
| G
|
Cst3
|
cystatin C
|
increases expression
|
ISO
|
Selenium results in increased expression of CST3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Csta
|
cystatin A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CSTA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822
|
|
| G
|
Ctbp1
|
C-terminal binding protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CTBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:81,679,956...81,707,331
Ensembl chr14:81,679,765...81,707,554
|
|
| G
|
Ctbp2
|
C-terminal binding protein 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Selenium results in decreased expression of CTBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261
|
|
| G
|
Ctbs
|
chitobiase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CTBS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:238,000,800...238,015,368
Ensembl chr 2:238,000,842...238,015,475
|
|
| G
|
Ctdnep1
|
CTD nuclear envelope phosphatase 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Selenium results in increased expression of CTDNEP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852
|
|
| G
|
Ctnna1
|
catenin alpha 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CTNNA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007
|
|
| G
|
Ctnnbl1
|
catenin, beta like 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CTNNBL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:166,807,899...166,968,932
Ensembl chr 3:166,807,858...166,968,931
|
|
| G
|
Ctsa
|
cathepsin A
|
increases expression
|
ISO
|
Selenium results in increased expression of CTSA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:173,988,443...173,994,320
Ensembl chr 3:173,988,460...173,995,539
|
|
| G
|
Ctsb
|
cathepsin B
|
increases expression
|
ISO
|
Selenium results in increased expression of CTSB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctso
|
cathepsin O
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CTSO mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:169,528,468...169,551,975
Ensembl chr 2:169,528,511...169,554,995
|
|
| G
|
Cuedc2
|
CUE domain containing 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CUEDC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:255,133,479...255,142,016
Ensembl chr 1:255,133,421...255,141,956
|
|
| G
|
Cul3
|
cullin 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CUL3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
|
|
| G
|
Cul4a
|
cullin 4A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:83,086,688...83,124,503
Ensembl chr16:83,086,921...83,124,457
|
|
| G
|
Cul7
|
cullin 7
|
increases expression
|
ISO
|
Selenium results in increased expression of CUL7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:21,816,703...21,830,344
Ensembl chr 9:21,816,703...21,830,344
|
|
| G
|
Cutc
|
cutC copper transporter
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Selenium results in decreased expression of CUTC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:252,571,489...252,586,269
Ensembl chr 1:252,571,521...252,597,272
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CXCL1 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression
|
ISO
|
Selenium results in increased expression of CXCL2 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
increases expression
|
ISO
|
Selenium results in increased expression of CXCL1 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CXCL9 mRNA
|
CTD |
PMID:18997278 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CXCR4 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cxxc1
|
CXXC finger protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of CXXC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:70,088,407...70,093,786
Ensembl chr18:70,088,460...70,093,778
|
|
| G
|
Cyb561d2
|
cytochrome b561 family, member D2
|
increases expression
|
ISO
|
Selenium results in increased expression of CYB561D2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,091,844...117,094,434
Ensembl chr 8:117,091,845...117,094,366
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
ISO EXP
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CYCS mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein]
|
CTD |
PMID:27920530 PMID:34612572 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA]
|
CTD |
PMID:37987225 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
Selenium promotes the reaction [Plant Extracts results in increased activity of CYP1A1 protein]
|
CTD |
PMID:19650632 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions
|
EXP
|
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein]
|
CTD |
PMID:21424224 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]
|
CTD |
PMID:36464106 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of CYP2B10 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
EXP
|
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein]
|
CTD |
PMID:21424224 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CYP3A4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of CYP3A5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp4b1
|
cytochrome P450, family 4, subfamily b, polypeptide 1
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of CYP4B1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
multiple interactions
|
EXP ISO
|
[Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]
|
CTD |
PMID:30031400 PMID:36464106 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Cyp7b1
|
cytochrome P450 family 7 subfamily B member 1
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of CYP7B1 mRNA; Selenium results in increased expression of CYP7B1 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804
|
|
| G
|
Cyp8b1
|
cytochrome P450 family 8 subfamily B member 1
|
increases expression multiple interactions
|
ISO
|
Selenium deficiency results in increased expression of CYP8B1 mRNA; Selenium results in increased expression of CYP8B1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]
|
CTD |
PMID:16170372 PMID:36464106 |
|
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
|
|
| G
|
Daam1
|
dishevelled associated activator of morphogenesis 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DAAM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049
|
|
| G
|
Dact1
|
dishevelled-binding antagonist of beta-catenin 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DACT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053
|
|
| G
|
Dad1
|
defender against cell death 1
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
| G
|
Dapk3
|
death-associated protein kinase 3
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Selenium results in increased expression of DAPK3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272
|
|
| G
|
Dctn1
|
dynactin subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of DCTN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:117,219,349...117,261,528
|
|
| G
|
Dcx
|
doublecortin
|
multiple interactions
|
ISO
|
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of DCX mRNA
|
CTD |
PMID:37914285 |
|
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
|
|
| G
|
Dcxr
|
dicarbonyl and L-xylulose reductase
|
increases expression
|
ISO
|
Selenium results in increased expression of DCXR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:106,504,730...106,506,619
|
|
| G
|
Ddah2
|
DDAH family member 2, ADMA-independent
|
increases expression
|
ISO
|
Selenium results in increased expression of DDAH2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183
|
|
| G
|
Ddost
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of DDOST mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:155,805,612...155,812,728
Ensembl chr 5:155,805,454...155,813,121
|
|
| G
|
Ddx17
|
DEAD-box helicase 17
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Selenium results in decreased expression of DDX17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747
|
|
| G
|
Ddx18
|
DEAD-box helicase 18
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of DDX18 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:35,282,391...35,296,038
Ensembl chr13:35,282,467...35,295,972
|
|
| G
|
Ddx24
|
DEAD-box helicase 24
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Selenium results in decreased expression of DDX24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:128,329,554...128,349,625
|
|
| G
|
Ddx39b
|
DExD-box helicase 39B
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of DDX39B mRNA Selenium results in increased expression of DDX39B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,576,734...3,589,651
|
|
| G
|
Ddx3y
|
DEAD box helicase 3, Y-linked
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DDX3Y mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr Y:1,190,042...1,210,699
Ensembl chr Y:1,191,242...1,210,650
|
|
| G
|
Ddx41
|
DEAD-box helicase 41
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA Selenium results in increased expression of DDX41 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,108,074...9,113,561
|
|
| G
|
Ddx49
|
DEAD-box helicase 49
|
increases expression
|
ISO
|
Selenium results in increased expression of DDX49 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,159,353...19,167,003
Ensembl chr16:19,159,087...19,167,580
|
|
| G
|
Decr2
|
2,4-dienoyl-CoA reductase 2
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of DECR2 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr10:15,609,389...15,617,779
Ensembl chr10:15,611,092...15,617,397
|
|
| G
|
Dedd
|
death effector domain-containing
|
increases expression
|
ISO
|
Selenium results in increased expression of DEDD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:86,286,341...86,301,789
Ensembl chr13:86,288,350...86,302,446
|
|
| G
|
Degs1
|
delta(4)-desaturase, sphingolipid 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DEGS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302
|
|
| G
|
Dennd2b
|
DENN domain containing 2B
|
increases expression
|
ISO
|
Selenium results in increased expression of DENND2B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:172,978,895...173,129,623
Ensembl chr 1:172,978,895...173,129,810
|
|
| G
|
Dera
|
deoxyribose-phosphate aldolase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DERA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:172,394,971...172,473,746
Ensembl chr 4:172,394,962...172,490,142
|
|
| G
|
Des
|
desmin
|
increases expression
|
ISO
|
Selenium results in increased expression of DES mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
| G
|
Desi2
|
desumoylating isopeptidase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DESI2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:92,493,765...92,543,307
Ensembl chr13:92,493,989...92,564,981
|
|
| G
|
Dgcr6
|
DiGeorge syndrome critical region gene 6
|
increases expression
|
ISO
|
Selenium results in increased expression of DGCR6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,432,024...96,442,766
Ensembl chr11:96,432,024...96,437,255
|
|
| G
|
Dgcr8
|
DGCR8 microprocessor complex subunit
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA Selenium results in increased expression of DGCR8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,208,959...96,241,560
Ensembl chr11:96,209,038...96,241,551
|
|
| G
|
Dhcr24
|
24-dehydrocholesterol reductase
|
increases expression
|
ISO
|
Selenium results in increased expression of DHCR24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
|
|
| G
|
Dhcr7
|
7-dehydrocholesterol reductase
|
increases expression
|
ISO
|
Selenium results in increased expression of DHCR7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
|
|
| G
|
Dhps
|
deoxyhypusine synthase
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432
|
|
| G
|
Dhrs4
|
dehydrogenase/reductase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of DHRS4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:32,924,482...32,948,103
Ensembl chr15:32,936,522...32,948,101
|
|
| G
|
Dhrs7b
|
dehydrogenase/reductase 7B
|
increases expression
|
ISO
|
Selenium results in increased expression of DHRS7B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:46,003,845...46,036,498
Ensembl chr10:46,003,845...46,036,499
|
|
| G
|
Dhx30
|
DExH-box helicase 30
|
increases expression
|
ISO
|
Selenium results in increased expression of DHX30 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,943,186...118,975,319
Ensembl chr 8:118,943,187...118,975,592
|
|
| G
|
Dhx35
|
DEAH-box helicase 35
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of DHX35 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 3:167,869,971...167,927,300
Ensembl chr 3:167,870,055...167,927,300
|
|
| G
|
Dicer1
|
dicer 1 ribonuclease III
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DICER1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252
|
|
| G
|
Dio1
|
iodothyronine deiodinase 1
|
decreases expression increases expression affects expression increases activity multiple interactions
|
ISO EXP
|
Selenium deficiency results in decreased expression of DIO1 mRNA Selenium results in increased expression of DIO1 mRNA Selenium deficiency affects the expression of DIO1 mRNA Selenium results in increased activity of DIO1 protein Selenium inhibits the reaction [Iodine results in decreased activity of DIO1 protein]; Selenium inhibits the reaction [Iodine results in decreased expression of DIO1 mRNA]; Selenium inhibits the reaction [potassium iodate results in decreased activity of DIO1 protein]
|
CTD |
PMID:16170372 PMID:16271152 PMID:16874406 PMID:16959840 PMID:17044649 PMID:18095564 More...
|
|
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771
|
|
| G
|
Dio2
|
iodothyronine deiodinase 2
|
multiple interactions increases activity
|
ISO
|
Selenium results in increased expression of and results in increased activity of DIO2 protein Selenium results in increased activity of DIO2 protein
|
CTD |
PMID:11425850 PMID:15471965 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
| G
|
Dip2c
|
disco-interacting protein 2 homolog C
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DIP2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:65,338,711...65,724,111
Ensembl chr17:65,338,711...65,723,344
|
|
| G
|
Dlg1
|
discs large MAGUK scaffold protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DLG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
|
|
| G
|
Dmgdh
|
dimethylglycine dehydrogenase
|
affects abundance
|
ISO
|
DMGDH gene SNP affects the abundance of Selenium
|
CTD |
PMID:23720494 |
|
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071
|
|
| G
|
Dmtf1
|
cyclin D binding myb-like transcription factor 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Selenium results in decreased expression of DMTF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:25,865,447...25,905,943
|
|
| G
|
Dmwd
|
DM1 locus, WD repeat containing
|
increases expression
|
ISO
|
Selenium results in increased expression of DMWD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:87,850,475...87,857,263
Ensembl chr 1:87,850,604...87,857,624
|
|
| G
|
Dmxl2
|
Dmx-like 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DMXL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:63,637,314...63,803,911
Ensembl chr 8:63,637,314...63,781,116
|
|
| G
|
Dnaja3
|
DnaJ heat shock protein family (Hsp40) member A3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Selenium results in decreased expression of DNAJA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:11,361,168...11,386,599
Ensembl chr10:11,361,168...11,386,599
|
|
| G
|
Dnajb3
|
DnaJ heat shock protein family (Hsp40) member B3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Selenium] results in decreased expression of DNAJB3 mRNA Selenium deficiency results in decreased expression of DNAJB3 mRNA
|
CTD |
PMID:19367646 |
|
NCBI chr 9:96,243,345...96,244,358
Ensembl chr 9:96,243,071...96,244,408
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DNAJB4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnajc2
|
DnaJ heat shock protein family (Hsp40) member C2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:14,162,490...14,189,662
Ensembl chr 4:14,163,838...14,192,846
|
|
| G
|
Dnajc7
|
DnaJ heat shock protein family (Hsp40) member C7
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489
|
|
| G
|
Dnajc9
|
DnaJ heat shock protein family (Hsp40) member C9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DNAJC9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
affects activity
|
EXP
|
Selenium affects the activity of DNMT1 protein
|
CTD |
PMID:16632891 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Dnpep
|
aspartyl aminopeptidase
|
increases expression
|
ISO
|
Selenium results in increased expression of DNPEP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,248,581...84,257,484
Ensembl chr 9:84,233,486...84,256,977
|
|
| G
|
Dohh
|
deoxyhypusine hydroxylase
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of DOHH mRNA [Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:8,972,202...8,977,025
Ensembl chr 7:8,972,202...8,977,025
|
|
| G
|
Dolpp1
|
dolichyldiphosphatase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of DOLPP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:34,063,825...34,072,133
Ensembl chr 3:34,063,825...34,072,132
|
|
| G
|
Dpyd
|
dihydropyrimidine dehydrogenase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DPYD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778
|
|
| G
|
Dr1
|
down-regulator of transcription 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:1,603,203...1,614,556
Ensembl chr14:1,603,204...1,614,556
|
|
| G
|
Drg2
|
developmentally regulated GTP binding protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of DRG2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:45,755,072...45,769,493
Ensembl chr10:45,755,059...45,769,523
|
|
| G
|
Dsc2
|
desmocollin 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA Selenium results in decreased expression of DSC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
|
|
| G
|
Dse
|
dermatan sulfate epimerase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DSE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:26,661,326...26,740,011
Ensembl chr20:26,661,326...26,740,114
|
|
| G
|
Duox1
|
dual oxidase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of DUOX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187
|
|
| G
|
Dusp8
|
dual specificity phosphatase 8
|
increases expression
|
ISO
|
Selenium results in increased expression of DUSP8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441
|
|
| G
|
Dxo
|
decapping exoribonuclease
|
increases expression
|
ISO
|
Selenium results in increased expression of DXO mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,997,953...4,000,115
Ensembl chr20:3,997,955...4,000,037
|
|
| G
|
Dym
|
dymeclin
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DYM mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:70,879,835...71,176,006
Ensembl chr18:70,880,255...71,176,004
|
|
| G
|
Dync1h1
|
dynein cytoplasmic 1 heavy chain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of DYNC1H1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116
|
|
| G
|
Dynlrb1
|
dynein light chain roadblock-type 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of DYNLRB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:164,197,892...164,224,409
Ensembl chr 3:164,202,953...164,224,409
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of E2F1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f4
|
E2F transcription factor 4
|
increases expression
|
ISO
|
Selenium results in increased expression of E2F4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,084,335...50,091,731
Ensembl chr19:50,084,335...50,091,834
|
|
| G
|
E2f6
|
E2F transcription factor 6
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Selenium results in decreased expression of E2F6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428
|
|
| G
|
E4f1
|
E4F transcription factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of E4F1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:13,978,975...13,999,646
Ensembl chr10:13,978,990...13,990,506
|
|
| G
|
Ecm2
|
extracellular matrix protein 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ECM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,326,359...15,358,855
|
|
| G
|
Ecsit
|
ECSIT signaling integrator
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA Selenium results in increased expression of ECSIT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:28,881,594...28,894,397
|
|
| G
|
Edf1
|
endothelial differentiation-related factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of EDF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:28,764,906...28,779,499
|
|
| G
|
Ednra
|
endothelin receptor type A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Selenium results in decreased expression of EDNRA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA Selenium results in increased expression of EEF1A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712
|
|
| G
|
Eef1d
|
eukaryotic translation elongation factor 1 delta
|
increases expression
|
ISO
|
Selenium results in increased expression of EEF1D mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,462,645...109,478,021
Ensembl chr 7:109,462,646...109,489,531
|
|
| G
|
Efcab14
|
EF-hand calcium binding domain 14
|
increases expression
|
ISO
|
Selenium results in increased expression of EFCAB14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:134,454,908...134,493,714
Ensembl chr 5:134,454,924...134,495,384
|
|
| G
|
Efemp2
|
EGF containing fibulin extracellular matrix protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EFEMP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739
|
|
| G
|
Efhc1
|
EF-hand domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EFHC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703
|
|
| G
|
Efhd2
|
EF-hand domain family, member D2
|
increases expression
|
ISO
|
Selenium results in increased expression of EFHD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:159,443,960...159,460,369
|
|
| G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]; Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]
|
CTD |
PMID:11158190 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EGFR mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Ehbp1
|
EH domain binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EHBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579
|
|
| G
|
Ehd2
|
EH-domain containing 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EHD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943
|
|
| G
|
Eif1b
|
eukaryotic translation initiation factor 1B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EIF1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:129,080,497...129,083,772
Ensembl chr 8:129,078,293...129,083,772 Ensembl chr 5:129,078,293...129,083,772
|
|
| G
|
Eif2ak2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EIF2AK2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3b
|
eukaryotic translation initiation factor 3, subunit B
|
increases expression
|
ISO
|
Selenium results in increased expression of EIF3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
|
|
| G
|
Eif3c
|
eukaryotic translation initiation factor 3, subunit C
|
increases expression
|
ISO
|
Selenium results in increased expression of EIF3C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
|
|
| G
|
Eif4g1
|
eukaryotic translation initiation factor 4 gamma 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Selenium results in increased expression of EIF4G1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
|
|
| G
|
Eif5a
|
eukaryotic translation initiation factor 5A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
|
|
| G
|
Eif5b
|
eukaryotic translation initiation factor 5B
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Selenium results in decreased expression of IF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583
|
|
| G
|
Eif6
|
eukaryotic translation initiation factor 6
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Selenium results in increased expression of EIF6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525
|
|
| G
|
Eloa
|
elongin A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:153,513,246...153,530,819
Ensembl chr 5:153,515,066...153,530,916
|
|
| G
|
Elp1
|
elongator acetyltransferase complex subunit 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ELP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:76,248,545...76,300,985
Ensembl chr 5:76,248,550...76,300,985
|
|
| G
|
Emc9
|
ER membrane protein complex subunit 9
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,041,840...33,046,056
Ensembl chr15:33,041,842...33,046,102
|
|
| G
|
Emilin1
|
elastin microfibril interfacer 1
|
increases expression
|
ISO
|
Selenium results in increased expression of EMILIN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:31,175,919...31,183,657
|
|
| G
|
Eml2
|
EMAP like 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Selenium results in increased expression of EML2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:87,955,606...87,987,366
|
|
| G
|
Emp2
|
epithelial membrane protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EMP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532
|
|
| G
|
Emp3
|
epithelial membrane protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of EMP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265
|
|
| G
|
Emsy
|
EMSY transcriptional repressor, BRCA2 interacting
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EMSY mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:162,295,167...162,364,742
Ensembl chr 1:162,295,169...162,364,707
|
|
| G
|
Endog
|
endonuclease G
|
increases expression
|
ISO
|
Selenium results in increased expression of ENDOG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Eng
|
endoglin
|
increases expression
|
ISO
|
Selenium results in increased expression of ENG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
| G
|
Eno2
|
enolase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of ENO2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ENPP1 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044
|
|
| G
|
Epb41l4b
|
erythrocyte membrane protein band 4.1 like 4B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EPB41L4B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752
|
|
| G
|
Ephb6
|
Eph receptor B6
|
increases expression
|
ISO
|
Selenium results in increased expression of EPHB6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EPHX2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Epn2
|
epsin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EPN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,697,238...46,759,092
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ERBB2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erc2
|
ELKS/RAB6-interacting/CAST family member 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of ERC2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258
|
|
| G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of ERCC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
|
|
| G
|
Ergic3
|
ERGIC and golgi 3
|
increases expression
|
ISO
|
Selenium results in increased expression of ERGIC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:164,985,108...164,994,897
Ensembl chr 3:164,984,853...164,994,897
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
EXP
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of ESR1 mRNA]
|
CTD |
PMID:30526071 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esrp2
|
epithelial splicing regulatory protein 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,944,401...50,951,919
Ensembl chr19:50,944,401...50,951,568
|
|
| G
|
Ess2
|
ess-2 splicing factor homolog
|
increases expression
|
ISO
|
Selenium results in increased expression of ESS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,580,185...96,596,673
Ensembl chr11:96,580,169...96,590,146
|
|
| G
|
Evc
|
EvC ciliary complex subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of EVC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:77,680,901...77,722,608
Ensembl chr14:77,680,943...77,723,100
|
|
| G
|
Evi5
|
ecotropic viral integration site 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EVI5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:2,020,524...2,166,593
Ensembl chr14:2,020,581...2,166,593
|
|
| G
|
Ewsr1
|
EWS RNA-binding protein 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Selenium results in increased expression of EWSR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
|
|
| G
|
Exoc2
|
exocyst complex component 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of EXOC2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr17:33,714,949...33,906,901
Ensembl chr17:33,715,008...33,901,944
|
|
| G
|
Exoc3
|
exocyst complex component 3
|
increases expression
|
ISO
|
Selenium results in increased expression of SEC6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:30,919,871...30,950,624
|
|
| G
|
Exosc4
|
exosome component 4
|
increases expression
|
ISO
|
Selenium results in increased expression of EXOSC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,928,491...109,931,233
Ensembl chr 7:109,928,498...109,931,820
|
|
| G
|
Exosc8
|
exosome component 8
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EXOSC8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229
|
|
| G
|
Ext1
|
exostosin glycosyltransferase 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:86,265,651...86,544,488
Ensembl chr 7:86,259,900...86,544,567
|
|
| G
|
Ext2
|
exostosin glycosyltransferase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of EXT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596
|
|
| G
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of EYA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034
|
|
| G
|
Ezr
|
ezrin
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
|
|
| G
|
F11r
|
F11 receptor
|
increases expression
|
ISO
|
Selenium results in increased expression of F11R mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
Faah
|
fatty acid amide hydrolase
|
increases expression
|
ISO
|
Selenium results in increased expression of FAAH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396
|
|
| G
|
Fadd
|
Fas associated via death domain
|
multiple interactions increases expression
|
ISO
|
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FADD mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of FADD mRNA] Selenium results in increased expression of FADD protein
|
CTD |
PMID:17970047 PMID:27920530 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fads3
|
fatty acid desaturase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of FADS3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758
|
|
| G
|
Fam107a
|
family with sequence similarity 107, member A
|
increases expression
|
ISO
|
Selenium results in increased expression of FAM107A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219
|
|
| G
|
Fam111a
|
FAM111 trypsin like peptidase A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA Selenium results in decreased expression of FAM111A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211
|
|
| G
|
Fam149a
|
family with sequence similarity 149, member A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Selenium results in decreased expression of FAM149A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072
|
|
| G
|
Fam32a
|
family with sequence similarity 32, member A
|
increases expression
|
ISO
|
Selenium results in increased expression of FAM32A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:17,637,078...17,641,448
Ensembl chr16:17,637,087...17,641,399
|
|
| G
|
Fam3a
|
FAM3 metabolism regulating signaling molecule A
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA Selenium results in increased expression of FAM3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:157,317,993...157,326,640
Ensembl chr X:157,317,990...157,326,612
|
|
| G
|
Fam50a
|
family with sequence similarity 50, member A
|
increases expression
|
ISO
|
Selenium results in increased expression of FAM50A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:157,246,533...157,253,650
Ensembl chr X:157,246,533...157,253,650
|
|
| G
|
Fam53b
|
family with sequence similarity 53, member B
|
increases expression
|
ISO
|
Selenium results in increased expression of FAM53B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:196,930,175...197,021,290
|
|
| G
|
Fan1
|
FANCD2 and FANCI associated nuclease 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FAN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:127,327,098...127,356,807
Ensembl chr 1:127,330,016...127,356,400
|
|
| G
|
Farp1
|
FERM, ARH/RhoGEF and pleckstrin domain protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FARP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:104,531,196...104,770,148
Ensembl chr15:104,531,813...104,770,147
|
|
| G
|
Farsa
|
phenylalanyl-tRNA synthetase subunit alpha
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Selenium results in increased expression of FARSA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:40,196,255...40,205,830
Ensembl chr19:40,173,716...40,205,823
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
multiple interactions
|
ISO
|
[Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of FAS mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of FAS mRNA]
|
CTD |
PMID:17970047 PMID:27920530 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO
|
[Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fasn
|
fatty acid synthase
|
increases expression multiple interactions
|
EXP ISO
|
Selenium results in increased expression of FASN mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]
|
CTD |
PMID:19022953 PMID:19244175 PMID:36464106 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fat4
|
FAT atypical cadherin 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FAT4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:123,855,289...123,984,716
Ensembl chr 2:123,855,289...123,984,716
|
|
| G
|
Faxdc2
|
fatty acid hydroxylase domain containing 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FAXDC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:42,747,323...42,772,156
Ensembl chr10:42,747,524...42,781,458
|
|
| G
|
Fbln1
|
fibulin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FBLN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965
|
|
| G
|
Fbln5
|
fibulin 5
|
increases expression
|
ISO
|
Selenium results in increased expression of FBLN5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296
|
|
| G
|
Fbp1
|
fructose-bisphosphatase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FBP1 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746
|
|
| G
|
Fbxl5
|
F-box and leucine-rich repeat protein 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FBXL5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:71,517,452...71,559,850
Ensembl chr14:71,480,270...71,560,652
|
|
| G
|
Fbxl8
|
F-box and leucine-rich repeat protein 8
|
increases expression
|
ISO
|
Selenium results in increased expression of FBXL8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,048,221...50,057,191
Ensembl chr19:50,052,393...50,057,453
|
|
| G
|
Fbxo11
|
F-box protein 11
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FBXO11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:12,240,348...12,316,223
Ensembl chr 6:12,239,801...12,316,221
|
|
| G
|
Fbxo17
|
F-box protein 17
|
increases expression
|
ISO
|
Selenium results in increased expression of FBXO17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981
|
|
| G
|
Fbxo2
|
F-box protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of FBXO2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508
|
|
| G
|
Fbxo28
|
F-box protein 28
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA Selenium results in decreased expression of FBXO28 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:96,527,667...96,553,138
Ensembl chr13:96,527,670...96,553,138
|
|
| G
|
Fcgrt
|
Fc gamma receptor and transporter
|
increases expression
|
ISO
|
Selenium results in increased expression of FCGRT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,710,902...104,720,685
Ensembl chr 1:104,710,909...104,720,532
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of FDFT1 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fech
|
ferrochelatase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FECH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546
|
|
| G
|
Fermt1
|
FERM domain containing kindlin 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FERMT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419
|
|
| G
|
Ffar2
|
free fatty acid receptor 2
|
increases expression
|
ISO
|
Selenium results in increased expression of FFAR2 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623
|
|
| G
|
Fgg
|
fibrinogen gamma chain
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
|
|
| G
|
Fggy
|
FGGY carbohydrate kinase domain containing
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of FGGY mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 5:115,514,573...115,901,713
Ensembl chr 5:115,472,211...115,901,714
|
|
| G
|
Fhod3
|
formin homology 2 domain containing 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FHOD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508
|
|
| G
|
Fig4
|
FIG4 phosphoinositide 5-phosphatase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Selenium results in decreased expression of FIG4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:46,183,225...46,306,686
Ensembl chr20:46,183,225...46,306,477
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FIS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Fkbp1a
|
FKBP prolyl isomerase 1A
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of FKBP1A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233
|
|
| G
|
Fkbp3
|
FKBP prolyl isomerase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FKBP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:88,843,879...88,863,447
|
|
| G
|
Flii
|
FLII, actin remodeling protein
|
increases expression
|
ISO
|
Selenium results in increased expression of FLII mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:45,893,566...45,907,547
Ensembl chr10:45,893,572...45,907,491
|
|
| G
|
Flna
|
filamin A
|
increases expression
|
ISO
|
Selenium results in increased expression of FLNA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:157,159,051...157,182,343
|
|
| G
|
Flot1
|
flotillin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FLOT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,922,655...2,932,771
|
|
| G
|
Flot2
|
flotillin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of FLOT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:63,424,084...63,445,811
Ensembl chr10:63,423,806...63,445,810
|
|
| G
|
Flrt3
|
fibronectin leucine rich transmembrane protein 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FLRT3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650
|
|
| G
|
Fmo5
|
flavin containing dimethylaniline monoxygenase 5
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464
|
|
| G
|
Folh1
|
folate hydrolase 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Selenium results in decreased expression of FOLH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:149,840,760...149,914,035
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
EXP
|
Selenium results in increased expression of FOS mRNA; Selenium results in increased expression of FOS protein [Selenium co-treated with Iodine] results in increased expression of FOS mRNA; [Selenium co-treated with Iodine] results in increased expression of FOS protein
|
CTD |
PMID:12475444 PMID:12666833 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxf2
|
forkhead box F2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FOXF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259
|
|
| G
|
Foxo1
|
forkhead box O1
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [arsenite results in decreased phosphorylation of FOXO1 protein]
|
CTD |
PMID:29324385 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo3
|
forkhead box O3
|
multiple interactions
|
ISO
|
Selenium results in decreased phosphorylation of and results in increased activity of FOXO3 protein
|
CTD |
PMID:17339365 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Frat1
|
FRAT regulator of WNT signaling pathway 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FRAT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:250,587,641...250,590,189
Ensembl chr 1:250,587,506...250,603,039
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [Acrylamide results in decreased expression of FSHB protein]; Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of FSHB protein]
|
CTD |
PMID:20957662 PMID:37987225 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Ftl1
|
ferritin light chain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of FTL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
|
|
| G
|
Fus
|
Fus RNA binding protein
|
increases expression
|
ISO
|
Selenium results in increased expression of FUS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fxr1
|
FMR1 autosomal homolog 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FXR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027
|
|
| G
|
Fzd7
|
frizzled class receptor 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of FZD7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585
|
|
| G
|
Fzr1
|
fizzy and cell division cycle 20 related 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA Selenium results in increased expression of FZR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,989,769...8,995,199
|
|
| G
|
G0s2
|
G0/G1switch 2
|
increases expression
|
ISO
|
Selenium results in increased expression of G0S2 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Selenium results in decreased expression of GALNT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
|
|
| G
|
Ganab
|
glucosidase II alpha subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of GANAB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:215,222,995...215,243,036
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
increases expression
|
ISO
|
Selenium results in increased expression of GAPDH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gas8
|
growth arrest specific 8
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of DRC4 mRNA Selenium results in increased expression of DRC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:68,461,280...68,480,810
Ensembl chr19:68,461,304...68,480,806
|
|
| G
|
Gatad2a
|
GATA zinc finger domain containing 2A
|
increases expression
|
ISO
|
Selenium results in increased expression of GATAD2A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,463,500...19,553,497
Ensembl chr16:19,463,500...19,553,497
|
|
| G
|
Gbp1
|
guanylate binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802 Ensembl chr 2:234,190,708...234,206,802
|
|
| G
|
Gcat
|
glycine C-acetyltransferase
|
increases expression
|
ISO
|
Selenium results in increased expression of GCAT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gfus
|
GDP-L-fucose synthase
|
increases expression
|
ISO
|
Selenium results in increased expression of GFUS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,492,808...109,497,719
Ensembl chr 7:109,492,809...109,497,662
|
|
| G
|
Ggps1
|
geranylgeranyl diphosphate synthase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GGPS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:55,958,750...55,982,762
Ensembl chr17:55,958,755...55,971,709
|
|
| G
|
Ggt1
|
gamma-glutamyltransferase 1
|
multiple interactions
|
ISO EXP
|
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]
|
CTD |
PMID:19244175 PMID:24485406 |
|
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
| G
|
Gipc1
|
GIPC PDZ domain containing family, member 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA Selenium results in increased expression of GIPC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:41,380,125...41,392,078
Ensembl chr19:41,380,125...41,391,725
|
|
| G
|
Gjb1
|
gap junction protein, beta 1
|
increases expression
|
ISO
|
Selenium results in increased expression of GJB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
|
|
| G
|
Glg1
|
golgi glycoprotein 1
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of GLG1 mRNA Selenium results in increased expression of GLG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528
|
|
| G
|
Gli2
|
GLI family zinc finger 2
|
increases expression
|
ISO
|
Selenium results in increased expression of GLI2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418
|
|
| G
|
Glmn
|
glomulin, FKBP associated protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GLMN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:2,332,052...2,375,366
Ensembl chr14:2,332,497...2,375,695
|
|
| G
|
Glrx
|
glutaredoxin
|
increases expression affects expression
|
ISO EXP
|
Selenium deficiency results in increased expression of GLRX mRNA; Selenium results in increased expression of GLRX mRNA Selenium affects the expression of GLRX mRNA
|
CTD |
PMID:16170372 PMID:19351701 |
|
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Glrx2
|
glutaredoxin 2
|
affects activity affects expression
|
EXP
|
Selenium affects the activity of GLRX2 protein Selenium affects the expression of GLRX2 protein
|
CTD |
PMID:19351701 |
|
NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
affects expression
|
EXP
|
Selenium affects the expression of GLUD1 protein
|
CTD |
PMID:19351701 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Gmnn
|
geminin, DNA replication inhibitor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GMNN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068
|
|
| G
|
Gmppa
|
GDP-mannose pyrophosphorylase A
|
increases expression
|
ISO
|
Selenium results in increased expression of GMPPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,375,373...84,382,917
Ensembl chr 9:84,375,425...84,382,916
|
|
| G
|
Gmpr2
|
guanosine monophosphate reductase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of GMPR2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,135,455...33,144,923
Ensembl chr15:33,135,682...33,144,899
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
increases expression
|
ISO
|
Selenium results in increased expression of GNAI2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnas
|
GNAS complex locus
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA Selenium results in decreased expression of GNAS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
|
|
| G
|
Gnb2
|
G protein subunit beta 2
|
increases expression
|
ISO
|
Selenium results in increased expression of GNB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:24,795,505...24,800,796
Ensembl chr12:24,795,827...24,800,796
|
|
| G
|
Gnl1
|
G protein nucleolar 1
|
increases expression
|
ISO
|
Selenium results in increased expression of GNL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:2,787,939...2,796,924
Ensembl chr20:2,787,940...2,797,577
|
|
| G
|
Gnmt
|
glycine N-methyltransferase
|
affects activity
|
EXP
|
Selenium affects the activity of GNMT protein
|
CTD |
PMID:16632891 |
|
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
|
|
| G
|
Gns
|
glucosamine (N-acetyl)-6-sulfatase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GNS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:58,774,625...58,808,650
|
|
| G
|
Golga3
|
golgin A3
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of GOLGA3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:52,112,129...52,160,311
Ensembl chr12:52,114,590...52,160,226
|
|
| G
|
Gorasp1
|
golgi reassembly stacking protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of GORASP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:128,532,933...128,544,686
Ensembl chr 8:128,532,934...128,544,636
|
|
| G
|
Gosr1
|
golgi SNAP receptor complex member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GOSR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:62,068,662...62,105,442
Ensembl chr10:61,948,693...62,105,324
|
|
| G
|
Gpi
|
glucose-6-phosphate isomerase
|
increases expression
|
ISO
|
Selenium results in increased expression of GPI mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
|
|
| G
|
Gpkow
|
G patch domain and KOW motifs
|
increases expression
|
ISO
|
Selenium results in increased expression of GPKOW mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:17,463,521...17,478,298
Ensembl chr X:17,463,525...17,478,298
|
|
| G
|
Gpr107
|
G protein-coupled receptor 107
|
increases expression
|
ISO
|
Selenium results in increased expression of GPR107 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:34,832,462...34,893,692
Ensembl chr 3:34,832,480...34,893,654
|
|
| G
|
Gpr137
|
G protein-coupled receptor 137
|
increases expression
|
ISO
|
Selenium results in increased expression of GPR137 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:213,558,846...213,562,422
Ensembl chr 1:213,558,846...213,563,966
|
|
| G
|
Gpr137b
|
G protein-coupled receptor 137B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GPR137B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:92,987,792...93,026,003
Ensembl chr17:92,942,559...93,025,911
|
|
| G
|
Gprin2
|
G protein regulated inducer of neurite outgrowth 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:9,502,697...9,518,901
Ensembl chr16:9,502,711...9,513,259
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP ISO
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of GPT protein]; [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of GPT protein]; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in increased activity of GPT protein]; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of GPT protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of GPT protein]; Selenium inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]
|
CTD |
PMID:20688495 PMID:24485406 PMID:30031400 PMID:32233808 PMID:36464106 PMID:37676925 More...
|
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
affects response to substance decreases activity increases activity increases expression decreases expression multiple interactions affects expression affects activity
|
ISO EXP
|
GPX1 gene polymorphism affects the susceptibility to Selenium; GPX1 protein polymorphism affects the susceptibility to Selenium Selenium deficiency results in decreased activity of GPX1 protein Selenium results in increased activity of GPX1 protein Selenium results in increased expression of GPX1 mRNA; Selenium results in increased expression of GPX1 protein Selenium deficiency results in decreased expression of GPX1 mRNA; Selenium deficiency results in decreased expression of GPX1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; Selenium inhibits the reaction [2-iodohexadecanal results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [arsenite results in decreased expression of GPX1 protein]; Selenium inhibits the reaction [Cisplatin results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of GPX1 mRNA]; Selenium results in increased expression of and results in decreased degradation of GPX1 mRNA Selenium affects the expression of GPX1 mRNA Selenium affects the activity of GPX1 protein Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein]; Selenium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of GPX1 protein]; Selenium deficiency results in decreased expression of and results in decreased activity of GPX1 protein Selenium affects the expression of GPX1 mRNA; Selenium affects the expression of GPX1 protein
|
CTD |
PMID:10874123 PMID:10949970 PMID:11294903 PMID:11444866 PMID:11463357 PMID:11776067 PMID:12031252 PMID:12667700 PMID:12810669 PMID:15203190 PMID:15203381 PMID:15670848 PMID:15792362 PMID:15795427 PMID:16170372 PMID:16837816 PMID:17052796 PMID:17109141 PMID:17150329 PMID:17512462 PMID:17513408 PMID:17709542 PMID:19022953 PMID:19076066 PMID:19106321 PMID:19125369 PMID:19234057 PMID:19415410 PMID:21775527 PMID:29324385 PMID:38013145 More...
|
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
decreases activity decreases expression
|
ISO
|
Selenium deficiency results in decreased activity of GPX2 protein Selenium deficiency results in decreased expression of GPX2 mRNA
|
CTD |
PMID:15795427 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
increases expression affects activity increases activity affects expression
|
ISO EXP
|
Selenium results in increased expression of GPX3 mRNA Selenium affects the activity of GPX3 protein Selenium results in increased activity of GPX3 protein Selenium affects the expression of GPX3 mRNA
|
CTD |
PMID:15894816 PMID:19022953 PMID:19106321 PMID:19244175 PMID:19351701 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
increases activity decreases expression multiple interactions increases expression decreases activity affects activity decreases abundance
|
ISO EXP
|
Selenium analog results in increased activity of GPX4 protein Selenium deficiency results in decreased expression of GPX4 protein Selenomethionine inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein] [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in increased expression of GPX4 protein; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of GPX4 protein] Selenium deficiency results in decreased expression of GPX4 mRNA Selenium results in increased expression of GPX4 mRNA Selenium deficiency results in decreased activity of GPX4 protein Selenium affects the activity of GPX4 protein Selenium results in increased activity of GPX4 protein GPX4 gene mutant form results in decreased abundance of Selenium Selenium results in increased expression of and results in increased activity of GPX4 protein Selenium results in increased expression of GPX4 mRNA; Selenium results in increased expression of GPX4 protein
|
CTD |
PMID:11673642 PMID:12031252 PMID:15670848 PMID:15792362 PMID:16246897 PMID:17052796 PMID:17150329 PMID:19022953 PMID:19106321 PMID:19244175 PMID:32233808 PMID:34116104 PMID:34970773 More...
|
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gpx5
|
glutathione peroxidase 5
|
affects expression multiple interactions
|
ISO EXP
|
Selenium affects the expression of GPX5 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of GPX5 protein]
|
CTD |
PMID:10542376 PMID:32233808 |
|
NCBI chr17:48,131,853...48,138,801
Ensembl chr17:48,093,895...48,138,801
|
|
| G
|
Grb10
|
growth factor receptor bound protein 10
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of GRB10 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GRIA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Grina
|
glutamate ionotropic receptor NMDA type subunit associated protein 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA Selenium results in increased expression of GRINA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
|
|
| G
|
Grk6
|
G protein-coupled receptor kinase 6
|
increases expression
|
ISO
|
Selenium results in increased expression of GRK6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954
|
|
| G
|
Grn
|
granulin precursor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Selenium results in increased expression of GRN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
|
|
| G
|
Gsdme
|
gasdermin E
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GSDME mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525
|
|
| G
|
Gsk3a
|
glycogen synthase kinase 3 alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of GSK3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions decreases phosphorylation decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] Selenium results in decreased phosphorylation of GSK3B protein Selenium results in decreased expression of GSK3B mRNA
|
CTD |
PMID:17339365 PMID:19244175 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsn
|
gelsolin
|
increases expression
|
ISO
|
Selenium results in increased expression of GSN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [cyfluthrin results in decreased activity of GSR protein]
|
CTD |
PMID:23595963 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsta3
|
glutathione S-transferase alpha 3
|
affects expression
|
EXP
|
Selenium affects the expression of GSTA3 protein
|
CTD |
PMID:4004801 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
|
|
| G
|
Gsta4
|
glutathione S-transferase alpha 4
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of GSTA4 mRNA; Selenium results in increased expression of GSTA4 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488
|
|
| G
|
Gsta5
|
glutathione S-transferase alpha 5
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of GSTA5 mRNA; Selenium deficiency results in increased expression of GSTA5 protein
|
CTD |
PMID:9331086 |
|
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions affects expression increases expression
|
ISO EXP
|
[Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA Selenium affects the expression of GSTP1 protein Selenium results in increased expression of GSTP1 mRNA
|
CTD |
PMID:7532609 PMID:19244175 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of GSTT1
|
CTD |
PMID:9331086 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gtf2f1
|
general transcription factor IIF subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of GTF2F1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,930,055...1,940,197
|
|
| G
|
Gtf3c1
|
general transcription factor IIIC subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of GTF3C1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995
|
|
| G
|
Gtpbp8
|
GTP binding protein 8
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA Selenium results in decreased expression of GTPBP8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:69,451,776...69,461,744
Ensembl chr11:69,451,795...69,461,743
|
|
| G
|
Gulp1
|
GULP PTB domain containing engulfment adaptor 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of GULP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression multiple interactions
|
ISO EXP
|
Selenium results in increased expression of H2AX mRNA Selenium inhibits the reaction [Acrylamide results in increased expression of H2AX protein]
|
CTD |
PMID:19244175 PMID:37987225 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H3f3a
|
H3.3 histone A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of H3-3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:95,065,085...95,076,695
Ensembl chr13:95,065,085...95,076,695
|
|
| G
|
H4c3
|
H4 clustered histone 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of H4C6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:41,796,600...41,860,389
|
|
| G
|
H6pd
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA Selenium results in increased expression of H6PD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125
|
|
| G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HADHA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
| G
|
Hagh
|
hydroxyacyl glutathione hydrolase
|
increases expression
|
ISO
|
Selenium results in increased expression of HAGH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043
|
|
| G
|
Hars1
|
histidyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of HARS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712
|
|
| G
|
Haus3
|
HAUS augmin-like complex, subunit 3
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of HAUS3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:80,805,036...80,977,012
Ensembl chr14:80,806,040...80,977,015
|
|
| G
|
Haus4
|
HAUS augmin-like complex, subunit 4
|
increases expression
|
ISO
|
Selenium results in increased expression of HAUS4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941
|
|
| G
|
Hba-a3
|
hemoglobin alpha, adult chain 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,816,096...15,817,167
|
|
| G
|
Hdgf
|
heparin binding growth factor
|
increases expression
|
ISO
|
Selenium results in increased expression of HDGF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225
|
|
| G
|
Hdlbp
|
high density lipoprotein binding protein
|
increases expression
|
ISO
|
Selenium results in increased expression of HDLBP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:101,395,491...101,465,446
Ensembl chr 9:101,397,305...101,465,379
|
|
| G
|
Heph
|
hephaestin
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HEPH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:65,160,628...65,412,457
Ensembl chr X:65,305,773...65,412,453
|
|
| G
|
Hes1
|
hes family bHLH transcription factor 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of HES1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
|
|
| G
|
Hgs
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
increases expression
|
ISO
|
Selenium results in increased expression of HGS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:106,237,988...106,256,174
Ensembl chr10:106,237,824...106,256,174
|
|
| G
|
Hhip
|
Hedgehog-interacting protein
|
increases expression
|
ISO
|
Selenium results in increased expression of HHIP mRNA
|
CTD |
PMID:18997278 |
|
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
|
|
| G
|
Hip1r
|
huntingtin interacting protein 1 related
|
increases expression
|
ISO
|
Selenium results in increased expression of HIP1R mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654
|
|
| G
|
Hipk2
|
homeodomain interacting protein kinase 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Selenium results in decreased expression of HIPK2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
|
|
| G
|
Hirip3
|
HIRA interacting protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of HIRIP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:190,902,593...190,905,607
|
|
| G
|
Hlf
|
HLF transcription factor, PAR bZIP family member
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HLF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619
|
|
| G
|
Hmbs
|
hydroxymethylbilane synthase
|
increases expression
|
ISO
|
Selenium results in increased expression of HMBS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP ISO
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]; Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]
|
CTD |
PMID:16581047 PMID:30031400 PMID:36464106 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmgxb3
|
HMG-box containing 3
|
increases expression
|
ISO
|
Selenium results in increased expression of HMGXB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:56,860,947...56,908,419
Ensembl chr18:56,860,947...56,908,419
|
|
| G
|
Hmgxb4
|
HMG-box containing 4
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Selenium results in decreased expression of HMGXB4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:13,370,559...13,409,306
Ensembl chr19:13,370,376...13,409,306
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression affects expression affects activity
|
ISO EXP
|
[Arsenic co-treated with Selenium] results in increased expression of HMOX1 mRNA; [Arsenic co-treated with Selenium] results in increased expression of HMOX1 protein; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of HMOX1 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of HMOX1 mRNA Selenium deficiency results in increased expression of HMOX1 mRNA Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein]; Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of HMOX1 mRNA]; Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein; Selenium inhibits the reaction [Cisplatin results in increased expression of HMOX1 protein] Selenium affects the expression of HMOX1 protein Selenium affects the activity of HMOX1 protein NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] Selenium results in increased expression of HMOX1 mRNA; Selenium results in increased expression of HMOX1 protein
|
CTD |
PMID:12751798 PMID:16837816 PMID:18279678 PMID:20478284 PMID:21481475 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hmx1
|
H6 family homeobox 1
|
increases expression
|
ISO
|
Selenium results in increased expression of HMX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:79,585,840...79,589,626
Ensembl chr14:79,585,840...79,589,626
|
|
| G
|
Hnf1b
|
HNF1 homeobox B
|
increases expression
|
ISO
|
Selenium results in increased expression of HNF1B mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361
|
|
| G
|
Hnmt
|
histamine N-methyltransferase
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of HNMT mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482
|
|
| G
|
Hnrnpd
|
heterogeneous nuclear ribonucleoprotein D
|
increases expression
|
ISO
|
Selenium results in increased expression of HNRNPD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066
|
|
| G
|
Hnrnpm
|
heterogeneous nuclear ribonucleoprotein M
|
increases expression
|
ISO
|
Selenium results in increased expression of HNRNPM mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871
|
|
| G
|
Homer1
|
homer scaffold protein 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of HOMER1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657
|
|
| G
|
Hook1
|
hook microtubule-tethering protein 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Selenium results in decreased expression of HOOK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:115,940,199...116,003,482
Ensembl chr 5:115,940,080...116,003,482
|
|
| G
|
Hpcal1
|
hippocalcin-like 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA Selenium results in increased expression of HPCAL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353
|
|
| G
|
Hpgds
|
hematopoietic prostaglandin D synthase
|
multiple interactions
|
ISO
|
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with rosiglitazone] results in increased expression of HPGDS protein
|
CTD |
PMID:21669866 |
|
NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501
|
|
| G
|
Hpn
|
hepsin
|
increases expression
|
ISO
|
Selenium results in increased expression of HPN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA Selenium results in increased expression of HRAS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hs3st3a1
|
heparan sulfate-glucosamine 3-sulfotransferase 3A1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HS3ST3A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,593,009...49,679,854
|
|
| G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
multiple interactions
|
EXP ISO
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of HSD11B2 protein
|
CTD |
PMID:11444866 PMID:35384129 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
| G
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of HSD17B11 mRNA; Selenium results in increased expression of HSD17B11 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811
|
|
| G
|
Hsd17b3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
multiple interactions
|
EXP
|
[Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased expression of HSD17B3 mRNA]; Selenium inhibits the reaction [Acrylamide results in decreased expression of HSD17B3 mRNA]
|
CTD |
PMID:33372294 PMID:37987225 |
|
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283
|
|
| G
|
Hsd17b8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
increases expression
|
ISO
|
Selenium results in increased expression of HSD17B8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,828,608...4,830,634
|
|
| G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
multiple interactions increases expression
|
EXP ISO
|
[Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased expression of HSD3B1 mRNA] Selenium deficiency results in increased expression of HSD3B2 mRNA; Selenium results in increased expression of HSD3B2 mRNA
|
CTD |
PMID:16170372 PMID:33372294 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
| G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
multiple interactions increases expression decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]] Selenium deficiency results in increased expression of HSP90AA1 mRNA; Selenium deficiency results in increased expression of HSP90AA1 protein Selenium results in decreased expression of HSP90AA1 mRNA
|
CTD |
PMID:19244175 PMID:37422542 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
| G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of HSP90AB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Selenium results in decreased expression of HSP90B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of HSPA1A mRNA; Selenium results in increased expression of HSPA1A protein [Selenium co-treated with Fluorides] results in increased expression of HSPA1A mRNA; Fluorides promotes the reaction [Selenium results in increased expression of HSPA1A protein]
|
CTD |
PMID:19244175 PMID:19652462 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa4
|
heat shock protein family A (Hsp70) member 4
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of HSPB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Hspb2
|
heat shock protein family B (small) member 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HSPB2 mRNA
|
CTD |
PMID:18997278 |
|
NCBI chr 8:59,989,640...59,991,215
Ensembl chr 8:59,976,623...59,990,901
|
|
| G
|
Hspbap1
|
HSPB1 associated protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of HSPBAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:78,445,376...78,500,034
Ensembl chr11:78,445,376...78,500,034
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]] Selenium deficiency results in increased expression of HSPD1 mRNA; Selenium deficiency results in increased expression of HSPD1 protein
|
CTD |
PMID:37422542 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Htr4
|
5-hydroxytryptamine receptor 4
|
increases expression
|
ISO
|
Selenium results in increased expression of HTR4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622
|
|
| G
|
Iars1
|
isoleucyl-tRNA synthetase 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Selenium results in decreased expression of IARS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
|
|
| G
|
Ica1
|
islet cell autoantigen 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Selenium results in increased expression of ICA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:37,622,759...37,770,569
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ID1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Id2
|
inhibitor of DNA binding 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ID2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
|
|
| G
|
Idh3b
|
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta
|
increases expression
|
ISO
|
Selenium results in increased expression of IDH3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:137,934,971...137,940,275
Ensembl chr 3:137,934,697...137,940,107
|
|
| G
|
Idh3g
|
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Selenium results in increased expression of IDH3G mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:156,666,573...156,675,482
Ensembl chr X:156,666,577...156,675,799
|
|
| G
|
Idua
|
alpha-L-iduronidase
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA Selenium results in increased expression of IDUA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:1,175,994...1,203,913
Ensembl chr14:1,176,577...1,204,066
|
|
| G
|
Ier3
|
immediate early response 3
|
increases expression
|
ISO
|
Selenium results in increased expression of IER3 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Ifi35
|
interferon-induced protein 35
|
increases expression
|
ISO
|
Selenium results in increased expression of IFI35 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750
|
|
| G
|
Ifitm1
|
interferon induced transmembrane protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of IFITM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
|
|
| G
|
Ifitm2
|
interferon induced transmembrane protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of IFITM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,481,168...205,482,348
|
|
| G
|
Ifitm3
|
interferon induced transmembrane protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of IFITM3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of IFNA1 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifng
|
interferon gamma
|
decreases expression
|
ISO
|
Selenium results in decreased expression of IFNG protein
|
CTD |
PMID:14624943 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifrd2
|
interferon-related developmental regulator 2
|
increases expression
|
ISO
|
Selenium results in increased expression of IFRD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
| G
|
Ift74
|
intraflagellar transport 74
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of IFT74 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:114,576,106...114,679,581
Ensembl chr 5:114,593,397...114,679,581
|
|
| G
|
Ift81
|
intraflagellar transport 81
|
decreases expression
|
ISO
|
Selenium results in decreased expression of IFT81 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:39,618,559...39,697,971
Ensembl chr12:39,618,651...39,697,962
|
|
| G
|
Igf2r
|
insulin-like growth factor 2 receptor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of IGF2R mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265
|
|
| G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of IGFBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of IGFBP3 mRNA; Selenium results in increased expression of IGFBP3 protein
|
CTD |
PMID:15318950 PMID:18997278 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Igfbp4
|
insulin-like growth factor binding protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of IGFBP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
increases expression
|
ISO
|
Selenium results in increased expression of IGFBP6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Ik
|
IK cytokine
|
increases expression
|
ISO
|
Selenium results in increased expression of IK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of IKBKB protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IKBKB mRNA
|
CTD |
PMID:17439952 PMID:21481475 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP ISO
|
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL10 protein] [Drugs, Chinese Herbal co-treated with Selenium] results in increased expression of IL10 mRNA [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL10 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL10 mRNA
|
CTD |
PMID:15862027 PMID:21481475 PMID:24626144 PMID:26089086 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il16
|
interleukin 16
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of IL16 mRNA
|
CTD |
PMID:37422542 |
|
NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023
|
|
| G
|
Il17rc
|
interleukin 17 receptor C
|
increases expression
|
ISO
|
Selenium results in increased expression of IL17RC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:148,174,573...148,187,071
Ensembl chr 4:148,174,578...148,187,068
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
ISO EXP
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL1B mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]]; Selenium affects the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium inhibits the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium promotes the reaction [T-2 Toxin results in increased expression of IL1B protein] Selenium inhibits the reaction [Acrylamide results in increased expression of IL1B protein] [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA] Selenium deficiency results in increased expression of IL1B mRNA; Selenium deficiency results in increased expression of IL1B protein; Selenium results in increased expression of IL1B mRNA
|
CTD |
PMID:10802230 PMID:17293063 PMID:17630198 PMID:18196609 PMID:21481475 PMID:21775527 PMID:25187657 PMID:37422542 PMID:37987225 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r2
|
interleukin 1 receptor type 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1R2 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
|
|
| G
|
Il1rapl2
|
interleukin 1 receptor accessory protein-like 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RAPL2 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr X:105,547,403...107,080,369
Ensembl chr X:105,754,490...107,065,223
|
|
| G
|
Il1rl2
|
interleukin 1 receptor-like 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RL2 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 9:50,087,271...50,134,225
Ensembl chr 9:50,083,903...50,204,607
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RN mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il2
|
interleukin 2
|
affects expression
|
EXP
|
Selenium affects the expression of IL2 protein
|
CTD |
PMID:19035182 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il4
|
interleukin 4
|
decreases expression multiple interactions
|
ISO EXP
|
Selenium results in decreased expression of IL4 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; [Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of TNF mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein
|
CTD |
PMID:14624943 PMID:15862027 PMID:21775527 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA Selenium results in increased expression of IL4R mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO EXP
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL6 mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]] [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of IL6 protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL6 protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of IL6 protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of IL6 protein]
|
CTD |
PMID:21481475 PMID:26089086 PMID:37422542 PMID:37676925 PMID:37987225 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
decreases expression
|
ISO
|
Selenium results in decreased expression of IL6ST mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Ilf3
|
interleukin enhancer binding factor 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612
|
|
| G
|
Ilk
|
integrin-linked kinase
|
increases expression
|
ISO
|
Selenium results in increased expression of ILK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:169,498,681...169,506,964
|
|
| G
|
Ilrun
|
inflammation and lipid regulator with UBA-like and NBR1-like domains
|
increases expression
|
ISO
|
Selenium results in increased expression of ILRUN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:5,811,721...5,878,082
Ensembl chr20:5,811,734...5,877,978
|
|
| G
|
Immp2l
|
inner mitochondrial membrane peptidase subunit 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of IMMP2L mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 6:63,797,189...64,696,906
Ensembl chr 6:63,797,237...64,697,749
|
|
| G
|
Inpp5k
|
inositol polyphosphate-5-phosphatase K
|
increases expression
|
ISO
|
Selenium results in increased expression of INPP5K mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:60,974,183...60,995,047
Ensembl chr10:60,973,950...60,995,046
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein
|
CTD |
PMID:20108212 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ins2
|
insulin 2
|
multiple interactions
|
ISO
|
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein]
|
CTD |
PMID:27920530 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Ints1
|
integrator complex subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of INTS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:19,975,166...19,999,893
Ensembl chr12:19,975,171...19,999,900
|
|
| G
|
Ints15
|
integrator complex subunit 15
|
increases expression
|
ISO
|
Selenium results in increased expression of INTS15 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:16,358,644...16,373,763
Ensembl chr12:16,359,604...16,373,763
|
|
| G
|
Ints3
|
integrator complex subunit 3
|
increases expression
|
ISO
|
Selenium results in increased expression of INTS3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:178,157,015...178,209,263
Ensembl chr 2:178,157,015...178,209,137
|
|
| G
|
Ints6
|
integrator complex subunit 6
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA Selenium results in decreased expression of INTS6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:41,080,584...41,224,350
Ensembl chr15:41,109,125...41,197,519
|
|
| G
|
Iqcb1
|
IQ motif containing B1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA Selenium results in decreased expression of IQCB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:77,410,986...77,465,540
Ensembl chr11:77,410,314...77,465,478
|
|
| G
|
Iqck
|
IQ motif containing K
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of IQCK mRNA Selenium results in decreased expression of IQCK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:182,630,678...182,748,325
Ensembl chr 1:182,630,673...182,748,325
|
|
| G
|
Irak2
|
interleukin-1 receptor-associated kinase 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IRAK2 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
|
|
| G
|
Irf3
|
interferon regulatory factor 3
|
increases expression
|
ISO
|
Selenium results in increased expression of IRF3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401
|
|
| G
|
Irf9
|
interferon regulatory factor 9
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of IRF9 mRNA Selenium results in increased expression of IRF9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:33,065,659...33,071,879
|
|
| G
|
Isyna1
|
inositol-3-phosphate synthase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ISYNA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,873,121...18,875,955
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ITGA3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ITGA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itgae
|
integrin subunit alpha E
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ITGAE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:58,203,331...58,262,606
Ensembl chr10:58,203,364...58,262,606
|
|
| G
|
Itm2c
|
integral membrane protein 2C
|
increases expression
|
ISO
|
Selenium results in increased expression of ITM2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:93,993,922...94,007,737
Ensembl chr 9:93,993,895...94,007,704
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
EXP
|
[Selenium co-treated with Iodine] results in increased expression of JUN mRNA; [Selenium co-treated with Iodine] results in increased expression of JUN protein Selenium results in increased expression of JUN mRNA; Selenium results in increased expression of JUN protein
|
CTD |
PMID:12475444 PMID:12666833 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kansl2
|
KAT8 regulatory NSL complex subunit 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KANSL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,548,062...131,564,876
Ensembl chr 7:131,548,062...131,564,753
|
|
| G
|
Kat5
|
lysine acetyltransferase 5
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of KAT5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:212,325,090...212,332,587
|
|
| G
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
increases expression
|
ISO
|
Selenium results in increased expression of KCNJ15 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457
|
|
| G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of KCNMA1 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117
|
|
| G
|
Kctd17
|
potassium channel tetramerization domain containing 17
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of KCTD17 mRNA Selenium results in increased expression of KCTD17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:111,859,556...111,891,869
Ensembl chr 7:111,859,256...111,870,692
|
|
| G
|
Kdm6b
|
lysine demethylase 6B
|
increases expression
|
ISO
|
Selenium results in increased expression of KDM6B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:54,619,520...54,641,014
Ensembl chr10:54,619,544...54,629,610
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of KEAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Kiaa0040
|
KIAA0040 ortholog
|
increases expression
|
ISO
|
Selenium results in increased expression of KIAA0040 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:74,807,959...74,845,530
Ensembl chr13:74,807,982...74,845,530
|
|
| G
|
Kif1c
|
kinesin family member 1C
|
increases expression
|
ISO
|
Selenium results in increased expression of KIF1C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,913,010...55,942,220
Ensembl chr10:55,913,093...55,942,220
|
|
| G
|
Kif5c
|
kinesin family member 5C
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KIF5C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:54,441,266...54,591,630
Ensembl chr 3:54,441,310...54,594,813
|
|
| G
|
Kl
|
Klotho
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of KL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
| G
|
Klf12
|
KLF transcription factor 12
|
increases expression
|
ISO
|
Selenium results in increased expression of KLF12 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:83,045,463...83,670,640
|
|
| G
|
Klf6
|
KLF transcription factor 6
|
increases expression
|
ISO
|
Selenium results in increased expression of KLF6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601
|
|
| G
|
Klf9
|
KLF transcription factor 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KLF9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641
|
|
| G
|
Klhdc10
|
kelch domain containing 10
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KLHDC10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:59,988,710...60,046,518
Ensembl chr 4:59,988,646...60,046,516
|
|
| G
|
Klhl20
|
kelch-like family member 20
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of KLHL20 mRNA Selenium results in decreased expression of KLHL20 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:75,896,802...75,941,724
Ensembl chr13:75,898,410...75,945,061
|
|
| G
|
Klhl24
|
kelch-like family member 24
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of KLHL24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
|
|
| G
|
Klhl9
|
kelch-like family member 9
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:108,449,492...108,453,676
Ensembl chr 5:108,437,583...108,454,140
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KLK3 mRNA; Selenium results in decreased expression of KLK3 protein
|
CTD |
PMID:14729601 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Kmt2b
|
lysine methyltransferase 2B
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of KMT2B mRNA Selenium results in increased expression of KMT2B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:94,949,144...94,969,239
Ensembl chr 1:94,949,144...94,968,441
|
|
| G
|
Kpna1
|
karyopherin subunit alpha 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of KPNA1 mRNA Selenium results in decreased expression of KPNA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
|
|
| G
|
Kpna6
|
karyopherin subunit alpha 6
|
increases expression
|
ISO
|
Selenium results in increased expression of KPNA6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:147,272,466...147,307,523
Ensembl chr 5:147,275,918...147,305,851
|
|
| G
|
Kpnb1
|
karyopherin subunit beta 1
|
multiple interactions increases expression decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of KPNB1 mRNA Selenium results in increased expression of KPNB1 mRNA Selenium results in decreased expression of KPNB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856
|
|
| G
|
Krr1
|
KRR1, small subunit processome component homolog
|
decreases expression
|
ISO
|
Selenium results in decreased expression of KRR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:49,361,794...49,374,222
Ensembl chr 7:49,361,901...49,374,216
|
|
| G
|
Krt17
|
keratin 17
|
increases expression
|
ISO
|
Selenium results in increased expression of KRT17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787
|
|
| G
|
Krt18
|
keratin 18
|
increases expression
|
ISO
|
Selenium results in increased expression of KRT18 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt19
|
keratin 19
|
increases expression
|
ISO
|
Selenium results in increased expression of KRT19 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
| G
|
Krt7
|
keratin 7
|
increases expression
|
ISO
|
Selenium results in increased expression of KRT7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786
|
|
| G
|
Krt8
|
keratin 8
|
increases expression
|
ISO
|
Selenium results in increased expression of KRT8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
| G
|
Ktn1
|
kinectin 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of KTN1 mRNA Selenium results in decreased expression of KTN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263
|
|
| G
|
Lamb3
|
laminin subunit beta 3
|
increases expression
|
ISO
|
Selenium results in increased expression of LAMB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081
|
|
| G
|
Lamp1
|
lysosomal-associated membrane protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of LAMP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159
|
|
| G
|
Larp4b
|
La ribonucleoprotein 4B
|
increases expression
|
ISO
|
Selenium results in increased expression of LARP4B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:65,813,125...65,908,920
Ensembl chr17:65,830,022...65,908,676
|
|
| G
|
Lcat
|
lecithin cholesterol acyltransferase
|
multiple interactions
|
EXP
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA]
|
CTD |
PMID:30031400 |
|
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions increases expression increases activity decreases activity decreases expression
|
EXP ISO
|
Selenium inhibits the reaction [Cholesterol results in decreased activity of LDLR protein]; Selenium inhibits the reaction [Cholesterol results in decreased expression of LDLR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA] Selenium results in increased expression of LDLR mRNA Selenium results in increased activity of LDLR protein Selenium deficiency results in decreased activity of LDLR protein Selenium deficiency results in decreased expression of LDLR mRNA
|
CTD |
PMID:16271152 PMID:16317514 PMID:16937255 PMID:36464106 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Ldlrad4
|
low density lipoprotein receptor class A domain containing 4
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of LDLRAD4 mRNA Selenium inhibits the reaction [Cadmium results in increased expression of LDLRAD4 mRNA]
|
CTD |
PMID:19244175 PMID:34773240 |
|
NCBI chr18:63,789,089...64,118,166
Ensembl chr18:63,790,440...64,113,064
|
|
| G
|
Ldlrap1
|
low density lipoprotein receptor adaptor protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of ARH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290
|
|
| G
|
Lep
|
leptin
|
decreases abundance
|
ISO
|
LEP gene mutant form results in decreased abundance of Selenium
|
CTD |
PMID:10965932 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [Acrylamide results in increased expression of LHB protein]; Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of LHB protein]
|
CTD |
PMID:20957662 PMID:37987225 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Limch1
|
LIM and calponin homology domains 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA Selenium results in decreased expression of LIMCH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837
|
|
| G
|
Lime1
|
Lck interacting transmembrane adaptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of LIME1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:188,868,338...188,870,661
Ensembl chr 3:188,868,320...188,870,658
|
|
| G
|
Lipt1
|
lipoyltransferase 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of LIPT1 mRNA Selenium results in decreased expression of LIPT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:47,603,972...47,609,365
Ensembl chr 9:47,594,058...47,614,669
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
increases expression
|
ISO
|
Selenium results in increased expression of LITAF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lman2
|
lectin, mannose-binding 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of LMAN2 mRNA Selenium results in increased expression of LMAN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:9,274,362...9,294,950
Ensembl chr17:9,274,136...9,292,370
|
|
| G
|
Lmna
|
lamin A/C
|
increases expression
|
ISO
|
Selenium results in increased expression of LMNA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
|
|
| G
|
Lpar1
|
lysophosphatidic acid receptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of LPAR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188
|
|
| G
|
Lpar2
|
lysophosphatidic acid receptor 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,625,974...19,633,905
Ensembl chr16:19,625,983...19,633,905
|
|
| G
|
Lpin1
|
lipin 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of LPIN1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]
|
CTD |
PMID:19244175 PMID:36464106 |
|
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
|
|
| G
|
Lrp8
|
LDL receptor related protein 8
|
affects response to substance affects abundance increases uptake
|
ISO
|
LRP8 protein affects the susceptibility to Selenium LRP8 protein affects the abundance of Selenium LRP8 protein results in increased uptake of Selenium
|
CTD |
PMID:17314095 PMID:17553992 PMID:18172410 PMID:19007311 |
|
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207
|
|
| G
|
Lrrc41
|
leucine rich repeat containing 41
|
increases expression
|
ISO
|
Selenium results in increased expression of LRRC41 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:134,791,256...134,812,177
Ensembl chr 5:134,791,256...134,812,177
|
|
| G
|
Lrrc47
|
leucine rich repeat containing 47
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of LRRC47 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:169,852,926...169,862,598
Ensembl chr 5:169,852,897...169,862,598
|
|
| G
|
Lrrfip1
|
LRR binding FLII interacting protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of LRRFIP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:99,039,590...99,167,805
Ensembl chr 9:99,039,614...99,167,779
|
|
| G
|
Lsp1
|
lymphocyte-specific protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of LSP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893
|
|
| G
|
Lsr
|
lipolysis stimulated lipoprotein receptor
|
increases expression
|
ISO
|
Selenium results in increased expression of LSR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354
|
|
| G
|
Ltbp3
|
latent transforming growth factor beta binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of LTBP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,458,362...212,475,302
Ensembl chr 1:212,459,185...212,475,302
|
|
| G
|
Ltbp4
|
latent transforming growth factor beta binding protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of LTBP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:91,727,769...91,760,006
|
|
| G
|
Ltbr
|
lymphotoxin beta receptor
|
increases expression
|
ISO
|
Selenium results in increased expression of LTBR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296
|
|
| G
|
Luc7l2
|
LUC7 pre-mRNA splicing factor like 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of LUC7L2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:68,271,414...68,314,837
|
|
| G
|
Luc7l3
|
LUC7 pre-mRNA splicing factor like 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of LUC7L3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:79,737,457...79,773,478
Ensembl chr10:79,736,853...79,773,429
|
|
| G
|
Ly6e
|
lymphocyte antigen 6 family member E
|
increases expression
|
ISO
|
Selenium results in increased expression of LY6E mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443
|
|
| G
|
Lypla1
|
lysophospholipase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of LYPLA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:19,477,409...19,506,522
|
|
| G
|
Lypla2
|
lysophospholipase 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of LYPLA2 mRNA Selenium results in increased expression of LYPLA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:153,481,973...153,486,692
Ensembl chr 5:153,481,974...153,486,601
|
|
| G
|
Macf1
|
microtubule-actin crosslinking factor 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MACF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890
|
|
| G
|
Macir
|
macrophage immunometabolism regulator
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MACIR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:105,868,072...105,888,128
Ensembl chr 9:105,866,641...105,889,758
|
|
| G
|
Macroh2a2
|
macroH2A.2 histone
|
increases expression
|
ISO
|
Selenium results in increased expression of MACROH2A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:30,220,975...30,270,652
Ensembl chr20:30,221,011...30,270,652
|
|
| G
|
Maged2
|
MAGE family member D2
|
increases expression
|
ISO
|
Selenium results in increased expression of MAGED2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:23,160,928...23,364,994
Ensembl chr X:23,160,931...23,169,104
|
|
| G
|
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MAGI2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:15,278,518...16,762,199
|
|
| G
|
Mall
|
mal, T-cell differentiation protein-like
|
increases expression
|
ISO
|
Selenium results in increased expression of MALL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066
|
|
| G
|
Malt1
|
MALT1 paracaspase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MALT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:61,212,290...61,266,272
Ensembl chr18:61,212,317...61,266,272
|
|
| G
|
Man1b1
|
mannosidase, alpha, class 1B, member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MAN1B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:28,539,778...28,563,155
Ensembl chr 3:28,541,347...28,563,154
|
|
| G
|
Man2b1
|
mannosidase, alpha, class 2B, member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MAN2B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:39,959,964...39,979,299
Ensembl chr19:39,959,965...39,979,246
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
EXP
|
[Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of MAP1LC3B protein]
|
CTD |
PMID:32233808 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of MAP2 mRNA
|
CTD |
PMID:37914285 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map2k2
|
mitogen activated protein kinase kinase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of MAP2K2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
|
|
| G
|
Map2k3
|
mitogen activated protein kinase kinase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of MAP2K3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MAP3K5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MAP3K7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA Selenium results in decreased expression of MAP3K8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452
|
|
| G
|
Map4
|
microtubule-associated protein 4
|
increases expression
|
ISO
|
Selenium results in increased expression of MAP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:118,804,022...118,942,805
|
|
| G
|
Map4k5
|
mitogen-activated protein kinase kinase kinase kinase 5
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MAP4K5 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:94,020,079...94,112,943
|
|
| G
|
Map7d1
|
MAP7 domain containing 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MAP7D1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:143,812,467...143,837,597
Ensembl chr 5:143,811,924...143,837,021
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
Selenium results in increased phosphorylation of and results in increased activity of MAPK1 protein
|
CTD |
PMID:17997286 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk10
|
mitogen activated protein kinase 10
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of MAPK10 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
increases expression
|
ISO
|
Selenium results in increased expression of MAPK11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [Acrylamide results in increased expression of MAPK14 mRNA]
|
CTD |
PMID:37987225 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO EXP
|
Selenium results in increased phosphorylation of and results in increased activity of MAPK3 protein Selenium inhibits the reaction [arsenite results in decreased expression of MAPK3 protein]
|
CTD |
PMID:17997286 PMID:29324385 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
decreases phosphorylation decreases expression multiple interactions
|
ISO
|
Selenium results in decreased phosphorylation of MAPK8 protein Selenium results in decreased expression of MAPK8 mRNA Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:17997286 PMID:26187450 PMID:28810182 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:26187450 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions
|
EXP ISO
|
Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of MAPT protein modified form] Selenium inhibits the reaction [Cadmium results in decreased expression of MAPT mRNA]
|
CTD |
PMID:30695686 PMID:34773240 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Marchf2
|
membrane associated ring-CH-type finger 2
|
increases expression
|
ISO
|
Selenium results in increased expression of MARCHF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:15,183,925...15,202,002
|
|
| G
|
Marchf6
|
membrane associated ring-CH-type finger 6
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MARCHF6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:84,166,570...84,243,817
Ensembl chr 2:84,166,570...84,243,792
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
increases expression
|
ISO
|
Selenium results in increased expression of MARCKS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Matcap2
|
microtubule associated tyrosine carboxypeptidase 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of MATCAP2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 8:29,197,154...29,247,056
Ensembl chr 8:29,196,927...29,247,058
|
|
| G
|
Mau2
|
MAU2 sister chromatid cohesion factor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MAU2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:19,417,812...19,448,922
Ensembl chr16:19,417,613...19,445,841
|
|
| G
|
Max
|
MYC associated factor X
|
increases expression
|
ISO
|
Selenium results in increased expression of MAX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:101,369,988...101,395,549
|
|
| G
|
Maz
|
MYC associated zinc finger protein
|
increases expression
|
ISO
|
Selenium results in increased expression of MAZ mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,060,271...191,065,722
Ensembl chr 1:191,060,280...191,065,339
|
|
| G
|
Mbd1
|
methyl-CpG binding domain protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MBD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:70,145,093...70,159,744
Ensembl chr18:70,145,114...70,159,703
|
|
| G
|
Mbd3
|
methyl-CpG binding domain protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of MBD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,963,797...9,970,265
|
|
| G
|
Mbd4
|
methyl-CpG binding domain 4 DNA glycosylase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MBD4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:150,565,655...150,577,578
|
|
| G
|
Mbnl1
|
muscleblind-like splicing regulator 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of MBNL1 mRNA Selenium results in decreased expression of MBNL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:146,789,596...146,964,134
|
|
| G
|
Mbp
|
myelin basic protein
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Iodine results in decreased expression of MBP mRNA]
|
CTD |
PMID:16229266 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mccc1
|
methylcrotonyl-CoA carboxylase subunit 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MCCC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:120,727,313...120,779,334
Ensembl chr 2:120,727,316...120,779,554
|
|
| G
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like
|
increases expression
|
ISO
|
Selenium results in increased expression of MCF2L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956
|
|
| G
|
Mcm5
|
minichromosome maintenance complex component 5
|
increases expression
|
ISO
|
Selenium results in increased expression of MCM5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758
|
|
| G
|
Mcm7
|
minichromosome maintenance complex component 7
|
increases expression
|
ISO
|
Selenium results in increased expression of MCM7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771
|
|
| G
|
Mcrs1
|
microspherule protein 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MCRS1 mRNA Selenium results in increased expression of MCRS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:132,262,722...132,271,533
|
|
| G
|
Mdk
|
midkine
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA Selenium results in increased expression of MDK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mdm1
|
Mdm1 nuclear protein
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of MDM1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MDM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888
|
|
| G
|
Me1
|
malic enzyme 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ME1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
|
|
| G
|
Med13l
|
mediator complex subunit 13L
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MED13L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:43,468,556...43,665,819
Ensembl chr12:43,468,556...43,665,819
|
|
| G
|
Med15
|
mediator complex subunit 15
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MED15 mRNA Selenium results in increased expression of MED15 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,784,974...96,859,635
Ensembl chr11:96,784,999...96,859,644
|
|
| G
|
Med24
|
mediator complex subunit 24
|
increases expression
|
ISO
|
Selenium results in increased expression of MED24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:84,160,866...84,198,607
Ensembl chr10:84,160,866...84,186,379
|
|
| G
|
Metap2
|
methionyl aminopeptidase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of METAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521
|
|
| G
|
Mfap2
|
microfibril associated protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of MFAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656
|
|
| G
|
Mfge8
|
milk fat globule EGF and factor V/VIII domain containing
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MFGE8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431
|
|
| G
|
Mfn1
|
mitofusin 1
|
multiple interactions
|
EXP
|
[Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased expression of MFN1 mRNA]
|
CTD |
PMID:33372294 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
| G
|
Mfn2
|
mitofusin 2
|
multiple interactions
|
EXP
|
[Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased expression of MFN2 mRNA]
|
CTD |
PMID:33372294 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mfsd10
|
major facilitator superfamily domain containing 10
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC75A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:80,327,961...80,331,984
Ensembl chr14:80,328,410...80,332,063
|
|
| G
|
Mgat1
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
|
increases expression
|
ISO
|
Selenium results in increased expression of MGAT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:34,064,548...34,083,833
Ensembl chr10:34,062,837...34,095,975
|
|
| G
|
Miip
|
migration and invasion inhibitory protein
|
increases expression
|
ISO
|
Selenium results in increased expression of MIIP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:163,575,689...163,582,739
Ensembl chr 5:163,575,437...163,582,873
|
|
| G
|
Mink1
|
misshapen-like kinase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MINK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,776,879...55,829,406
Ensembl chr10:55,776,993...55,829,406
|
|
| G
|
Mios
|
meiosis regulator for oocyte development
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MIOS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:37,229,533...37,255,862
Ensembl chr 4:37,230,213...37,256,974
|
|
| G
|
Mir26a1
|
microRNA 26a-1
|
decreases expression multiple interactions
|
ISO
|
Selenium deficiency results in decreased expression of MIR26A1 bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of MIR26A1 protein]
|
CTD |
PMID:37422542 |
|
NCBI chr 8:127,633,048...127,633,137
Ensembl chr 8:127,633,048...127,633,137
|
|
| G
|
Mis12
|
MIS12 kinetochore complex component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MIS12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:56,238,317...56,246,491
Ensembl chr10:56,238,181...56,253,800
|
|
| G
|
Misp
|
mitotic spindle positioning
|
increases expression
|
ISO
|
Selenium results in increased expression of MISP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:10,526,980...10,537,159
Ensembl chr 7:10,503,209...10,537,159
|
|
| G
|
Mlec
|
malectin
|
increases expression decreases expression multiple interactions
|
ISO
|
Selenium results in increased expression of MLEC mRNA Selenium results in decreased expression of MLEC mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MLEC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:47,118,918...47,133,598
Ensembl chr12:47,118,855...47,130,064
|
|
| G
|
Mlf2
|
myeloid leukemia factor 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA Selenium results in increased expression of MLF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:159,411,732...159,430,571
|
|
| G
|
Mlkl
|
mixed lineage kinase domain like pseudokinase
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of MLKL protein]] Selenium deficiency results in increased expression of MLKL mRNA; Selenium deficiency results in increased expression of MLKL protein
|
CTD |
PMID:37422542 |
|
NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858
|
|
| G
|
Mlst8
|
MTOR associated protein, LST8 homolog
|
increases expression
|
ISO
|
Selenium results in increased expression of MLST8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,002,927...14,008,678
Ensembl chr10:14,002,938...14,008,678
|
|
| G
|
Mme
|
membrane metallo-endopeptidase
|
multiple interactions
|
EXP
|
Selenium deficiency affects the expression of and affects the localization of MME protein
|
CTD |
PMID:17109141 |
|
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [T-2 Toxin results in increased expression of MMP13 mRNA]; Selenium inhibits the reaction [T-2 Toxin results in increased expression of MMP13 protein]
|
CTD |
PMID:21144892 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MMP14 mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp15
|
matrix metallopeptidase 15
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MMP15 mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
|
|
| G
|
Mmp16
|
matrix metallopeptidase 16
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MMP16 mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of MMP2 mRNA Selenium results in increased expression of MMP2 mRNA
|
CTD |
PMID:17390030 PMID:19244175 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp24
|
matrix metallopeptidase 24
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of MMP24 mRNA Selenium results in increased expression of MMP24 mRNA
|
CTD |
PMID:17390030 PMID:19244175 |
|
NCBI chr 3:164,739,226...164,783,696
Ensembl chr 3:164,739,226...164,783,696
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MMP9 mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mms19
|
MMS19 homolog, cytosolic iron-sulfur assembly component
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MMS19 mRNA Selenium results in increased expression of MMS19 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:250,706,595...250,743,604
Ensembl chr 1:250,706,595...250,743,582
|
|
| G
|
Mmut
|
methylmalonyl-CoA mutase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MMUT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:27,425,935...27,454,202
Ensembl chr 9:27,425,935...27,454,342
|
|
| G
|
Mon1b
|
MON1 homolog B, secretory trafficking associated
|
increases expression
|
ISO
|
Selenium results in increased expression of MON1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:58,526,503...58,534,478
Ensembl chr19:58,526,326...58,533,950
|
|
| G
|
Mon2
|
MON2 homolog, regulator of endosome-to-Golgi trafficking
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MON2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:60,534,772...60,613,467
Ensembl chr 7:60,534,772...60,613,467
|
|
| G
|
Mpst
|
mercaptopyruvate sulfurtransferase
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of MPST mRNA [Selenium co-treated with Vitamin E] results in increased expression of MPST mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650
|
|
| G
|
Mpv17
|
mitochondrial inner membrane protein MPV17
|
increases expression
|
ISO
|
Selenium results in increased expression of MPV17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:30,941,693...30,956,389
Ensembl chr 6:30,943,356...30,956,386
|
|
| G
|
Mrc1
|
mannose receptor, C type 1
|
multiple interactions
|
ISO
|
2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA]; [Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA
|
CTD |
PMID:21775527 |
|
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
|
|
| G
|
Mrpl12
|
mitochondrial ribosomal protein L12
|
increases expression
|
ISO
|
Selenium results in increased expression of MRPL12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:106,256,746...106,261,249
Ensembl chr10:106,256,547...106,263,088
|
|
| G
|
Mrpl2
|
mitochondrial ribosomal protein L2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MRPL2 mRNA Selenium results in increased expression of MRPL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:21,830,834...21,834,607
Ensembl chr 9:21,830,835...21,834,641
|
|
| G
|
Mrpl34
|
mitochondrial ribosomal protein L34
|
increases expression
|
ISO
|
Selenium results in increased expression of MRPL34 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,185,306...18,187,181
|
|
| G
|
Mrpl4
|
mitochondrial ribosomal protein L4
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA Selenium results in increased expression of MRPL4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:27,815,771...27,821,786
Ensembl chr 8:27,815,740...27,821,780
|
|
| G
|
Mrpl44
|
mitochondrial ribosomal protein L44
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of MRPL44 mRNA Selenium results in decreased expression of MRPL44 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:88,555,050...88,560,101
Ensembl chr 9:88,555,019...88,561,215
|
|
| G
|
Mrpl49
|
mitochondrial ribosomal protein L49
|
increases expression
|
ISO
|
Selenium results in increased expression of MRPL49 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888
|
|
| G
|
Mrpl9
|
mitochondrial ribosomal protein L9
|
increases expression
|
ISO
|
Selenium results in increased expression of MRPL9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:184,768,837...184,775,787
Ensembl chr 2:184,763,529...184,775,777
|
|
| G
|
Mrps33
|
mitochondrial ribosomal protein S33
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MRPS33 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:69,563,501...69,572,317
Ensembl chr 4:69,563,503...69,572,177
|
|
| G
|
Msh5
|
mutS homolog 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MSH5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,781,578...3,797,994
|
|
| G
|
Msn
|
moesin
|
increases expression
|
ISO
|
Selenium results in increased expression of MSN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
|
|
| G
|
Msrb1
|
methionine sulfoxide reductase B1
|
decreases expression multiple interactions
|
ISO
|
Selenium deficiency results in decreased expression of MSRB1 mRNA Selenium deficiency results in decreased expression of and results in decreased activity of MSRB1 protein
|
CTD |
PMID:12792026 PMID:16170372 |
|
NCBI chr10:14,269,414...14,275,140
Ensembl chr10:14,269,414...14,274,184
|
|
| G
|
Mt1a
|
metallothionein 1A
|
multiple interactions
|
EXP
|
[Zinc co-treated with Selenium] inhibits the reaction [Cadmium results in increased expression of MT1 mRNA]; Selenium inhibits the reaction [Cadmium results in increased expression of MT1 mRNA]
|
CTD |
PMID:20238111 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt3
|
metallothionein 3
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MT3 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Mtch2
|
mitochondrial carrier 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MTCH2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:97,286,388...97,306,028
Ensembl chr 3:97,285,894...97,307,327
|
|
| G
|
Mtf1
|
metal-regulatory transcription factor 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MTF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:142,347,054...142,391,810
|
|
| G
|
Mtf2
|
metal response element binding transcription factor 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MTF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:1,784,218...1,828,463
Ensembl chr14:1,783,627...1,828,414
|
|
| G
|
Mtmr9
|
myotubularin related protein 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MTMR9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:41,945,102...41,967,136
Ensembl chr15:41,945,105...41,967,136
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [arsenite results in decreased expression of and results in decreased phosphorylation of MTOR protein]
|
CTD |
PMID:29324385 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Muc4
|
mucin 4, cell surface associated
|
increases expression
|
ISO
|
Selenium results in increased expression of MUC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:81,513,321...81,575,200
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
decreases expression
|
ISO
|
Selenium results in decreased expression of MUC5AC mRNA
|
CTD |
PMID:17512462 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
|
|
| G
|
Mvk
|
mevalonate kinase
|
increases expression
|
ISO
|
Selenium results in increased expression of MVK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503
|
|
| G
|
Mvp
|
major vault protein
|
increases expression
|
ISO
|
Selenium results in increased expression of MVP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873
|
|
| G
|
Mx1
|
MX dynamin like GTPase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
decreases expression multiple interactions
|
ISO EXP
|
Selenium deficiency results in decreased expression of MYC mRNA; Selenium results in decreased expression of MYC mRNA Selenium inhibits the reaction [Cadmium Chloride results in increased expression of MYC protein]
|
CTD |
PMID:11925459 PMID:16600092 PMID:17948765 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myh9
|
myosin, heavy chain 9
|
increases expression
|
ISO
|
Selenium results in increased expression of MYH9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963
|
|
| G
|
Myl6
|
myosin light chain 6
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA Selenium results in increased expression of MYL6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344
|
|
| G
|
Mylk
|
myosin light chain kinase
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of MYLK mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Mylk3
|
myosin light chain kinase 3
|
decreases expression
|
EXP
|
Selenium results in decreased expression of MYLK3 mRNA
|
CTD |
PMID:39059692 |
|
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827
|
|
| G
|
Myo18a
|
myosin XVIIIa
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of MYO18A mRNA Selenium results in increased expression of MYO18A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:63,152,303...63,253,543
Ensembl chr10:63,152,103...63,253,543
|
|
| G
|
Myo6
|
myosin VI
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA Selenium results in decreased expression of MYO6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:89,967,377...90,122,215
|
|
| G
|
Mzf1
|
myeloid zinc finger 1
|
increases expression
|
ISO
|
Selenium results in increased expression of MZF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:82,742,709...82,755,069
Ensembl chr 1:82,742,726...82,753,820
|
|
| G
|
N4bp2l2
|
NEDD4 binding protein 2-like 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of N4BP2L2 mRNA Selenium results in decreased expression of N4BP2L2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:4,972,967...5,038,027
Ensembl chr12:4,972,990...5,033,405
|
|
| G
|
Naa10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of NAA10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:156,807,378...156,812,632
Ensembl chr X:156,807,378...156,812,574
|
|
| G
|
Naca
|
nascent polypeptide associated complex subunit alpha
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NACA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:1,053,474...1,066,606
Ensembl chr 7:1,054,338...1,066,605
|
|
| G
|
Nagk
|
N-acetylglucosamine kinase
|
increases expression
|
ISO
|
Selenium results in increased expression of NAGK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:117,838,761...117,846,304
Ensembl chr 4:117,838,826...117,847,836
|
|
| G
|
Naglu
|
N-acetyl-alpha-glucosaminidase
|
increases expression
|
ISO
|
Selenium results in increased expression of NAGLU mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,501,836...86,509,315
|
|
| G
|
Napa
|
NSF attachment protein alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of NAPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:85,915,088...85,934,054
Ensembl chr 1:85,915,119...85,934,053
|
|
| G
|
Nasp
|
nuclear autoantigenic sperm protein
|
increases expression
|
ISO
|
Selenium results in increased expression of NASP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591
|
|
| G
|
Nav2
|
neuron navigator 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NAV2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:107,799,968...108,458,546
Ensembl chr 1:107,805,096...108,458,546
|
|
| G
|
Ncdn
|
neurochondrin
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NCDN mRNA Selenium results in increased expression of NCDN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:144,322,287...144,332,117
Ensembl chr 5:144,322,287...144,332,047
|
|
| G
|
Ncoa2
|
nuclear receptor coactivator 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NCOA2 mRNA Selenium results in decreased expression of NCOA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
| G
|
Ndufa1
|
NADH:ubiquinone oxidoreductase subunit A1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NDUFA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:121,289,904...121,293,555
Ensembl chr X:121,289,925...121,293,555
|
|
| G
|
Ndufa4
|
Ndufa4, mitochondrial complex associated
|
decreases expression
|
ISO
|
Selenium results in decreased expression of COXFA4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559
|
|
| G
|
Ndufa7
|
NADH:ubiquinone oxidoreductase subunit A7
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:15,311,446...15,324,226
Ensembl chr 7:15,311,286...15,334,138
|
|
| G
|
Ndufb1
|
NADH:ubiquinone oxidoreductase subunit B1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NDUFB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:126,880,537...126,888,935
Ensembl chr 6:126,880,537...126,888,864
|
|
| G
|
Ndufb2
|
NADH:ubiquinone oxidoreductase subunit B2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NDUFB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:69,334,307...69,341,394
Ensembl chr 4:69,334,307...69,340,136 Ensembl chr15:69,334,307...69,340,136
|
|
| G
|
Ndufs3
|
NADH:ubiquinone oxidoreductase core subunit S3
|
increases expression
|
ISO
|
Selenium results in increased expression of NDUFS3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:97,332,477...97,339,654
Ensembl chr 3:97,332,477...97,345,323
|
|
| G
|
Ndufs4
|
NADH:ubiquinone oxidoreductase subunit S4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NDUFS4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:47,684,420...47,794,914
Ensembl chr 2:47,684,406...47,794,931
|
|
| G
|
Ndufv1
|
NADH:ubiquinone oxidoreductase core subunit V1
|
increases expression
|
ISO
|
Selenium results in increased expression of NDUFV1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,729,856...210,735,103
Ensembl chr 1:210,729,858...210,734,949
|
|
| G
|
Nectin2
|
nectin cell adhesion molecule 2
|
increases expression
|
ISO
|
Selenium results in increased expression of NECTIN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:88,500,086...88,535,474
Ensembl chr 1:88,500,087...88,535,305
|
|
| G
|
Nedd8
|
NEDD8 ubiquitin like modifier
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NEDD8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,123,505...33,135,522
Ensembl chr15:33,123,505...33,135,522
|
|
| G
|
Nek1
|
NIMA-related kinase 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of NEK1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NEK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:34,009,092...34,137,418
Ensembl chr16:34,009,094...34,128,576
|
|
| G
|
Nek2
|
NIMA-related kinase 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NEK2 mRNA Selenium results in decreased expression of NEK2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
|
|
| G
|
Nelfa
|
negative elongation factor complex member A
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA Selenium results in increased expression of NELFA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:81,033,470...81,057,546
Ensembl chr14:81,033,514...81,058,719
|
|
| G
|
Nf2
|
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NF2 mRNA Selenium results in increased expression of NF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:83,850,894...83,934,263
Ensembl chr14:83,850,894...83,934,151
|
|
| G
|
Nfat5
|
nuclear factor of activated T-cells 5
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA Selenium results in decreased expression of NFAT5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
decreases expression multiple interactions affects activity
|
ISO EXP
|
Selenium results in decreased expression of NFE2L2 mRNA [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] Selenium affects the activity of NFE2L2 protein NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA
|
CTD |
PMID:18279678 PMID:19244175 PMID:32233808 PMID:37415728 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfic
|
nuclear factor I/C
|
increases expression
|
ISO
|
Selenium results in increased expression of NFIC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:8,928,423...8,963,455
Ensembl chr 7:8,904,117...8,963,409
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of NFKB2 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
[Drugs, Chinese Herbal co-treated with Selenium] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased degradation of NFKBIA protein]; Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of NFKBIA mRNA
|
CTD |
PMID:17439952 PMID:17630198 PMID:21481475 PMID:24626144 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nfkbib
|
NFKB inhibitor beta
|
increases expression
|
ISO
|
Selenium results in increased expression of NFKBIB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366
|
|
| G
|
Nfs1
|
NFS1 cysteine desulfurase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NFS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:165,097,390...165,119,730
Ensembl chr 3:165,097,391...165,119,737
|
|
| G
|
Niban1
|
niban apoptosis regulator 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NIBAN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
|
|
| G
|
Nid2
|
nidogen 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NID2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949
|
|
| G
|
Ninj1
|
ninjurin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of NINJ1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nipbl
|
NIPBL, cohesin loading factor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NIPBL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:59,126,676...59,314,841
Ensembl chr 2:59,126,676...59,293,277
|
|
| G
|
Nktr
|
natural killer cell triggering receptor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NKTR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:130,259,461...130,298,008
|
|
| G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
increases expression
|
ISO
|
Selenium results in increased expression of NLRP3 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
| G
|
Noc3l
|
NOC3-like DNA replication regulator
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NOC3L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:245,969,179...245,997,761
Ensembl chr 1:245,969,179...245,997,708
|
|
| G
|
Nol3
|
nucleolar protein 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722
|
|
| G
|
Nol8
|
nucleolar protein 8
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA Selenium results in decreased expression of NOL8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:15,196,881...15,220,265
Ensembl chr17:15,196,881...15,220,202
|
|
| G
|
Nolc1
|
nucleolar and coiled-body phosphoprotein 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:254,870,195...254,881,070
Ensembl chr 1:254,870,319...254,881,069
|
|
| G
|
Nomo1
|
Nodal modulator 1
|
increases expression
|
ISO
|
Selenium results in increased expression of NOMO3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:105,641,867...105,692,708
Ensembl chr 1:105,641,879...105,692,707
|
|
| G
|
Nop10
|
NOP10 ribonucleoprotein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NOLA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:119,521,255...119,522,340
Ensembl chr 3:119,521,255...119,522,340
|
|
| G
|
Nop56
|
NOP56 ribonucleoprotein
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of NOP56 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NOP56 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
[Drugs, Chinese Herbal co-treated with Selenium] results in decreased expression of NOS2 mRNA; [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
|
CTD |
PMID:14734799 PMID:17630198 PMID:24626144 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of NOS3 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nosip
|
nitric oxide synthase interacting protein
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NOSIP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,679,783...104,695,570
Ensembl chr 1:104,679,882...104,695,119
|
|
| G
|
Notch3
|
notch receptor 3
|
increases expression
|
ISO
|
Selenium results in increased expression of NOTCH3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
increases expression
|
ISO
|
Selenium deficiency results in increased expression of NOX4 mRNA
|
CTD |
PMID:16170372 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Npepl1
|
aminopeptidase-like 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NPEPL1 mRNA Selenium results in increased expression of NPEPL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:183,312,185...183,324,744
Ensembl chr 3:183,312,185...183,324,744
|
|
| G
|
Npm1
|
nucleophosmin 1
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
affects activity decreases activity multiple interactions increases expression
|
ISO EXP
|
Selenium affects the activity of NQO1 protein Selenium results in decreased activity of NQO1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA; Selenium promotes the reaction [Plant Extracts results in increased activity of NQO1 protein] Selenium deficiency results in increased expression of NQO1 mRNA
|
CTD |
PMID:11444866 PMID:18279678 PMID:19650632 PMID:28810182 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
multiple interactions
|
EXP
|
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] affects the reaction [Dietary Fats results in increased expression of NR1H3 mRNA]
|
CTD |
PMID:30031400 |
|
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Nr2c1
|
nuclear receptor subfamily 2, group C, member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NR2C1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:30,602,338...30,655,610
Ensembl chr 7:30,603,018...30,658,349
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NR3C1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Nrf1
|
nuclear respiratory factor 1
|
multiple interactions increases expression
|
EXP
|
NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA] Selenium results in increased expression of NRF1 mRNA
|
CTD |
PMID:17936198 |
|
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353
|
|
| G
|
Nsmaf
|
neutral sphingomyelinase activation associated factor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NSMAF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:24,315,319...24,378,346
Ensembl chr 5:24,315,319...24,375,355
|
|
| G
|
Nt5dc2
|
5'-nucleotidase domain containing 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA Selenium results in increased expression of NT5DC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,328,523...6,336,980
|
|
| G
|
Nucb1
|
nucleobindin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of NUCB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:105,104,793...105,135,730
Ensembl chr 1:105,104,793...105,135,837
|
|
| G
|
Nucks1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of NUCKS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
|
|
| G
|
Nudc
|
nuclear distribution C, dynein complex regulator
|
increases expression
|
ISO
|
Selenium results in increased expression of NUDC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:151,041,875...151,055,260
|
|
| G
|
Nup93
|
nucleoporin 93
|
increases expression
|
ISO
|
Selenium results in increased expression of NUP93 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:10,690,154...10,793,937
Ensembl chr19:10,687,115...10,793,380
|
|
| G
|
Nutf2
|
nuclear transport factor 2
|
increases expression
|
ISO
|
Selenium results in increased expression of NUTF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,662,168...50,683,457
Ensembl chr19:50,662,394...50,683,454
|
|
| G
|
Oaz1
|
ornithine decarboxylase antizyme 1
|
increases expression
|
ISO
|
Selenium results in increased expression of OAZ1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990
|
|
| G
|
Oaz2
|
ornithine decarboxylase antizyme 2
|
increases expression
|
ISO
|
Selenium results in increased expression of OAZ2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:75,094,817...75,108,634
Ensembl chr 8:75,094,798...75,108,630
|
|
| G
|
Obsl1
|
obscurin like cytoskeletal adaptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of OBSL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,416,447...84,442,415
Ensembl chr 9:84,416,240...84,442,415
|
|
| G
|
Ocln
|
occludin
|
multiple interactions
|
ISO
|
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; Selenium results in increased expression of and results in increased localization of OCLN protein
|
CTD |
PMID:16514648 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
| G
|
Ogfr
|
opioid growth factor receptor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA Selenium results in increased expression of OGFR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:188,080,743...188,087,028
Ensembl chr 3:188,080,042...188,087,471
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Arsenic] results in increased expression of OGG1 protein Selenium results in increased expression of OGG1 protein
|
CTD |
PMID:20478284 |
|
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Ola1
|
Obg-like ATPase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of OLA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:78,374,440...78,493,401
Ensembl chr 3:78,374,441...78,492,012
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of OPA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Optn
|
optineurin
|
increases expression
|
ISO
|
Selenium results in increased expression of OPTN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
|
|
| G
|
Orm1
|
orosomucoid 1
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of ORM1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667
|
|
| G
|
Os9
|
OS9, endoplasmic reticulum lectin
|
increases expression
|
ISO
|
Selenium results in increased expression of OS9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:64,802,517...64,829,185
Ensembl chr 7:64,802,103...64,829,070
|
|
| G
|
Osbp2
|
oxysterol binding protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of OSBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:82,808,693...82,970,386
Ensembl chr14:82,808,693...82,970,532
|
|
| G
|
Osbpl1a
|
oxysterol binding protein-like 1A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of OSBPL1A mRNA Selenium results in decreased expression of OSBPL1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:4,179,631...4,369,421
|
|
| G
|
Osgep
|
O-sialoglycoprotein endopeptidase
|
increases expression
|
ISO
|
Selenium results in increased expression of OSGEP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:26,610,694...26,618,113
Ensembl chr15:26,610,698...26,618,113
|
|
| G
|
Otulinl
|
OTU deubiquitinase with linear linkage specificity like
|
decreases expression
|
ISO
|
Selenium results in decreased expression of OTULINL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:80,139,262...80,166,962
|
|
| G
|
Pa2g4
|
proliferation-associated 2G4
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802
|
|
| G
|
Pafah1b1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PAFAH1B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196
|
|
| G
|
Pafah1b3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
|
increases expression
|
ISO
|
Selenium results in increased expression of PAFAH1B3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:90,009,085...90,011,611
Ensembl chr 1:90,009,085...90,011,611
|
|
| G
|
Pak4
|
p21 (RAC1) activated kinase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PAK4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:92,977,437...93,016,721
Ensembl chr 1:92,977,437...93,016,721
|
|
| G
|
Pakap
|
paralemmin A kinase anchor protein
|
increases expression
|
ISO
|
Selenium results in increased expression of PALM2AKAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:76,977,112...77,443,656
|
|
| G
|
Palld
|
palladin, cytoskeletal associated protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PALLD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232
|
|
| G
|
Pam
|
peptidylglycine alpha-amidating monooxygenase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PAM mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:105,445,929...105,719,285
|
|
| G
|
Pank1
|
pantothenate kinase 1
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:241,741,083...241,807,824
|
|
| G
|
Pank4
|
pantothenate kinase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PANK4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:170,807,744...170,824,478
Ensembl chr 5:170,807,745...170,824,477
|
|
| G
|
Paox
|
polyamine oxidase
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PAOX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:204,349,326...204,358,140
Ensembl chr 1:204,348,987...204,358,481
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]
|
CTD |
PMID:17339365 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pax6
|
paired box 6
|
multiple interactions
|
ISO
|
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of PAX6 mRNA
|
CTD |
PMID:37914285 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Paxbp1
|
PAX3 and PAX7 binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PAXBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:43,758,116...43,787,624
Ensembl chr11:43,758,116...43,787,542
|
|
| G
|
Pc
|
pyruvate carboxylase
|
increases expression
|
ISO
|
Selenium results in increased expression of PC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940
|
|
| G
|
Pcbp1
|
poly(rC) binding protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PCBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:120,530,100...120,532,107
Ensembl chr 4:120,529,172...120,539,111
|
|
| G
|
Pcdh9
|
protocadherin 9
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of PCDH9 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr15:75,748,472...76,646,644 NCBI chr15:76,078,024...76,127,778
Ensembl chr15:75,749,278...76,645,302
|
|
| G
|
Pcdhgc3
|
protocadherin gamma subfamily C, 3
|
increases expression
|
ISO
|
Selenium results in increased expression of PCDHGC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:29,884,245...29,919,095
|
|
| G
|
Pcm1
|
pericentriolar material 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PCM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:57,711,833...57,808,842
Ensembl chr16:57,711,833...57,808,599
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression
|
ISO
|
Selenium deficiency results in decreased expression of PCNA mRNA
|
CTD |
PMID:11925459 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pcolce
|
procollagen C-endopeptidase enhancer
|
increases expression
|
ISO
|
Selenium results in increased expression of PCOLCE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287
|
|
| G
|
Pcp4
|
Purkinje cell protein 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PCP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:49,229,185...49,331,186
Ensembl chr11:49,270,186...49,331,186
|
|
| G
|
Pcsk5
|
proprotein convertase subtilisin/kexin type 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PCSK5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347
|
|
| G
|
Pcsk7
|
proprotein convertase subtilisin/kexin type 7
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PCSK7 mRNA Selenium results in increased expression of PCSK7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:55,098,821...55,121,416
Ensembl chr 8:55,098,806...55,121,382
|
|
| G
|
Pcyox1l
|
prenylcysteine oxidase 1 like
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PCYOX1L mRNA Selenium results in decreased expression of PCYOX1L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:57,420,971...57,431,632
Ensembl chr18:57,420,977...57,431,632
|
|
| G
|
Pde8a
|
phosphodiesterase 8A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PDE8A mRNA Selenium results in decreased expression of PDE8A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:144,575,428...144,698,215
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PDGFA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdlim4
|
PDZ and LIM domain 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PDLIM4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:38,699,444...38,713,696
Ensembl chr10:38,699,444...38,713,659
|
|
| G
|
Pdlim7
|
PDZ and LIM domain 7
|
increases expression
|
ISO
|
Selenium results in increased expression of PDLIM7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956
|
|
| G
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
|
|
| G
|
Pds5b
|
PDS5 cohesin associated factor B
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA Selenium results in decreased expression of APRIN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:5,038,114...5,181,208
Ensembl chr12:5,038,160...5,181,208
|
|
| G
|
Pdss2
|
decaprenyl diphosphate synthase subunit 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PDSS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:48,291,788...48,520,846
Ensembl chr20:48,291,797...48,535,689
|
|
| G
|
Pea15
|
proliferation and apoptosis adaptor protein 15
|
increases expression
|
ISO
|
Selenium results in increased expression of PEA15 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
|
|
| G
|
Pef1
|
penta-EF hand domain containing 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PEF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:147,735,973...147,759,239
Ensembl chr 5:147,735,976...147,761,092
|
|
| G
|
Per3
|
period circadian regulator 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PER3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
|
|
| G
|
Pes1
|
pescadillo ribosomal biogenesis factor 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PES1 mRNA Selenium results in increased expression of PES1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:83,074,346...83,090,726
Ensembl chr14:83,074,319...83,091,718
|
|
| G
|
Pex1
|
peroxisomal biogenesis factor 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PEX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:31,474,670...31,513,621
Ensembl chr 4:31,470,845...31,513,811
|
|
| G
|
Pex14
|
peroxisomal biogenesis factor 14
|
increases expression
|
ISO
|
Selenium results in increased expression of PEX14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:164,682,876...164,819,352
Ensembl chr 5:164,682,715...164,819,352
|
|
| G
|
Pex3
|
peroxisomal biogenesis factor 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PEX3 mRNA Selenium results in decreased expression of PEX3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:9,732,641...9,774,479
Ensembl chr 1:9,732,492...9,774,576
|
|
| G
|
Pex7
|
peroxisomal biogenesis factor 7
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PEX7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:16,402,319...16,466,304
Ensembl chr 1:16,402,320...16,466,366
|
|
| G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of PFKFB3 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052
|
|
| G
|
Pfkl
|
phosphofructokinase, liver type
|
increases expression
|
ISO
|
Selenium results in increased expression of PFKL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,663,955...10,685,966
|
|
| G
|
Pfn1
|
profilin 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PFN1 mRNA Selenium results in increased expression of PFN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611
|
|
| G
|
Pgap1
|
post-GPI attachment to proteins inositol deacylase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PGAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:63,470,023...63,538,772
Ensembl chr 9:63,470,024...63,538,772
|
|
| G
|
Pgap2
|
post-GPI attachment to proteins 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PGAP2 mRNA Selenium results in increased expression of PGAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:166,003,593...166,030,088
Ensembl chr 1:166,003,523...166,030,088
|
|
| G
|
Pglyrp3
|
peptidoglycan recognition protein 3
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PGLYRP3 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 2:180,174,931...180,186,007
Ensembl chr 2:179,201,527...179,219,994 Ensembl chr 2:179,201,527...179,219,994
|
|
| G
|
Pgm3
|
phosphoglucomutase 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA Selenium results in decreased expression of PGM3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:96,398,331...96,416,045
Ensembl chr 8:96,398,269...96,416,021
|
|
| G
|
Phactr2
|
phosphatase and actin regulator 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PHACTR2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:9,411,412...9,680,648
Ensembl chr 1:9,418,085...9,680,583
|
|
| G
|
Phf3
|
PHD finger protein 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PHF3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:40,559,929...40,632,096
Ensembl chr 9:40,559,929...40,632,056
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PHLDA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Pias4
|
protein inhibitor of activated STAT, 4
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PIAS4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,197,032...9,210,557
Ensembl chr 7:9,196,896...9,210,527
|
|
| G
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PIEZO1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:67,453,120...67,515,347
Ensembl chr19:67,453,122...67,515,037
|
|
| G
|
Pigg
|
phosphatidylinositol glycan anchor biosynthesis, class G
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PIGG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:1,549,891...1,578,174
Ensembl chr14:1,549,891...1,578,167
|
|
| G
|
Pigk
|
phosphatidylinositol glycan anchor biosynthesis, class K
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PIGK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:244,289,928...244,375,394
Ensembl chr 2:244,250,621...244,376,030
|
|
| G
|
Pigp
|
phosphatidylinositol glycan anchor biosynthesis, class P
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PIGP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:47,152,601...47,158,766
Ensembl chr11:47,148,465...47,160,082
|
|
| G
|
Pih1d1
|
PIH1 domain containing 1
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of PIH1D1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIH1D1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,774,562...104,781,757
Ensembl chr 1:104,776,082...104,781,756
|
|
| G
|
Pik3cd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of PIK3CD mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIK3CD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PIK3R1 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pitpna
|
phosphatidylinositol transfer protein, alpha
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PITPNA mRNA Selenium results in increased expression of PITPNA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:60,929,050...60,969,614
Ensembl chr10:60,929,007...60,971,830
|
|
| G
|
Pitpnm1
|
phosphatidylinositol transfer protein, membrane-associated 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PITPNM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,823,568...210,836,989
Ensembl chr 1:210,823,565...210,836,990
|
|
| G
|
Pitx1
|
paired-like homeodomain 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PITX1 mRNA Selenium results in increased expression of PITX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:8,794,051...8,805,477
Ensembl chr17:8,799,319...8,805,476
|
|
| G
|
Pja1
|
praja ring finger ubiquitin ligase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PJA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:68,621,101...68,626,001
Ensembl chr X:68,620,084...68,638,407
|
|
| G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
increases expression
|
ISO
|
Selenium results in increased expression of PKD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
|
|
| G
|
Pkm
|
pyruvate kinase M1/2
|
increases expression
|
ISO
|
Selenium results in increased expression of PKM mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396
|
|
| G
|
Pkn2
|
protein kinase N2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PKN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:234,454,001...234,559,369
Ensembl chr 2:234,454,001...234,594,649
|
|
| G
|
Pla2g12a
|
phospholipase A2, group XIIA
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA Selenium results in decreased expression of PLA2G12A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
|
|
| G
|
Plaat3
|
phospholipase A and acyltransferase 3
|
increases expression
|
ISO
|
Selenium results in increased expression of PLAAT3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:214,211,755...214,245,551
Ensembl chr 1:214,211,791...214,246,763
|
|
| G
|
Plcb4
|
phospholipase C, beta 4
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of PLCB4 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PLCB4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:143,405,950...143,775,113
|
|
| G
|
Plec
|
plectin
|
increases expression
|
ISO
|
Selenium results in increased expression of PLEC mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:109,768,447...109,828,089
|
|
| G
|
Plekha5
|
pleckstrin homology domain containing A5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PLEKHA5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:175,065,011...175,234,672
Ensembl chr 4:175,065,183...175,234,672
|
|
| G
|
Plekhj1
|
pleckstrin homology domain containing J1
|
increases expression
|
ISO
|
Selenium results in increased expression of PLEKHJ1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,566,200...9,570,993
|
|
| G
|
Plekho1
|
pleckstrin homology domain containing O1
|
increases expression
|
ISO
|
Selenium results in increased expression of PLEKHO1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:186,233,435...186,242,114
Ensembl chr 2:186,233,452...186,241,354
|
|
| G
|
Pllp
|
plasmolipin
|
increases expression
|
ISO
|
Selenium results in increased expression of PLLP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226
|
|
| G
|
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PLOD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022
|
|
| G
|
Plpp3
|
phospholipid phosphatase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PLPP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
|
|
| G
|
Plvap
|
plasmalemma vesicle associated protein
|
increases expression
|
ISO
|
Selenium results in increased expression of PLVAP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,218,966...18,231,279
Ensembl chr16:18,218,967...18,231,454
|
|
| G
|
Plxnb2
|
plexin B2
|
increases expression
|
ISO
|
Selenium results in increased expression of PLXNB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746
|
|
| G
|
Pml
|
PML nuclear body scaffold
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PML mRNA Selenium results in increased expression of PML mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
|
|
| G
|
Pmpcb
|
peptidase, mitochondrial processing subunit beta
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PMPCB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:14,189,807...14,202,584
Ensembl chr 4:14,165,844...14,202,615
|
|
| G
|
Pms1
|
PMS1 homolog 1, mismatch repair system component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PMS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:55,721,393...55,832,225
Ensembl chr 9:55,745,374...55,832,221
|
|
| G
|
Pnisr
|
PNN interacting serine and arginine rich protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PNISR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611
|
|
| G
|
Pnkp
|
polynucleotide kinase 3'-phosphatase
|
increases expression
|
ISO
|
Selenium results in increased expression of PNKP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,476,801...104,483,409
Ensembl chr 1:104,478,088...104,483,408
|
|
| G
|
Pnpla6
|
patatin-like phospholipase domain containing 6
|
increases expression
|
ISO
|
Selenium results in increased expression of PNPLA6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:6,372,284...6,401,632
Ensembl chr12:6,372,293...6,401,631
|
|
| G
|
Pola2
|
DNA polymerase alpha 2, accessory subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of POLA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,656,500...212,680,667
Ensembl chr 1:212,656,501...212,680,542
|
|
| G
|
Poldip3
|
DNA polymerase delta interacting protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of POLDIP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:116,154,892...116,183,319
Ensembl chr 7:116,154,892...116,183,300
|
|
| G
|
Poll
|
DNA polymerase lambda
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA Selenium results in increased expression of POLL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:254,349,229...254,357,689
Ensembl chr 1:254,349,231...254,358,020
|
|
| G
|
Polr2a
|
RNA polymerase II subunit A
|
increases expression
|
ISO
|
Selenium results in increased expression of POLR2A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179
|
|
| G
|
Polr2c
|
RNA polymerase II subunit C
|
increases expression
|
ISO
|
Selenium results in increased expression of POLR2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:10,164,148...10,170,930
Ensembl chr19:10,164,145...10,170,971
|
|
| G
|
Polr2k
|
RNA polymerase II, I and III subunit K
|
decreases expression
|
ISO
|
Selenium results in decreased expression of POLR2K mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:69,241,233...69,244,579
Ensembl chr 7:69,232,179...69,244,578
|
|
| G
|
Polr2m
|
RNA polymerase II subunit M
|
decreases expression
|
ISO
|
Selenium results in decreased expression of POLR2M mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:81,012,770...81,020,201
Ensembl chr 8:81,012,771...81,020,302
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Mercury results in decreased activity of PON1 protein]; Selenium inhibits the reaction [Methylmercury Compounds results in decreased activity of PON1 protein]
|
CTD |
PMID:21543280 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PON2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Por
|
cytochrome p450 oxidoreductase
|
increases expression
|
ISO
|
Selenium results in increased expression of POR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
| G
|
Postn
|
periostin
|
decreases expression
|
ISO
|
Selenium results in decreased expression of POSTN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of PPARA mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]; Selenium promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein]
|
CTD |
PMID:17439952 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PPARGC1A mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PPAT mRNA Selenium results in decreased expression of PPAT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405
|
|
| G
|
Ppfibp1
|
PPFIA binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PPFIBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:181,538,249...181,682,079
Ensembl chr 4:181,539,450...181,682,076
|
|
| G
|
Ppib
|
peptidylprolyl isomerase B
|
increases expression
|
ISO
|
Selenium results in increased expression of PPIB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:75,498,966...75,504,823
Ensembl chr 8:75,498,797...75,504,847
|
|
| G
|
Ppig
|
peptidylprolyl isomerase G
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PPIG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:74,891,846...74,920,750
|
|
| G
|
Ppil2
|
peptidylprolyl isomerase like 2
|
increases expression
|
ISO
|
Selenium results in increased expression of PPIL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:97,401,944...97,424,581
Ensembl chr11:97,401,963...97,430,769
|
|
| G
|
Ppm1j
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J
|
increases expression
|
ISO
|
Selenium results in increased expression of PPM1J mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:194,966,854...194,972,228
Ensembl chr 2:194,966,950...194,972,227
|
|
| G
|
Ppme1
|
protein phosphatase methylesterase 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA Selenium results in increased expression of PPME1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:164,080,242...164,127,261
Ensembl chr 1:164,080,242...164,127,220
|
|
| G
|
Ppp1ca
|
protein phosphatase 1 catalytic subunit alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of PPP1CA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193
|
|
| G
|
Ppp1r10
|
protein phosphatase 1, regulatory subunit 10
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R10 mRNA Selenium results in increased expression of PPP1R10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,827,802...2,842,418
|
|
| G
|
Ppp1r14b
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
increases expression
|
ISO
|
Selenium results in increased expression of PPP1R14B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431 Ensembl chr 1:21,088,517...21,101,431
|
|
| G
|
Ppp1r9a
|
protein phosphatase 1, regulatory subunit 9A
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA Selenium results in decreased expression of PPP1R9A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,988,827...34,258,927
|
|
| G
|
Ppp2r1a
|
protein phosphatase 2 scaffold subunit A alpha
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PPP2R1A mRNA Selenium results in increased expression of PPP2R1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:69,213,038...69,238,242
|
|
| G
|
Ppp2r5d
|
protein phosphatase 2, regulatory subunit B', delta
|
increases expression
|
ISO
|
Selenium results in increased expression of PPP2R5D mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:21,767,963...21,797,997
Ensembl chr 9:21,767,688...21,797,996
|
|
| G
|
Ppp2r5e
|
protein phosphatase 2 regulatory subunit B', epsilon
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PPP2R5E mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573
|
|
| G
|
Ppp4c
|
protein phosphatase 4, catalytic subunit
|
increases expression
|
ISO
|
Selenium results in increased expression of PPP4C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168
|
|
| G
|
Ppp6r2
|
protein phosphatase 6, regulatory subunit 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PPP6R2 mRNA Selenium results in increased expression of PPP6R2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:122,164,968...122,236,625
Ensembl chr 7:122,194,723...122,236,621
|
|
| G
|
Praf2
|
PRA1 domain family, member 2
|
increases expression
|
ISO
|
Selenium results in increased expression of PRAF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:17,445,313...17,447,950
Ensembl chr X:17,445,313...17,447,950
|
|
| G
|
Prdm2
|
PR/SET domain 2
|
increases expression
|
ISO
|
Selenium results in increased expression of PRDM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:160,704,396...160,815,184
Ensembl chr 5:160,705,462...160,815,140
|
|
| G
|
Prdx2
|
peroxiredoxin 2
|
decreases expression
|
EXP
|
Selenium deficiency results in decreased expression of PRDX2 mRNA
|
CTD |
PMID:15792362 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
|
|
| G
|
Prickle2
|
prickle planar cell polarity protein 2
|
decreases methylation
|
ISO
|
Selenium results in decreased methylation of PRICKLE2 gene
|
CTD |
PMID:21606628 |
|
NCBI chr 4:126,426,767...126,771,986
Ensembl chr 4:126,426,771...126,772,008
|
|
| G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
decreases expression multiple interactions
|
EXP
|
Selenium deficiency results in decreased expression of PRKAA2 mRNA [Selenium deficiency co-treated with T-2 Toxin] results in decreased expression of PRKAA2 mRNA
|
CTD |
PMID:38796086 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
|
|
| G
|
Prkag1
|
protein kinase AMP-activated non-catalytic subunit gamma 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PRKAG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,842,058...131,859,484
Ensembl chr 7:131,842,060...131,859,503
|
|
| G
|
Prkag2
|
protein kinase AMP-activated non-catalytic subunit gamma 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of PRKAG2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,744,588...10,985,939
|
|
| G
|
Prkcb
|
protein kinase C, beta
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PRKCB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
|
|
| G
|
Prkci
|
protein kinase C, iota
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PRKCI mRNA Selenium results in decreased expression of PRKCI mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
|
|
| G
|
Prkd2
|
protein kinase D2
|
increases expression
|
ISO
|
Selenium results in increased expression of PRKD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
|
|
| G
|
Prmt1
|
protein arginine methyltransferase 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PRMT1 mRNA Selenium results in increased expression of PRMT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827
|
|
| G
|
Prmt2
|
protein arginine methyltransferase 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PRMT2 mRNA Selenium results in increased expression of PRMT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:12,391,388...12,420,096
Ensembl chr20:12,394,268...12,420,108
|
|
| G
|
Prmt3
|
protein arginine methyltransferase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PRMT3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:108,628,899...108,718,803
Ensembl chr 1:108,626,749...108,718,803
|
|
| G
|
Prmt5
|
protein arginine methyltransferase 5
|
increases expression
|
ISO
|
Selenium results in increased expression of PRMT5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:31,938,927...31,948,318
Ensembl chr15:31,938,719...31,948,426
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of PROC mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Prpf40a
|
pre-mRNA processing factor 40 homolog A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PRPF40A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:58,038,042...58,099,363
|
|
| G
|
Prpf4b
|
pre-mRNA processing factor 4B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PRP4K mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:30,190,721...30,230,153
Ensembl chr17:30,193,907...30,225,420
|
|
| G
|
Prpf6
|
pre-mRNA processing factor 6
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PRPF6 mRNA Selenium results in increased expression of PRPF6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:189,084,465...189,148,705
Ensembl chr 3:189,081,794...189,152,786
|
|
| G
|
Prpf8
|
pre-mRNA processing factor 8
|
increases expression
|
ISO
|
Selenium results in increased expression of PRPF8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:60,829,778...60,852,887
Ensembl chr10:60,829,778...60,852,887
|
|
| G
|
Prrc2c
|
proline-rich coiled-coil 2C
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PRRC2C mRNA Selenium results in decreased expression of PRRC2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:77,537,226...77,606,926
Ensembl chr13:77,537,814...77,607,001
|
|
| G
|
Prss8
|
serine protease 8
|
increases expression
|
ISO
|
Selenium results in increased expression of PRSS8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,966,701...191,971,271
Ensembl chr 1:191,966,701...191,971,193
|
|
| G
|
Prune1
|
prune exopolyphosphatase 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PRUNE1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:185,519,569...185,548,402
Ensembl chr 2:185,520,781...185,548,402
|
|
| G
|
Prx
|
periaxin
|
increases expression
|
ISO
|
Selenium results in increased expression of PRX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:91,912,669...91,934,754
Ensembl chr 1:91,911,999...91,937,235
|
|
| G
|
Psap
|
prosaposin
|
increases expression
|
ISO
|
Selenium results in increased expression of PSAP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,757,181...28,783,421
|
|
| G
|
Psip1
|
PC4 and SRSF1 interacting protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PSIP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:102,892,929...102,925,191
Ensembl chr 5:102,892,932...102,925,170
|
|
| G
|
Psmb10
|
proteasome 20S subunit beta 10
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMB10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210
|
|
| G
|
Psmb4
|
proteasome 20S subunit beta 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMB4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
|
|
| G
|
Psmc1
|
proteasome 26S subunit, ATPase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:125,122,490...125,134,858
|
|
| G
|
Psmc4
|
proteasome 26S subunit, ATPase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060
|
|
| G
|
Psmd4
|
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMD4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:185,286,868...185,297,201
|
|
| G
|
Psmd6
|
proteasome 26S subunit, non-ATPase 6
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMD6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:13,532,675...13,542,682
Ensembl chr15:13,532,675...13,542,682
|
|
| G
|
Psmd8
|
proteasome 26S subunit, non-ATPase 8
|
increases expression
|
ISO
|
Selenium results in increased expression of PSMD8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:93,601,857...93,608,689
Ensembl chr 1:93,601,853...93,608,689
|
|
| G
|
Psme1
|
proteasome activator subunit 1
|
increases expression
|
ISO
|
Selenium results in increased expression of PSME1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,038,962...33,041,849
Ensembl chr15:33,038,597...33,041,848
|
|
| G
|
Ptafr
|
platelet-activating factor receptor
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PTAFR mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408
|
|
| G
|
Ptgds
|
prostaglandin D2 synthase
|
increases expression
|
ISO
|
Selenium results in increased expression of PTGDS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978
|
|
| G
|
Ptges
|
prostaglandin E synthase
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of PTGES mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of PTGES protein Selenium results in increased expression of PTGES mRNA
|
CTD |
PMID:19244175 PMID:21669866 |
|
NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995
|
|
| G
|
Ptgr1
|
prostaglandin reductase 1
|
affects expression
|
EXP
|
Selenium affects the expression of PTGR1 protein
|
CTD |
PMID:19351701 |
|
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions increases expression
|
ISO EXP
|
PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]; Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Selenium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] Selenium deficiency results in increased expression of PTGS2 mRNA; Selenium deficiency results in increased expression of PTGS2 protein Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of PTGS2 protein]] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA]; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 protein
|
CTD |
PMID:11978490 PMID:17439952 PMID:22223226 PMID:30526071 PMID:37422542 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptms
|
parathymosin
|
increases expression
|
ISO
|
Selenium results in increased expression of PTMS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:159,408,649...159,415,212
|
|
| G
|
Ptov1
|
PTOV1, extended AT-hook containing adaptor protein
|
increases expression
|
ISO
|
Selenium results in increased expression of PTOV1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:104,483,553...104,496,161
Ensembl chr 1:104,483,556...104,490,101
|
|
| G
|
Ptpa
|
protein phosphatase 2 phosphatase activator
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PTPA mRNA Selenium results in increased expression of PTPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:34,087,575...34,162,772
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
increases expression multiple interactions decreases glutathionylation
|
EXP
|
Selenium results in increased expression of PTPN1 protein Selenium inhibits the reaction [Potassium Iodide results in decreased expression of PTPN1 mRNA] Selenium results in decreased glutathionylation of PTPN1 protein
|
CTD |
PMID:19022953 PMID:38013145 |
|
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18
|
increases expression
|
ISO
|
Selenium results in increased expression of PTPN18 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:44,166,571...44,185,885
Ensembl chr 9:44,168,269...44,186,917
|
|
| G
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of PTPN6 mRNA Selenium results in increased expression of PTPN6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,212,320...159,237,069
Ensembl chr 4:159,212,320...159,237,069
|
|
| G
|
Ptpro
|
protein tyrosine phosphatase, receptor type, O
|
decreases expression
|
ISO
|
Selenium results in decreased expression of PTPRO mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:171,895,232...172,105,903
|
|
| G
|
Ptx3
|
pentraxin 3
|
increases expression
|
ISO
|
Selenium results in increased expression of PTX3 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372
|
|
| G
|
Puf60
|
poly-U binding splicing factor 60
|
increases expression
|
ISO
|
Selenium results in increased expression of PUF60 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,663,490...109,674,443
Ensembl chr 7:109,663,490...109,674,724
|
|
| G
|
Pwp1
|
PWP1 homolog, endonuclein
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PWP1 mRNA Selenium results in decreased expression of PWP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:19,870,465...19,886,463
Ensembl chr 7:19,866,927...19,886,463
|
|
| G
|
Pycard
|
PYD and CARD domain containing
|
increases expression
|
ISO
|
Selenium results in increased expression of PYCARD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
|
|
| G
|
Pycr3
|
pyrroline-5-carboxylate reductase 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of PYCR3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:109,484,263...109,489,554
|
|
| G
|
Pygb
|
glycogen phosphorylase B
|
increases expression
|
ISO
|
Selenium results in increased expression of PYGB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:160,072,115...160,123,961
|
|
| G
|
Qtrt1
|
queuine tRNA-ribosyltransferase catalytic subunit 1
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of QTRT1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of QTRT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,239,993...28,249,983
Ensembl chr 8:28,242,472...28,250,398
|
|
| G
|
R3hdm1
|
R3H domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of R3HDM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:42,148,281...42,286,311
Ensembl chr13:42,148,290...42,286,311
|
|
| G
|
Rab11b
|
RAB11B, member RAS oncogene family
|
increases expression
|
ISO
|
Selenium results in increased expression of RAB11B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:15,223,613...15,236,754
Ensembl chr 7:15,223,534...15,236,756
|
|
| G
|
Rab14
|
RAB14, member RAS oncogene family
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RAB14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:38,899,430...38,920,572
Ensembl chr 3:38,901,400...38,912,273
|
|
| G
|
Rab25
|
RAB25, member RAS oncogene family
|
increases expression
|
ISO
|
Selenium results in increased expression of RAB25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:176,298,124...176,304,221
Ensembl chr 2:176,298,124...176,304,221
|
|
| G
|
Rab2a
|
RAB2A, member RAS oncogene family
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RAB2 mRNA Selenium results in increased expression of RAB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488
|
|
| G
|
Rabac1
|
Rab acceptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RABAC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:89,691,884...89,695,017
Ensembl chr 1:89,691,884...89,695,017
|
|
| G
|
Rabgap1
|
RAB GTPase activating protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RABGAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:41,617,784...41,735,795
Ensembl chr 3:41,617,793...41,735,791
|
|
| G
|
Rad23a
|
RAD23 homolog A, nucleotide excision repair protein
|
increases expression
|
ISO
|
Selenium results in increased expression of RAD23A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543
|
|
| G
|
Rad23b
|
RAD23 homolog B, nucleotide excision repair protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RAD23B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426
|
|
| G
|
Ralbp1
|
ralA binding protein 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of RALBP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:112,903,289...112,940,093
Ensembl chr 9:112,903,302...112,939,659
|
|
| G
|
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RALGPS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:36,831,029...37,067,659
Ensembl chr 3:36,831,029...37,067,659
|
|
| G
|
Raly
|
RALY heterogeneous nuclear ribonucleoprotein
|
increases expression
|
ISO
|
Selenium results in increased expression of RALY mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:163,766,183...163,830,726
Ensembl chr 3:163,766,478...163,830,740
|
|
| G
|
Ranbp2
|
RAN binding protein 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA Selenium results in decreased expression of RANBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,985,275...27,036,571
|
|
| G
|
Ranbp3
|
RAN binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of RANBP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:1,594,344...1,631,587
Ensembl chr 9:1,594,346...1,631,587
|
|
| G
|
Ranbp9
|
RAN binding protein 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RANBP9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:21,426,717...21,508,964
Ensembl chr17:21,426,777...21,508,964
|
|
| G
|
Rangap1
|
RAN GTPase activating protein 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA Selenium results in increased expression of RANGAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
|
|
| G
|
Rapgef6
|
Rap guanine nucleotide exchange factor 6
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RAPGEF6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:39,156,573...39,324,947
Ensembl chr10:39,156,620...39,324,946
|
|
| G
|
Rassf1
|
Ras association domain family member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RASSF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805
|
|
| G
|
Rassf7
|
Ras association domain family member 7
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,749,173...205,753,350
Ensembl chr 1:205,747,654...205,753,360
|
|
| G
|
Rbbp4
|
RB binding protein 4, chromatin remodeling factor
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RBBP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501
|
|
| G
|
Rbbp6
|
RB binding protein 6, ubiquitin ligase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RBBP6 mRNA Selenium results in decreased expression of RBBP6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:186,934,938...186,966,852
|
|
| G
|
Rbck1
|
RANBP2-type and C3HC4-type zinc finger containing 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RBCK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:161,249,389...161,266,321
Ensembl chr 3:161,249,390...161,266,032
|
|
| G
|
Rbfox3
|
RNA binding fox-1 homolog 3
|
multiple interactions
|
ISO
|
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of RBFOX3 mRNA
|
CTD |
PMID:37914285 |
|
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
|
|
| G
|
Rbm10
|
RNA binding motif protein 10
|
increases expression
|
ISO
|
Selenium results in increased expression of RBM10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:4,093,914...4,126,060
Ensembl chr X:4,093,914...4,126,060
|
|
| G
|
Rbm14
|
RNA binding motif protein 14
|
increases expression
|
ISO
|
Selenium results in increased expression of RBM14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:211,523,972...211,535,065
|
|
| G
|
Rbm25
|
RNA binding motif protein 25
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RBM25 mRNA Selenium results in decreased expression of RBM25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:108,993,119...109,050,159
Ensembl chr 6:109,002,869...109,050,159
|
|
| G
|
Rbm4
|
RNA binding motif protein 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RBM4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:211,507,845...211,516,907
Ensembl chr 1:211,506,343...211,516,891
|
|
| G
|
Rbm42
|
RNA binding motif protein 42
|
increases expression
|
ISO
|
Selenium results in increased expression of RBM42 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:95,026,050...95,036,020
Ensembl chr 1:95,026,050...95,035,980
|
|
| G
|
Rbm5
|
RNA binding motif protein 5
|
increases expression
|
ISO
|
Selenium results in increased expression of RBM5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,298,866...117,328,107
Ensembl chr 8:117,299,084...117,327,706
|
|
| G
|
Rbms1
|
RNA binding motif, single stranded interacting protein 1
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of RBMS1 mRNA Selenium results in increased expression of RBMS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:65,604,475...65,829,072
Ensembl chr 3:65,606,358...65,829,013
|
|
| G
|
Rbpms
|
RNA binding protein, mRNA processing factor
|
increases expression
|
ISO
|
Selenium results in increased expression of RBPMS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:64,942,159...65,098,504
Ensembl chr16:64,942,530...65,098,503
|
|
| G
|
Rchy1
|
ring finger and CHY zinc finger domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RCHY1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:16,397,533...16,413,286
Ensembl chr14:16,397,494...16,413,451
|
|
| G
|
Rcor3
|
REST corepressor 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RCOR3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:106,156,166...106,196,542
Ensembl chr13:106,157,232...106,196,575
|
|
| G
|
Rdh11
|
retinol dehydrogenase 11
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RDH11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:103,712,373...103,728,247
Ensembl chr 6:103,712,374...103,729,741
|
|
| G
|
Reck
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RECK mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,898,717...62,965,274
Ensembl chr 5:62,898,668...62,965,270
|
|
| G
|
Recql
|
RecQ like helicase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RECQL mRNA Selenium results in decreased expression of RECQL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:177,039,351...177,063,968
Ensembl chr 4:177,035,128...177,063,838
|
|
| G
|
Recql5
|
RecQ like helicase 5
|
increases expression
|
ISO
|
Selenium results in increased expression of RECQL5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:101,625,477...101,664,582
Ensembl chr10:101,625,480...101,664,663
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases expression
|
ISO EXP
|
Selenium inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] [Vitamin E co-treated with Selenium] results in decreased activity of RELA protein; Selenium inhibits the reaction [arsenite results in decreased expression of RELA protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of RELA protein Selenium results in increased expression of RELA mRNA
|
CTD |
PMID:14734799 PMID:19244175 PMID:21481475 PMID:22223226 PMID:29324385 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Retreg2
|
reticulophagy regulator family member 2
|
increases expression
|
ISO
|
Selenium results in increased expression of RETREG2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:84,088,935...84,095,072
Ensembl chr 9:84,088,964...84,094,837
|
|
| G
|
Rftn1
|
raftlin lipid raft linker 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RFTN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:18,285,934...18,499,819
|
|
| G
|
Rhbdd3
|
rhomboid domain containing 3
|
increases expression
|
ISO
|
Selenium results in increased expression of RHBDD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:84,208,155...84,214,334
Ensembl chr14:84,209,432...84,214,332
|
|
| G
|
Rhobtb1
|
Rho-related BTB domain containing 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB1 mRNA Selenium results in decreased expression of RHOBTB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:19,326,197...19,455,182
Ensembl chr20:19,326,212...19,402,057
|
|
| G
|
Rhobtb3
|
Rho-related BTB domain containing 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA Selenium results in decreased expression of RHOBTB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906
|
|
| G
|
Rhog
|
ras homolog family member G
|
increases expression
|
ISO
|
Selenium results in increased expression of RHOG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:166,030,685...166,046,254
Ensembl chr 1:166,017,427...166,044,787
|
|
| G
|
Ring1
|
ring finger protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RING1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,832,013...4,835,516
Ensembl chr20:4,831,993...4,835,513
|
|
| G
|
Ripk1
|
receptor interacting serine/threonine kinase 1
|
increases expression multiple interactions
|
ISO
|
Selenium deficiency results in increased expression of RIPK1 mRNA; Selenium deficiency results in increased expression of RIPK1 protein Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK1 protein]]
|
CTD |
PMID:37422542 |
|
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
|
|
| G
|
Ripk3
|
receptor-interacting serine-threonine kinase 3
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of RIPK3 protein]] Selenium deficiency results in increased expression of RIPK3 mRNA; Selenium deficiency results in increased expression of RIPK3 protein
|
CTD |
PMID:37422542 |
|
NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025
|
|
| G
|
Rnaseh1
|
ribonuclease H1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RNASEH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:51,011,244...51,020,638
Ensembl chr 6:51,011,234...51,020,627
|
|
| G
|
Rnd1
|
Rho family GTPase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RND1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
|
|
| G
|
Rnd3
|
Rho family GTPase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RND3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
|
|
| G
|
Rnf111
|
ring finger protein 111
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RNF111 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:79,984,831...80,061,022
Ensembl chr 8:79,984,837...80,060,984
|
|
| G
|
Rnf114
|
ring finger protein 114
|
increases expression
|
ISO
|
Selenium results in increased expression of RNF114 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:176,641,456...176,653,262
Ensembl chr 3:176,641,499...176,671,960
|
|
| G
|
Rnf220
|
ring finger protein 220
|
increases expression
|
ISO
|
Selenium results in increased expression of RNF220 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:135,975,739...136,198,017
Ensembl chr 5:135,975,739...136,197,858
|
|
| G
|
Rnf40
|
ring finger protein 40
|
increases expression
|
ISO
|
Selenium results in increased expression of RNF40 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,632,988...191,649,231
Ensembl chr 1:191,633,034...191,648,421
|
|
| G
|
Rnh1
|
ribonuclease/angiogenin inhibitor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RNH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,698,882...205,711,348
Ensembl chr 1:205,698,882...205,711,582
|
|
| G
|
Rnpep
|
arginyl aminopeptidase
|
increases expression
|
ISO
|
Selenium results in increased expression of RNPEP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:49,251,259...49,271,440
Ensembl chr13:49,251,264...49,269,799
|
|
| G
|
Rnps1
|
RNA binding protein with serine rich domain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RNPS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:13,950,151...13,960,396
Ensembl chr10:13,950,184...13,960,393
|
|
| G
|
Ro60
|
Ro60, Y RNA binding protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RO60 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:58,049,838...58,070,828
Ensembl chr13:58,049,858...58,076,264
|
|
| G
|
Rpl10a
|
ribosomal protein L10A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL10A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:6,390,533...6,393,091
Ensembl chr20:6,390,179...6,393,091
|
|
| G
|
Rpl14
|
ribosomal protein L14
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:129,163,317...129,167,459
|
|
| G
|
Rpl23
|
ribosomal protein L23
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL23 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:83,268,223...83,272,184
Ensembl chr10:83,262,592...83,272,214
|
|
| G
|
Rpl27
|
ribosomal protein L27
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL27 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,875,758...86,879,457
Ensembl chr10:86,876,024...86,879,441
|
|
| G
|
Rpl31
|
ribosomal protein L31
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL31 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:49,143,044...49,147,155
Ensembl chr 9:49,142,955...49,147,155
|
|
| G
|
Rpl37a
|
ribosomal protein L37A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL37A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:81,748,091...81,750,174
Ensembl chr 9:81,748,103...81,751,975
|
|
| G
|
Rpl38
|
ribosomal protein L38
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL38 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:100,200,414...100,204,070
Ensembl chr16:10,188,932...10,189,144 Ensembl chr 2:10,188,932...10,189,144 Ensembl chr 3:10,188,932...10,189,144 Ensembl chr14:10,188,932...10,189,144 Ensembl chr10:10,188,932...10,189,144
|
|
| G
|
Rpl39
|
ribosomal protein L39
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL39 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:121,192,901...121,195,896
Ensembl chr 7:31,721,884...31,722,039 Ensembl chr15:31,721,884...31,722,039 Ensembl chr X:31,721,884...31,722,039
|
|
| G
|
Rpl7
|
ribosomal protein L7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPL7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:8,000,446...8,003,454
Ensembl chr 5:7,850,630...8,003,451
|
|
| G
|
Rprd2
|
regulation of nuclear pre-mRNA domain containing 2
|
increases expression
|
ISO
|
Selenium results in increased expression of RPRD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:186,000,375...186,056,943
Ensembl chr 2:186,000,316...186,056,943
|
|
| G
|
Rps20
|
ribosomal protein S20
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS20 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:21,616,687...21,618,068
Ensembl chr 3:42,839,965...43,095,621 Ensembl chr 9:42,839,965...43,095,621 Ensembl chr 5:42,839,965...43,095,621
|
|
| G
|
Rps21-ps1
|
ribosomal protein S21, pseudogene 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS21 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:158,670,141...158,670,484
Ensembl chr 5:158,670,116...158,670,490
|
|
| G
|
Rps25
|
ribosomal protein s25
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:53,630,333...53,632,810
Ensembl chr 8:53,629,861...53,632,808 Ensembl chr 8:53,629,861...53,632,808
|
|
| G
|
Rps27
|
ribosomal protein S27
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS27 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:177,963,499...177,964,708
Ensembl chr 2:177,963,496...177,964,607 Ensembl chr12:177,963,496...177,964,607
|
|
| G
|
Rps27l
|
ribosomal protein S27-like
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS27L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130 Ensembl chr 8:33,713,661...33,714,130
|
|
| G
|
Rps29
|
ribosomal protein S29
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS29 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:93,371,293...93,372,731
Ensembl chr13:87,816,954...87,817,267 Ensembl chr 6:87,816,954...87,817,267
|
|
| G
|
Rps6ka1
|
ribosomal protein S6 kinase A1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA Selenium results in increased expression of RPS6KA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:151,362,819...151,476,044
|
|
| G
|
Rps6ka2
|
ribosomal protein S6 kinase A2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA Selenium results in increased expression of RPS6KA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:55,178,988...55,454,271
Ensembl chr 1:55,179,319...55,454,338
|
|
| G
|
Rps7
|
ribosomal protein S7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RPS7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:50,994,581...50,999,447
|
|
| G
|
Rrbp1
|
ribosome binding protein 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:151,768,386...151,830,255
|
|
| G
|
Rrp1
|
ribosomal RNA processing 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of RRP1 mRNA Selenium results in increased expression of RRP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:10,260,580...10,271,829
Ensembl chr20:10,260,592...10,275,076
|
|
| G
|
Rrp7a
|
ribosomal RNA processing 7 homolog A
|
increases expression
|
ISO
|
Selenium results in increased expression of RRP7A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:116,142,976...116,152,874
Ensembl chr 7:116,136,385...116,152,864
|
|
| G
|
Rsad1
|
radical S-adenosyl methionine domain containing 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RSAD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:79,980,817...79,996,493
Ensembl chr10:79,982,203...79,996,447
|
|
| G
|
Rsrc2
|
arginine and serine rich coiled-coil 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RSRC2 mRNA Selenium results in decreased expression of RSRC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:38,500,709...38,520,715
Ensembl chr12:38,500,770...38,520,707
|
|
| G
|
Rsrp1
|
arginine and serine rich protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RSRP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:152,431,478...152,435,126
|
|
| G
|
RT1-A2
|
RT1 class Ia, locus A2
|
increases expression
|
ISO
|
Selenium results in increased expression of HLA-E mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,872,720...4,876,425
|
|
| G
|
RT1-Bb
|
RT1 class II, locus Bb
|
increases expression
|
ISO
|
Selenium results in increased expression of HLA-DQB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
|
|
| G
|
RT1-CE5
|
RT1 class I, locus CE5
|
increases expression decreases expression
|
ISO
|
Selenium results in increased expression of HLA-F mRNA Selenium results in decreased expression of HLA-F mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,407,880...3,484,130
|
|
| G
|
RT1-Da
|
RT1 class II, locus Da
|
increases expression
|
ISO
|
Selenium results in increased expression of HLA-DRA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383
|
|
| G
|
RT1-Ha
|
RT1 class II, locus Ha
|
increases expression
|
ISO
|
Selenium results in increased expression of HLA-DPA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,762,425...4,772,439
Ensembl chr20:4,763,033...4,772,141
|
|
| G
|
RT1-M3-1
|
RT1 class Ib, locus M3, gene 1
|
increases expression
|
ISO
|
Selenium results in increased expression of HLA-G mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366
|
|
| G
|
Rtl8a
|
retrotransposon Gag like 8A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RTL8A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:138,436,824...138,438,037
Ensembl chr X:138,436,605...138,470,972
|
|
| G
|
Rufy3
|
RUN and FYVE domain containing 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of RUFY3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:19,715,593...19,790,530
Ensembl chr14:19,715,593...19,790,608
|
|
| G
|
Runx1t1
|
RUNX1 partner transcriptional co-repressor 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:31,984,855...32,132,855
|
|
| G
|
Rusc2
|
RUN and SH3 domain containing 2
|
increases expression
|
ISO
|
Selenium results in increased expression of RUSC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,424,185...62,471,317
Ensembl chr 5:62,444,665...62,471,314
|
|
| G
|
Ruvbl1
|
RuvB-like AAA ATPase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of RUVBL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:122,489,754...122,524,666
Ensembl chr 4:122,489,680...122,524,665
|
|
| G
|
Ruvbl2
|
RuvB-like AAA ATPase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of RUVBL2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:105,038,487...105,051,851
Ensembl chr 1:105,038,174...105,051,720
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of RXRA protein
|
CTD |
PMID:15318950 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
Rybp
|
RING1 and YY1 binding protein
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of RYBP mRNA Selenium results in decreased expression of RYBP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:134,432,663...134,484,732
Ensembl chr 4:134,432,663...134,484,930
|
|
| G
|
S100a11
|
S100 calcium binding protein A11
|
increases expression
|
ISO
|
Selenium results in increased expression of S100A11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
| G
|
S100a6
|
S100 calcium binding protein A6
|
increases expression
|
ISO
|
Selenium results in increased expression of S100A6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762
|
|
| G
|
Sacs
|
sacsin molecular chaperone
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SACS mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:39,461,853...39,546,419
Ensembl chr15:39,472,905...39,546,419
|
|
| G
|
Safb
|
scaffold attachment factor B
|
increases expression
|
ISO
|
Selenium results in increased expression of SAFB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:1,504,657...1,525,545
Ensembl chr 9:1,504,456...1,525,781
|
|
| G
|
Safb2
|
scaffold attachment factor B2
|
increases expression
|
ISO
|
Selenium results in increased expression of SAFB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:1,482,985...1,504,142
Ensembl chr 9:1,479,061...1,504,142
|
|
| G
|
Samm50
|
SAMM50 sorting and assembly machinery component
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:117,197,460...117,221,668
Ensembl chr 7:117,197,381...117,224,581
|
|
| G
|
Sar1b
|
secretion associated, Ras related GTPase 1B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SAR1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,519,384...36,555,005
|
|
| G
|
Sardh
|
sarcosine dehydrogenase
|
increases expression
|
ISO
|
Selenium results in increased expression of SARDH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:30,908,621...30,972,137
|
|
| G
|
Sart1
|
spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP
|
increases expression
|
ISO
|
Selenium results in increased expression of SART1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:212,119,824...212,128,517
Ensembl chr 1:212,104,557...212,128,486
|
|
| G
|
Sart3
|
spliceosome associated factor 3, U4/U6 recycling protein
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SART3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:48,519,579...48,547,584
Ensembl chr12:48,519,849...48,547,583
|
|
| G
|
Sat1
|
spermidine/spermine N1-acetyl transferase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SAT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374
|
|
| G
|
Satb1
|
SATB homeobox 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SATB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,917,215...4,989,925
|
|
| G
|
Scaf11
|
SR-related CTD-associated factor 11
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SCAF11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:129,450,872...129,503,280
Ensembl chr 7:129,417,955...129,503,280
|
|
| G
|
Scaf4
|
SR-related CTD-associated factor 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SCAF4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:42,951,254...43,007,293
Ensembl chr11:42,951,254...43,007,293
|
|
| G
|
Scamp1
|
secretory carrier membrane protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SCAMP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742
|
|
| G
|
Scamp3
|
secretory carrier membrane protein 3
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SCAMP3 mRNA Selenium results in increased expression of SCAMP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:176,880,873...176,886,750
Ensembl chr 2:176,880,909...176,886,748
|
|
| G
|
Scaper
|
S-phase cyclin A-associated protein in the ER
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SCAPER mRNA Selenium results in decreased expression of SCAPER mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:64,828,789...65,228,240
Ensembl chr 8:64,828,789...65,228,453
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SCD4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Scml1
|
Scm polycomb group protein like 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of SCML1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:36,526,068...36,543,336
Ensembl chr X:36,526,068...36,544,450
|
|
| G
|
Scml2
|
Scm polycomb group protein like 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SCML2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:37,331,893...37,486,465
Ensembl chr X:37,334,841...37,439,276
|
|
| G
|
Scrg1
|
stimulator of chondrogenesis 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SCRG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:37,770,739...37,799,010
Ensembl chr16:37,770,739...37,799,010
|
|
| G
|
Sdc3
|
syndecan 3
|
increases expression
|
ISO
|
Selenium results in increased expression of SDC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:148,249,792...148,282,524
Ensembl chr 5:148,271,842...148,280,614
|
|
| G
|
Sdccag8
|
SHH signaling and ciliogenesis regulator SDCCAG8
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of SDCCAG8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SDCCAG8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:91,286,787...91,518,255
Ensembl chr13:91,286,645...91,511,490
|
|
| G
|
Sec13
|
SEC13 homolog, nuclear pore and COPII coat complex component
|
increases expression
|
ISO
|
Selenium results in increased expression of SEC13 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:148,433,349...148,446,755
|
|
| G
|
Sec16a
|
SEC16 homolog A, endoplasmic reticulum export factor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SEC16A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:29,627,779...29,662,925
Ensembl chr 3:29,627,779...29,662,319
|
|
| G
|
Sec22b
|
SEC22 homolog B, vesicle trafficking protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SEC22B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:188,188,783...188,209,565
Ensembl chr 2:188,188,751...188,211,600
|
|
| G
|
Sec23b
|
Sec23 homolog B, COPII coat complex component
|
increases expression
|
ISO
|
Selenium results in increased expression of SEC23B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:152,392,340...152,434,813
Ensembl chr 3:152,392,308...152,434,800
|
|
| G
|
Sec24b
|
SEC24 homolog B, COPII coat complex component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SEC24B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:221,236,897...221,306,986
Ensembl chr 2:221,236,898...221,306,919
|
|
| G
|
Sec31a
|
SEC31 homolog A, COPII coat complex component
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SEC31A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:9,518,655...9,573,579
Ensembl chr14:9,518,648...9,573,585
|
|
| G
|
Sec62
|
SEC62 homolog, preprotein translocation factor
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of SEC62 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SEC62 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:114,499,317...114,526,705
Ensembl chr 2:114,499,317...114,530,321
|
|
| G
|
Secisbp2l
|
SECIS binding protein 2-like
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA Selenium results in decreased expression of SECISBP2L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:133,443,023...133,489,467
Ensembl chr 3:133,445,317...133,489,291
|
|
| G
|
Selenbp1
|
selenium binding protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SELENBP1 mRNA; Selenium results in increased expression of SELENBP1 protein
|
CTD |
PMID:16380993 |
|
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295
|
|
| G
|
Selenof
|
selenoprotein F
|
decreases expression decreases response to substance
|
ISO
|
Selenium deficiency results in decreased expression of SELENOF protein SELENOF gene polymorphism results in decreased susceptibility to Selenium
|
CTD |
PMID:15107826 PMID:16170372 |
|
NCBI chr 2:236,302,439...236,335,216
Ensembl chr 2:236,302,683...236,335,210
|
|
| G
|
Selenoh
|
selenoprotein H
|
affects expression
|
ISO EXP
|
Selenium affects the expression of SELH mRNA
|
CTD |
PMID:19076066 PMID:19106321 |
|
NCBI chr 3:90,158,541...90,160,108
Ensembl chr 3:90,158,543...90,160,108
|
|
| G
|
Selenok
|
selenoprotein K
|
affects expression
|
EXP
|
Selenium affects the expression of SELENOK mRNA
|
CTD |
PMID:19106321 |
|
NCBI chr16:5,158,601...5,167,183
Ensembl chr16:5,158,621...5,168,512
|
|
| G
|
Selenop
|
selenoprotein P
|
multiple interactions affects abundance decreases expression increases transport affects expression affects response to substance
|
ISO EXP
|
[Mercury results in increased expression of SELENOP protein] which results in increased abundance of Selenium; SELENOP gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium]; TUBA4A mutant form results in increased abundance of [Selenium binds to SELENOP protein] SELENOP protein affects the transport of and affects the abundance of Selenium SELENOP protein affects the abundance of Selenium Selenium deficiency results in decreased expression of SELENOP mRNA SELENOP protein results in increased transport of Selenium Selenium affects the expression of SELENOP protein SELENOP protein affects the susceptibility to Selenium SELENOP gene SNP affects the susceptibility to Selenium Selenium results in decreased expression of SELENOP mRNA
|
CTD |
PMID:12521380 PMID:12574155 PMID:15638810 PMID:17014962 PMID:17314095 PMID:17709542 PMID:17961124 PMID:18172410 PMID:19074884 PMID:19234057 PMID:19244175 PMID:19351701 PMID:23038251 PMID:27989593 PMID:28478440 More...
|
|
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019
|
|
| G
|
Selenow
|
selenoprotein W
|
decreases expression increases expression increases degradation affects expression
|
ISO EXP
|
Selenium deficiency results in decreased expression of SELENOW mRNA Selenium results in increased expression of SELENOW mRNA Selenium deficiency results in increased degradation of SELENOW mRNA Selenium affects the expression of SELENOW mRNA; Selenium deficiency affects the expression of SELENOW protein
|
CTD |
PMID:11330475 PMID:12405536 PMID:15670848 PMID:15823556 PMID:16170372 PMID:19076066 PMID:19106321 PMID:19234057 PMID:28810182 More...
|
|
NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703
|
|
| G
|
Sell
|
selectin L
|
increases expression
|
ISO
|
Selenium results in increased expression of SELL mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
|
|
| G
|
Sem1
|
SEM1 26S proteasome subunit
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SEM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:35,638,306...35,658,462
Ensembl chr 4:35,638,306...35,658,462
|
|
| G
|
Sema3b
|
semaphorin 3B
|
increases expression
|
ISO
|
Selenium results in increased expression of SEMA3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,150,307...117,161,570
Ensembl chr 8:117,150,589...117,157,658
|
|
| G
|
Sephs2
|
selenophosphate synthetase 2
|
affects expression
|
EXP
|
Selenium affects the expression of SEPHS2 mRNA
|
CTD |
PMID:19106321 |
|
NCBI chr 1:191,323,637...191,325,955
Ensembl chr 1:191,323,641...191,325,955
|
|
| G
|
Serbp1
|
Serpine1 mRNA binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SERBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:97,731,200...97,748,438
Ensembl chr 4:97,731,277...97,751,518
|
|
| G
|
Serpina1
|
serpin family A member 1
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of SERPINA1 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpina3n
|
serpin family A member 3N
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of SERPINA3N mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SERPINF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Sertad2
|
SERTA domain containing 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SERTAD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:98,935,428...99,039,536
Ensembl chr14:98,934,769...99,041,468
|
|
| G
|
Set
|
Set nuclear proto-oncogene
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:33,732,319...33,743,433
|
|
| G
|
Setbp1
|
SET binding protein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SETBP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:74,465,616...74,827,455
Ensembl chr18:74,465,616...74,827,455
|
|
| G
|
Setd6
|
SET domain containing 6, protein lysine methyltransferase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SETD6 mRNA Selenium results in decreased expression of SETD6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,353,520...9,356,515
|
|
| G
|
Setmar
|
SET domain and mariner transposase fusion gene
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SETMAR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:142,602,066...142,614,208
Ensembl chr 4:142,602,088...142,614,206
|
|
| G
|
Sf1
|
splicing factor 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SF1 mRNA Selenium results in decreased expression of SF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590
|
|
| G
|
Sf3a2
|
splicing factor 3A subunit 2
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of SF3A2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SF3A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:9,560,182...9,566,205
Ensembl chr 7:9,560,182...9,566,205
|
|
| G
|
Sf3b1
|
splicing factor 3b, subunit 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SF3B1 mRNA Selenium results in decreased expression of SF3B1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:63,986,829...64,026,723
Ensembl chr 9:63,986,829...64,026,719
|
|
| G
|
Sf3b4
|
splicing factor 3B subunit 4
|
increases expression
|
ISO
|
Selenium results in increased expression of SF3B4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:186,421,667...186,426,419
Ensembl chr 2:186,421,636...186,426,833
|
|
| G
|
Sgf29
|
SAGA complex associated factor 29
|
increases expression
|
ISO
|
Selenium results in increased expression of SGF29 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,668,803...190,702,500
Ensembl chr 1:190,669,028...190,717,906
|
|
| G
|
Sgsh
|
N-sulfoglucosamine sulfohydrolase
|
increases expression
|
ISO
|
Selenium results in increased expression of SGSH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:105,095,336...105,112,037
Ensembl chr10:105,095,336...105,112,009
|
|
| G
|
Sgsm3
|
small G protein signaling modulator 3
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SGSM3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:114,394,813...114,424,489
|
|
| G
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SHANK2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:208,598,772...209,018,736
|
|
| G
|
Shb
|
SH2 domain containing adaptor protein B
|
increases expression
|
ISO
|
Selenium results in increased expression of SHB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:64,473,694...64,581,072
Ensembl chr 5:64,473,694...64,581,072
|
|
| G
|
Shmt1
|
serine hydroxymethyltransferase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SHMT1 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,960,434...45,997,326
|
|
| G
|
Siah1
|
siah E3 ubiquitin protein ligase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SIAH1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:36,552,165...36,575,773
Ensembl chr19:36,540,947...36,581,541
|
|
| G
|
Sigirr
|
single Ig and TIR domain containing
|
increases expression
|
ISO
|
Selenium results in increased expression of SIGIRR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,625,742...205,637,883
Ensembl chr 1:205,627,708...205,637,802
|
|
| G
|
Sin3b
|
SIN3 transcription regulator family member B
|
increases expression
|
ISO
|
Selenium results in increased expression of SIN3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:17,157,352...17,194,051
Ensembl chr16:17,157,352...17,270,664
|
|
| G
|
Sipa1l3
|
signal-induced proliferation-associated 1 like 3
|
increases expression
|
ISO
|
Selenium results in increased expression of SIPA1L3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:93,746,187...93,953,606
Ensembl chr 1:93,746,192...93,831,268
|
|
| G
|
Sirpa
|
signal-regulatory protein alpha
|
increases expression
|
ISO
|
Selenium results in increased expression of SIRPA mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:137,272,932...137,311,279
Ensembl chr 3:137,273,042...137,311,279
|
|
| G
|
Sirt1
|
sirtuin 1
|
decreases expression multiple interactions
|
ISO EXP
|
Selenium results in decreased expression of SIRT1 mRNA [Selenium deficiency co-treated with T-2 Toxin] results in decreased expression of SIRT1 mRNA
|
CTD |
PMID:19244175 PMID:38796086 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Ski
|
Ski proto-oncogene
|
increases expression
|
ISO
|
Selenium results in increased expression of SKI mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:170,995,851...171,064,957
Ensembl chr 5:170,995,851...171,064,957
|
|
| G
|
Skic3
|
SKI3 subunit of superkiller complex
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SKIC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:7,363,417...7,526,351
Ensembl chr 2:7,363,535...7,483,496
|
|
| G
|
Slc11a2
|
solute carrier family 11 member 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941
|
|
| G
|
Slc12a2
|
solute carrier family 12 member 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SLC12A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
| G
|
Slc13a4
|
solute carrier family 13 member 4
|
affects transport multiple interactions
|
EXP
|
SLC13A4 protein affects the transport of Selenium Selenium inhibits the reaction [SLC13A4 protein affects the transport of Sulfates]
|
CTD |
PMID:16129486 |
|
NCBI chr 4:64,910,505...64,955,986
Ensembl chr 4:64,910,507...64,955,986
|
|
| G
|
Slc19a1
|
solute carrier family 19 member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC19A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:11,583,928...11,601,959
Ensembl chr20:11,583,929...11,601,488
|
|
| G
|
Slc19a2
|
solute carrier family 19 member 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC19A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315
|
|
| G
|
Slc1a1
|
solute carrier family 1 member 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC1A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:235,963,437...236,045,469
|
|
| G
|
Slc22a18
|
solute carrier family 22, member 18
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC67A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:208,101,136...208,124,380
|
|
| G
|
Slc25a1
|
solute carrier family 25 member 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC25A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,560,054...96,563,071
Ensembl chr11:96,560,041...96,565,052
|
|
| G
|
Slc25a12
|
solute carrier family 25 member 12
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC25A12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:76,504,868...76,599,536
|
|
| G
|
Slc25a16
|
solute carrier family 25 member 16
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA Selenium results in decreased expression of SLC25A16 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:25,659,847...25,717,080
Ensembl chr20:25,660,339...25,689,285 Ensembl chr20:25,660,339...25,689,285
|
|
| G
|
Slc25a17
|
solute carrier family 25 member 17
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC25A17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:114,724,533...114,767,163
Ensembl chr 7:114,724,533...114,767,345
|
|
| G
|
Slc25a22
|
solute carrier family 25 member 22
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC25A22 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,954,713...205,966,188
Ensembl chr 1:205,958,032...205,965,877
|
|
| G
|
Slc25a36
|
solute carrier family 25 member 36
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC25A36 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:106,539,355...106,573,240
|
|
| G
|
Slc25a37
|
solute carrier family 25 member 37
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC25A37 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:50,944,085...50,986,506
Ensembl chr15:50,946,236...50,986,808
|
|
| G
|
Slc25a5-ps11
|
solute carrier family 25 member 5, pseudogene 11
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC25A6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:70,846,358...70,847,597
Ensembl chr18:70,846,358...70,847,597
|
|
| G
|
Slc29a1
|
solute carrier family 29 member 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
|
|
| G
|
Slc35d1
|
solute carrier family 35 member D1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SLC35D1 mRNA Selenium results in decreased expression of SLC35D1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:123,157,739...123,210,350
Ensembl chr 5:123,155,407...123,210,073
|
|
| G
|
Slc39a1
|
solute carrier family 39 member 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:178,001,119...178,006,689
|
|
| G
|
Slc39a7
|
solute carrier family 39 member 7
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC39A7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,824,967...4,828,431
Ensembl chr20:4,824,688...4,828,430
|
|
| G
|
Slc3a2
|
solute carrier family 3 member 2
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC3A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
|
|
| G
|
Slc44a4
|
solute carrier family 44, member 4
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC44A4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,907,737...3,923,911
Ensembl chr20:3,907,737...3,923,854
|
|
| G
|
Slc4a4
|
solute carrier family 4 member 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC4A4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:19,125,394...19,577,379
Ensembl chr14:19,129,264...19,577,435
|
|
| G
|
Slc4a7
|
solute carrier family 4 member 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC4A7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:13,015,854...13,095,485
Ensembl chr15:13,015,854...13,095,292
|
|
| G
|
Slc5a5
|
solute carrier family 5 member 5
|
increases expression multiple interactions
|
EXP
|
Selenium results in increased expression of SLC5A5 mRNA Selenium inhibits the reaction [Potassium Iodide results in decreased expression of SLC5A5 mRNA]
|
CTD |
PMID:38013145 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
| G
|
Slc6a2
|
solute carrier family 6 member 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLC6A2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:30,183,289...30,228,292
Ensembl chr19:30,183,383...30,223,348
|
|
| G
|
Slc6a3
|
solute carrier family 6 member 3
|
increases activity increases expression
|
EXP
|
Selenium deficiency results in increased activity of DAT protein Selenium deficiency results in increased expression of DAT mRNA
|
CTD |
PMID:11113527 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
| G
|
Slc6a8
|
solute carrier family 6 member 8
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC6A8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:156,536,017...156,545,321
Ensembl chr X:156,536,017...156,545,321
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases import
|
ISO
|
SLC7A11 mRNA results in increased import of Selenium
|
CTD |
PMID:28070112 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Slc7a5
|
solute carrier family 7 member 5
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC7A5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
|
|
| G
|
Slc7a8
|
solute carrier family 7 member 8
|
increases expression
|
ISO
|
Selenium results in increased expression of SLC7A8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715
|
|
| G
|
Slit2
|
slit guidance ligand 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SLIT2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146
|
|
| G
|
Smarca4
|
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
|
increases expression
|
ISO
|
Selenium results in increased expression of SMARCA4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:28,443,810...28,535,070
|
|
| G
|
Smarca5
|
SNF2 related chromatin remodeling ATPase 5
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SMARCA5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:44,172,465...44,208,967
Ensembl chr19:44,175,733...44,208,957
|
|
| G
|
Smarcc1
|
SWI/SNF related BAF chromatin remodeling complex subunit C1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of SMARCC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,986,917...119,093,161
Ensembl chr 8:118,989,516...119,093,152
|
|
| G
|
Smarcd2
|
SWI/SNF related BAF chromatin remodeling complex subunit D2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SMARCD2 mRNA Selenium results in increased expression of SMARCD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:91,693,542...91,702,408
Ensembl chr10:91,693,542...91,702,522
|
|
| G
|
Smarcd3
|
SWI/SNF related BAF chromatin remodeling complex subunit D3
|
increases expression
|
ISO
|
Selenium results in increased expression of SMARCD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:11,441,142...11,472,781
Ensembl chr 4:11,441,157...11,472,781
|
|
| G
|
Smchd1
|
structural maintenance of chromosomes flexible hinge domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SMCHD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:118,690,050...118,837,281
Ensembl chr 9:118,690,057...118,833,452
|
|
| G
|
Smg5
|
SMG5 nonsense mediated mRNA decay factor
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA Selenium results in increased expression of SMG5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:176,102,812...176,129,925
Ensembl chr 2:176,102,794...176,129,924
|
|
| G
|
Smg7
|
SMG7 nonsense mediated mRNA decay factor
|
increases expression
|
ISO
|
Selenium results in increased expression of SMG7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:67,536,016...67,600,624
Ensembl chr13:67,536,044...67,600,437
|
|
| G
|
Smox
|
spermine oxidase
|
increases expression
|
ISO
|
Selenium results in increased expression of SMOX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170 Ensembl chr X:139,184,798...139,220,170
|
|
| G
|
Smtn
|
smoothelin
|
increases expression
|
ISO
|
Selenium results in increased expression of SMTN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:82,622,223...82,644,525
Ensembl chr14:82,621,375...82,644,514
|
|
| G
|
Smurf1
|
SMAD specific E3 ubiquitin protein ligase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SMURF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:14,748,717...14,840,273
Ensembl chr12:14,749,043...14,840,273
|
|
| G
|
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SMURF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:92,261,516...92,362,185
Ensembl chr10:92,261,525...92,362,552
|
|
| G
|
Snap25
|
synaptosome associated protein 25
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA Selenium results in decreased expression of SNAP25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:144,494,595...144,576,448
|
|
| G
|
Snf8
|
SNF8 subunit of ESCRT-II
|
increases expression
|
ISO
|
Selenium results in increased expression of SNF8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:81,481,054...81,493,430
Ensembl chr10:81,481,057...81,494,610
|
|
| G
|
Snrnp27
|
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SNRNP27 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:120,681,054...120,691,343
Ensembl chr 4:120,679,255...120,690,656
|
|
| G
|
Snrnp35
|
small nuclear ribonucleoprotein U11/U12 subunit 35
|
increases expression
|
ISO
|
Selenium results in increased expression of SNRNP35 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:37,773,052...37,781,635
Ensembl chr12:37,771,759...37,783,908
|
|
| G
|
Snrpb
|
small nuclear ribonucleoprotein polypeptides B and B1
|
increases expression
|
ISO
|
Selenium results in increased expression of SNRPB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:137,824,870...137,832,479
Ensembl chr 3:137,824,683...137,832,515
|
|
| G
|
Snu13
|
small nuclear ribonucleoprotein 13
|
increases expression
|
ISO
|
Selenium results in increased expression of SNU13 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:115,445,415...115,451,008
Ensembl chr 1:269,702,002...269,703,004 Ensembl chr 7:269,702,002...269,703,004
|
|
| G
|
Snx1
|
sorting nexin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SNX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:75,515,780...75,565,487
Ensembl chr 8:75,525,181...75,565,561
|
|
| G
|
Snx17
|
sorting nexin 17
|
increases expression
|
ISO
|
Selenium results in increased expression of SNX17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:30,897,500...30,902,972
Ensembl chr 6:30,897,501...30,902,972
|
|
| G
|
Sobp
|
sine oculis binding protein homolog
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SOBP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:48,064,445...48,243,607
Ensembl chr20:48,064,445...48,243,607
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
decreases expression
|
EXP
|
Selenium deficiency results in decreased expression of SOD1 mRNA
|
CTD |
PMID:11260395 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
increases expression affects response to substance multiple interactions
|
ISO
|
Selenium results in increased expression of SOD2 mRNA SOD2 gene polymorphism affects the susceptibility to Selenium; SOD2 gene SNP affects the susceptibility to Selenium SELENOP gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium]
|
CTD |
PMID:17293063 PMID:19074884 PMID:19528373 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Son
|
SON DNA and RNA binding protein
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of SON mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SON mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:44,336,818...44,409,127
Ensembl chr11:44,377,976...44,409,127
|
|
| G
|
Sorbs2
|
sorbin and SH3 domain containing 2
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in increased expression of SORBS2 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr16:53,167,795...53,481,300
Ensembl chr16:53,167,827...53,358,986
|
|
| G
|
Sorbs3
|
sorbin and SH3 domain containing 3
|
increases expression
|
ISO
|
Selenium results in increased expression of SORBS3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:51,662,639...51,699,161
Ensembl chr15:51,663,095...51,694,522
|
|
| G
|
Sord
|
sorbitol dehydrogenase
|
increases expression
|
EXP
|
Selenium results in increased expression of SORD protein
|
CTD |
PMID:1588439 |
|
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100
|
|
| G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SOS1 mRNA Selenium results in decreased expression of SOS1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
|
|
| G
|
Sox4
|
SRY-box transcription factor 4
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SOX4 mRNA Selenium results in decreased expression of SOX4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024
|
|
| G
|
Sox9
|
SRY-box transcription factor 9
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA Selenium results in decreased expression of SOX9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
| G
|
Sp1
|
Sp1 transcription factor
|
multiple interactions
|
ISO EXP
|
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of SP1 protein
|
CTD |
PMID:35384129 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
| G
|
Sp100
|
SP100 nuclear antigen
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SP100 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:93,758,975...93,825,068
Ensembl chr 9:93,759,075...93,825,068
|
|
| G
|
Spcs2
|
signal peptidase complex subunit 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SPCS2 mRNA Selenium results in decreased expression of SPCS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:163,575,842...163,595,271
|
|
| G
|
Spen
|
spen family transcriptional repressor
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SPEN mRNA Selenium results in decreased expression of SPEN mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:159,058,258...159,131,789
Ensembl chr 5:159,058,258...159,165,934
|
|
| G
|
Spint1
|
serine peptidase inhibitor, Kunitz type 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SPINT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:126,685,017...126,697,957
Ensembl chr 3:126,685,422...126,697,956
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SPP1 protein
|
CTD |
PMID:15318939 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Spsb3
|
splA/ryanodine receptor domain and SOCS box containing 3
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SPSB3 mRNA Selenium results in increased expression of SPSB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,411,692...14,417,357
Ensembl chr10:14,408,136...14,421,771
|
|
| G
|
Sptan1
|
spectrin, alpha, non-erythrocytic 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SPTAN1 mRNA Selenium results in increased expression of SPTAN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:33,607,210...33,703,889
|
|
| G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
EXP
|
Selenium inhibits the reaction [arsenite results in increased expression of SQSTM1 protein]
|
CTD |
PMID:29324385 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
increases expression multiple interactions
|
EXP ISO
|
Selenium results in increased expression of SREBF1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA] [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:19022953 PMID:28810182 PMID:30031400 PMID:36464106 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
increases expression
|
ISO
|
Selenium results in increased expression of SREBF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
| G
|
Srpk1
|
SRSF protein kinase 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SRPK1 mRNA Selenium results in decreased expression of SRPK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:6,647,539...6,684,129
Ensembl chr20:6,649,450...6,683,835
|
|
| G
|
Srrm2
|
serine/arginine repetitive matrix 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
|
|
| G
|
Srsf1
|
serine and arginine rich splicing factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SRSF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548
|
|
| G
|
Srsf10
|
serine and arginine rich splicing factor 10
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SRSF10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:153,372,307...153,386,520
Ensembl chr 5:153,372,316...153,386,513
|
|
| G
|
Srsf11
|
serine and arginine rich splicing factor 11
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SRSF11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:249,733,464...249,760,296
Ensembl chr 2:249,733,464...249,760,499
|
|
| G
|
Srsf7
|
serine and arginine rich splicing factor 7
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of SRSF7 mRNA Selenium results in decreased expression of SRSF7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212
|
|
| G
|
Srsf9
|
serine and arginine rich splicing factor 9
|
increases expression
|
ISO
|
Selenium results in increased expression of SRSF9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:46,938,948...46,945,213
Ensembl chr12:46,938,950...46,945,283
|
|
| G
|
Ss18l2
|
SS18 like 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SS18L2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:130,252,774...130,255,388
Ensembl chr 8:130,252,782...130,257,367
|
|
| G
|
Ssna1
|
SS nuclear autoantigen 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SSNA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:28,483,107...28,484,571
Ensembl chr 3:28,483,107...28,484,608
|
|
| G
|
Ssrp1
|
structure specific recognition protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of SSRP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:90,531,024...90,541,132
Ensembl chr 3:90,530,829...90,541,129
|
|
| G
|
Ssx2ip
|
SSX family member 2 interacting protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SSX2IP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017
|
|
| G
|
St13
|
ST13, Hsp70 interacting protein
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ST13 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 7:114,769,758...114,805,877
Ensembl chr 7:114,769,759...114,805,941
|
|
| G
|
St14
|
ST14 transmembrane serine protease matriptase
|
increases expression
|
ISO
|
Selenium results in increased expression of ST14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652
|
|
| G
|
Stab1
|
stabilin 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of STAB1 mRNA Selenium results in increased expression of STAB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,336,871...6,364,579
|
|
| G
|
Stag2
|
STAG2 cohesin complex component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of STAG2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:125,839,660...125,971,209
Ensembl chr X:125,840,401...125,971,209
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
EXP
|
[Selenium co-treated with retinol acetate co-treated with Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased expression of STAR mRNA]; Selenium inhibits the reaction [Acrylamide results in decreased expression of STAR mRNA]
|
CTD |
PMID:33372294 PMID:37987225 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stard5
|
StAR-related lipid transfer domain containing 5
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of STARD5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:147,015,304...147,025,170
Ensembl chr 1:147,015,299...147,026,351
|
|
| G
|
Stbd1
|
starch binding domain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of STBD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659
|
|
| G
|
Stk11
|
serine/threonine kinase 11
|
increases expression
|
ISO
|
Selenium results in increased expression of STK11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965
|
|
| G
|
Stk24
|
serine/threonine kinase 24
|
increases expression
|
ISO
|
Selenium results in increased expression of STK24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:104,770,556...104,866,524
Ensembl chr15:104,773,569...104,865,975
|
|
| G
|
Stk38l
|
serine/threonine kinase 38 like
|
decreases expression
|
ISO
|
Selenium results in decreased expression of STK38L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:181,346,969...181,423,844
Ensembl chr 4:181,364,919...181,423,840
|
|
| G
|
Stoml2
|
stomatin like 2
|
increases expression
|
ISO
|
Selenium results in increased expression of STOML2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,052,042...62,055,639
Ensembl chr 5:62,052,045...62,055,670
|
|
| G
|
Stt3a
|
STT3 oligosaccharyltransferase complex catalytic subunit A
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of STT3A mRNA Selenium results in increased expression of STT3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:44,632,473...44,671,960
Ensembl chr 8:44,632,473...44,672,226
|
|
| G
|
Stub1
|
STIP1 homology and U-box containing protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of STUB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:15,355,278...15,357,559
Ensembl chr10:15,355,279...15,357,559
|
|
| G
|
Styxl1
|
serine/threonine/tyrosine interacting-like 1
|
increases expression
|
ISO
|
Selenium results in increased expression of STYXL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:26,544,059...26,576,365
Ensembl chr12:26,544,067...26,576,366
|
|
| G
|
Sulf1
|
sulfatase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SULF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643
|
|
| G
|
Sumo2
|
small ubiquitin-like modifier 2
|
increases expression
|
ISO
|
Selenium results in increased expression of SUMO2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:101,270,899...101,283,458
Ensembl chr10:101,270,900...101,283,938 Ensembl chr 5:101,270,900...101,283,938
|
|
| G
|
Supt5h
|
SPT5 homolog, DSIF elongation factor subunit
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of SUPT5H mRNA Selenium results in increased expression of SUPT5H mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:92,714,276...92,745,489
Ensembl chr 1:92,714,281...92,744,445
|
|
| G
|
Supt7l
|
SPT7 like, STAGA complex subunit gamma
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SUPT7L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:30,653,928...30,664,066
Ensembl chr 6:30,653,888...30,664,642
|
|
| G
|
Suz12
|
SUZ12 polycomb repressive complex 2 subunit
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SUZ12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:65,464,948...65,510,846
Ensembl chr10:65,464,969...65,510,846
|
|
| G
|
Svil
|
supervillin
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of SVIL mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr17:57,343,910...57,539,508
Ensembl chr17:57,343,910...57,462,660
|
|
| G
|
Syncrip
|
synaptotagmin binding, cytoplasmic RNA interacting protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of SYNCRIP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:98,282,358...98,315,386
|
|
| G
|
Synj2
|
synaptojanin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of SYNJ2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:48,923,737...49,038,650
|
|
| G
|
Synpo
|
synaptopodin
|
increases expression
|
ISO
|
Selenium results in increased expression of SYNPO mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:56,326,369...56,347,359
Ensembl chr18:56,319,571...56,353,306
|
|
| G
|
Tada3
|
transcriptional adaptor 3
|
increases expression
|
ISO
|
Selenium results in increased expression of TADA3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:148,065,859...148,077,347
Ensembl chr 4:148,065,877...148,077,320
|
|
| G
|
Taf10
|
TATA-box binding protein associated factor 10
|
increases expression
|
ISO
|
Selenium results in increased expression of TAF10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:169,506,940...169,508,234
Ensembl chr 1:169,506,940...169,508,208
|
|
| G
|
Taf2
|
TATA-box binding protein associated factor 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TAF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:88,312,374...88,369,399
Ensembl chr 7:88,312,374...88,369,377
|
|
| G
|
Taf5l1
|
TATA-box binding protein associated factor 5 like 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TAF5L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:68,889,153...68,908,480
Ensembl chr19:68,889,158...68,908,466
|
|
| G
|
Tagln2
|
transgelin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of TAGLN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330
|
|
| G
|
Taldo1
|
transaldolase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TALDO1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535
|
|
| G
|
Tap1
|
transporter 1, ATP binding cassette subfamily B member
|
increases expression
|
ISO
|
Selenium results in increased expression of TAP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810
|
|
| G
|
Tapbp
|
TAP binding protein
|
increases expression
|
ISO
|
Selenium results in increased expression of TAPBP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:4,958,821...4,967,958
Ensembl chr20:4,959,926...4,971,834
|
|
| G
|
Tarbp2
|
Tarbp2 subunit of RISC loading complex
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of TARBP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,527,710...135,532,826
Ensembl chr 7:135,527,589...135,533,323
|
|
| G
|
Tas2r116
|
taste receptor, type 2, member 116
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TAS2R14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:167,998,392...167,999,366
Ensembl chr 4:167,998,392...167,999,366
|
|
| G
|
Tasor
|
transcription activation suppressor
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TASOR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:2,612,942...2,669,870
Ensembl chr16:2,613,505...2,669,867
|
|
| G
|
Tax1bp3
|
Tax1 binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of TAX1BP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:58,294,357...58,298,875
Ensembl chr10:58,294,073...58,298,875
|
|
| G
|
Tbc1d30
|
TBC1 domain family, member 30
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TBC1D30 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:58,665,054...58,754,614
|
|
| G
|
Tbc1d8b
|
TBC1 domain family member 8B
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TBC1D8B mRNA Selenium results in decreased expression of TBC1D8B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:108,107,796...108,195,744
Ensembl chr X:108,107,769...108,195,732
|
|
| G
|
Tbc1d9b
|
TBC1 domain family member 9B
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA Selenium results in increased expression of TBC1D9B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:34,961,012...34,998,227
Ensembl chr10:34,960,996...34,998,213
|
|
| G
|
Tbcb
|
tubulin folding cofactor B
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TBCB mRNA Selenium results in increased expression of TBCB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:94,605,100...94,610,949
Ensembl chr 1:94,605,101...94,610,949
|
|
| G
|
Tbl1x
|
transducin (beta)-like 1 X-linked
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TBL1X mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:45,452,983...45,609,532
Ensembl chr X:45,454,482...45,609,525
|
|
| G
|
Tbl3
|
transducin (beta)-like 3
|
increases expression
|
ISO
|
Selenium results in increased expression of TBL3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,230,660...14,235,873
Ensembl chr10:14,230,661...14,235,873
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
multiple interactions
|
ISO
|
[Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of TBXAS1 mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of TBXAS1 protein
|
CTD |
PMID:21669866 |
|
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tcaf1
|
TRPM8 channel-associated factor 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TCAF1 mRNA Selenium results in decreased expression of TCAF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:72,589,710...72,639,304
Ensembl chr 4:72,589,710...72,639,475
|
|
| G
|
Tcea2
|
transcription elongation factor A2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TCEA2 mRNA Selenium results in increased expression of TCEA2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:189,173,756...189,181,633
Ensembl chr 3:189,165,603...189,182,540
|
|
| G
|
Tcerg1
|
transcription elongation regulator 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA Selenium results in decreased expression of TCERG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:34,756,558...34,817,441
Ensembl chr18:34,756,725...34,817,441
|
|
| G
|
Tcf12
|
transcription factor 12
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TCF12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:81,373,321...81,679,922
|
|
| G
|
Tcf7l2
|
transcription factor 7 like 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA Selenium results in decreased expression of TCF7L2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225
|
|
| G
|
Tcp1
|
t-complex 1
|
multiple interactions
|
EXP
|
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of TCP1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:50,376,848...50,384,527
|
|
| G
|
Tctn1
|
tectonic family member 1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TCTN1 mRNA Selenium results in decreased expression of TCTN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:39,970,554...40,003,727
Ensembl chr12:39,970,621...40,003,725
|
|
| G
|
Tead3
|
TEA domain transcription factor 3
|
increases expression
|
ISO
|
Selenium results in increased expression of TEAD3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:6,393,786...6,413,177
Ensembl chr20:6,393,786...6,413,174
|
|
| G
|
Tecr
|
trans-2,3-enoyl-CoA reductase
|
increases expression
|
ISO
|
Selenium results in increased expression of TECR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:41,431,422...41,472,880
Ensembl chr19:41,446,071...41,474,432
|
|
| G
|
Terf1
|
telomeric repeat binding factor 1
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of TERF1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TERF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:8,226,345...8,255,753
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
decreases activity multiple interactions decreases expression
|
ISO EXP
|
Selenium results in decreased activity of TERT protein [Benzene co-treated with Selenium] results in increased activity of TERT protein Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TERT mRNA] Selenium results in decreased expression of TERT mRNA
|
CTD |
PMID:16600092 PMID:17948765 PMID:19080380 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
multiple interactions increases expression
|
EXP
|
NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]
|
CTD |
PMID:17936198 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tfb2m
|
transcription factor B2, mitochondrial
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TFB2M mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:93,810,859...93,828,678
Ensembl chr13:93,810,731...93,828,594
|
|
| G
|
Tfeb
|
transcription factor EB
|
increases expression
|
ISO
|
Selenium results in increased expression of TFEB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:20,696,440...20,752,265
Ensembl chr 9:20,696,441...20,727,863
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions increases expression
|
ISO EXP
|
Selenium promotes the reaction [Drugs, Chinese Herbal inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]]; Selenium promotes the reaction [Drugs, Chinese Herbal inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]] Selenium inhibits the reaction [2-iodohexadecanal results in increased expression of TGFB1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in increased expression of TGFB1 mRNA] Selenium deficiency results in increased expression of TGFB1 mRNA
|
CTD |
PMID:11260395 PMID:14991942 PMID:38013145 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfbr3
|
transforming growth factor beta receptor 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TGFBR3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:2,634,294...2,810,269
Ensembl chr14:2,634,188...2,810,271
|
|
| G
|
Tgoln2
|
trans-golgi network protein 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:106,221,503...106,229,360
Ensembl chr 4:106,221,509...106,229,262
|
|
| G
|
Th
|
tyrosine hydroxylase
|
increases activity increases expression multiple interactions
|
EXP
|
Selenium deficiency results in increased activity of TH protein Selenium deficiency results in increased expression of TH mRNA [Selenium deficiency results in increased activity of TH protein] which results in increased chemical synthesis of Dopamine
|
CTD |
PMID:11113527 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Thap11
|
THAP domain containing 11
|
increases expression
|
ISO
|
Selenium results in increased expression of THAP11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:50,656,839...50,658,656
Ensembl chr19:50,656,366...50,659,362
|
|
| G
|
Thap7
|
THAP domain containing 7
|
increases expression
|
ISO
|
Selenium results in increased expression of THAP7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:96,986,720...96,990,375
Ensembl chr11:96,987,275...96,990,371
|
|
| G
|
Thbd
|
thrombomodulin
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of THBD mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Thoc2
|
THO complex subunit 2
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of THOC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of THOC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:125,500,549...125,615,139
Ensembl chr X:125,500,549...125,615,087
|
|
| G
|
Thra
|
thyroid hormone receptor alpha
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Iodine results in increased expression of THRA mRNA]
|
CTD |
PMID:17555094 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Iodine results in increased expression of THRB mRNA]
|
CTD |
PMID:17555094 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Thsd7a
|
thrombospondin type 1 domain containing 7A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of THSD7A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:41,426,275...41,865,723
|
|
| G
|
Thumpd1
|
THUMP domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of THUMPD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:183,510,242...183,516,282
Ensembl chr 1:183,431,657...183,516,282
|
|
| G
|
Thyn1
|
thymocyte nuclear protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of THYN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:33,665,614...33,674,593
Ensembl chr 8:33,665,650...33,675,414
|
|
| G
|
Tia1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA Selenium results in decreased expression of TIA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:120,410,180...120,440,676
Ensembl chr 4:120,410,251...120,440,665
|
|
| G
|
Timm8a1
|
translocase of inner mitochondrial membrane 8A1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TIMM8A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:102,011,206...102,015,444
Ensembl chr X:102,011,206...102,015,444
|
|
| G
|
Timm8b
|
translocase of inner mitochondrial membrane 8 homolog B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TIMM8B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:59,850,737...59,852,117
Ensembl chr 8:59,850,728...59,852,962
|
|
| G
|
Timm9
|
translocase of inner mitochondrial membrane 9
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TIMM9 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:95,346,065...95,358,895
Ensembl chr 6:95,346,065...95,358,895
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Selenium results in decreased expression of TIMP1 mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of TIMP1 protein] Selenium deficiency results in increased expression of TIMP1 mRNA
|
CTD |
PMID:11444866 PMID:17390030 PMID:21144892 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of TIMP2 mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of TIMP2 protein]
|
CTD |
PMID:17390030 PMID:21144892 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Timp3
|
TIMP metallopeptidase inhibitor 3
|
increases expression decreases expression
|
ISO
|
Selenium results in increased expression of TIMP3 mRNA Selenium results in decreased expression of TIMP3 mRNA
|
CTD |
PMID:17390030 PMID:19244175 |
|
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547
|
|
| G
|
Timp4
|
TIMP metallopeptidase inhibitor 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TIMP4 mRNA
|
CTD |
PMID:17390030 |
|
NCBI chr 4:149,978,667...149,985,350
Ensembl chr 4:149,978,685...149,985,452
|
|
| G
|
Tjp1
|
tight junction protein 1
|
multiple interactions
|
ISO
|
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Selenium results in increased expression of and results in increased localization of TJP1 protein
|
CTD |
PMID:16514648 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
| G
|
Tkt
|
transketolase
|
increases expression
|
ISO
|
Selenium results in increased expression of TKT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
|
|
| G
|
Tle2
|
TLE family member 2, transcriptional corepressor
|
increases expression
|
ISO
|
Selenium results in increased expression of TLE2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:8,769,815...8,789,493
Ensembl chr 7:8,769,816...8,785,256
|
|
| G
|
Tln1
|
talin 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TLN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:62,583,731...62,613,687
|
|
| G
|
Tlr10
|
toll-like receptor 10
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of TLR10 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr14:43,758,940...43,768,352
Ensembl chr14:43,759,827...43,768,351
|
|
| G
|
Tm2d1
|
TM2 domain containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TM2D1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:118,136,299...118,177,639
Ensembl chr 5:118,136,299...118,170,283
|
|
| G
|
Tm9sf1
|
transmembrane 9 superfamily member 1
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TM9SF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:33,097,541...33,108,106
Ensembl chr15:33,097,552...33,105,290
|
|
| G
|
Tm9sf4
|
transmembrane 9 superfamily member 4
|
increases expression
|
ISO
|
Selenium results in increased expression of TM9SF4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:162,086,758...162,135,620
Ensembl chr 3:162,087,347...162,151,721
|
|
| G
|
Tma7
|
translation machinery associated 7 homolog
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMA7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,604,680...118,609,368
Ensembl chr 8:118,604,680...118,609,368
|
|
| G
|
Tmc5
|
transmembrane channel-like 5
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TMC5 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:182,349,102...182,433,679
Ensembl chr 1:182,355,473...182,433,679
|
|
| G
|
Tmem168
|
transmembrane protein 168
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMEM168 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:42,796,714...42,824,854
Ensembl chr 4:42,796,720...42,824,854
|
|
| G
|
Tmem222
|
transmembrane protein 222
|
increases expression
|
ISO
|
Selenium results in increased expression of TMEM222 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:150,749,746...150,763,031
Ensembl chr 5:150,749,748...150,767,278
|
|
| G
|
Tmem243
|
transmembrane protein 243
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMEM243 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:25,905,740...25,923,588
Ensembl chr 4:25,905,740...25,923,028
|
|
| G
|
Tmem258
|
transmembrane protein 258
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMEM258 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:216,274,607...216,278,505
|
|
| G
|
Tmem53
|
transmembrane protein 53
|
increases expression
|
ISO
|
Selenium results in increased expression of TMEM53 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:135,958,344...135,974,258
Ensembl chr 5:135,958,163...135,974,258
|
|
| G
|
Tmem63a
|
transmembrane protein 63a
|
increases expression
|
ISO
|
Selenium results in increased expression of TMEM63A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:95,194,323...95,227,944
Ensembl chr13:95,195,234...95,228,302
|
|
| G
|
Tmf1
|
TATA element modulatory factor 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:131,316,630...131,345,666
Ensembl chr 4:131,311,801...131,342,436
|
|
| G
|
Tmprss6
|
transmembrane serine protease 6
|
increases expression
|
ISO
|
Selenium results in increased expression of TMPRSS6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:111,871,504...111,902,127
Ensembl chr 7:111,871,031...111,902,116
|
|
| G
|
Tmsb15b2
|
thymosin beta 15B2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TMSB15A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:105,090,980...105,093,094
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
ISO EXP
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TNF mRNA; Selenium affects the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Selenium inhibits the reaction [Cadmium results in increased expression of and results in increased secretion of TNF protein]; Selenium inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Selenium promotes the reaction [T-2 Toxin results in increased expression of TNF protein] [Drugs, Chinese Herbal co-treated with Selenium] results in decreased expression of TNF mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of TNF mRNA [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of TNF protein]; [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of TNF protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of TNF protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of TNF protein] Selenium results in increased expression of TNF mRNA
|
CTD |
PMID:10802230 PMID:15862027 PMID:17293063 PMID:18196609 PMID:21481475 PMID:21775527 PMID:24626144 PMID:26089086 PMID:29028684 PMID:37676925 PMID:37987225 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfaip2
|
TNF alpha induced protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of TNFAIP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:136,297,388...136,311,106
Ensembl chr 6:136,298,082...136,311,106
|
|
| G
|
Tnfaip6
|
TNF alpha induced protein 6
|
increases expression
|
ISO
|
Selenium results in increased expression of TNFAIP6 mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
|
|
| G
|
Tnfrsf10b
|
TNF receptor superfamily member 10b
|
multiple interactions
|
ISO
|
Selenium analog inhibits the reaction [Diazinon results in decreased expression of TNFRSF10A mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
increases expression
|
ISO
|
Selenium results in increased expression of TNFRSF12A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
multiple interactions increases expression
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TNFRSF1A mRNA; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of TNFRSF1A mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of TNFRSF1A protein]; Selenium analog inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA] Selenium deficiency results in increased expression of TNFRSF1A mRNA; Selenium deficiency results in increased expression of TNFRSF1A protein
|
CTD |
PMID:21481475 PMID:27920530 PMID:37422542 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf22
|
tumor necrosis factor receptor superfamily, member 22
|
increases expression
|
ISO
|
Selenium results in increased expression of TNFRSF10C mRNA
|
CTD |
PMID:17293063 |
|
NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:208,258,836...208,289,832
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TNFSF10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Tnk1
|
tyrosine kinase, non-receptor, 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TNK1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:55,070,362...55,084,383
Ensembl chr10:55,069,837...55,078,710
|
|
| G
|
Tnpo1
|
transportin 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TNPO1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:31,941,731...32,034,326
|
|
| G
|
Tnpo2
|
transportin 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TNPO2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:40,004,271...40,024,565
Ensembl chr19:40,004,275...40,024,187
|
|
| G
|
Tns2
|
tensin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of TNS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:135,108,401...135,126,505
Ensembl chr 7:135,108,202...135,126,504
|
|
| G
|
Tob2
|
transducer of ERBB2, 2
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TOB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:115,239,895...115,258,155
|
|
| G
|
Tomm7
|
translocase of outer mitochondrial membrane 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TOMM7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:12,197,503...12,204,344
Ensembl chr 4:12,197,491...12,204,343
|
|
| G
|
Top1
|
DNA topoisomerase I
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of TOP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TOP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:169,713,195...169,796,330
Ensembl chr 3:169,713,130...169,796,327
|
|
| G
|
Tor1a
|
torsin family 1, member A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TOR1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:34,648,421...34,655,453
Ensembl chr 3:34,648,422...34,655,417
|
|
| G
|
Tor3a
|
torsin family 3, member A
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TOR3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:71,324,073...71,348,625
Ensembl chr13:71,324,076...71,348,624
|
|
| G
|
Tox4
|
TOX high mobility group box family member 4
|
increases expression
|
ISO
|
Selenium results in increased expression of TOX4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:27,462,735...27,476,320
Ensembl chr15:27,462,727...27,477,617
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA]; [Selenium co-treated with Vitamin E] results in increased expression of TP53 mRNA Selenium results in decreased expression of TP53 protein [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA]; Selenium inhibits the reaction [Acrylamide results in increased expression of TP53 mRNA]; Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein] Selenium results in increased expression of TP53 mRNA
|
CTD |
PMID:16600092 PMID:17523932 PMID:19244175 PMID:21628957 PMID:27920530 PMID:37987225 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tpi1
|
triosephosphate isomerase 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TPI1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
|
|
| G
|
Tpm2
|
tropomyosin 2
|
increases expression
|
ISO
|
Selenium results in increased expression of TPM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:62,566,712...62,576,066
Ensembl chr 5:62,566,652...62,575,726
|
|
| G
|
Tpp1
|
tripeptidyl peptidase 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TPP1 mRNA Selenium results in increased expression of TPP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:169,509,816...169,515,939
Ensembl chr 1:169,509,815...169,516,024
|
|
| G
|
Tpr
|
translocated promoter region, nuclear basket protein
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA Selenium results in decreased expression of TPR mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:64,974,419...65,037,604
Ensembl chr13:64,974,419...65,037,602
|
|
| G
|
Tra2a
|
transformer 2 alpha
|
decreases expression increases expression
|
ISO
|
Selenium results in decreased expression of TRA2A mRNA Selenium results in increased expression of TRA2A mRNA
|
CTD |
PMID:17293063 PMID:19244175 |
|
NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619
|
|
| G
|
Traf2
|
Tnf receptor-associated factor 2
|
multiple interactions
|
ISO
|
Selenium analog inhibits the reaction [Diazinon results in increased expression of TRAF2 mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
|
|
| G
|
Traf4
|
Tnf receptor associated factor 4
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TRAF4 mRNA Selenium results in increased expression of TRAF4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,552,253...63,558,356
|
|
| G
|
Trafd1
|
TRAF type zinc finger domain containing 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TRAFD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:40,826,251...40,840,169
Ensembl chr12:40,825,851...40,841,320
|
|
| G
|
Trappc14
|
trafficking protein particle complex subunit 14
|
increases expression
|
ISO
|
Selenium results in increased expression of TRAPPC14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:22,376,361...22,380,706
Ensembl chr12:22,376,363...22,380,697
|
|
| G
|
Trappc8
|
trafficking protein particle complex subunit 8
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRAPPC8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:12,378,825...12,455,364
Ensembl chr18:12,378,828...12,455,046
|
|
| G
|
Trem1
|
triggering receptor expressed on myeloid cells 1
|
multiple interactions
|
ISO
|
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TREM1 mRNA
|
CTD |
PMID:21481475 |
|
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892
|
|
| G
|
Trex1
|
three prime repair exonuclease 1
|
increases expression
|
ISO
|
Selenium results in increased expression of TREX1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083
|
|
| G
|
Trib2
|
tribbles pseudokinase 2
|
increases expression
|
ISO
|
Selenium results in increased expression of TRIB2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:44,274,762...44,299,094
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIB3 mRNA
|
CTD |
PMID:28810182 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Trim24
|
tripartite motif-containing 24
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TRIM24 mRNA Selenium results in decreased expression of TRIM24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:67,534,335...67,684,226
|
|
| G
|
Trim27
|
tripartite motif-containing 27
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIM27 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:48,233,999...48,246,348
Ensembl chr17:48,234,002...48,246,348
|
|
| G
|
Trim28
|
tripartite motif-containing 28
|
increases expression
|
ISO
|
Selenium results in increased expression of TRIM28 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:82,724,838...82,731,572
|
|
| G
|
Trim29
|
tripartite motif-containing 29
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TRIM29 mRNA Selenium results in increased expression of TRIM29 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:52,579,175...52,603,919
Ensembl chr 8:52,579,175...52,603,919
|
|
| G
|
Trim36
|
tripartite motif-containing 36
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIM36 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr18:41,047,657...41,099,497
Ensembl chr18:41,047,657...41,104,704
|
|
| G
|
Trim38
|
tripartite motif containing 38
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIM38 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:41,774,419...41,787,709
|
|
| G
|
Trim52
|
tripartite motif-containing 52
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIM52 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:89,300,495...89,324,140
Ensembl chr15:89,300,754...89,302,433
|
|
| G
|
Trip6
|
thyroid hormone receptor interactor 6
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TRIP6 mRNA Selenium results in increased expression of TRIP6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:25,022,959...25,027,366
Ensembl chr12:25,022,909...25,027,363
|
|
| G
|
Trit1
|
tRNA isopentenyltransferase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRIT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:140,578,459...140,623,881
Ensembl chr 5:140,580,453...140,623,881
|
|
| G
|
Trmt11
|
tRNA methyltransferase 11 homolog
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRMT11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:28,873,361...28,928,679
Ensembl chr 1:28,873,318...29,020,343
|
|
| G
|
Tro
|
trophinin
|
increases expression
|
ISO
|
Selenium results in increased expression of TRO mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:22,990,922...23,001,955
Ensembl chr X:22,990,922...23,001,944
|
|
| G
|
Trpc4
|
transient receptor potential cation channel, subfamily C, member 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TRPC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:140,457,841...140,629,556
Ensembl chr 2:140,458,296...140,626,969
|
|
| G
|
Trrap
|
transformation/transcription domain-associated protein
|
increases expression
|
ISO
|
Selenium results in increased expression of TRRAP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:14,851,758...14,941,444
Ensembl chr12:14,851,758...14,941,407
|
|
| G
|
Tsc2
|
TSC complex subunit 2
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TSC2 mRNA Selenium results in increased expression of TSC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,125,679...14,160,317
Ensembl chr10:14,125,680...14,160,600
|
|
| G
|
Tspan14
|
tetraspanin 14
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA Selenium results in increased expression of TSPAN14 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:16,818,344...16,875,462
Ensembl chr16:16,818,344...16,875,674
|
|
| G
|
Tsr3
|
TSR3 ribosome maturation factor
|
increases expression
|
ISO
|
Selenium results in increased expression of TSR3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:14,761,656...14,764,061
Ensembl chr10:14,761,663...14,764,061
|
|
| G
|
Tssc4
|
tumor suppressing subtransferable candidate 4
|
increases expression
|
ISO
|
Selenium results in increased expression of TSSC4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:207,681,420...207,684,244
Ensembl chr 1:207,682,322...207,685,485
|
|
| G
|
Ttc17
|
tetratricopeptide repeat domain 17
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TTC17 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:100,718,820...100,829,464
Ensembl chr 3:100,718,827...100,829,129
|
|
| G
|
Ttc3
|
tetratricopeptide repeat domain 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TTC3 mRNA Selenium results in decreased expression of TTC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:47,158,792...47,258,418
|
|
| G
|
Tuba1b
|
tubulin, alpha 1B
|
increases expression
|
ISO
|
Selenium results in increased expression of TUBA1B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Tuba1c
|
tubulin, alpha 1C
|
increases expression
|
ISO
|
Selenium results in increased expression of TUBA1C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
| G
|
Tuba4a
|
tubulin, alpha 4A
|
increases expression multiple interactions increases abundance
|
ISO
|
Selenium results in increased expression of TUBA4A mRNA TUBA4A mutant form results in increased abundance of [Selenium binds to SELENOP protein]; TUBA4A mutant form results in increased abundance of [Selenomethionine binds to Selenium] TUBA4A mutant form results in increased abundance of Selenium
|
CTD |
PMID:19244175 PMID:28478440 |
|
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of TUBB3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TUBB3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
| G
|
Tubb5
|
tubulin, beta 5 class I
|
increases expression
|
ISO
|
Selenium results in increased expression of TUBB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
|
|
| G
|
Tug1
|
taurine up-regulated 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TUG1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:82,743,501...82,750,534
Ensembl chr14:82,746,113...82,750,534
|
|
| G
|
Tulp3
|
TUB like protein 3
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of TULP3 mRNA Selenium results in decreased expression of TULP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:163,276,583...163,318,297
Ensembl chr 4:163,276,583...163,318,390
|
|
| G
|
Tut7
|
terminal uridylyl transferase 7
|
decreases expression
|
ISO
|
Selenium results in decreased expression of TUT7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:4,854,553...4,908,758
Ensembl chr17:4,855,936...4,909,070
|
|
| G
|
Txn1
|
thioredoxin 1
|
increases expression affects expression
|
EXP
|
Selenium results in increased expression of TXN1 mRNA Selenium affects the expression of TXN1 mRNA
|
CTD |
PMID:15792362 PMID:19351701 |
|
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions decreases expression affects activity increases activity increases expression
|
ISO EXP
|
[sulforaphane co-treated with Selenium] results in increased activity of TXNRD1 protein; Selenium promotes the reaction [erucin results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium promotes the reaction [iberin results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium promotes the reaction [Selenium results in increased expression of TXNRD1 protein]; Selenium promotes the reaction [sulforaphane results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium results in increased expression of and results in increased activity of TXNRD1 protein Selenium inhibits the reaction [2-iodohexadecanal results in decreased expression of TXNRD1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of TXNRD1 mRNA] Selenium deficiency results in decreased expression of TXNRD1 mRNA Selenium affects the activity of TXNRD1 protein Selenium results in increased activity of TXNRD1 protein Selenium deficiency results in increased expression of TXNRD1 mRNA; Selenium results in increased expression of TXNRD1 mRNA Selenium deficiency results in decreased expression of TXNRD1 mRNA; Selenium deficiency results in decreased expression of TXNRD1 protein
|
CTD |
PMID:12667700 PMID:12949356 PMID:15471857 PMID:15740016 PMID:15792362 PMID:16170372 PMID:17150329 PMID:19022953 PMID:19076066 PMID:19351701 PMID:38013145 More...
|
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Txnrd2
|
thioredoxin reductase 2
|
increases activity decreases expression increases expression
|
ISO EXP
|
Selenium results in increased activity of TXNRD2 protein Selenium deficiency results in decreased expression of TXNRD2 mRNA Selenium results in increased expression of TXNRD2 mRNA
|
CTD |
PMID:15471857 PMID:15792362 PMID:17291446 |
|
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
|
|
| G
|
Tymp
|
thymidine phosphorylase
|
increases expression
|
ISO
|
Selenium results in increased expression of TYMP mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:122,316,520...122,324,003
|
|
| G
|
U2af1
|
U2 small nuclear RNA auxiliary factor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of U2AF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:9,744,206...9,755,146
Ensembl chr20:9,744,207...9,755,094
|
|
| G
|
Uba1
|
ubiquitin-like modifier activating enzyme 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of UBA1 mRNA Selenium results in increased expression of UBA1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:4,062,216...4,084,192
Ensembl chr X:4,062,182...4,084,246
|
|
| G
|
Uba52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UBA52 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,952,583...18,954,780
|
|
| G
|
Uba7
|
ubiquitin-like modifier activating enzyme 7
|
increases expression
|
ISO
|
Selenium results in increased expression of UBA7 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,543,902...117,552,709
Ensembl chr 8:117,543,957...117,556,142
|
|
| G
|
Ubap2
|
ubiquitin-associated protein 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UBAP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:61,144,182...61,233,355
Ensembl chr 5:61,144,182...61,232,828
|
|
| G
|
Ubap2l
|
ubiquitin associated protein 2-like
|
increases expression
|
ISO
|
Selenium results in increased expression of UBAP2L mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:177,736,378...177,791,746
Ensembl chr 2:177,736,696...177,791,646
|
|
| G
|
Ube2l3
|
ubiquitin-conjugating enzyme E2L 3
|
increases expression
|
ISO
|
Selenium results in increased expression of UBE2L3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:97,300,584...97,343,084
Ensembl chr11:97,301,945...97,343,084
|
|
| G
|
Ube2v1
|
ubiquitin conjugating enzyme E2 V1
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA Selenium results in decreased expression of UBE2V1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:176,736,325...176,759,174
Ensembl chr 3:176,736,325...176,788,278
|
|
| G
|
Ube2z
|
ubiquitin-conjugating enzyme E2Z
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of UBE2Z mRNA Selenium results in increased expression of UBE2Z mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:81,494,522...81,513,641
Ensembl chr10:81,494,523...81,513,641
|
|
| G
|
Ube4b
|
ubiquitination factor E4B
|
increases expression
|
ISO
|
Selenium results in increased expression of UBE4B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:165,049,897...165,153,572
Ensembl chr 5:165,049,897...165,153,572
|
|
| G
|
Ubl3
|
ubiquitin-like 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UBL3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:11,509,912...11,554,548
Ensembl chr12:11,509,848...11,554,547
|
|
| G
|
Ubn1
|
ubinuclein 1
|
multiple interactions increases expression decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of UBN1 mRNA; [Selenium co-treated with Vitamin E] results in increased expression of UBN1 mRNA Selenium results in increased expression of UBN1 mRNA Selenium results in decreased expression of UBN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:11,003,036...11,038,466
Ensembl chr10:11,003,036...11,038,466
|
|
| G
|
Ubxn1
|
UBX domain protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of UBXN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343
|
|
| G
|
Ubxn4
|
UBX domain protein 4
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of UBXD2 mRNA Selenium results in decreased expression of UBXD2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:42,292,346...42,324,928
Ensembl chr13:42,292,528...42,326,143
|
|
| G
|
Ubxn6
|
UBX domain protein 6
|
increases expression
|
ISO
|
Selenium results in increased expression of UBXN6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:988,051...993,221
Ensembl chr 9:988,051...993,497
|
|
| G
|
Ufd1
|
ubiquitin recognition factor in ER associated degradation 1
|
increases expression
|
ISO
|
Selenium results in increased expression of UFD1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:95,665,971...95,689,423
Ensembl chr11:95,665,972...95,689,434
|
|
| G
|
Ugcg
|
UDP-glucose ceramide glucosyltransferase
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA Selenium results in decreased expression of UGCG mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417
|
|
| G
|
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of UGT1A7 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1
|
increases expression
|
EXP
|
Selenium deficiency results in increased expression of UGT2B1 mRNA
|
CTD |
PMID:11444866 |
|
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331
|
|
| G
|
Unc5b
|
unc-5 netrin receptor B
|
increases expression
|
ISO
|
Selenium results in increased expression of UNC5B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270
|
|
| G
|
Upf3a
|
UPF3A, regulator of nonsense mediated mRNA decay
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of UPF3A mRNA Selenium results in decreased expression of UPF3A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:82,459,651...82,470,686
Ensembl chr16:82,459,906...82,470,686
|
|
| G
|
Upf3b
|
UPF3B, regulator of nonsense mediated mRNA decay
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UPF3B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:121,200,993...121,219,059
Ensembl chr X:121,200,993...121,218,921
|
|
| G
|
Uqcr10
|
ubiquinol-cytochrome c reductase, complex III subunit X
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UQCR10 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:83,789,657...83,791,914
Ensembl chr14:83,789,658...83,791,914
|
|
| G
|
Uqcrb
|
ubiquinol-cytochrome c reductase binding protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UQCRB mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:65,700,016...65,705,382
Ensembl chr 7:65,700,029...65,705,558
|
|
| G
|
Uqcrc1
|
ubiquinol-cytochrome c reductase core protein 1
|
increases expression
|
ISO
|
Selenium results in increased expression of UQCRC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
|
|
| G
|
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UQCRH mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:134,782,255...134,790,926
|
|
| G
|
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UQCRQ mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:38,086,691...38,093,871
Ensembl chr10:38,087,715...38,089,996
|
|
| G
|
Use1
|
unconventional SNARE in the ER 1
|
increases expression
|
ISO
|
Selenium results in increased expression of USE1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:18,069,118...18,075,816
Ensembl chr16:18,070,793...18,075,814
|
|
| G
|
Usf2
|
upstream transcription factor 2, c-fos interacting
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of USF2 mRNA Selenium results in increased expression of USF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:95,302,109...95,321,334
Ensembl chr 1:95,302,105...95,313,119
|
|
| G
|
Usp3
|
ubiquitin specific peptidase 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of USP3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:75,974,615...76,049,153
|
|
| G
|
Usp33
|
ubiquitin specific peptidase 33
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA Selenium results in decreased expression of USP33 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:243,938,958...243,988,424
Ensembl chr 2:243,943,175...243,988,424
|
|
| G
|
Usp4
|
ubiquitin specific peptidase 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of USP4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:117,912,576...117,957,934
Ensembl chr 8:117,914,614...117,957,949
|
|
| G
|
Usp47
|
ubiquitin specific peptidase 47
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of USP47 mRNA Selenium results in decreased expression of USP47 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:175,586,758...175,669,904
Ensembl chr 1:175,586,723...175,669,904
|
|
| G
|
Usp9x
|
ubiquitin specific peptidase 9, X-linked
|
decreases expression
|
ISO
|
Selenium results in decreased expression of USP9X mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:12,261,633...12,399,780
Ensembl chr X:12,261,633...12,369,491
|
|
| G
|
Uspl1
|
ubiquitin specific peptidase like 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of USPL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:10,859,764...10,886,761
Ensembl chr12:10,859,764...10,886,744
|
|
| G
|
Utp11
|
UTP11, small subunit processome component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UTP11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:142,215,974...142,230,859
Ensembl chr 5:142,215,975...142,230,859
|
|
| G
|
Utp25
|
UTP25 small subunit processome component
|
decreases expression
|
ISO
|
Selenium results in decreased expression of UTP25 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:107,159,092...107,180,361
Ensembl chr13:107,149,183...107,180,361
|
|
| G
|
Vamp8
|
vesicle-associated membrane protein 8
|
increases expression
|
ISO
|
Selenium results in increased expression of VAMP8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073
|
|
| G
|
Vars2
|
valyl-tRNA synthetase 2, mitochondrial
|
increases expression
|
ISO
|
Selenium results in increased expression of VARS2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:3,081,869...3,092,907
Ensembl chr20:3,081,893...3,092,901
|
|
| G
|
Vat1
|
vesicle amine transport 1
|
increases expression
|
ISO
|
Selenium results in increased expression of VAT1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411
|
|
| G
|
Vcpkmt
|
valosin containing protein lysine methyltransferase
|
decreases expression
|
ISO
|
Selenium results in decreased expression of VCPKMT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:93,772,558...93,778,400
Ensembl chr 6:93,772,575...93,777,975
|
|
| G
|
Vgf
|
VGF nerve growth factor inducible
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:25,274,004...25,281,803
Ensembl chr12:25,273,333...25,282,703
|
|
| G
|
Vill
|
villin-like
|
increases expression
|
ISO
|
Selenium results in increased expression of VILL mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:127,654,491...127,672,742
Ensembl chr 8:127,654,595...127,672,753
|
|
| G
|
Vim
|
vimentin
|
increases expression multiple interactions
|
ISO EXP
|
Selenium results in increased expression of VIM mRNA Selenium deficiency results in increased expression of VIM protein Selenium inhibits the reaction [Cisplatin results in increased expression of VIM protein]
|
CTD |
PMID:16837816 PMID:17109141 PMID:19244175 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vipr1
|
vasoactive intestinal peptide receptor 1
|
increases expression
|
ISO
|
Selenium results in increased expression of VIPR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:130,181,219...130,217,098
Ensembl chr 8:130,187,731...130,217,096
|
|
| G
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA Selenium results in increased expression of VKORC1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,932,969...191,935,490
|
|
| G
|
Vps28
|
VPS28 subunit of ESCRT-I
|
increases expression
|
ISO
|
Selenium results in increased expression of VPS28 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:110,222,638...110,226,486
Ensembl chr 7:110,222,638...110,225,569
|
|
| G
|
Vps39
|
VPS39 subunit of HOPS complex
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA Selenium results in increased expression of VPS39 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:127,721,076...127,758,658
Ensembl chr 3:127,721,076...127,758,768
|
|
| G
|
Vps4a
|
vacuolar protein sorting 4 homolog A
|
increases expression
|
ISO
|
Selenium results in increased expression of VPS4A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr19:51,838,411...51,858,639
Ensembl chr19:51,833,914...51,872,423
|
|
| G
|
Vps72
|
vacuolar protein sorting 72 homolog
|
increases expression
|
ISO
|
Selenium results in increased expression of TCFL1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:185,367,329...185,379,199
Ensembl chr 2:185,367,623...185,379,191
|
|
| G
|
Wasf2
|
WASP family member 2
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of WASF2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:150,620,733...150,685,943
Ensembl chr 5:150,620,733...150,685,943
|
|
| G
|
Washc2c
|
WASH complex subunit 2C
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of WASHC2C mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:150,912,863...150,998,301
Ensembl chr 4:150,912,395...150,998,301
|
|
| G
|
Washc3
|
WASH complex subunit 3
|
decreases expression
|
ISO
|
Selenium results in decreased expression of WASHC3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:24,508,544...24,553,012
Ensembl chr 7:24,508,544...24,618,473
|
|
| G
|
Wbp2
|
WW domain binding protein 2
|
increases expression
|
ISO
|
Selenium results in increased expression of WBP2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:101,811,308...101,819,766
Ensembl chr10:101,812,321...101,819,770
|
|
| G
|
Wdr1
|
WD repeat domain 1
|
increases expression
|
ISO
|
Selenium results in increased expression of WDR1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:76,470,238...76,504,086
Ensembl chr14:76,470,176...76,504,080
|
|
| G
|
Wdr19
|
WD repeat domain 19
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of WDR19 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of WDR19 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr14:43,396,130...43,460,012
Ensembl chr14:43,397,835...43,459,939
|
|
| G
|
Wdr45
|
WD repeat domain 45
|
increases expression
|
ISO
|
Selenium results in increased expression of WDR45 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr X:17,448,195...17,454,117
Ensembl chr X:17,448,207...17,454,117
|
|
| G
|
Wdr5b
|
WD repeat domain 5B
|
decreases expression
|
ISO
|
Selenium results in decreased expression of WDR5B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:78,216,266...78,218,125
Ensembl chr11:78,190,355...78,218,501
|
|
| G
|
Wdr6
|
WD repeat domain 6
|
increases expression
|
ISO
|
Selenium results in increased expression of WDR6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
|
|
| G
|
Wfdc2
|
WAP four-disulfide core domain 2
|
increases expression
|
ISO
|
Selenium results in increased expression of WFDC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
|
|
| G
|
Wnt5b
|
Wnt family member 5B
|
increases expression
|
ISO
|
Selenium results in increased expression of WNT5B mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:154,281,852...154,406,081
Ensembl chr 4:154,281,852...154,405,681
|
|
| G
|
Wrap53
|
WD repeat containing, antisense to TP53
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of WRAP53 mRNA Selenium results in increased expression of WRAP53 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:54,780,873...54,797,919
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Wsb1
|
WD repeat and SOCS box-containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of WSB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:64,700,752...64,717,038
Ensembl chr10:64,700,762...64,716,832
|
|
| G
|
Wwp1
|
WW domain containing E3 ubiquitin protein ligase 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of WWP1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:37,889,280...37,982,743
Ensembl chr 5:37,895,398...37,982,959
|
|
| G
|
Xpo6
|
exportin 6
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of XPO6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of XPO6 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:190,102,719...190,192,138
Ensembl chr 1:190,102,724...190,192,138
|
|
| G
|
Ybx3
|
Y box binding protein 3
|
increases expression
|
ISO
|
Selenium results in increased expression of YBX3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:166,861,181...166,884,691
|
|
| G
|
Yipf3
|
Yip1 domain family, member 3
|
increases expression
|
ISO
|
Selenium results in increased expression of YIPF3 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 9:22,227,867...22,233,177
Ensembl chr 9:22,227,871...22,233,177
|
|
| G
|
Ylpm1
|
YLP motif containing 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of YLPM1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:110,373,371...110,449,578
Ensembl chr 6:110,373,686...110,449,578
|
|
| G
|
Ywhae
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
decreases expression
|
ISO
|
Selenium results in decreased expression of YWHAE mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:61,082,934...61,120,618
Ensembl chr10:61,106,716...61,114,291
|
|
| G
|
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of YWHAZ mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007
|
|
| G
|
Zbtb11
|
zinc finger and BTB domain containing 11
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZBTB11 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:58,061,355...58,121,768
Ensembl chr11:58,085,351...58,120,110
|
|
| G
|
Zbtb44
|
zinc finger and BTB domain containing 44
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZBTB44 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 8:37,724,237...37,782,220
Ensembl chr 8:37,724,250...37,776,691
|
|
| G
|
Zc2hc1a
|
zinc finger, C2HC-type containing 1A
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZC2HC1A mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:96,194,665...96,231,957
Ensembl chr 2:96,194,671...96,232,288
|
|
| G
|
Zc3h15
|
zinc finger CCCH-type containing 15
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of ZC3H15 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZC3H15 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:89,151,432...89,171,203
Ensembl chr 3:89,151,509...89,171,202
|
|
| G
|
Zc3hav1
|
zinc finger CCCH-type containing, antiviral 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZC3HAV1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:67,979,055...68,029,353
Ensembl chr 4:67,979,055...68,029,353
|
|
| G
|
Zcchc2
|
zinc finger CCHC-type containing 2
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ZCCHC2 mRNA Selenium results in decreased expression of ZCCHC2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr13:22,621,275...22,708,232
Ensembl chr13:22,634,171...22,708,464
|
|
| G
|
Zcchc24
|
zinc finger CCHC-type containing 24
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZCCHC24 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr16:1,281,350...1,333,278
Ensembl chr16:1,281,350...1,333,350
|
|
| G
|
Zcchc8
|
zinc finger CCHC-type containing 8
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZCCHC8 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:38,530,037...38,553,595
Ensembl chr12:38,530,164...38,553,595
|
|
| G
|
Zcwpw1
|
zinc finger CW-type and PWWP domain containing 1
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ZCWPW1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:24,517,428...24,547,942
Ensembl chr12:24,516,574...24,548,630
|
|
| G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZEB1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
| G
|
Zer1
|
zyg-11 related, cell cycle regulator
|
increases expression
|
ISO
|
Selenium results in increased expression of ZER1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 3:33,767,520...33,806,716
Ensembl chr 3:33,767,520...33,807,098
|
|
| G
|
Zfp110
|
zinc finger protein 110
|
multiple interactions decreases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF274 mRNA Selenium results in decreased expression of ZNF274 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:82,509,563...82,533,294
Ensembl chr 1:82,517,769...82,533,292
|
|
| G
|
Zfp12
|
zinc finger protein 12
|
decreases expression multiple interactions
|
ISO
|
Selenium results in decreased expression of ZNF12 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZNF12 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:16,430,546...16,446,063
Ensembl chr12:16,430,581...16,450,303
|
|
| G
|
Zfp131
|
zinc finger protein 131
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZNF131 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 2:53,457,893...53,486,348
Ensembl chr 2:53,458,515...53,485,285
|
|
| G
|
Zfp148
|
zinc finger protein 148
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZNF148 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr11:80,780,865...80,890,877
Ensembl chr11:80,786,087...80,890,877
|
|
| G
|
Zfp180
|
zinc finger protein 180
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZNF180 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:88,780,342...88,800,637
Ensembl chr 1:88,780,342...88,800,627
|
|
| G
|
Zfp212
|
Zinc finger protein 212
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ZNF212 mRNA Selenium results in increased expression of ZNF212 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:78,254,582...78,267,017
Ensembl chr 4:78,254,529...78,267,006
|
|
| G
|
Zfp219
|
zinc finger protein 219
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ZNF219 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZNF219 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:27,169,335...27,183,555
Ensembl chr15:27,169,339...27,182,926
|
|
| G
|
Zfp358
|
zinc finger protein 358
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ZNF358 mRNA Selenium results in increased expression of ZNF358 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:6,350,266...6,354,359
Ensembl chr12:6,350,067...6,354,897
|
|
| G
|
Zfp580
|
zinc finger protein 580
|
multiple interactions increases expression
|
ISO
|
[Selenium co-treated with Vitamin E] results in increased expression of ZNF580 mRNA Selenium results in increased expression of ZNF580 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:77,815,959...77,818,127
Ensembl chr 1:77,815,461...77,834,295
|
|
| G
|
Zfp692
|
zinc finger protein 692
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:42,988,946...42,997,009
Ensembl chr10:42,988,938...42,997,015
|
|
| G
|
Zfp768
|
zinc finger protein 768
|
increases expression
|
ISO
|
Selenium results in increased expression of ZNF768 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 1:191,396,807...191,401,880
Ensembl chr 1:191,396,809...191,399,640
|
|
| G
|
Zfp839
|
zinc finger protein 839
|
multiple interactions
|
ISO
|
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 6:135,686,132...135,711,856
Ensembl chr 6:135,687,100...135,704,299
|
|
| G
|
Zfyve28
|
zinc finger FYVE-type containing 28
|
multiple interactions
|
ISO
|
Selenium inhibits the reaction [Cadmium results in decreased expression of ZFYVE28 mRNA]
|
CTD |
PMID:34773240 |
|
NCBI chr14:80,692,997...80,778,606
Ensembl chr14:80,692,819...80,778,586
|
|
| G
|
Zkscan1
|
zinc finger with KRAB and SCAN domains 1
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZKSCAN1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr12:22,080,319...22,101,389
Ensembl chr12:22,080,324...22,101,387
|
|
| G
|
Zmym2
|
zinc finger MYM-type containing 2
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZMYM2 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr15:35,151,356...35,224,528
Ensembl chr15:35,127,994...35,224,941
|
|
| G
|
Zmym4
|
zinc finger MYM-type containing 4
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZMYM4 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 5:144,431,255...144,551,747
Ensembl chr 5:144,431,255...144,548,849
|
|
| G
|
Zwint
|
ZW10 interacting kinetochore protein
|
decreases expression
|
ISO
|
Selenium results in decreased expression of ZWINT mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203
|
|
| G
|
Zyx
|
zyxin
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ZYX mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZYX mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr 4:72,203,991...72,213,181
Ensembl chr 4:72,204,007...72,213,181
|
|
| G
|
Zzef1
|
zinc finger ZZ-type and EF-hand domain containing 1
|
increases expression multiple interactions
|
ISO
|
Selenium results in increased expression of ZZEF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA
|
CTD |
PMID:19244175 |
|
NCBI chr10:57,911,728...58,049,412
Ensembl chr10:57,911,728...58,049,412
|
|
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
multiple interactions affects expression decreases expression
|
ISO
|
AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mRNA] methylselenic acid affects the expression of ABCC4 mRNA
|
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Acp3
|
acid phosphatase 3
|
affects expression
|
ISO
|
methylselenic acid affects the expression of ACP3 mRNA
|
CTD |
PMID:14617803 |
|
NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
affects expression decreases expression
|
ISO
|
methylselenic acid affects the expression of ACSL3 mRNA methylselenic acid results in decreased expression of ACSL3 mRNA
|
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ACTA2 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ACTG2 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Adam22
|
ADAM metallopeptidase domain 22
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ADAM22 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843
|
|
| G
|
Add3
|
adducin 3
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ADD3 mRNA
|
CTD |
PMID:12517777 |
|
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
|
|
| G
|
Adgrl3
|
adhesion G protein-coupled receptor L3
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ADGRL3 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,722,194...27,280,418
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of AHR mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of AKAP12 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of AKR1B1 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions decreases response to substance decreases phosphorylation
|
ISO
|
[methylselenic acid results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] AKT1 protein results in decreased susceptibility to methylselenic acid
|
CTD |
PMID:15845651 PMID:17339365 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
decreases expression
|
ISO
|
methylselenic acid results in decreased expression of AKT2 mRNA
|
CTD |
PMID:11830524 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Alad
|
aminolevulinate dehydratase
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ALAD mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
| G
|
Alg3
|
ALG3, alpha-1,3- mannosyltransferase
|
decreases expression
|
ISO
|
methylselenic acid results in decreased expression of ALG3 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060
|
|
| G
|
Alg8
|
ALG8, alpha-1,3-glucosyltransferase
|
decreases expression
|
ISO
|
methylselenic acid results in decreased expression of ALG8 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 1:161,095,570...161,115,533
Ensembl chr 1:161,095,412...161,115,527
|
|
| G
|
Amt
|
aminomethyltransferase
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of AMT mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 8:117,859,700...117,866,692
Ensembl chr 8:117,860,345...117,866,803
|
|
| G
|
Ank2
|
ankyrin 2
|
increases expression
|
ISO
|
methylselenic acid results in increased expression of ANK2 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259
|
|
| G
|
Ank3
|
ankyrin 3
|
decreases expression
|
ISO
|
methylselenic acid results in decreased expression of ANK3 mRNA
|
CTD |
PMID:18548127 |
|
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879
|
|
| G
|
Apod
|
apolipoprotein D
|
affects expression
|
ISO
|
methylselenic acid affects the expression of APOD mRNA
|
CTD |
PMID:14617803 |
|
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
|
|
| G
|
Ar
|
androgen receptor
|
affects response to substance increases degradation decreases expression decreases activity multiple interactions
|
ISO
|
AR protein affects the susceptibility to methylselenic acid methylselenic acid results in increased degradation of AR mRNA; methylselenic acid results in increased degradation of AR protein methylselenic acid results in decreased expression of AR mRNA; methylselenic acid results in decreased expression of AR protein methylselenic acid results in decreased activity of AR protein AR protein inhibi | |